data_2n54_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n54 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 74.109999999999999 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.530000000000001 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 73.0 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 75.439999999999998 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 75.409999999999997 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.510000000000005 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.120000000000005 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.409999999999997 112.617 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 74.450000000000003 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.129999999999995 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.420000000000002 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.020000000000003 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.319999999999993 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 73.209999999999994 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 75.519999999999996 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.030000000000001 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 74.409999999999997 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.599 HD13 HD12 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 71.540000000000006 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.319999999999993 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' HZ3' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.400000000000006 106.943 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.329999999999998 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.109999999999999 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.049999999999997 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 74.140000000000001 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.230000000000004 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.319999999999993 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.530000000000001 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.59 HD13 HD12 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.439999999999998 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.230000000000004 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 73.329999999999998 113.378 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.209999999999994 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 37.219999999999999 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.120000000000005 110.005 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 71.439999999999998 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.040000000000006 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 72.230000000000004 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 73.409999999999997 110.403 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.209999999999994 110.006 175.219 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.542 0.687 . . . . 74.129999999999995 109.636 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 75.510000000000005 107.443 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.473 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.420000000000002 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 74.150000000000006 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.446 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 74.409999999999997 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 74.219999999999999 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 71.219999999999999 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.439999999999998 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 73.200000000000003 109.847 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 74.120000000000005 113.211 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 70.099999999999994 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 73.219999999999999 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.519999999999996 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.439999999999998 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' A' ' 31' ' ' GLU . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 72.140000000000001 110.944 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 72.040000000000006 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 72.219999999999999 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 64.420000000000002 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.450000000000003 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.239999999999995 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.549999999999997 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.129999999999995 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.340000000000003 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.439999999999998 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 63.32 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.209999999999994 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.48 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 73.329999999999998 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.140000000000001 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.471 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 74.319999999999993 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.420000000000002 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 72.510000000000005 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 73.109999999999999 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.439999999999998 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' B' ' 238' ' ' ILE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 70.099999999999994 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.150000000000006 107.822 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.510000000000005 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.530000000000001 111.467 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.42 -1.963 0 N-CA-C 109.16 -0.682 . . . . 75.140000000000001 109.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.140000000000001 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.340000000000003 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.120000000000005 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 61.039999999999999 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.129999999999995 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.430000000000007 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.209999999999994 110.673 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 61.009999999999998 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.109999999999999 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 70.200000000000003 109.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.545 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 71.129999999999995 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.409999999999997 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 74.109999999999999 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 73.430000000000007 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.450000000000003 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 74.420000000000002 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 74.129999999999995 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD13 HD12 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.200000000000003 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 55.43 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.686 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.420000000000002 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.240000000000002 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 74.209999999999994 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.540000000000006 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.200000000000003 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.510000000000005 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.120000000000005 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 HD12 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 71.420000000000002 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.519999999999996 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 73.049999999999997 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.543 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 65.340000000000003 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.430000000000007 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 75.140000000000001 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.129999999999995 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 71.010000000000005 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.530000000000001 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.400000000000006 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 75.200000000000003 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.430000000000007 113.278 -177.59 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.419 -2.012 0 CA-C-O 121.364 0.602 . . . . 72.230000000000004 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.329999999999998 107.377 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.509 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 73.400000000000006 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.230000000000004 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.439999999999998 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.450000000000003 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.109999999999999 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 51.240000000000002 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.319999999999993 111.775 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 71.150000000000006 110.266 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.439999999999998 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.420000000000002 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.329999999999998 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 74.019999999999996 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 64.099999999999994 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.049999999999997 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.230000000000004 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.430000000000007 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.556 HD12 HD13 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 74.109999999999999 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.731 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.439999999999998 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.545 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.219999999999999 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.209999999999994 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 71.530000000000001 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.549999999999997 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.129999999999995 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.409999999999997 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.439999999999998 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 74.230000000000004 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.519999999999996 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.595 HD12 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.430000000000007 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 62.5 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 63.520000000000003 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.129999999999995 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 75.120000000000005 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' B' ' 238' ' ' ILE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.109999999999999 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.329999999999998 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.119999999999997 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.329999999999998 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.539999999999999 109.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 43.32 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.349999999999994 110.378 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.229999999999997 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD12 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 73.340000000000003 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 71.150000000000006 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.510000000000005 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 73.450000000000003 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.409999999999997 112.579 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.450000000000003 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.109999999999999 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 72.5 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 73.150000000000006 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.510000000000005 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 72.019999999999996 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 HD12 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 74.230000000000004 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.140000000000001 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.310000000000002 111.993 -177.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.150000000000006 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 75.230000000000004 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 75.450000000000003 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.400000000000006 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.209999999999994 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.200000000000003 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.531 HD13 HD12 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.129999999999995 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.494 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.349999999999994 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 74.409999999999997 115.806 -176.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.120000000000005 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.019999999999996 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' B' ' 249' ' ' CYS . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.540000000000006 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 65.200000000000003 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.399999999999999 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 74.319999999999993 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.319999999999993 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HG2' HD21 ' B' ' 219' ' ' LEU . 26.9 Cg_exo . . . . . 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 74.230000000000004 115.045 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.099999999999994 108.86 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.403 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.430000000000007 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.540000000000006 111.988 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 71.510000000000005 110.113 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 72.299999999999997 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.530000000000001 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.239999999999995 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.209999999999994 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.349999999999994 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.510000000000005 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 75.019999999999996 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 73.409999999999997 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.528 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 73.439999999999998 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.299999999999997 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.239999999999995 108.938 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.531 HD12 HD13 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 75.140000000000001 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.229999999999997 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.230000000000004 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.129999999999995 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 62.530000000000001 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 74.329999999999998 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 73.109999999999999 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 70.150000000000006 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 71.450000000000003 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 73.329999999999998 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.5 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 74.109999999999999 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.498 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.340000000000003 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.340000000000003 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.230000000000004 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.329999999999998 113.847 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.049999999999997 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.329999999999998 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.409999999999997 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 74.409999999999997 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.340000000000003 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.329999999999998 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 114.912 -172.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.424 -1.741 0 CA-C-O 121.478 0.656 . . . . 71.439999999999998 110.541 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.299999999999997 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.209999999999994 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 44.229999999999997 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 74.150000000000006 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 65.340000000000003 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 73.409999999999997 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 73.0 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 75.120000000000005 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.439999999999998 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.519999999999996 108.766 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 72.030000000000001 113.298 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 64.030000000000001 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 231' ' ' GLU . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.150000000000006 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.549999999999997 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.120000000000005 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 60.210000000000001 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.528 HD13 HD12 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 72.540000000000006 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 74.109999999999999 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.430000000000007 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.210000000000001 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.400000000000006 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 73.25 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.349999999999994 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.420000000000002 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.510000000000005 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 75.430000000000007 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 72.129999999999995 114.426 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.219999999999999 112.153 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 71.409999999999997 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.412 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.540000000000006 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 73.120000000000005 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 71.450000000000003 110.962 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.409999999999997 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.349999999999994 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.209999999999994 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo . . . . . 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.230000000000004 112.491 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 114.162 1.171 . . . . 72.129999999999995 114.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.140000000000001 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 73.319999999999993 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.130000000000003 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 73.209999999999994 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.428 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.010000000000005 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 74.209999999999994 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.340000000000003 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 65.140000000000001 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 75.030000000000001 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 73.129999999999995 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.310000000000002 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.120000000000005 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.511 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.140000000000001 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.120000000000005 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.420000000000002 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 72.430000000000007 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 74.299999999999997 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.340000000000003 110.162 -176.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.340000000000003 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 64.540000000000006 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.109999999999999 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 74.150000000000006 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.210000000000001 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.420000000000002 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.757 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.340000000000003 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.230000000000004 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.349999999999994 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.435 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 74.25 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 75.400000000000006 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.209999999999994 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.420000000000002 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 72.510000000000005 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 65.430000000000007 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.412 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.129999999999995 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.349999999999994 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.420000000000002 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 72.400000000000006 113.208 -178.651 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 120.724 0.297 . . . . 73.510000000000005 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.209999999999994 108.024 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 74.319999999999993 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.329999999999998 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 73.530000000000001 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 71.430000000000007 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.310000000000002 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.540000000000006 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.510000000000005 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 71.25 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.310000000000002 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.409999999999997 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.219999999999999 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.219999999999999 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.712 ' NZ ' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.310000000000002 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 72.109999999999999 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.514 ' HH ' HG22 ' B' ' 229' ' ' ILE . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.140000000000001 108.629 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 74.5 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.48 HD13 HD12 ' B' ' 240' ' ' ILE . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.430000000000007 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.019999999999996 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.120000000000005 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.019999999999996 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 74.430000000000007 110.925 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.758 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 74.200000000000003 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.209999999999994 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.140000000000001 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 70.5 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.239999999999995 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.430000000000007 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.712 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 74.409999999999997 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.120000000000005 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.129999999999995 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 15' ' ' THR . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 72.430000000000007 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.019999999999996 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' HG22 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 74.430000000000007 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.540000000000006 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 63.340000000000003 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 74.209999999999994 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.349999999999994 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 73.510000000000005 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo . . . . . 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 71.430000000000007 111.675 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.429 -1.51 0 CA-C-O 120.956 0.408 . . . . 73.010000000000005 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.140000000000001 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 73.200000000000003 109.677 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.299999999999997 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.329999999999998 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.400000000000006 107.777 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.549999999999997 110.72 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . 0.47 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.200000000000003 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 70.140000000000001 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.47 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.439999999999998 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 74.430000000000007 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 64.319999999999993 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.420000000000002 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 65.209999999999994 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 72.010000000000005 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.759 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 72.129999999999995 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 75.400000000000006 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.519999999999996 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.510000000000005 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 71.310000000000002 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.450000000000003 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 62.509999999999998 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.409999999999997 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.539999999999999 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.230000000000004 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 228' ' ' THR . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.039999999999999 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 75.030000000000001 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.230000000000004 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.019999999999996 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 73.150000000000006 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.140000000000001 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 71.540000000000006 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.414 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.319999999999993 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.414 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 74.549999999999997 109.819 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.019999999999996 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.340000000000003 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 61.420000000000002 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.230000000000004 112.049 177.761 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 109.0 -0.741 . . . . 74.420000000000002 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 64.120000000000005 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.409999999999997 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.219999999999999 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.310000000000002 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 73.209999999999994 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 74.010000000000005 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.400000000000006 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 HG22 ' HZ3' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.319999999999993 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 75.010000000000005 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 75.239999999999995 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 72.099999999999994 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.519999999999996 107.83 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.430000000000007 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.55 HD13 HD12 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 74.319999999999993 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 63.509999999999998 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 72.25 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.120000000000005 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.319999999999993 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 74.129999999999995 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.019999999999996 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 74.019999999999996 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 75.310000000000002 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 73.400000000000006 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 75.099999999999994 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.478 ' HA ' HD13 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 70.340000000000003 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.329999999999998 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 72.299999999999997 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.530000000000001 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 75.209999999999994 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 74.540000000000006 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 62.229999999999997 109.382 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 72.239999999999995 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.120000000000005 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.140000000000001 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.420000000000002 112.993 179.69 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.421 -1.921 0 CA-C-O 121.005 0.431 . . . . 64.430000000000007 109.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.340000000000003 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.439999999999998 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 74.150000000000006 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 75.439999999999998 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.441 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.510000000000005 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 65.239999999999995 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 74.340000000000003 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.577 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.530000000000001 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.522 HD13 ' O ' ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.230000000000004 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.420000000000002 110.681 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 75.420000000000002 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.319999999999993 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 64.439999999999998 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.430000000000007 104.811 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.505 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 74.409999999999997 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.430000000000007 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.513 ' HH ' HG21 ' A' ' 29' ' ' ILE . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.120000000000005 107.895 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.140000000000001 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' B' ' 236' ' ' CYS . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.519999999999996 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.140000000000001 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 73.420000000000002 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 63.109999999999999 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.150000000000006 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.040000000000006 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 75.329999999999998 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 228' ' ' THR . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.530000000000001 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 71.519999999999996 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.519999999999996 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.55 HD12 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.450000000000003 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' THR . . . . . . . . . . . . . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 75.209999999999994 110.233 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 64.150000000000006 112.554 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 74.329999999999998 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.030000000000001 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 49' ' ' CYS . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.430000000000007 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 72.140000000000001 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 72.109999999999999 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.340000000000003 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.350000000000001 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.519999999999996 109.662 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 74.340000000000003 111.241 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.422 -1.861 0 CA-C-O 121.364 0.602 . . . . 65.129999999999995 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.049999999999997 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 74.140000000000001 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 72.409999999999997 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HG ' ' CD2' ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 74.010000000000005 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 75.140000000000001 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.129999999999995 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.310000000000002 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.230000000000004 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 63.439999999999998 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 73.129999999999995 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 72.140000000000001 108.329 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.519999999999996 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 73.340000000000003 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.439999999999998 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.040000000000006 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.349999999999994 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HH ' HG22 ' B' ' 229' ' ' ILE . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.409999999999997 108.355 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 74.510000000000005 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 73.430000000000007 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.299999999999997 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.099999999999994 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.099999999999994 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.409999999999997 110.684 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.79 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 70.409999999999997 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.450000000000003 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.329999999999998 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 74.319999999999993 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 60.409999999999997 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 72.129999999999995 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.519999999999996 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.402 ' HA ' HD13 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.549999999999997 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.450000000000003 114.65 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.120000000000005 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.140000000000001 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD23 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 62.200000000000003 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.310000000000002 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 74.510000000000005 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 63.420000000000002 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.400000000000006 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.420000000000002 105.949 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo . . . . . 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.540000000000006 113.368 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 70.400000000000006 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.329999999999998 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.68 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 64.230000000000004 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.349999999999994 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.549999999999997 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.409999999999997 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.540000000000006 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 75.120000000000005 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.099999999999994 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.399999999999999 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.530000000000001 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.230000000000004 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 74.310000000000002 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.140000000000001 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 75.310000000000002 108.54 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 74.329999999999998 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.319999999999993 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.010000000000005 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.140000000000001 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.340000000000003 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 72.209999999999994 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.409999999999997 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 74.310000000000002 108.76 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.130000000000003 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 74.150000000000006 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.737 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.040000000000006 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.538 ' HB ' ' HE3' ' B' ' 225' ' ' LYS . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.430000000000007 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 75.230000000000004 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 74.430000000000007 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.430000000000007 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.109999999999999 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.230000000000004 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.140000000000001 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.519999999999996 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.522 ' SG ' HD23 ' A' ' 45' ' ' LEU . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.439999999999998 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.219999999999999 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.010000000000005 110.899 176.194 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 109.577 -0.527 . . . . 72.340000000000003 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 74.519999999999996 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 73.299999999999997 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.219999999999999 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.239999999999995 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 65.019999999999996 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.530000000000001 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.239999999999995 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 72.019999999999996 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.310000000000002 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 60.32 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.510000000000005 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.129999999999995 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.200000000000003 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.540000000000006 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 74.310000000000002 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 74.319999999999993 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.552 HD13 HD12 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.120000000000005 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 64.400000000000006 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.230000000000004 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.340000000000003 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.219999999999999 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.439999999999998 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.319999999999993 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.209999999999994 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.439999999999998 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 72.310000000000002 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.140000000000001 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.575 HD13 HD12 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.329999999999998 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.418 HG21 HG22 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.409999999999997 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.319999999999993 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.200000000000003 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.039999999999999 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 72.030000000000001 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.430000000000007 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' B' ' 214' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.219999999999999 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.229999999999997 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.099999999999994 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.040000000000006 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 71.340000000000003 110.349 174.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 108.962 -0.755 . . . . 74.439999999999998 108.962 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.319999999999993 107.395 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.432 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.519999999999996 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.430000000000007 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 74.150000000000006 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 61.450000000000003 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 75.010000000000005 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.420000000000002 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.299999999999997 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.402 ' H ' HD21 ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.329999999999998 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.030000000000001 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.439999999999998 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 74.239999999999995 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.019999999999996 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.76 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.450000000000003 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.319999999999993 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.109999999999999 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 72.400000000000006 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 72.349999999999994 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.409999999999997 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 74.230000000000004 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.119999999999997 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.319999999999993 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 71.540000000000006 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.129999999999995 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 73.219999999999999 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.549999999999997 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.400000000000006 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.140000000000001 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.219999999999999 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.420000000000002 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.329999999999998 111.182 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 72.340000000000003 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.310000000000002 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.340000000000003 107.391 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.450000000000003 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.239999999999995 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.049999999999997 108.289 168.143 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 114.712 1.375 . . . . 71.319999999999993 114.712 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 62.509999999999998 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.510000000000005 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.409999999999997 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 61.450000000000003 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.409999999999997 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.608 HE21 ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 109.201 -177.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.510000000000005 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 70.510000000000005 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 114.063 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 73.340000000000003 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.439999999999998 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.120000000000005 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.230000000000004 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 72.120000000000005 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.009999999999998 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.299999999999997 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.578 HD13 HD12 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 65.040000000000006 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 73.109999999999999 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.119999999999997 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.240000000000002 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.140000000000001 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 71.340000000000003 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.239999999999995 111.053 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 34' ' ' LEU . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.439999999999998 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.239999999999995 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.540000000000006 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 74.109999999999999 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD13 HD12 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.109999999999999 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.210000000000001 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.140000000000001 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.439999999999998 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 74.219999999999999 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 75.340000000000003 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.109999999999999 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.230000000000004 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.129999999999995 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.530000000000001 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.200000000000003 110.364 174.005 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 121.363 0.601 . . . . 74.129999999999995 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.540000000000006 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 73.040000000000006 108.823 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.439999999999998 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.476 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 73.25 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.400000000000006 109.194 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 73.040000000000006 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . 0.586 HE21 ' HA ' ' B' ' 217' ' ' GLN . 0.0 OUTLIER 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 75.340000000000003 111.465 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 72.400000000000006 110.329 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 65.25 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 73.420000000000002 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.340000000000003 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.120000000000005 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 72.430000000000007 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' B' ' 225' ' ' LYS . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.210000000000001 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 29' ' ' ILE . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.329999999999998 107.883 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 71.230000000000004 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 74.140000000000001 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 75.329999999999998 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.140000000000001 106.353 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.240000000000002 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.409999999999997 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.631 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 74.209999999999994 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 73.420000000000002 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 55.039999999999999 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.200000000000003 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.319999999999993 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.519999999999996 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.420000000000002 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.310000000000002 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 73.129999999999995 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.519999999999996 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.417 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 64.230000000000004 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.417 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 74.030000000000001 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 63.420000000000002 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 64.030000000000001 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.140000000000001 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.407 ' SG ' HD23 ' B' ' 234' ' ' LEU . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 73.439999999999998 111.536 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.430000000000007 109.46 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo . . . . . 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.219999999999999 111.698 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.641 0.734 . . . . 74.150000000000006 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 71.209999999999994 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.400000000000006 110.455 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.230000000000004 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.010000000000005 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.340000000000003 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.405 HG23 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.319999999999993 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.409999999999997 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.430000000000007 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.409999999999997 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.519999999999996 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.129999999999995 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.530000000000001 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.510000000000005 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.540000000000006 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 73.549999999999997 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.019999999999996 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 65.129999999999995 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 HD12 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 74.140000000000001 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.310000000000002 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.230000000000004 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.439999999999998 111.41 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 71.329999999999998 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 75.510000000000005 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 72.109999999999999 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 75.099999999999994 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.349999999999994 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.606 HD13 HD12 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 73.319999999999993 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.239999999999995 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 72.409999999999997 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.549999999999997 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 62.350000000000001 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.340000000000003 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 73.549999999999997 110.504 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.430000000000007 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.340000000000003 106.992 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 74.319999999999993 112.085 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.417 -2.077 0 CA-C-O 121.226 0.536 . . . . 64.430000000000007 110.932 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.420000000000002 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.319999999999993 109.539 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.450000000000003 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.129999999999995 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.340000000000003 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . 0.429 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 74.329999999999998 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.120000000000005 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.230000000000004 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.530000000000001 110.606 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.420000000000002 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.230000000000004 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.329999999999998 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.130000000000003 110.304 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 73.319999999999993 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.430000000000007 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 74.340000000000003 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 65.030000000000001 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.520000000000003 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.456 ' HB2' HD13 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.219999999999999 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.439999999999998 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.439999999999998 110.744 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.704 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.120000000000005 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.299999999999997 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.704 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 70.319999999999993 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.120000000000005 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.120000000000005 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.409999999999997 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.420000000000002 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.509 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.510000000000005 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 215' ' ' THR . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 74.030000000000001 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.140000000000001 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 74.5 111.135 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.319999999999993 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.100000000000001 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 72.230000000000004 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.140000000000001 106.343 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 63.049999999999997 111.573 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.400000000000006 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.521 HG11 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.019999999999996 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 73.230000000000004 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.230000000000004 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 72.040000000000006 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.481 HG23 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.310000000000002 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.140000000000001 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 72.420000000000002 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.439999999999998 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 74.409999999999997 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.510000000000005 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.209999999999994 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HG22 HG21 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.329999999999998 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.450000000000003 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 HD12 ' B' ' 240' ' ' ILE . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 73.430000000000007 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.450000000000003 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.129999999999995 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 71.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.450000000000003 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 64.439999999999998 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 73.420000000000002 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.409999999999997 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.430000000000007 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 HD12 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 75.420000000000002 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.436 HG21 HG22 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.230000000000004 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 74.040000000000006 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 72.530000000000001 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 72.109999999999999 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.420000000000002 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 63.439999999999998 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 72.310000000000002 109.071 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.120000000000005 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 75.329999999999998 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 53.539999999999999 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 75.040000000000006 112.392 -178.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.418 -2.037 0 N-CA-C 108.675 -0.861 . . . . 63.439999999999998 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.140000000000001 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 72.409999999999997 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.510000000000005 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.521 HD12 HG11 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.140000000000001 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 243' ' ' ARG . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.109999999999999 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.109999999999999 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.510000000000005 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 73.219999999999999 107.432 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 75.25 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.430000000000007 110.539 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.219999999999999 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 72.120000000000005 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.239999999999995 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.109999999999999 110.477 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 73.209999999999994 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.450000000000003 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 74.239999999999995 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.430000000000007 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.099999999999994 110.265 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 75.519999999999996 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 65.230000000000004 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.310000000000002 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.140000000000001 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.129999999999995 109.427 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 228' ' ' THR . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.420000000000002 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.510000000000005 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 75.310000000000002 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 75.030000000000001 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.140000000000001 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.310000000000002 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.409999999999997 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.42 ' O ' HG23 ' B' ' 216' ' ' THR . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.439999999999998 108.726 170.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.210000000000001 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.412 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' B' ' 213' ' ' SER . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 72.25 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 74.409999999999997 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 72.140000000000001 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.340000000000003 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.340000000000003 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.549999999999997 112.853 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.401 -2.883 0 N-CA-C 108.896 -0.779 . . . . 62.210000000000001 108.896 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.510000000000005 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 71.129999999999995 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 75.030000000000001 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.62 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 75.400000000000006 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.019999999999996 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 HG23 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.010000000000005 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 72.030000000000001 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 65.209999999999994 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 71.129999999999995 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.150000000000006 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.040000000000006 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 71.340000000000003 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.450000000000003 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 73.5 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 62.229999999999997 109.274 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 73.209999999999994 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.209999999999994 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.450000000000003 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.506 ' CG2' ' HG2' ' A' ' 31' ' ' GLU . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.409999999999997 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.349999999999994 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.019999999999996 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.299999999999997 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 60.219999999999999 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.430000000000007 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.200000000000003 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.450000000000003 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 71.099999999999994 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.530000000000001 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.099999999999994 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 74.019999999999996 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 73.019999999999996 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.329999999999998 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.340000000000003 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 72.329999999999998 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 63.509999999999998 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.450000000000003 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 71.340000000000003 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 74.329999999999998 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 245' ' ' LEU . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.420000000000002 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.209999999999994 108.183 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.540000000000006 112.799 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.413 -2.319 0 CA-C-O 122.086 0.946 . . . . 73.519999999999996 109.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 45.329999999999998 107.638 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.62 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.439999999999998 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.030000000000001 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 74.129999999999995 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.439999999999998 110.931 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.040000000000006 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.439999999999998 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 73.200000000000003 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.25 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 71.209999999999994 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.420000000000002 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 74.540000000000006 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.230000000000004 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 72.310000000000002 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.129999999999995 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.439999999999998 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' B' ' 235' ' ' ARG . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.430000000000007 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 75.420000000000002 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.537 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.420000000000002 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.040000000000006 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 75.209999999999994 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 73.430000000000007 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.040000000000006 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 73.420000000000002 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.319999999999993 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.239999999999995 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 75.230000000000004 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.491 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 73.25 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.230000000000004 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.150000000000006 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.019999999999996 113.383 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.503 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 74.230000000000004 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.299999999999997 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.239999999999995 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.019999999999996 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.539999999999999 109.154 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 63.25 111.674 177.043 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 113.217 0.821 . . . . 63.539999999999999 113.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.129999999999995 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 73.140000000000001 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.109999999999999 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.530000000000001 110.876 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.409999999999997 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.439999999999998 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.019999999999996 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 72.099999999999994 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.120000000000005 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.210000000000001 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 73.439999999999998 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.450000000000003 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.549999999999997 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 65.140000000000001 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.319999999999993 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 72.329999999999998 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 HD13 HD12 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.239999999999995 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 74.099999999999994 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 74.109999999999999 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 74.340000000000003 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.430000000000007 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 71.200000000000003 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.299999999999997 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.420000000000002 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.400000000000006 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.736 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 74.140000000000001 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.349999999999994 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 74.099999999999994 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.457 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.409999999999997 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.439999999999998 113.262 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 74.430000000000007 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.430000000000007 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 75.25 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG22 HD21 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 71.200000000000003 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.310000000000002 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.409999999999997 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.409999999999997 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.349999999999994 111.995 177.046 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.598 0.237 . . . . 64.0 110.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 53.020000000000003 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.400000000000006 110.134 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.417 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 72.420000000000002 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.319999999999993 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.43 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 71.120000000000005 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 71.030000000000001 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.239999999999995 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.447 ' H ' HD22 ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.420000000000002 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.299999999999997 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.450000000000003 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.219999999999999 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 73.010000000000005 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 70.420000000000002 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.523 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.230000000000004 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.319999999999993 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 74.209999999999994 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.517 HD12 HD13 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 73.230000000000004 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 75.519999999999996 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 72.120000000000005 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.109999999999999 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.340000000000003 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 74.430000000000007 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 64.219999999999999 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.140000000000001 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 72.450000000000003 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.150000000000006 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.523 ' HB ' ' HE3' ' B' ' 225' ' ' LYS . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 74.549999999999997 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.445 ' HA ' HD11 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 72.450000000000003 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.409999999999997 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 75.420000000000002 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.530000000000001 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.584 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 75.319999999999993 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.510000000000005 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.210000000000001 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 73.030000000000001 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 75.319999999999993 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo . . . . . 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 74.150000000000006 113.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.422 -1.87 0 CA-C-O 120.996 0.427 . . . . 75.209999999999994 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.420000000000002 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.109999999999999 109.319 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 74.239999999999995 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 72.5 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 74.150000000000006 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 74.329999999999998 109.008 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.299999999999997 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.140000000000001 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.439999999999998 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.109999999999999 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 74.150000000000006 108.285 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.049999999999997 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.519999999999996 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.450000000000003 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HZ1' ' HG2' ' B' ' 231' ' ' GLU . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 74.409999999999997 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 71.340000000000003 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 73.120000000000005 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 75.349999999999994 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.56 HD13 HD12 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 74.120000000000005 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.230000000000004 109.834 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' HZ2' ' B' ' 225' ' ' LYS . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.140000000000001 108.581 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 72.030000000000001 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.299999999999997 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 72.030000000000001 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.430000000000007 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.219999999999999 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.420000000000002 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.597 HD13 HD12 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.310000000000002 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.219999999999999 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 74.510000000000005 113.534 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 71.450000000000003 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 73.219999999999999 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.209999999999994 109.602 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.099999999999994 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.409999999999997 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.030000000000001 111.826 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 109.372 -0.603 . . . . 62.5 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 73.530000000000001 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.497 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.200000000000003 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 72.120000000000005 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.473 HD23 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 74.219999999999999 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.310000000000002 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 61.219999999999999 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.510000000000005 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 74.409999999999997 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 64.519999999999996 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 75.5 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.209999999999994 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.299999999999997 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.340000000000003 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 71.519999999999996 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.435 ' HD2' HD11 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.219999999999999 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 75.219999999999999 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.109999999999999 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.597 HD12 HD13 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 75.040000000000006 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.099999999999994 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.435 ' HG2' ' HZ1' ' A' ' 25' ' ' LYS . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.129999999999995 108.176 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.219999999999999 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.200000000000003 108.659 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.340000000000003 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.442 ' N ' HD12 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 74.129999999999995 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.319999999999993 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 75.209999999999994 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 75.450000000000003 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.329999999999998 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.129999999999995 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.040000000000006 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.200000000000003 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 75.439999999999998 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.420000000000002 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.450000000000003 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.019999999999996 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.230000000000004 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.049999999999997 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 75.450000000000003 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.530000000000001 108.087 174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.340000000000003 112.926 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.806 0.336 . . . . 73.030000000000001 111.811 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.150000000000006 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.230000000000004 110.567 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.129999999999995 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' HG ' HD23 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 75.219999999999999 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.219999999999999 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 HG23 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.109999999999999 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 74.129999999999995 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 74.340000000000003 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.209999999999994 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 73.340000000000003 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 62.32 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.540000000000006 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.030000000000001 111.079 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.239999999999995 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.319999999999993 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 74.439999999999998 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' CG2' ' HG2' ' A' ' 31' ' ' GLU . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.329999999999998 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 72.140000000000001 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 72.109999999999999 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.310000000000002 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 64.430000000000007 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 64.450000000000003 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.239999999999995 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.019999999999996 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.736 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 72.219999999999999 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.430000000000007 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.495 HD13 HD12 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.340000000000003 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 74.519999999999996 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.329999999999998 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.430000000000007 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.120000000000005 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.129999999999995 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 75.450000000000003 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.239999999999995 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 71.010000000000005 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.420000000000002 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.140000000000001 114.119 -178.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.429 -1.494 0 CA-C-O 121.296 0.57 . . . . 75.109999999999999 111.58 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 74.400000000000006 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 75.450000000000003 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.150000000000006 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.485 HD23 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.519999999999996 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.459 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.439999999999998 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.209999999999994 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.150000000000006 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.310000000000002 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.430000000000007 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.319999999999993 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.030000000000001 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.319999999999993 110.436 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 73.219999999999999 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.409999999999997 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.329999999999998 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.040000000000006 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.25 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.483 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 63.109999999999999 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.340000000000003 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.310000000000002 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 71.310000000000002 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.219999999999999 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 75.109999999999999 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 73.030000000000001 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.340000000000003 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.439 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.409999999999997 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.230000000000004 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 71.349999999999994 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.420000000000002 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.464 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.239999999999995 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 63.439999999999998 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.510000000000005 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.420000000000002 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.430000000000007 111.994 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m . . . . . 0 N--CA 1.421 -1.916 0 CA-C-O 121.198 0.523 . . . . 74.340000000000003 109.952 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.219999999999999 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 74.239999999999995 109.212 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD21 ' HG ' ' B' ' 214' ' ' LEU . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.129999999999995 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 72.299999999999997 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.150000000000006 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 72.439999999999998 107.829 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 75.400000000000006 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.329999999999998 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 75.120000000000005 108.858 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 73.239999999999995 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 72.439999999999998 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 73.019999999999996 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' B' ' 231' ' ' GLU . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 75.439999999999998 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.340000000000003 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.540000000000006 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 74.030000000000001 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HD12 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.510000000000005 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 74.420000000000002 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 75.099999999999994 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 74.129999999999995 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 64.140000000000001 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.430000000000007 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 64.239999999999995 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 52.020000000000003 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 62.409999999999997 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 73.040000000000006 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 75.530000000000001 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 HD12 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.209999999999994 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.439999999999998 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.540000000000006 111.032 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.409999999999997 112.109 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 75.310000000000002 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 75.349999999999994 109.113 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.409999999999997 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.219999999999999 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo . . . . . 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.409999999999997 113.366 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.422 -1.873 0 CA-C-O 121.08 0.467 . . . . 70.200000000000003 110.599 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.019999999999996 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.530000000000001 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.439999999999998 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.421 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.439999999999998 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.447 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.409999999999997 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.219999999999999 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.310000000000002 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.030000000000001 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.420000000000002 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.150000000000006 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 71.230000000000004 107.613 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.420000000000002 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 72.140000000000001 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.329999999999998 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.53 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.150000000000006 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.731 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.450000000000003 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.329999999999998 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 71.109999999999999 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.239999999999995 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 73.409999999999997 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.439999999999998 112.24 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.340000000000003 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 74.140000000000001 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 74.340000000000003 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.040000000000006 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.409999999999997 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 72.230000000000004 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 64.340000000000003 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.514 HD12 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 73.5 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.140000000000001 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 74.340000000000003 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.109999999999999 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.430000000000007 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.423 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 72.129999999999995 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.230000000000004 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.549999999999997 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.340000000000003 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 55.229999999999997 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . 0.412 ' O ' HD22 ' B' ' 234' ' ' LEU . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 73.5 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.219999999999999 112.154 177.767 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 112.002 0.371 . . . . 72.439999999999998 112.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.310000000000002 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.510000000000005 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 64.310000000000002 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.239999999999995 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.319999999999993 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 70.310000000000002 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.230000000000004 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.230000000000004 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.319999999999993 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 74.140000000000001 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.439999999999998 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.239999999999995 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.340000000000003 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 73.040000000000006 110.928 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 72.420000000000002 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.230000000000004 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.567 HG23 ' CD1' ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 74.150000000000006 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 53.329999999999998 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.340000000000003 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 72.209999999999994 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.310000000000002 111.488 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.685 HD12 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.310000000000002 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.242 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD12 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 72.129999999999995 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 74.219999999999999 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.430000000000007 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.209999999999994 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.572 HD13 HD12 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.5 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.413 HG21 HG22 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.219999999999999 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.019999999999996 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.140000000000001 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.430000000000007 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.319999999999993 109.086 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.140000000000001 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 72.450000000000003 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.540000000000006 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.575 ' SG ' HD23 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 73.430000000000007 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.519999999999996 108.161 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.219999999999999 112.13 176.69 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.412 -2.368 0 CA-C-O 120.835 0.35 . . . . 75.319999999999993 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 73.030000000000001 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 63.119999999999997 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 14' ' ' LEU . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.239999999999995 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 73.120000000000005 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 43.43 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 72.150000000000006 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 73.140000000000001 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.219999999999999 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 72.400000000000006 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.200000000000003 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.209999999999994 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 73.450000000000003 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 110.835 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.519999999999996 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.430000000000007 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 62.130000000000003 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 74.450000000000003 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 74.540000000000006 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.310000000000002 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.439999999999998 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.450000000000003 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 62.240000000000002 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 71.409999999999997 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 228' ' ' THR . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.030000000000001 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.239999999999995 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.019999999999996 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.230000000000004 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.567 ' CD1' HG23 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.209999999999994 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.349999999999994 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.200000000000003 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.340000000000003 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 44.0 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.340000000000003 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.310000000000002 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.239999999999995 109.017 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 75.030000000000001 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 71.239999999999995 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.409999999999997 111.746 179.403 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 74.400000000000006 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.109999999999999 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 74.420000000000002 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.310000000000002 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.049999999999997 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.409999999999997 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.150000000000006 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.540000000000006 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.310000000000002 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.209999999999994 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 63.530000000000001 109.044 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.239999999999995 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.519999999999996 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 74.510000000000005 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 74.219999999999999 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.200000000000003 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 75.510000000000005 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.329999999999998 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD12 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.150000000000006 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 73.109999999999999 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.349999999999994 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.310000000000002 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.747 HD23 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 73.540000000000006 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.549999999999997 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.420000000000002 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 74.219999999999999 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.539999999999999 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.129999999999995 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HD13 HD12 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 73.540000000000006 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.030000000000001 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.430000000000007 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 74.340000000000003 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.010000000000005 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.655 HD13 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.219999999999999 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.498 ' HE2' ' CE1' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.549999999999997 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.109999999999999 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.409999999999997 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 42.420000000000002 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 74.099999999999994 112.115 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.240000000000002 109.011 171.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 63.130000000000003 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.299999999999997 107.636 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.5 109.325 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.129999999999995 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.150000000000006 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.400000000000006 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.430000000000007 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 73.409999999999997 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.230000000000004 111.362 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.439999999999998 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.219999999999999 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.200000000000003 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.530000000000001 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.493 ' HD2' HD11 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.099999999999994 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.129999999999995 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.319999999999993 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.030000000000001 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.537 HG23 ' OE2' ' B' ' 231' ' ' GLU . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.150000000000006 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.129999999999995 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.537 ' OE2' HG23 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 73.540000000000006 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.239999999999995 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.310000000000002 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.040000000000006 109.255 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.400000000000006 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.240000000000002 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.129999999999995 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 74.519999999999996 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 74.129999999999995 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.493 HD11 ' HD2' ' B' ' 225' ' ' LYS . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 74.420000000000002 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 75.439999999999998 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 74.310000000000002 115.189 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.310000000000002 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.530000000000001 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.427 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.319999999999993 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 72.549999999999997 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.624 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.655 ' SG ' HD13 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.109999999999999 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.439999999999998 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.109999999999999 110.601 174.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.340000000000003 109.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.319999999999993 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 72.040000000000006 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.219999999999999 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD23 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 72.120000000000005 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.239999999999995 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.150000000000006 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' B' ' 251' ' ' PRO . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.099999999999994 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 74.030000000000001 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.219999999999999 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 74.109999999999999 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.239999999999995 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 73.319999999999993 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 74.209999999999994 112.957 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.319999999999993 106.447 176.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 23' ' ' ARG . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 75.439999999999998 110.604 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 64.140000000000001 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.439999999999998 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 73.400000000000006 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 HD12 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 72.230000000000004 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.782 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.239999999999995 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.310000000000002 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.120000000000005 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.129999999999995 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.782 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 72.310000000000002 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.120000000000005 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 62.240000000000002 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 63.340000000000003 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 72.439999999999998 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 HD13 HD12 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 75.019999999999996 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.150000000000006 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 75.409999999999997 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.209999999999994 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.149999999999999 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.430000000000007 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 73.219999999999999 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 73.430000000000007 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.129999999999995 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.229999999999997 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 72.400000000000006 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.349999999999994 112.018 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 74.510000000000005 110.077 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.140000000000001 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.492 HD23 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.420000000000002 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 73.409999999999997 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 75.439999999999998 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.519999999999996 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.430000000000007 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 74.109999999999999 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 65.140000000000001 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.540000000000006 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 74.340000000000003 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 60.240000000000002 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.299999999999997 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.049999999999997 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.450000000000003 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' B' ' 235' ' ' ARG . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.099999999999994 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.150000000000006 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.420000000000002 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.209999999999994 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.310000000000002 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 64.519999999999996 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 73.400000000000006 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 74.040000000000006 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.319999999999993 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.030000000000001 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.409999999999997 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.544 HD12 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 74.010000000000005 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.449 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 71.219999999999999 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.41 ' CB ' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.210000000000001 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 62.030000000000001 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.442 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.409999999999997 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.109999999999999 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.230000000000004 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 74.230000000000004 109.52 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.140000000000001 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 73.400000000000006 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.439999999999998 111.937 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.315 -0.624 . . . . 65.519999999999996 109.315 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 53.32 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 75.239999999999995 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.019999999999996 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CG ' ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.510000000000005 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 74.230000000000004 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.129999999999995 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.439999999999998 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.119999999999997 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 74.5 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.319999999999993 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.340000000000003 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.457 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 71.349999999999994 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.310000000000002 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG22 HG21 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.519999999999996 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.329999999999998 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 74.0 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.530000000000001 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 75.340000000000003 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 HD12 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 75.010000000000005 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 63.100000000000001 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.299999999999997 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.140000000000001 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.230000000000004 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.746 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 72.239999999999995 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.200000000000003 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 34' ' ' LEU . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 61.25 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 71.239999999999995 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 75.25 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 74.329999999999998 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 HD13 HD12 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 72.400000000000006 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 73.219999999999999 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 75.019999999999996 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.140000000000001 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 73.319999999999993 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.420000000000002 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 74.310000000000002 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.400000000000006 106.938 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.472 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.340000000000003 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.439999999999998 108.531 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.439999999999998 111.941 179.786 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.181 0.515 . . . . 75.120000000000005 112.024 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 71.549999999999997 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.340000000000003 110.284 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' SER . . . . . 0.483 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.530000000000001 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.210000000000001 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.120000000000005 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.340000000000003 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.040000000000006 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 71.349999999999994 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 74.519999999999996 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.310000000000002 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.530000000000001 109.772 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.430000000000007 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.210000000000001 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 75.319999999999993 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.549999999999997 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.120000000000005 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.200000000000003 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 62.399999999999999 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 75.439999999999998 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 70.409999999999997 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 70.549999999999997 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.099999999999994 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.549999999999997 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.120000000000005 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.299999999999997 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' CYS . . . . . 0.639 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.140000000000001 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.420000000000002 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.329999999999998 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 74.140000000000001 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' THR . . . . . 0.482 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.049999999999997 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 74.340000000000003 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 74.209999999999994 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . 0.456 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.140000000000001 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.456 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.519999999999996 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.140000000000001 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 73.120000000000005 109.977 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 74.099999999999994 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . 0.59 ' SG ' HD23 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.209999999999994 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.409999999999997 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.340000000000003 112.173 -179.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.834 -0.432 . . . . 74.5 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.53 -140.39 6.69 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.232 -1.147 . . . . 60.25 110.232 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -85.37 -5.45 59.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.163 0.481 . . . . 65.239999999999995 112.002 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -83.87 107.0 15.99 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.524 -0.547 . . . . 74.200000000000003 109.524 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.61 89.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 121.864 0.84 . . . . 74.200000000000003 111.452 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -100.35 -16.93 17.48 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.329 -0.619 . . . . 72.540000000000006 109.329 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.68 123.38 31.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.379 -0.828 . . . . 71.099999999999994 110.449 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -146.75 166.89 25.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.24 -1.763 . . . . 65.230000000000004 106.24 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -70.45 106.52 3.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.778 -1.564 . . . . 75.310000000000002 106.778 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p -72.35 85.95 1.11 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 74.109999999999999 112.245 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.530000000000001 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 73.0 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 75.439999999999998 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 75.409999999999997 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.510000000000005 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.482 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.120000000000005 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.409999999999997 112.617 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 74.450000000000003 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.129999999999995 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.420000000000002 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.020000000000003 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.319999999999993 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 73.209999999999994 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 75.519999999999996 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.030000000000001 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 74.409999999999997 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.599 HD13 HD12 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 71.540000000000006 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.319999999999993 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' HZ3' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.400000000000006 106.943 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.329999999999998 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.109999999999999 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.049999999999997 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 74.140000000000001 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.230000000000004 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.319999999999993 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.530000000000001 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.59 HD13 HD12 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.439999999999998 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.230000000000004 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 73.329999999999998 113.378 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.209999999999994 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.482 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 37.219999999999999 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.120000000000005 110.005 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 71.439999999999998 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.040000000000006 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 72.230000000000004 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' GLN . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 73.409999999999997 110.403 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.89 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.209999999999994 110.006 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' ASP 0.267 25.4 mt-30 70.75 75.22 0.19 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.252 1.821 . . . . 71.010000000000005 112.146 -176.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.29 -35.34 0.28 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.589 -1.187 . . . . 74.329999999999998 111.929 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.6 p -84.99 28.55 0.69 Allowed 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.929 0.492 . . . . 73.230000000000004 112.325 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 52' ' ' GLN . 14.2 m95 -78.01 88.58 4.15 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 73.319999999999993 111.594 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.96 150.86 17.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.742 -1.117 . . . . 73.329999999999998 108.076 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -101.67 97.39 7.81 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.854 0.835 . . . . 73.25 113.076 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -173.82 -171.63 0.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.928 -2.249 . . . . 75.230000000000004 104.928 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t 74.18 -65.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.373 0.669 . . . . 70.329999999999998 109.466 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t 55.27 83.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.615 1.166 . . . . 75.420000000000002 110.202 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -103.28 115.62 30.9 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.248 -0.887 . . . . 65.319999999999993 111.792 -175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.3 m -77.62 125.28 29.1 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.093 -1.817 . . . . 72.540000000000006 106.093 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.2 ttt -51.06 109.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.912 0.757 . . . . 75.519999999999996 112.369 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.78 129.9 41.38 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 106.741 -1.577 . . . . 74.109999999999999 106.741 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -64.93 106.7 1.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.905 0.86 . . . . 75.219999999999999 112.889 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 C--N 1.299 -1.619 0 CA-C-N 114.042 -1.435 . . . . 73.209999999999994 110.151 178.819 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.243 0.752 0 N-CA-C 109.509 -0.552 . . . . 72.430000000000007 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -162.65 -175.49 33.74 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.796 -0.922 . . . . 62.109999999999999 110.796 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.2 m -82.43 27.88 0.49 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.632 0.729 . . . . 71.409999999999997 110.994 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -151.36 136.69 17.64 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.479 -0.934 . . . . 74.209999999999994 108.479 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.06 90.26 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 122.076 0.941 . . . . 73.430000000000007 110.292 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 50.4 m -141.85 -72.56 0.33 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.571 -0.74 . . . . 63.32 111.071 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -137.07 98.63 3.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.091 0.472 . . . . 72.400000000000006 111.099 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . 0.479 ' C ' ' HD2' ' B' ' 209' ' ' ARG . 40.0 ttmt -95.0 -82.54 0.37 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.78 -1.563 . . . . 74.049999999999997 106.78 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.604 ' HB2' ' SG ' ' B' ' 211' ' ' CYS . 3.3 mpt_? -160.24 163.93 33.12 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.977 -2.972 . . . . 74.129999999999995 102.977 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p -83.18 85.52 7.19 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.937 -1.105 . . . . 74.129999999999995 109.636 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' B' ' 209' ' ' ARG . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 75.510000000000005 107.443 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.473 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.420000000000002 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 74.150000000000006 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.446 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 74.409999999999997 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 74.219999999999999 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 71.219999999999999 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.439999999999998 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 73.200000000000003 109.847 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 74.120000000000005 113.211 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 70.099999999999994 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 73.219999999999999 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.519999999999996 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.439999999999998 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' A' ' 31' ' ' GLU . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 72.140000000000001 110.944 -173.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 72.040000000000006 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 74.200000000000003 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 72.219999999999999 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 64.420000000000002 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.450000000000003 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.663 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.239999999999995 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.549999999999997 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.129999999999995 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.340000000000003 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.439999999999998 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 63.32 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.209999999999994 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.48 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 73.329999999999998 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.140000000000001 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.471 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 74.319999999999993 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.420000000000002 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 72.510000000000005 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 73.109999999999999 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.439999999999998 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' B' ' 238' ' ' ILE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 70.099999999999994 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.150000000000006 107.822 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.510000000000005 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 36.21 0.6 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.530000000000001 111.467 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 68.93 34.38 3.21 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.103 0.961 . . . . 72.239999999999995 109.352 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.93 73.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 75.439999999999998 111.553 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 19.4 m -78.28 -4.27 47.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.446 0.641 . . . . 71.120000000000005 110.208 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -77.99 89.5 4.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.105 0.955 . . . . 72.409999999999997 112.291 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.7 m -121.33 -174.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.672 -1.603 . . . . 72.409999999999997 106.672 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -92.56 79.83 4.85 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.113 -1.035 . . . . 75.109999999999999 110.524 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -100.27 142.07 32.25 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.708 -1.133 . . . . 64.0 108.796 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 68.7 t 72.31 -43.43 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 72.540000000000006 112.805 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.22 95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 110.271 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -83.83 148.61 26.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.512 -0.767 . . . . 71.329999999999998 111.341 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 70.6 m -152.7 114.97 4.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.95 . . . . 64.420000000000002 108.436 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -81.59 131.63 35.28 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.053 0.454 . . . . 75.540000000000006 110.932 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.9 125.68 28.15 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.55 -0.75 . . . . 74.430000000000007 110.379 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.76 117.23 10.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.303 -0.862 . . . . 75.329999999999998 112.449 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.256 1.442 0 N-CA-C 107.446 -1.316 . . . . 75.319999999999993 107.446 173.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 108.809 -0.812 . . . . 73.319999999999993 108.809 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.86 -149.01 11.92 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.811 -0.709 . . . . 64.230000000000004 111.6 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -86.58 127.66 34.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.932 -0.766 . . . . 54.229999999999997 108.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.03 100.65 3.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.782 -0.451 . . . . 62.039999999999999 109.782 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.7 157.59 18.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.138 -1.06 . . . . 64.040000000000006 108.138 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -126.91 159.96 32.43 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.772 -0.455 . . . . 73.310000000000002 109.772 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -86.91 79.3 8.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.969 -1.493 . . . . 73.340000000000003 106.969 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -151.99 137.48 17.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.166 -0.925 . . . . 70.239999999999995 109.3 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -82.98 136.82 34.4 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.736 -0.839 . . . . 74.150000000000006 108.736 175.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -113.09 149.07 34.0 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 109.16 -0.682 . . . . 75.140000000000001 109.16 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.140000000000001 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.340000000000003 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.120000000000005 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 61.039999999999999 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.129999999999995 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.430000000000007 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.209999999999994 110.673 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 61.009999999999998 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.109999999999999 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 70.200000000000003 109.48 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.545 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 71.129999999999995 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.409999999999997 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 74.109999999999999 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.498 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 73.430000000000007 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.450000000000003 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 74.420000000000002 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 74.129999999999995 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD13 HD12 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.200000000000003 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 55.43 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.686 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.420000000000002 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.240000000000002 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.686 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 74.209999999999994 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.540000000000006 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.200000000000003 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.510000000000005 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.120000000000005 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.556 HD13 HD12 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 71.420000000000002 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.519999999999996 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 73.049999999999997 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.543 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 65.340000000000003 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.430000000000007 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 75.140000000000001 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.129999999999995 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 71.010000000000005 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.530000000000001 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.400000000000006 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 75.200000000000003 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.12 -4.12 13.62 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.430000000000007 113.278 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 58.48 77.85 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.79 0.805 . . . . 72.450000000000003 110.909 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.45 -64.95 1.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.955 -1.02 . . . . 60.229999999999997 108.748 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.8 m -146.19 103.34 3.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.95 -0.568 . . . . 73.140000000000001 109.526 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 176.25 -27.93 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 124.072 0.857 . . . . 62.100000000000001 110.385 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.94 104.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.141 0.972 . . . . 74.239999999999995 113.166 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -132.93 92.06 2.98 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.043 -1.435 . . . . 75.439999999999998 107.636 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 59' ' ' VAL . 18.0 t70 66.19 -166.24 0.22 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 108.121 -1.066 . . . . 71.409999999999997 108.121 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 20.9 t 60.8 29.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 122.544 1.164 . . . . 70.420000000000002 108.189 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.89 115.94 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.044 -0.98 . . . . 73.239999999999995 111.63 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -137.67 110.51 7.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.188 -0.914 . . . . 74.299999999999997 109.325 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 m -145.78 135.2 23.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.828 -0.805 . . . . 65.010000000000005 108.828 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttm -83.09 94.62 7.85 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.059 -0.719 . . . . 74.519999999999996 109.059 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.49 111.07 8.05 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.926 -0.579 . . . . 75.530000000000001 110.062 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.92 93.81 2.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.534 -1.654 . . . . 73.310000000000002 106.534 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.764 -0.653 . . . . 74.230000000000004 109.531 -175.551 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.719 -0.475 . . . . 71.230000000000004 109.719 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.86 -44.67 3.38 Favored Glycine 0 C--N 1.314 -0.68 0 N-CA-C 111.144 -0.782 . . . . 42.219999999999999 111.144 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 p -74.89 128.88 36.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.465 0.706 . . . . 74.420000000000002 109.828 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.45 115.6 23.17 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.315 -0.402 . . . . 63.140000000000001 110.684 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.52 143.95 10.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.167 -0.679 . . . . 65.450000000000003 109.167 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -97.57 125.56 42.36 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 120.175 -0.61 . . . . 74.340000000000003 111.259 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -91.03 -33.98 15.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.772 -1.936 . . . . 73.200000000000003 105.772 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.93 127.06 31.57 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 113.268 -1.787 . . . . 55.530000000000001 107.273 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.449 ' H ' ' NE ' ' B' ' 209' ' ' ARG . 0.1 OUTLIER -68.95 98.41 0.95 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.524 0.678 . . . . 74.510000000000005 110.467 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p -88.41 120.47 29.81 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.555 -0.748 . . . . 72.230000000000004 110.71 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.329999999999998 107.377 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.509 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 73.400000000000006 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.230000000000004 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.481 HD23 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.439999999999998 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.450000000000003 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.109999999999999 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 51.240000000000002 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.319999999999993 111.775 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 71.150000000000006 110.266 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.439999999999998 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.420000000000002 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.329999999999998 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 74.019999999999996 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 64.099999999999994 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.049999999999997 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.230000000000004 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.430000000000007 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.556 HD12 HD13 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 74.109999999999999 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.731 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.439999999999998 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.545 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.219999999999999 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.209999999999994 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 71.530000000000001 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.549999999999997 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.129999999999995 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.409999999999997 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.439999999999998 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 74.230000000000004 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.519999999999996 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.595 HD12 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.430000000000007 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 62.5 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 63.520000000000003 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.129999999999995 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 75.120000000000005 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' B' ' 238' ' ' ILE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.109999999999999 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.329999999999998 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.119999999999997 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.329999999999998 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.96 -8.92 23.85 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 51.66 32.99 10.03 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.737 1.384 . . . . 74.439999999999998 114.737 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.03 -66.62 0.8 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.293 -0.563 . . . . 72.420000000000002 110.291 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 57.3 m -156.9 91.36 1.2 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.702 0.286 . . . . 73.400000000000006 110.594 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.12 17.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.66 -0.867 . . . . 74.510000000000005 108.66 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.27 101.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.537 1.16 . . . . 63.439999999999998 113.909 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -131.73 29.12 4.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.208 -1.36 . . . . 75.120000000000005 107.478 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' B' ' 259' ' ' VAL . 18.7 t70 -136.74 -153.56 0.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 104.819 -2.289 . . . . 74.25 104.819 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' B' ' 258' ' ' ASP . 48.7 t 71.2 61.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 122.966 1.365 . . . . 75.030000000000001 109.898 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.68 113.16 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.833 -1.531 . . . . 74.329999999999998 107.12 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -83.0 94.88 7.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.114 0.483 . . . . 73.140000000000001 109.835 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.9 m -84.35 94.9 8.58 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.775 -0.648 . . . . 64.409999999999997 110.355 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -87.29 70.42 10.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.618 -0.882 . . . . 72.040000000000006 108.618 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -143.57 93.15 2.44 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.676 -1.147 . . . . 64.409999999999997 110.881 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -118.03 92.75 3.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.447 -1.686 . . . . 72.340000000000003 106.447 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 105.744 -1.947 . . . . 75.120000000000005 105.744 -178.667 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.115 -0.698 . . . . 60.100000000000001 109.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.95 91.38 1.5 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 108.96 -1.656 . . . . 72.530000000000001 108.96 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -71.56 95.63 1.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.983 0.735 . . . . 64.129999999999995 112.983 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.55 85.29 1.64 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.883 -1.053 . . . . 73.329999999999998 109.445 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 145.95 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.843 -0.617 . . . . 75.129999999999995 112.176 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -103.93 33.73 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.668 -1.234 . . . . 61.299999999999997 107.668 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.26 -55.68 12.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.547 -1.206 . . . . 73.299999999999997 110.854 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -102.95 -72.24 0.7 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.399 -0.593 . . . . 75.540000000000006 109.399 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -150.76 158.37 44.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.981 0.912 . . . . 72.099999999999994 108.989 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p -97.15 85.64 3.75 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.539999999999999 109.236 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 43.32 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.349999999999994 110.378 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.229999999999997 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD12 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 73.340000000000003 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.41 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 71.150000000000006 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.510000000000005 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 73.450000000000003 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.409999999999997 112.579 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.450000000000003 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.109999999999999 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 72.5 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 73.150000000000006 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.510000000000005 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 72.019999999999996 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 HD12 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 74.230000000000004 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.140000000000001 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.310000000000002 111.993 -177.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.150000000000006 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 75.230000000000004 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 75.450000000000003 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.400000000000006 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.209999999999994 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.200000000000003 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.531 HD13 HD12 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.129999999999995 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.494 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.349999999999994 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 74.409999999999997 115.806 -176.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.120000000000005 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.019999999999996 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' B' ' 249' ' ' CYS . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.540000000000006 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 65.200000000000003 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.399999999999999 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 74.319999999999993 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.319999999999993 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HG2' HD21 ' B' ' 219' ' ' LEU . 26.9 Cg_exo -63.91 2.21 1.15 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 74.230000000000004 115.045 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 49.94 27.06 2.23 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.342 1.457 . . . . 73.099999999999994 112.894 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.46 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.532 -0.758 . . . . 64.540000000000006 111.334 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 m -120.16 10.15 11.3 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.708 0.766 . . . . 74.439999999999998 109.8 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -128.51 95.03 4.02 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.771 0.656 . . . . 75.200000000000003 112.771 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t 61.61 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 115.092 1.515 . . . . 74.319999999999993 115.092 172.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.32 99.47 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.931 -0.577 . . . . 74.140000000000001 111.222 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -158.11 110.62 2.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.322 -0.992 . . . . 75.420000000000002 108.322 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.84 -37.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 120.823 0.344 . . . . 75.129999999999995 110.696 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.48 145.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 108.923 -0.769 . . . . 54.140000000000001 108.923 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' NH2' HG22 ' A' ' 30' ' ' THR . 68.6 mtt180 -129.63 118.23 21.64 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.605 -0.271 . . . . 73.420000000000002 110.453 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 m -84.8 74.31 10.49 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 122.207 1.003 . . . . 71.329999999999998 108.679 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.24 101.25 3.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.17 -1.789 . . . . 72.319999999999993 106.17 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.16 148.22 46.45 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.697 -1.594 . . . . 72.25 106.697 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 71.02 99.55 0.06 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.954 0.784 . . . . 74.510000000000005 110.342 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 C--N 1.308 -1.227 0 CA-C-N 115.911 -0.586 . . . . 74.239999999999995 110.02 178.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.081 0.467 . . . . 72.230000000000004 109.782 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.45 165.99 16.03 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 110.446 -1.062 . . . . 64.040000000000006 110.446 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.8 m 57.75 81.53 0.14 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.397 0.679 . . . . 72.129999999999995 109.902 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.44 84.57 7.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.336 1.065 . . . . 73.030000000000001 113.539 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.7 129.03 53.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.526 -1.215 . . . . 75.319999999999993 108.025 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -79.62 122.9 27.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.527 0.68 . . . . 71.340000000000003 111.701 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.71 173.0 13.04 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.838 -1.541 . . . . 74.319999999999993 106.838 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -66.75 -33.29 75.3 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.225 -1.028 . . . . 74.120000000000005 108.225 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -112.23 97.23 6.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.346 -0.843 . . . . 74.109999999999999 108.854 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p -81.23 101.96 10.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.099999999999994 108.86 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.403 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.430000000000007 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.540000000000006 111.988 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 71.510000000000005 110.113 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 72.299999999999997 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.530000000000001 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.239999999999995 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.209999999999994 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.349999999999994 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.510000000000005 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 75.019999999999996 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 73.409999999999997 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.528 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 73.439999999999998 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.299999999999997 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.239999999999995 108.938 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.531 HD12 HD13 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 75.140000000000001 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.229999999999997 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.230000000000004 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.129999999999995 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 62.530000000000001 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.817 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 74.329999999999998 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.489 ' CZ ' ' HB2' ' B' ' 258' ' ' ASP . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 73.109999999999999 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 70.150000000000006 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 71.450000000000003 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 73.329999999999998 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.5 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 74.109999999999999 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.498 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.340000000000003 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.340000000000003 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.230000000000004 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.329999999999998 113.847 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.049999999999997 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.329999999999998 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.409999999999997 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 74.409999999999997 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.340000000000003 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.329999999999998 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.62 -4.48 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 114.912 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' B' ' 255' ' ' TRP . 12.2 pt20 52.86 1.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.969 1.841 . . . . 70.349999999999994 115.969 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.53 -55.15 19.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.108 0.48 . . . . 73.299999999999997 110.267 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 7.7 m -107.32 15.52 24.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.95 0.881 . . . . 43.520000000000003 108.664 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . 0.443 ' HB2' ' HA ' ' B' ' 252' ' ' GLN . 67.4 m95 -126.62 22.8 6.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.996 -0.547 . . . . 75.120000000000005 111.535 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 77.1 t 78.42 119.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.908 0.883 . . . . 75.310000000000002 112.272 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -70.53 118.98 14.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.565 -0.743 . . . . 75.310000000000002 109.719 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.489 ' HB2' ' CZ ' ' B' ' 235' ' ' ARG . 28.6 t70 -86.69 73.48 10.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.92 0.867 . . . . 71.329999999999998 109.921 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.9 -28.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.682 -1.145 . . . . 65.140000000000001 108.498 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 18.2 m -88.92 87.28 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-N 114.87 -1.059 . . . . 74.329999999999998 109.585 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -118.9 104.17 10.28 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.486 -1.233 . . . . 74.099999999999994 107.734 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -76.76 72.93 3.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.908 0.861 . . . . 73.519999999999996 112.094 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.19 90.78 0.98 Allowed 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.116 -1.439 . . . . 75.140000000000001 107.116 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' B' ' 265' ' ' ARG . 23.8 t70 -146.29 95.3 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 103.712 -2.699 . . . . 74.310000000000002 103.712 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' B' ' 264' ' ' ASP . 70.0 ttt180 75.76 136.2 0.06 Allowed 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.64 1.213 . . . . 74.519999999999996 107.863 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp . . . . . 0 C--O 1.254 1.341 0 C-N-CA 120.259 -0.576 . . . . 72.019999999999996 109.691 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 110.124 -0.325 . . . . 74.140000000000001 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.15 35.34 1.12 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.766 -0.731 . . . . 75.219999999999999 112.506 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 m -91.69 -42.34 10.22 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.315 0.579 . . . . 62.149999999999999 110.191 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.93 107.14 8.5 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.645 0.736 . . . . 54.240000000000002 110.71 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -172.87 -45.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.945 -1.025 . . . . 72.400000000000006 108.933 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.4 p -128.38 157.04 42.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.724 -0.843 . . . . 75.530000000000001 108.724 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.49 120.41 24.98 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.751 -0.833 . . . . 74.439999999999998 108.751 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -104.13 105.02 15.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 121.293 0.568 . . . . 72.430000000000007 110.464 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -94.52 128.99 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.229 -2.137 . . . . 75.439999999999998 105.229 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m -92.11 94.6 9.31 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.457 -0.897 . . . . 71.439999999999998 110.541 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.299999999999997 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.209999999999994 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 44.229999999999997 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 74.150000000000006 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 65.340000000000003 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 73.409999999999997 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 73.0 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 75.120000000000005 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.439999999999998 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.519999999999996 108.766 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 72.030000000000001 113.298 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 64.030000000000001 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 231' ' ' GLU . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.150000000000006 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.549999999999997 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.120000000000005 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 60.210000000000001 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.528 HD13 HD12 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 72.540000000000006 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 74.109999999999999 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.430000000000007 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.210000000000001 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.400000000000006 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 73.25 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.349999999999994 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.420000000000002 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.510000000000005 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 75.430000000000007 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 72.129999999999995 114.426 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.219999999999999 112.153 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 71.409999999999997 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.540000000000006 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 73.120000000000005 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 71.450000000000003 110.962 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.409999999999997 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.349999999999994 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.209999999999994 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo -77.77 20.85 0.68 Allowed 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.230000000000004 112.491 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 73.86 -51.67 0.69 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.577 1.551 . . . . 73.200000000000003 112.321 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 55.77 25.26 8.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 74.340000000000003 110.825 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 m 74.93 8.53 4.13 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 124.793 1.237 . . . . 74.230000000000004 112.623 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -67.1 -29.79 69.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.262 0.553 . . . . 74.230000000000004 110.607 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.82 150.47 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.816 -0.809 . . . . 74.239999999999995 108.816 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -67.64 144.37 55.56 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.512 0.508 . . . . 73.239999999999995 109.637 175.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -71.06 100.75 2.07 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.645 0.736 . . . . 72.430000000000007 110.582 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.56 -16.52 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.291 -0.633 . . . . 73.25 109.291 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.53 101.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.812 -0.81 . . . . 72.230000000000004 108.812 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 66.23 88.61 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.454 -1.313 . . . . 75.420000000000002 107.454 -171.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 p -102.76 9.78 38.88 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.727 -0.67 . . . . 54.109999999999999 111.651 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.59 98.37 0.07 Allowed 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.595 1.158 . . . . 72.319999999999993 112.934 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -131.45 158.67 40.23 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 104.931 -2.248 . . . . 73.219999999999999 104.931 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -69.21 -23.05 63.85 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.363 -0.535 . . . . 70.329999999999998 111.255 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 110.129 -0.322 . . . . 75.439999999999998 110.129 179.616 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.241 0.643 0 N-CA-C 110.232 -0.284 . . . . 64.140000000000001 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 140.27 125.57 2.2 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.171 -1.172 . . . . 61.340000000000003 110.171 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.6 m -60.75 -36.63 79.38 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.777 0.431 . . . . 75.430000000000007 111.242 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.67 153.69 42.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 113.153 0.797 . . . . 61.310000000000002 113.153 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.3 -3.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.894 -1.15 . . . . 63.020000000000003 107.894 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.2 p -159.77 166.68 29.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.023 -1.103 . . . . 75.219999999999999 108.023 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.66 86.21 6.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.342 1.067 . . . . 63.119999999999997 108.238 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' B' ' 209' ' ' ARG . 2.1 tmmm? -81.62 120.54 25.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 75.310000000000002 108.044 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.476 ' O ' ' HD2' ' B' ' 208' ' ' LYS . 27.6 mmm180 -77.54 140.17 39.69 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.727 -1.212 . . . . 72.049999999999997 107.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m -71.38 116.84 12.18 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.162 1.171 . . . . 72.129999999999995 114.162 -168.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.140000000000001 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 73.319999999999993 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.130000000000003 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 73.209999999999994 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.428 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.010000000000005 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 74.209999999999994 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.340000000000003 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 65.140000000000001 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 75.030000000000001 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 73.129999999999995 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.310000000000002 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.120000000000005 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.511 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.140000000000001 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.120000000000005 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.420000000000002 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 72.430000000000007 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 74.299999999999997 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.434 ' HB2' ' HZ3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.340000000000003 110.162 -176.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.340000000000003 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 64.540000000000006 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.109999999999999 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 74.150000000000006 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.210000000000001 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.420000000000002 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.757 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.340000000000003 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.230000000000004 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.349999999999994 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.435 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 74.25 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 75.400000000000006 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.209999999999994 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.420000000000002 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 72.510000000000005 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 65.430000000000007 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.412 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 74.319999999999993 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.129999999999995 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.349999999999994 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.420000000000002 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.19 6.11 5.56 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 72.400000000000006 113.208 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 58.76 -83.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.866 1.266 . . . . 64.129999999999995 112.777 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 52.13 84.24 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.943 1.297 . . . . 74.420000000000002 112.929 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 39.7 m 72.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.262 1.025 . . . . 73.430000000000007 112.982 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -50.01 -49.44 50.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 73.150000000000006 112.021 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.23 135.09 59.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.927 -0.768 . . . . 74.200000000000003 108.927 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -99.8 158.07 16.06 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.09 -1.078 . . . . 71.010000000000005 108.09 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -126.63 144.66 50.84 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.078 -0.649 . . . . 75.540000000000006 112.229 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.9 p 51.82 17.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.14 2.176 . . . . 75.150000000000006 113.907 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.67 105.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.002 0.906 . . . . 72.329999999999998 109.949 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -122.89 94.44 4.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.286 -0.87 . . . . 72.200000000000003 111.492 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 58.0 p -147.98 94.01 2.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.314 -0.857 . . . . 71.540000000000006 109.177 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.03 102.82 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.43 0.633 . . . . 74.239999999999995 109.974 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -137.56 165.04 27.27 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.775 -1.194 . . . . 73.299999999999997 107.775 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -65.77 -23.19 66.66 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.366 0.506 . . . . 74.109999999999999 112.366 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.872 -0.585 . . . . 74.310000000000002 109.635 177.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.575 0.226 . . . . 74.409999999999997 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.08 1.71 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.028 -1.229 . . . . 72.230000000000004 110.028 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -146.98 77.74 1.47 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.605 0.717 . . . . 74.319999999999993 110.621 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.87 112.84 26.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.093 -1.447 . . . . 72.310000000000002 107.093 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -67.85 146.81 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 115.136 1.532 . . . . 73.219999999999999 115.136 -171.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 t -158.71 156.97 30.87 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.37 -2.455 . . . . 70.010000000000005 104.37 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -93.61 -169.68 2.17 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.562 -1.255 . . . . 72.219999999999999 108.04 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -82.21 -43.55 17.5 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.52 -0.919 . . . . 71.400000000000006 108.52 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -97.53 134.54 40.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.094 -1.076 . . . . 71.239999999999995 108.094 176.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 p -100.51 114.54 28.24 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.572 -0.451 . . . . 73.510000000000005 110.895 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.209999999999994 108.024 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 74.319999999999993 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.329999999999998 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 73.530000000000001 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 71.430000000000007 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.310000000000002 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.540000000000006 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.510000000000005 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 71.25 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.310000000000002 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.409999999999997 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.219999999999999 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.219999999999999 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.712 ' NZ ' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.310000000000002 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 72.109999999999999 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.514 ' HH ' HG22 ' B' ' 229' ' ' ILE . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.140000000000001 108.629 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 74.5 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.48 HD13 HD12 ' B' ' 240' ' ' ILE . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.430000000000007 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.019999999999996 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.120000000000005 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.019999999999996 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.535 ' HA ' ' NE2' ' A' ' 52' ' ' GLN . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 74.430000000000007 110.925 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.758 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 74.200000000000003 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.209999999999994 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.140000000000001 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 70.5 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.239999999999995 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.430000000000007 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.712 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 74.409999999999997 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.406 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.120000000000005 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.129999999999995 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 15' ' ' THR . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 72.430000000000007 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.019999999999996 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' HG22 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 74.430000000000007 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.540000000000006 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 63.340000000000003 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 74.209999999999994 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.349999999999994 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 73.510000000000005 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo -77.06 37.46 0.59 Allowed 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 71.430000000000007 111.675 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.535 ' NE2' ' HA ' ' A' ' 33' ' ' SER . 77.9 mt-30 60.21 38.93 19.8 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.904 0.859 . . . . 73.200000000000003 110.408 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.28 -37.37 12.08 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.396 -1.335 . . . . 71.200000000000003 107.396 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 m -98.39 -28.74 13.51 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.039 -0.982 . . . . 74.209999999999994 109.292 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.2 m95 64.37 41.85 5.56 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.981 -1.118 . . . . 70.340000000000003 107.981 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.1 t -55.09 112.89 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.332 -1.303 . . . . 72.530000000000001 112.611 -174.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -111.95 134.19 53.66 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.294 -1.743 . . . . 70.420000000000002 106.294 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -115.25 140.65 48.92 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.072 -0.651 . . . . 74.230000000000004 111.033 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 m -82.8 -13.95 12.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.279 -1.008 . . . . 73.140000000000001 108.279 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.8 t -72.22 102.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.574 -1.639 . . . . 73.030000000000001 106.574 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -83.13 143.46 30.52 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 111.037 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.4 t -87.23 138.72 31.24 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.447 -0.946 . . . . 74.239999999999995 108.447 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 ptp -106.27 -171.95 1.99 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.6 -0.889 . . . . 64.540000000000006 108.6 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.6 149.66 46.84 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.255 -0.578 . . . . 65.040000000000006 109.682 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.74 -23.3 63.09 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.924 0.89 . . . . 74.239999999999995 112.501 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 tptp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.203 -0.295 . . . . 70.519999999999996 110.203 175.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.245 0.85 0 CA-C-O 120.832 0.349 . . . . 70.019999999999996 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -139.44 105.99 0.49 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.483 -1.447 . . . . 62.399999999999999 109.483 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.0 m -144.42 101.82 3.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.142 0.496 . . . . 75.319999999999993 110.991 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.59 143.88 35.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.145 -1.057 . . . . 63.100000000000001 108.145 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.76 140.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.15 0.5 . . . . 74.510000000000005 111.012 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 22.9 t -89.05 -170.28 2.84 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.128 -1.064 . . . . 73.109999999999999 108.128 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.16 157.53 19.3 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.727 -0.842 . . . . 70.409999999999997 108.727 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.7 -28.6 68.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.971 0.415 . . . . 74.019999999999996 110.043 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 103.16 6.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.525 -1.287 . . . . 74.5 107.525 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m -100.52 117.13 34.05 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.278 -0.569 . . . . 73.010000000000005 111.43 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.140000000000001 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 73.200000000000003 109.677 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.299999999999997 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.329999999999998 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.400000000000006 107.777 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.549999999999997 110.72 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.47 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.200000000000003 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 70.140000000000001 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.47 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.439999999999998 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 74.430000000000007 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 64.319999999999993 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.420000000000002 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 65.209999999999994 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 72.010000000000005 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.759 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 72.129999999999995 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 75.400000000000006 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.519999999999996 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.510000000000005 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 71.310000000000002 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.450000000000003 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 62.509999999999998 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.409999999999997 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.539999999999999 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.230000000000004 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 228' ' ' THR . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.039999999999999 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 75.030000000000001 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.230000000000004 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.019999999999996 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 73.150000000000006 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.140000000000001 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 71.540000000000006 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.414 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.319999999999993 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.414 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 74.549999999999997 109.819 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.019999999999996 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.340000000000003 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 61.420000000000002 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -84.78 18.12 1.62 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.230000000000004 112.049 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.438 ' O ' HG22 ' B' ' 256' ' ' VAL . 74.4 mt-30 61.79 24.32 14.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.28 1.032 . . . . 71.319999999999993 111.749 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.73 -34.11 70.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.487 0.715 . . . . 74.219999999999999 112.179 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 38.8 m -108.78 -8.78 15.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.675 0.75 . . . . 73.420000000000002 109.664 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -90.04 -10.68 43.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.913 0.709 . . . . 74.049999999999997 112.913 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 252' ' ' GLN . 58.7 t -79.42 94.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.603 -1.999 . . . . 70.319999999999993 105.603 168.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -138.87 145.67 40.25 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.068 -0.969 . . . . 63.420000000000002 110.708 -169.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -140.22 153.67 46.65 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.026 -1.842 . . . . 75.230000000000004 106.026 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.9 -1.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 117.886 0.312 . . . . 73.25 111.271 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 70.38 64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.353 -1.721 . . . . 71.340000000000003 106.353 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -60.63 150.31 32.3 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.769 -2.014 . . . . 74.109999999999999 112.094 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.2 t -140.13 129.15 23.51 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.123 -1.065 . . . . 63.329999999999998 108.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.04 156.97 34.67 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.31 -0.626 . . . . 73.209999999999994 109.31 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.01 156.11 39.2 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.796 -0.362 . . . . 63.43 110.227 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -56.37 -37.11 69.62 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.303 1.041 . . . . 75.150000000000006 110.375 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 118.073 -0.965 . . . . 71.420000000000002 110.341 177.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.643 -0.873 . . . . 71.019999999999996 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.79 88.55 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 119.565 -1.302 . . . . 50.240000000000002 113.723 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -71.52 -23.33 61.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.063 -1.458 . . . . 71.109999999999999 107.063 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.39 92.41 4.58 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.362 -1.718 . . . . 64.109999999999999 106.362 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.21 -37.43 12.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.422 -0.808 . . . . 74.040000000000006 110.663 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 p -150.6 -67.76 0.19 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.332 -0.988 . . . . 74.219999999999999 108.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.19 89.4 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.157 0.983 . . . . 65.310000000000002 113.256 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -102.31 -61.71 1.36 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.762 -0.654 . . . . 71.409999999999997 109.73 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -143.06 106.59 4.61 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.538 -0.755 . . . . 74.409999999999997 109.43 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m -98.93 133.02 43.81 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.0 -0.741 . . . . 74.420000000000002 109.0 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 64.120000000000005 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.409999999999997 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 70.230000000000004 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.219999999999999 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.310000000000002 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 73.209999999999994 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 74.010000000000005 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.400000000000006 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 HG22 ' HZ3' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.319999999999993 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 75.010000000000005 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 75.239999999999995 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 72.099999999999994 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.519999999999996 107.83 173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.430000000000007 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.55 HD13 HD12 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 74.319999999999993 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 63.509999999999998 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 72.25 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.120000000000005 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.319999999999993 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 74.129999999999995 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.019999999999996 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 74.019999999999996 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 75.310000000000002 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 73.400000000000006 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 75.099999999999994 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.478 ' HA ' HD13 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 70.340000000000003 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.329999999999998 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 72.299999999999997 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.530000000000001 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 75.209999999999994 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 74.540000000000006 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 62.229999999999997 109.382 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 72.239999999999995 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.120000000000005 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.140000000000001 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.85 -11.2 21.75 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.420000000000002 112.993 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 55' ' ' TRP . 87.7 mt-30 59.34 17.6 6.0 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.401 1.08 . . . . 75.209999999999994 113.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.61 94.22 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.44 0.533 . . . . 65.439999999999998 112.44 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.0 p -86.29 -0.45 55.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.977 0.732 . . . . 75.030000000000001 112.977 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.516 ' CD1' ' HA ' ' A' ' 52' ' ' GLN . 4.5 p-90 -139.85 69.32 1.36 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.624 1.202 . . . . 74.519999999999996 110.835 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.8 11.6 4.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.367 -1.288 . . . . 74.219999999999999 110.679 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -82.24 74.01 9.24 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.629 1.204 . . . . 72.540000000000006 111.727 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -177.77 78.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 112.967 -1.924 . . . . 73.310000000000002 107.088 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.02 -18.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.215 -0.902 . . . . 72.239999999999995 110.604 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.62 77.93 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 122.127 0.965 . . . . 75.310000000000002 109.015 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -147.13 161.7 40.34 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.547 -1.649 . . . . 62.009999999999998 106.547 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -115.47 91.74 3.7 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.258 -0.645 . . . . 70.219999999999999 109.258 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.5 ttm -159.72 128.51 5.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 75.510000000000005 110.208 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.86 144.41 8.55 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.827 -0.805 . . . . 74.510000000000005 108.827 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -120.14 132.95 55.6 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.529 -0.545 . . . . 74.209999999999994 109.529 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--N 1.301 -1.518 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 -179.232 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.243 0.736 0 CA-C-O 121.048 0.451 . . . . 73.230000000000004 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -153.46 75.86 0.23 Allowed Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.859 -0.686 . . . . 40.399999999999999 111.821 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 33.5 t -76.4 -45.89 29.66 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.795 -1.557 . . . . 75.230000000000004 106.795 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.57 90.78 3.12 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.521 -1.659 . . . . 71.420000000000002 106.521 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.8 -27.36 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.433 -0.803 . . . . 54.450000000000003 112.225 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 30.4 p -134.23 -84.91 0.43 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 121.005 -0.278 . . . . 72.450000000000003 111.005 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 53.81 86.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.11 0.964 . . . . 72.040000000000006 113.304 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.98 -55.9 3.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.418 -0.81 . . . . 74.510000000000005 110.802 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.41 ' CZ ' ' HA ' ' B' ' 209' ' ' ARG . 1.7 tpm_? -141.86 81.68 1.77 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.793 0.806 . . . . 75.340000000000003 109.134 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m -92.7 119.06 31.71 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.833 -1.076 . . . . 64.430000000000007 109.877 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.340000000000003 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.439999999999998 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.498 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 74.150000000000006 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 75.439999999999998 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.441 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.510000000000005 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 65.239999999999995 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 74.340000000000003 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.577 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.530000000000001 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.522 HD13 ' O ' ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.230000000000004 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.420000000000002 110.681 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 75.420000000000002 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.319999999999993 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 64.439999999999998 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.430000000000007 104.811 173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.505 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 74.409999999999997 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.430000000000007 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.513 ' HH ' HG21 ' A' ' 29' ' ' ILE . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.120000000000005 107.895 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.140000000000001 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' B' ' 236' ' ' CYS . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.519999999999996 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.140000000000001 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 73.420000000000002 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 63.109999999999999 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.150000000000006 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.040000000000006 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 75.329999999999998 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 228' ' ' THR . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.530000000000001 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 71.519999999999996 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.519999999999996 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.55 HD12 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.450000000000003 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' THR . . . . . . . . . . . . . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 75.209999999999994 110.233 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 64.150000000000006 112.554 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 74.329999999999998 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.030000000000001 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 49' ' ' CYS . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.430000000000007 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.513 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 72.140000000000001 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 72.109999999999999 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.340000000000003 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.485 ' SG ' HD23 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.350000000000001 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' B' ' 252' ' ' GLN . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.519999999999996 109.662 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo -76.88 38.26 0.63 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 74.340000000000003 111.241 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.494 ' HA ' ' CD1' ' B' ' 255' ' ' TRP . 95.0 mt-30 65.23 72.76 0.42 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.435 1.094 . . . . 72.409999999999997 111.309 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -140.41 -45.0 0.41 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.464 -1.244 . . . . 73.239999999999995 110.702 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 74.7 p -116.01 -1.86 12.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.583 0.586 . . . . 74.319999999999993 112.583 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . 0.494 ' CD1' ' HA ' ' B' ' 252' ' ' GLN . 5.6 p-90 -65.05 -25.26 67.74 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 111.579 0.214 . . . . 75.530000000000001 111.579 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 47.3 t 67.85 -80.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.694 1.198 . . . . 73.099999999999994 110.235 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -165.24 29.87 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.301 -0.629 . . . . 72.519999999999996 109.301 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.59 140.2 47.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.014 -0.993 . . . . 52.0 111.837 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.73 18.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.3 1.048 . . . . 73.0 108.532 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 85.8 t -93.18 91.19 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.205 -0.907 . . . . 71.310000000000002 111.905 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . 0.476 ' NE ' ' HA ' ' B' ' 261' ' ' ARG . 3.1 mmp_? -153.43 82.27 1.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.82 1.248 . . . . 74.329999999999998 110.144 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.9 p -79.43 96.16 5.97 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.331 -0.988 . . . . 71.329999999999998 108.331 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 45.4 ttm -128.77 145.46 51.18 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.051 -0.977 . . . . 75.129999999999995 109.616 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.55 134.22 53.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.693 -1.595 . . . . 74.400000000000006 106.693 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -149.52 132.14 15.85 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.095 -0.705 . . . . 74.5 109.095 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.572 ' HZ3' ' HB3' ' B' ' 266' ' ' LYS . 8.1 mtpm? . . . . . 0 C--N 1.293 -1.88 0 O-C-N 123.668 0.605 . . . . 73.349999999999994 110.691 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 2' ' ' GLY . 14.9 m . . . . . 0 C--O 1.217 -0.642 0 CA-C-O 119.787 -0.149 . . . . 74.0 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.526 ' H ' HG21 ' A' ' 1' ' ' VAL . . . -99.23 53.06 1.05 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 106.616 -2.594 . . . . 39.07 106.616 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -111.83 25.69 11.37 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.035 -1.082 . . . . 70.420000000000002 109.885 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.69 98.3 2.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.036 -0.529 . . . . 74.439999999999998 111.301 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.92 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 109.726 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 m -95.12 91.2 6.21 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.962 -1.125 . . . . 70.409999999999997 107.962 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.94 92.32 7.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.462 -1.245 . . . . 72.319999999999993 107.774 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 38.1 ttpt -118.97 142.94 47.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.565 -0.743 . . . . 64.340000000000003 111.574 -171.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' A' ' 8' ' ' LYS . 28.2 mmm180 64.91 14.17 9.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.222 1.409 . . . . 75.430000000000007 112.026 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -85.21 129.83 34.73 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.348 -0.842 . . . . 65.129999999999995 112.468 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.049999999999997 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 74.140000000000001 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 72.409999999999997 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HG ' ' CD2' ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 74.010000000000005 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 75.140000000000001 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.129999999999995 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.310000000000002 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.230000000000004 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 63.439999999999998 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 73.129999999999995 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 72.140000000000001 108.329 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.519999999999996 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 73.340000000000003 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.439999999999998 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.040000000000006 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.349999999999994 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HH ' HG22 ' B' ' 229' ' ' ILE . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.409999999999997 108.355 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 74.510000000000005 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 73.430000000000007 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.299999999999997 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.099999999999994 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.099999999999994 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.409999999999997 110.684 -173.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.79 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 70.409999999999997 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.450000000000003 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.329999999999998 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 74.319999999999993 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 60.409999999999997 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 72.129999999999995 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.519999999999996 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.402 ' HA ' HD13 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.549999999999997 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.450000000000003 114.65 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.120000000000005 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.140000000000001 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD23 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 62.200000000000003 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.310000000000002 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 74.510000000000005 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 63.420000000000002 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.400000000000006 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 52' ' ' GLN . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.420000000000002 105.949 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo -68.31 32.88 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.540000000000006 113.368 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 54.0 mt-30 56.77 38.58 29.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.595 1.188 . . . . 71.120000000000005 110.232 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.89 -50.31 7.2 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 113.116 -1.856 . . . . 60.329999999999998 108.525 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.44 HG22 ' OD1' ' A' ' 50' ' ' ASP . 15.3 t -99.23 -17.84 17.91 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.808 -0.757 . . . . 62.43 109.747 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -83.99 76.82 10.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.651 0.739 . . . . 75.340000000000003 112.503 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.8 m -97.23 137.81 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 107.358 -1.349 . . . . 64.430000000000007 107.358 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -132.45 152.61 51.45 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.379 -0.528 . . . . 74.519999999999996 110.129 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.99 109.71 2.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.386 -0.968 . . . . 73.310000000000002 108.386 174.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.98 3.36 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.251 0.548 . . . . 75.140000000000001 110.635 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.39 146.31 11.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.84 -1.17 . . . . 63.439999999999998 107.84 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -124.97 148.54 48.36 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.557 -0.457 . . . . 74.450000000000003 109.961 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.9 t -83.53 -17.25 42.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.186 -1.042 . . . . 71.129999999999995 108.186 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.7 tmm? 74.12 114.68 0.06 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.113 1.365 . . . . 63.340000000000003 111.907 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -140.18 -168.68 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.819 -1.919 . . . . 73.549999999999997 105.819 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HD2' ' N ' ' A' ' 65' ' ' ARG . 6.5 mpt_? -114.33 142.57 46.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 118.739 0.7 . . . . 75.340000000000003 110.353 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.293 179.175 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.339 0.59 . . . . 75.030000000000001 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.45 -101.59 2.02 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.024 -1.23 . . . . 74.510000000000005 110.024 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 45.7 m 63.9 16.53 9.92 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.033 0.921 . . . . 64.340000000000003 112.491 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.74 16.56 20.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.018 -0.992 . . . . 71.409999999999997 109.308 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.1 97.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.645 -1.161 . . . . 62.229999999999997 112.306 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 32.5 m -86.61 87.75 7.51 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.83 -1.544 . . . . 71.349999999999994 106.83 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.59 127.46 32.86 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.454 -0.793 . . . . 53.310000000000002 112.105 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -99.48 101.13 12.28 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.444 -0.798 . . . . 74.420000000000002 109.529 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 67.13 97.63 0.05 Allowed 'General case' 0 C--O 1.251 1.182 0 C-N-CA 125.162 1.385 . . . . 65.450000000000003 112.816 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m -79.54 85.78 5.26 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 109.535 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 70.400000000000006 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.329999999999998 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.68 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 64.230000000000004 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.349999999999994 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.549999999999997 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.409999999999997 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.540000000000006 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 75.120000000000005 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.099999999999994 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.399999999999999 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.530000000000001 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.230000000000004 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE2' ' N ' ' B' ' 225' ' ' LYS . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 74.310000000000002 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.140000000000001 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 75.310000000000002 108.54 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 74.329999999999998 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.319999999999993 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.010000000000005 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.140000000000001 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.340000000000003 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 72.209999999999994 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.409999999999997 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 74.310000000000002 108.76 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.130000000000003 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 74.150000000000006 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.737 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.040000000000006 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.538 ' HB ' ' HE3' ' B' ' 225' ' ' LYS . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.430000000000007 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 75.230000000000004 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 74.430000000000007 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.430000000000007 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.109999999999999 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.230000000000004 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.140000000000001 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.519999999999996 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.522 ' SG ' HD23 ' A' ' 45' ' ' LEU . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.439999999999998 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.219999999999999 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.53 15.59 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.010000000000005 110.899 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 67.31 -97.3 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.878 1.671 . . . . 74.409999999999997 112.497 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.51 -72.6 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 114.687 1.365 . . . . 74.129999999999995 114.687 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 9.9 t -78.66 -3.21 42.92 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.473 0.709 . . . . 75.120000000000005 112.365 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.36 103.41 11.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 112.507 0.558 . . . . 74.239999999999995 112.507 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.18 82.41 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 122.463 1.125 . . . . 73.430000000000007 109.059 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -140.41 116.59 10.55 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.717 -1.129 . . . . 73.310000000000002 109.226 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.06 175.66 5.68 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.324 -0.991 . . . . 64.219999999999999 108.324 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.09 -2.16 9.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 122.123 -0.361 . . . . 75.349999999999994 110.993 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.42 127.67 13.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 123.936 0.772 . . . . 74.319999999999993 112.739 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . 0.475 ' NH1' ' HB3' ' B' ' 264' ' ' ASP . 41.2 ptt180 -155.71 163.04 40.4 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.476 -1.305 . . . . 74.409999999999997 107.476 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.3 t -73.54 -64.88 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.039 -0.726 . . . . 71.209999999999994 109.039 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 48.0 ttm -173.32 112.02 0.21 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.884 -0.598 . . . . 73.310000000000002 109.77 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . 0.475 ' HB3' ' NH1' ' B' ' 261' ' ' ARG . 29.3 t70 -120.29 127.18 52.13 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.492 -1.299 . . . . 75.120000000000005 107.492 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -71.2 -78.76 0.07 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.765 0.654 . . . . 75.430000000000007 112.765 -173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 57.7 pttt . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.237 -0.887 . . . . 74.430000000000007 111.199 -178.084 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 111.849 0.314 . . . . 75.310000000000002 111.849 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.05 160.54 23.13 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.418 -1.073 . . . . 60.210000000000001 110.418 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -78.02 113.57 16.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.873 0.336 . . . . 71.230000000000004 110.147 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -74.09 112.71 10.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.678 -1.23 . . . . 72.510000000000005 107.678 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.74 122.45 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.212 0.529 . . . . 74.310000000000002 111.158 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -89.13 154.04 20.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.437 -1.32 . . . . 64.219999999999999 107.437 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.28 82.72 4.56 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -78.31 -70.32 0.5 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.409 -0.96 . . . . 73.310000000000002 108.409 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -85.33 98.95 10.83 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.025 -1.472 . . . . 70.439999999999998 107.025 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m -95.72 132.31 41.06 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 109.577 -0.527 . . . . 72.340000000000003 109.577 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 74.519999999999996 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 73.299999999999997 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.219999999999999 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.239999999999995 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 65.019999999999996 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.530000000000001 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.239999999999995 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 72.019999999999996 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.310000000000002 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 60.32 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.510000000000005 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.129999999999995 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.200000000000003 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.540000000000006 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 74.310000000000002 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 74.319999999999993 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.552 HD13 HD12 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.120000000000005 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 64.400000000000006 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.230000000000004 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.340000000000003 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.219999999999999 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.439999999999998 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.319999999999993 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.209999999999994 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.439999999999998 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 72.310000000000002 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.140000000000001 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.575 HD13 HD12 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.329999999999998 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.418 HG21 HG22 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.409999999999997 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.319999999999993 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.200000000000003 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.039999999999999 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 72.030000000000001 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.430000000000007 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' B' ' 214' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.219999999999999 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.229999999999997 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.099999999999994 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.040000000000006 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.53 33.17 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 71.340000000000003 110.349 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 78.41 -43.42 0.36 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.881 1.672 . . . . 75.129999999999995 111.643 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.51 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 117.408 2.373 . . . . 74.319999999999993 117.408 166.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.9 m 68.36 88.96 0.11 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.882 0.849 . . . . 73.239999999999995 112.971 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -170.45 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.073 -0.967 . . . . 74.420000000000002 109.67 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.3 m -56.82 -24.24 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.512 -0.767 . . . . 64.340000000000003 111.296 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 72.23 -63.07 0.44 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 124.69 1.196 . . . . 74.400000000000006 112.579 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.2 141.49 46.89 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.449 -0.574 . . . . 70.510000000000005 109.449 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.61 18.85 7.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.737 0.78 . . . . 62.210000000000001 109.92 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t 74.7 -81.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 124.522 1.129 . . . . 72.219999999999999 110.647 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 173.01 156.42 0.1 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.792 -1.559 . . . . 74.129999999999995 106.792 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 m -73.84 96.7 2.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.383 -0.969 . . . . 73.349999999999994 108.383 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.66 177.72 4.74 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.702 -0.681 . . . . 62.409999999999997 111.798 -176.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.86 107.22 2.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.044 -0.525 . . . . 74.340000000000003 111.133 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -155.06 114.53 3.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.715 -0.846 . . . . 72.519999999999996 108.715 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.295 -1.783 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.466 -179.073 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.635 -0.876 . . . . 75.310000000000002 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 134.59 69.17 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.579 -0.82 . . . . 75.329999999999998 111.398 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 28.3 m 68.87 155.68 0.13 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.575 1.15 . . . . 63.439999999999998 111.958 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -80.43 104.09 10.73 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 73.310000000000002 108.731 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.35 101.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.913 0.863 . . . . 73.549999999999997 110.861 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 31.7 t -100.92 -164.42 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.08 -0.964 . . . . 71.230000000000004 109.284 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.46 74.83 0.77 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.365 0.666 . . . . 73.540000000000006 112.679 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -104.67 -39.91 6.19 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.417 -1.697 . . . . 75.340000000000003 106.417 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -135.92 144.9 45.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m -102.05 121.7 42.69 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.962 -0.755 . . . . 74.439999999999998 108.962 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.319999999999993 107.395 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.432 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.519999999999996 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.430000000000007 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.562 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 74.150000000000006 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 61.450000000000003 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 75.010000000000005 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.420000000000002 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.299999999999997 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.402 ' H ' HD21 ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.329999999999998 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.030000000000001 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.439999999999998 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 74.239999999999995 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.019999999999996 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.76 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.450000000000003 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.319999999999993 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.109999999999999 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 72.400000000000006 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 72.349999999999994 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.409999999999997 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 74.230000000000004 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.119999999999997 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.319999999999993 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 71.540000000000006 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.129999999999995 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 73.219999999999999 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.549999999999997 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.400000000000006 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.140000000000001 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.219999999999999 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.420000000000002 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.329999999999998 111.182 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 72.340000000000003 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.310000000000002 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.340000000000003 107.391 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.450000000000003 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.239999999999995 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.58 -0.15 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.049999999999997 108.289 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.432 ' H ' ' C ' ' B' ' 250' ' ' ASP . 70.1 mt-30 73.19 -80.8 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.3 2.24 . . . . 72.140000000000001 109.2 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.07 -85.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 115.248 1.573 . . . . 74.120000000000005 115.248 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 21.3 p -97.2 -52.04 3.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 114.659 1.355 . . . . 73.25 114.659 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -60.69 -24.49 65.66 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.871 1.063 . . . . 75.150000000000006 113.871 -168.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.1 m -57.16 -32.32 40.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 112.384 0.513 . . . . 75.019999999999996 112.384 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 68.99 -42.11 0.48 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.412 1.085 . . . . 72.129999999999995 113.045 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.19 145.93 28.9 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 124.106 0.963 . . . . 71.5 109.629 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.1 25.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 122.435 1.112 . . . . 73.519999999999996 108.81 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.81 153.01 11.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.782 -0.821 . . . . 64.430000000000007 108.782 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -73.23 154.4 40.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.149 -0.685 . . . . 74.129999999999995 109.149 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 40.9 m -68.51 123.19 20.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.525 -0.546 . . . . 75.230000000000004 109.525 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.7 173.11 6.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.524 -0.307 . . . . 73.420000000000002 110.732 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.88 127.43 43.82 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.707 -0.479 . . . . 75.219999999999999 109.707 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -125.76 138.61 53.87 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.624 -0.51 . . . . 74.239999999999995 109.624 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.715 -0.846 . . . . 74.0 108.715 178.729 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.702 -0.481 . . . . 74.310000000000002 109.702 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.69 140.08 6.17 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 119.696 -1.24 . . . . 72.140000000000001 112.419 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -80.39 114.47 19.31 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 120.779 0.323 . . . . 71.439999999999998 110.158 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -79.2 130.33 35.37 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.439 -0.578 . . . . 74.340000000000003 109.439 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.36 92.46 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.235 1.017 . . . . 73.340000000000003 111.911 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -122.49 150.37 42.63 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.575 -1.193 . . . . 73.129999999999995 108.864 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -78.83 113.96 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.433 -0.951 . . . . 61.32 108.433 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 9' ' ' ARG . 87.0 tttt -98.36 -72.79 0.64 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.732 0.641 . . . . 74.25 112.732 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 22.2 mmm180 -127.28 112.16 14.75 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.635 -0.876 . . . . 72.510000000000005 108.635 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m -115.51 118.34 32.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 114.712 1.375 . . . . 71.319999999999993 114.712 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 62.509999999999998 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.510000000000005 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.409999999999997 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 61.450000000000003 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.409999999999997 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.608 HE21 ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 109.201 -177.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.510000000000005 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 70.510000000000005 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 114.063 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 73.340000000000003 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.439999999999998 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.120000000000005 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.230000000000004 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 72.120000000000005 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.009999999999998 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.299999999999997 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.578 HD13 HD12 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 65.040000000000006 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 73.109999999999999 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.119999999999997 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.240000000000002 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.140000000000001 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 71.340000000000003 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.239999999999995 111.053 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' HD12 ' A' ' 34' ' ' LEU . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.439999999999998 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.239999999999995 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.540000000000006 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 74.109999999999999 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD13 HD12 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.109999999999999 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.210000000000001 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.140000000000001 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.439999999999998 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 74.219999999999999 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 75.340000000000003 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.109999999999999 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.230000000000004 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.129999999999995 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.530000000000001 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.45 6.54 5.73 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.200000000000003 110.364 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 71.68 -44.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.548 1.939 . . . . 72.409999999999997 111.157 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 63.84 -86.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.369 1.468 . . . . 74.219999999999999 112.962 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.3 m -147.1 13.82 1.13 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.759 -0.83 . . . . 63.420000000000002 108.759 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -78.31 99.63 6.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.682 0.754 . . . . 64.510000000000005 109.703 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.67 133.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 114.937 1.458 . . . . 75.510000000000005 114.937 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HG2' ' H ' ' A' ' 58' ' ' ASP . 18.0 ttp180 -162.56 -173.57 3.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 103.126 -2.916 . . . . 73.340000000000003 103.126 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 15.1 m-20 -57.52 -26.02 60.73 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.75 1.159 . . . . 74.420000000000002 112.156 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.8 t 75.36 -45.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.037 1.335 . . . . 73.340000000000003 111.093 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.4 135.05 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 122.181 0.991 . . . . 70.140000000000001 112.466 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -129.11 47.6 2.46 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 102.382 -3.192 . . . . 73.040000000000006 102.382 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 79.08 1.53 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.085 -1.416 . . . . 64.140000000000001 113.619 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 tmm? 176.36 94.61 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 102.649 -3.093 . . . . 74.239999999999995 102.649 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -146.77 177.75 8.85 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.369 -0.533 . . . . 74.049999999999997 111.454 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -57.27 107.53 0.43 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.981 1.313 . . . . 75.439999999999998 111.318 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.734 -0.469 . . . . 73.5 109.734 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.764 -0.458 . . . . 73.310000000000002 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -119.1 128.69 7.75 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.962 -1.114 . . . . 73.230000000000004 112.723 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 54.5 m -95.86 102.43 14.23 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.318 -0.623 . . . . 73.319999999999993 109.318 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.43 149.41 21.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.448 -0.945 . . . . 74.310000000000002 108.448 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 137.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.049 0.759 . . . . 72.450000000000003 113.049 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 33.6 p -163.24 96.09 0.87 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.211 -0.904 . . . . 74.530000000000001 110.325 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -105.58 92.88 4.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.164 0.507 . . . . 73.519999999999996 110.805 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -93.06 -27.58 16.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.728 -1.212 . . . . 62.399999999999999 107.728 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' B' ' 250' ' ' ASP . 17.3 mmm180 -118.43 100.17 7.3 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.536 -2.024 . . . . 74.319999999999993 105.536 170.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m -95.34 101.28 12.99 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.363 0.601 . . . . 74.129999999999995 110.888 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.540000000000006 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 73.040000000000006 108.823 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.439999999999998 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.476 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 73.25 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.400000000000006 109.194 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 73.040000000000006 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.586 HE21 ' HA ' ' B' ' 217' ' ' GLN . 0.0 OUTLIER 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 75.340000000000003 111.465 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 73.340000000000003 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 72.400000000000006 110.329 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 65.25 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 73.420000000000002 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.340000000000003 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.120000000000005 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 72.430000000000007 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' B' ' 225' ' ' LYS . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.210000000000001 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 29' ' ' ILE . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.329999999999998 107.883 174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 71.230000000000004 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.535 HD12 HD13 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 74.140000000000001 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 75.329999999999998 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.140000000000001 106.353 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.240000000000002 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.409999999999997 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.631 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 74.209999999999994 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 73.420000000000002 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 55.039999999999999 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.200000000000003 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.319999999999993 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.519999999999996 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.420000000000002 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.310000000000002 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 73.129999999999995 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.519999999999996 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.417 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 64.230000000000004 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.417 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 74.030000000000001 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 63.420000000000002 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 64.030000000000001 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.140000000000001 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.407 ' SG ' HD23 ' B' ' 234' ' ' LEU . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 73.439999999999998 111.536 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.477 ' HB2' HH22 ' B' ' 209' ' ' ARG . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.430000000000007 109.46 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo -83.62 19.85 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.219999999999999 111.698 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 66.75 -66.05 0.19 Allowed 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.033 1.333 . . . . 73.340000000000003 112.236 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 46.0 -99.0 0.04 OUTLIER 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.135 1.374 . . . . 72.310000000000002 113.701 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 63.1 m -157.93 95.51 1.41 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.775 -0.824 . . . . 70.420000000000002 108.775 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -129.06 101.33 6.0 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.028 -0.987 . . . . 75.430000000000007 109.185 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.3 m -85.99 113.65 24.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.73 0.776 . . . . 71.219999999999999 110.924 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -157.9 -57.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.056 -0.975 . . . . 74.340000000000003 108.476 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -123.18 -63.23 1.27 Allowed 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.838 -0.619 . . . . 74.519999999999996 109.808 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 70.0 t 70.61 -57.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.302 1.041 . . . . 75.329999999999998 110.48 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.37 83.33 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 122.473 1.13 . . . . 63.119999999999997 111.637 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.05 93.26 4.33 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.117 -2.179 . . . . 71.310000000000002 105.117 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 36.9 m -106.47 101.1 10.58 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.431 -0.804 . . . . 62.219999999999999 112.492 -172.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.06 108.18 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.41 -2.07 . . . . 71.129999999999995 105.41 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.12 153.59 18.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.502 -0.479 . . . . 73.310000000000002 109.793 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -141.51 154.22 45.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.638 -0.504 . . . . 71.0 109.638 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.369 -0.974 . . . . 74.530000000000001 108.369 176.587 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.115 0.413 . . . . 74.120000000000005 112.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.91 9.27 37.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.397 -0.906 . . . . 61.43 113.028 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 p -98.94 108.74 21.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.392 -0.475 . . . . 70.040000000000006 110.056 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -118.57 98.83 6.44 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.638 -0.425 . . . . 73.25 112.077 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.41 90.56 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.213 -1.032 . . . . 74.319999999999993 108.213 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -146.38 -25.42 0.43 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.84 -0.618 . . . . 75.549999999999997 110.279 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -90.24 148.22 23.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.449 -1.315 . . . . 75.010000000000005 107.449 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.37 -15.65 35.03 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 111.894 0.331 . . . . 74.239999999999995 111.894 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HE ' ' HB2' ' A' ' 50' ' ' ASP . 69.9 ttt180 -144.42 99.39 3.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.641 -0.874 . . . . 70.120000000000005 108.641 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t -73.52 126.72 30.87 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.641 0.734 . . . . 74.150000000000006 112.42 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 71.209999999999994 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.400000000000006 110.455 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.230000000000004 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HG ' HD23 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.010000000000005 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.340000000000003 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.405 HG23 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.319999999999993 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.409999999999997 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.430000000000007 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.409999999999997 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.519999999999996 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.446 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.129999999999995 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.530000000000001 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.510000000000005 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.540000000000006 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 73.549999999999997 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.019999999999996 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 65.129999999999995 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD13 HD12 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 74.140000000000001 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.310000000000002 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.230000000000004 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.439999999999998 111.41 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.672 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 71.329999999999998 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 75.510000000000005 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 72.109999999999999 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 75.099999999999994 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.349999999999994 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.606 HD13 HD12 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 73.319999999999993 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.239999999999995 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 72.409999999999997 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.549999999999997 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 62.350000000000001 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.340000000000003 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 73.549999999999997 110.504 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.430000000000007 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.672 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' HB2' ' HE ' ' A' ' 9' ' ' ARG . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.340000000000003 106.992 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo -83.21 34.38 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 74.319999999999993 112.085 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 46.8 mt-30 67.22 43.05 2.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 124.073 0.949 . . . . 73.450000000000003 111.198 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 104.35 2.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.271 -0.877 . . . . 75.219999999999999 108.903 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.4 m 76.43 -0.17 3.11 Favored 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 124.106 0.962 . . . . 65.129999999999995 110.934 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 28.52 2.3 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.185 -0.672 . . . . 75.209999999999994 109.185 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.08 -17.93 12.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.06 -0.518 . . . . 74.319999999999993 111.507 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -67.24 -59.01 3.78 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.195 -0.457 . . . . 74.450000000000003 109.871 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.1 113.38 26.48 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 109.394 -0.595 . . . . 62.350000000000001 109.394 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.4 m -99.8 13.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.814 -0.63 . . . . 75.099999999999994 111.425 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t 62.64 90.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 121.619 0.723 . . . . 75.299999999999997 109.532 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -77.16 86.85 3.62 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.68 0.752 . . . . 75.530000000000001 110.846 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 t -171.95 39.49 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.701 -3.074 . . . . 75.25 102.701 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -107.85 15.67 24.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.026 -1.897 . . . . 61.219999999999999 112.641 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -81.63 87.28 6.29 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.534 -0.866 . . . . 74.530000000000001 109.398 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -176.72 129.85 0.19 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.561 1.145 . . . . 73.519999999999996 108.143 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 C--O 1.252 1.19 0 O-C-N 123.394 0.434 . . . . 70.209999999999994 110.833 179.796 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.806 0.813 . . . . 74.040000000000006 110.509 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.48 41.6 1.86 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 115.263 -0.881 . . . . 72.120000000000005 111.059 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 58.5 p -76.39 104.33 6.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.454 -0.573 . . . . 72.319999999999993 109.454 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -123.11 107.53 11.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 119.83 -0.748 . . . . 72.129999999999995 112.209 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.32 99.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 105.378 -2.082 . . . . 73.430000000000007 105.378 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.4 t -72.32 97.53 2.04 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.49 0.662 . . . . 60.219999999999999 111.425 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.76 95.08 3.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.396 -1.335 . . . . 74.540000000000006 107.396 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 90.61 1.01 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.348 0.87 . . . . 74.209999999999994 113.348 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -92.43 88.04 6.23 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.359 -2.089 . . . . 74.439999999999998 105.359 168.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -102.83 137.05 41.55 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.233 -0.894 . . . . 64.430000000000007 110.932 -171.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.420000000000002 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.319999999999993 109.539 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.450000000000003 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.489 HD23 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.129999999999995 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.340000000000003 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.429 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 74.329999999999998 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.120000000000005 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.230000000000004 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.530000000000001 110.606 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.420000000000002 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.230000000000004 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.329999999999998 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.130000000000003 110.304 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 73.319999999999993 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.430000000000007 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 74.340000000000003 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 65.030000000000001 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.520000000000003 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.456 ' HB2' HD13 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.219999999999999 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.439999999999998 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.59 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.439999999999998 110.744 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.704 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.120000000000005 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.299999999999997 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.704 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 70.319999999999993 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.120000000000005 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.120000000000005 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.409999999999997 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.420000000000002 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.509 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.510000000000005 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 215' ' ' THR . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 74.030000000000001 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.140000000000001 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 74.5 111.135 -175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.319999999999993 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.100000000000001 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 72.230000000000004 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' B' ' 252' ' ' GLN . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.140000000000001 106.343 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo -73.34 24.35 0.31 Allowed 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 63.049999999999997 111.573 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.59 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 49.9 mt-30 63.33 68.71 0.6 Allowed 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 125.478 1.511 . . . . 75.400000000000006 110.621 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -111.98 127.92 56.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.434 -1.712 . . . . 74.019999999999996 109.591 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 12.8 m 75.05 20.4 2.15 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.505 1.145 . . . . 65.019999999999996 109.533 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -82.54 69.56 9.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.125 0.964 . . . . 73.209999999999994 111.739 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.53 -6.39 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 113.807 -1.542 . . . . 65.010000000000005 107.154 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.38 106.31 10.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.352 -1.749 . . . . 75.530000000000001 109.52 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.6 t0 64.57 166.79 0.16 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.083 0.864 . . . . 54.539999999999999 113.286 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.37 22.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 124.182 0.993 . . . . 74.510000000000005 108.493 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 86.0 t 77.54 106.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.199 1.399 . . . . 62.329999999999998 110.447 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -74.32 79.2 1.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.81 -0.632 . . . . 73.400000000000006 110.841 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.7 t -177.7 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.843 -1.54 . . . . 75.150000000000006 106.843 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.37 72.21 1.31 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.901 0.858 . . . . 74.310000000000002 111.815 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -137.65 82.34 1.92 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.79 -1.096 . . . . 75.230000000000004 109.195 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -165.01 134.0 3.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.666 -0.697 . . . . 70.420000000000002 110.045 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 115.318 -0.855 . . . . 71.230000000000004 109.816 178.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 108.406 -0.961 . . . . 73.200000000000003 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.73 96.32 1.02 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.491 -0.862 . . . . 70.040000000000006 111.167 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -147.8 112.22 5.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.944 0.402 . . . . 75.420000000000002 111.158 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.28 154.27 19.37 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.488 -0.93 . . . . 73.140000000000001 108.488 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.24 141.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.744 -0.782 . . . . 63.520000000000003 111.284 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.0 m -89.71 123.43 33.72 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.586 -0.734 . . . . 73.239999999999995 109.292 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.51 -52.22 66.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.783 -0.821 . . . . 72.239999999999995 108.783 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -144.52 -176.03 4.88 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.824 -1.176 . . . . 65.129999999999995 107.824 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -61.94 110.86 1.68 Allowed 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.53 0.681 . . . . 63.109999999999999 112.452 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m -85.58 109.6 18.65 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.400000000000006 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.521 HG11 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.019999999999996 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 73.230000000000004 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.230000000000004 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 72.040000000000006 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.481 HG23 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.310000000000002 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.140000000000001 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 72.420000000000002 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.439999999999998 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 74.409999999999997 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.510000000000005 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.209999999999994 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HG22 HG21 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.329999999999998 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.450000000000003 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 HD12 ' B' ' 240' ' ' ILE . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 73.430000000000007 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.726 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.450000000000003 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.129999999999995 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 71.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.450000000000003 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 64.439999999999998 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 73.420000000000002 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.409999999999997 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.430000000000007 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 HD12 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 75.420000000000002 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.436 HG21 HG22 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.230000000000004 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 74.040000000000006 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 72.530000000000001 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 72.109999999999999 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.420000000000002 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 63.439999999999998 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 72.310000000000002 109.071 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.120000000000005 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 75.329999999999998 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 53.539999999999999 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.25 -1.95 12.07 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 75.040000000000006 112.392 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 67.55 -63.44 0.3 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.677 1.191 . . . . 73.25 111.799 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 66.73 -57.69 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.646 1.578 . . . . 70.239999999999995 113.05 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.2 m -110.25 92.84 4.21 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.122 -1.066 . . . . 71.219999999999999 108.122 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -139.83 -26.25 0.8 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.181 0.437 . . . . 74.439999999999998 112.181 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.19 122.29 11.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.664 0.745 . . . . 75.230000000000004 110.843 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -156.75 -42.93 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.66 -1.607 . . . . 74.409999999999997 106.66 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -125.94 -177.88 4.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 104.889 -2.263 . . . . 74.340000000000003 104.889 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.06 -5.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 107.523 -1.288 . . . . 74.420000000000002 107.523 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.1 t 78.55 75.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 113.016 -1.902 . . . . 70.439999999999998 110.461 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -91.07 99.86 12.81 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.786 -1.097 . . . . 74.420000000000002 109.293 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -142.98 -17.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.438 -0.801 . . . . 75.209999999999994 111.417 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.1 tmm? 65.69 96.77 0.05 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.056 0.943 . . . . 74.540000000000006 110.621 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.84 127.78 29.51 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.774 -0.648 . . . . 71.349999999999994 111.589 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -135.53 142.94 45.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.185 -0.672 . . . . 73.319999999999993 109.185 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 109.314 -0.624 . . . . 74.340000000000003 109.314 177.761 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.223 -0.658 . . . . 75.129999999999995 109.223 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -127.83 -71.95 0.16 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.037 -0.825 . . . . 75.420000000000002 111.037 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.9 t -156.29 81.51 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.333 -0.988 . . . . 75.239999999999995 108.333 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.73 91.56 2.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.871 0.843 . . . . 74.230000000000004 111.312 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.35 159.17 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.494 -0.775 . . . . 75.420000000000002 110.311 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 19.5 m -84.95 80.26 9.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.063 0.935 . . . . 73.239999999999995 109.27 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -144.87 -46.37 0.23 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.875 -1.898 . . . . 62.310000000000002 105.875 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -94.63 123.75 38.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.964 -1.495 . . . . 65.109999999999999 106.964 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -95.86 100.84 12.49 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.648 0.737 . . . . 75.129999999999995 112.985 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -82.79 132.06 35.18 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.782 -1.099 . . . . 63.439999999999998 108.675 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.140000000000001 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 72.409999999999997 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.510000000000005 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.521 HD12 HG11 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.140000000000001 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 ' O ' ' B' ' 243' ' ' ARG . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.109999999999999 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.109999999999999 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.510000000000005 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 73.219999999999999 107.432 176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 75.25 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.430000000000007 110.539 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.219999999999999 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 72.120000000000005 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.239999999999995 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.109999999999999 110.477 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 73.209999999999994 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.450000000000003 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 74.239999999999995 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.430000000000007 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.099999999999994 110.265 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 75.519999999999996 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 65.230000000000004 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.310000000000002 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.140000000000001 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.129999999999995 109.427 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 228' ' ' THR . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.420000000000002 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.510000000000005 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 75.310000000000002 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 75.030000000000001 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.140000000000001 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.310000000000002 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.409999999999997 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.42 ' O ' HG23 ' B' ' 216' ' ' THR . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.439999999999998 108.726 170.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.210000000000001 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.412 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' B' ' 213' ' ' SER . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 72.25 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 74.409999999999997 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 72.140000000000001 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.340000000000003 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.340000000000003 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo -77.89 14.8 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.549999999999997 112.853 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.428 ' HB3' ' NE1' ' B' ' 255' ' ' TRP . 95.8 mt-30 68.24 -75.36 0.07 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 73.040000000000006 112.159 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 35.83 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 74.439999999999998 116.424 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 16.6 m -69.1 -3.46 13.38 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.712 1.205 . . . . 74.430000000000007 112.755 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . 0.428 ' NE1' ' HB3' ' B' ' 252' ' ' GLN . 0.2 OUTLIER -81.51 -0.62 42.75 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.329 -0.857 . . . . 65.239999999999995 109.805 178.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.19 126.72 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.53 -1.214 . . . . 73.209999999999994 112.56 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 172.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.365 -2.087 . . . . 73.239999999999995 105.365 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.82 168.52 19.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.628 -1.99 . . . . 74.010000000000005 105.628 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.02 -16.71 16.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.24 0.543 . . . . 73.409999999999997 109.681 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 68.53 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.051 1.34 . . . . 71.319999999999993 111.892 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 124.29 16.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.8 -1.926 . . . . 73.129999999999995 105.8 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.6 m -146.6 -78.12 0.17 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 122.499 -0.126 . . . . 70.439999999999998 110.884 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -103.53 -57.48 2.03 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.835 -1.172 . . . . 70.019999999999996 107.835 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.1 136.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.2 1.926 . . . . 71.209999999999994 116.2 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -132.19 147.99 52.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.366 -1.346 . . . . 75.209999999999994 107.366 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 120.624 -0.43 . . . . 75.450000000000003 110.054 -177.885 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 109.292 -0.633 . . . . 64.200000000000003 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 32.1 2.45 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.453 -0.88 . . . . 53.039999999999999 111.269 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -101.2 102.72 13.68 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.782 0.325 . . . . 74.140000000000001 111.119 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.28 90.55 8.44 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.477 -1.305 . . . . 73.209999999999994 107.477 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.56 164.45 2.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.441 -0.8 . . . . 71.019999999999996 111.968 -172.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 m -86.27 138.59 31.73 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.921 -1.511 . . . . 73.420000000000002 106.921 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -123.62 144.25 49.73 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.629 -0.828 . . . . 74.409999999999997 110.477 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -55.57 131.64 46.74 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.158 0.983 . . . . 72.430000000000007 108.917 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -50.71 128.88 21.73 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 112.869 0.692 . . . . 75.019999999999996 112.869 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -94.94 122.82 37.99 Favored 'General case' 0 N--CA 1.401 -2.883 0 CA-C-N 115.163 -0.926 . . . . 62.210000000000001 108.896 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.510000000000005 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 71.129999999999995 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 75.030000000000001 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.62 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 75.400000000000006 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.019999999999996 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 HG23 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.010000000000005 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 72.030000000000001 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 65.209999999999994 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 71.129999999999995 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.150000000000006 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.040000000000006 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 71.340000000000003 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.450000000000003 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 73.5 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 62.229999999999997 109.274 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 73.209999999999994 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.209999999999994 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.450000000000003 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.506 ' CG2' ' HG2' ' A' ' 31' ' ' GLU . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.409999999999997 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.349999999999994 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.019999999999996 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.299999999999997 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 60.219999999999999 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.430000000000007 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.200000000000003 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.450000000000003 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 71.099999999999994 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.530000000000001 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.099999999999994 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 74.019999999999996 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 73.019999999999996 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.329999999999998 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.340000000000003 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 72.329999999999998 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 63.509999999999998 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.450000000000003 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 71.340000000000003 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 74.329999999999998 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' B' ' 245' ' ' LEU . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.420000000000002 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 52' ' ' GLN . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.209999999999994 108.183 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.49 28.84 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.540000000000006 112.799 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 50' ' ' ASP . 43.4 mt-30 69.65 21.44 6.6 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.834 1.254 . . . . 75.239999999999995 110.119 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.72 -25.51 35.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.261 -0.881 . . . . 62.119999999999997 109.74 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.3 m -101.14 11.21 39.9 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.474 1.13 . . . . 75.329999999999998 108.484 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -117.28 -55.44 2.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.021 -0.991 . . . . 74.510000000000005 109.834 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t 56.96 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.429 1.092 . . . . 72.120000000000005 112.011 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 68.85 94.85 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.448 1.099 . . . . 75.219999999999999 110.014 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -117.75 153.49 33.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.313 -0.403 . . . . 74.109999999999999 111.167 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -85.16 -16.59 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.4 0.68 . . . . 65.5 111.852 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.8 t -86.69 103.88 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.999 0.905 . . . . 75.439999999999998 110.336 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -86.81 150.65 23.99 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.603 -1.181 . . . . 72.329999999999998 108.548 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -67.75 93.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.398 0.618 . . . . 73.099999999999994 111.006 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 50.6 ttm -102.48 34.77 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.578 -1.638 . . . . 74.439999999999998 106.578 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.26 -37.79 86.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.967 -1.47 . . . . 70.129999999999995 111.203 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 50.18 85.08 0.03 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.149 0.98 . . . . 73.439999999999998 111.333 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.456 1.102 . . . . 74.200000000000003 111.68 -176.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.369 -0.604 . . . . 75.219999999999999 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 127.22 54.3 0.14 Allowed Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.741 -0.742 . . . . 73.329999999999998 111.266 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 30.4 m -143.04 87.48 1.98 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.476 0.655 . . . . 73.329999999999998 109.523 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -110.2 130.69 55.5 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.729 -1.212 . . . . 75.400000000000006 107.729 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 23.8 m -103.09 103.12 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.199 0.523 . . . . 75.319999999999993 110.478 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 69.1 p -73.66 102.46 3.93 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.191 -0.459 . . . . 54.140000000000001 110.234 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.87 108.24 10.97 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.817 -0.808 . . . . 54.409999999999997 108.817 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.62 -54.95 3.92 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.172 -0.922 . . . . 74.400000000000006 109.525 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -124.16 126.12 45.61 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.245 -1.02 . . . . 72.25 108.245 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t -95.82 97.75 9.9 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.086 0.946 . . . . 73.519999999999996 109.052 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 45.329999999999998 107.638 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.62 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.439999999999998 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.030000000000001 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 74.129999999999995 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.439999999999998 110.931 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.040000000000006 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.439999999999998 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 73.200000000000003 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.25 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 71.209999999999994 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.420000000000002 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 74.540000000000006 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.230000000000004 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 72.310000000000002 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.129999999999995 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.439999999999998 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' B' ' 235' ' ' ARG . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.430000000000007 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 75.420000000000002 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.537 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.420000000000002 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.040000000000006 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.747 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 75.209999999999994 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 73.430000000000007 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.040000000000006 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 73.420000000000002 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.319999999999993 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.239999999999995 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 75.230000000000004 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.491 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 73.25 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.230000000000004 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.150000000000006 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.019999999999996 113.383 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.503 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 74.230000000000004 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.299999999999997 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.239999999999995 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.019999999999996 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' B' ' 252' ' ' GLN . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.539999999999999 109.154 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.14 33.5 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 63.25 111.674 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' B' ' 250' ' ' ASP . 42.5 mt-30 67.67 44.06 1.72 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.661 1.185 . . . . 65.019999999999996 110.128 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.39 -43.01 7.85 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 113.494 -1.684 . . . . 53.350000000000001 108.122 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.8 m -85.55 -35.63 20.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.539 -0.755 . . . . 70.319999999999993 109.098 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . 0.431 ' HD1' ' OD2' ' B' ' 250' ' ' ASP . 82.5 m95 -79.65 -41.85 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.586 -0.734 . . . . 75.510000000000005 110.996 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 59.9 t 67.4 -64.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.476 1.111 . . . . 74.329999999999998 112.412 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -108.51 161.09 15.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.421 -0.955 . . . . 64.310000000000002 108.421 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.09 80.26 1.24 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.274 -1.01 . . . . 74.239999999999995 108.274 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.29 -11.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.001 -1.0 . . . . 72.409999999999997 110.757 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 52.1 t -76.28 97.66 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.179 -1.045 . . . . 64.430000000000007 108.179 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -103.11 106.4 16.91 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.947 -1.131 . . . . 74.239999999999995 107.947 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -140.48 86.9 2.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.339 0.59 . . . . 75.010000000000005 110.539 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -106.5 116.44 31.93 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.855 -0.795 . . . . 71.299999999999997 108.855 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.46 -25.74 23.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.043 -0.526 . . . . 75.25 110.963 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 71.05 166.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.157 0.983 . . . . 70.329999999999998 113.585 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 C--O 1.266 1.956 0 CA-C-N 115.277 -0.874 . . . . 74.230000000000004 109.993 178.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 120.561 0.22 . . . . 71.109999999999999 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.82 31.19 8.45 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.314 -0.946 . . . . 74.109999999999999 111.795 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -118.05 139.37 51.3 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.919 -0.771 . . . . 74.150000000000006 108.919 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.97 101.34 7.71 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.295 -0.632 . . . . 75.129999999999995 109.295 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.63 -50.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.924 0.869 . . . . 73.319999999999993 109.194 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 p -137.74 27.86 2.7 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.225 -1.398 . . . . 54.009999999999998 107.225 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.02 160.08 14.6 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.302 -1.317 . . . . 75.5 112.434 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -163.46 157.1 19.38 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.832 -2.284 . . . . 75.530000000000001 104.832 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -79.01 93.42 5.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.591 -2.003 . . . . 74.140000000000001 105.591 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m -90.81 121.86 33.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.01 -0.995 . . . . 63.539999999999999 113.217 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.129999999999995 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 73.140000000000001 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.109999999999999 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.530000000000001 110.876 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.409999999999997 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.439999999999998 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.019999999999996 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 72.099999999999994 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.120000000000005 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.210000000000001 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 73.439999999999998 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.450000000000003 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.549999999999997 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 65.140000000000001 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.319999999999993 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 72.329999999999998 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 HD13 HD12 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.239999999999995 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 74.099999999999994 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 74.109999999999999 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 74.340000000000003 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.430000000000007 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 71.200000000000003 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.299999999999997 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.609 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.420000000000002 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.400000000000006 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.736 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 74.140000000000001 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.349999999999994 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 25' ' ' LYS . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 74.099999999999994 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.457 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.409999999999997 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.439999999999998 113.262 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 74.430000000000007 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.430000000000007 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 75.25 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG22 HD21 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 71.200000000000003 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.310000000000002 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.409999999999997 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.409999999999997 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 -22.8 30.88 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.349999999999994 111.995 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 63.51 26.84 14.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.147 0.979 . . . . 73.299999999999997 112.16 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.74 97.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 75.420000000000002 110.526 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.1 p -103.93 12.45 34.3 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.914 -0.585 . . . . 72.239999999999995 110.208 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -133.68 33.88 3.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.982 -0.553 . . . . 70.310000000000002 110.28 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.21 106.18 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.949 0.881 . . . . 71.200000000000003 110.393 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -112.89 -164.16 0.9 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.435 -0.802 . . . . 74.010000000000005 109.695 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -72.28 -47.98 45.97 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 116.064 -0.516 . . . . 72.430000000000007 109.808 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.5 72.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.938 0.875 . . . . 73.120000000000005 110.586 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HE1' ' A' ' 63' ' ' MET . 11.4 p -122.76 -27.4 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.277 -1.329 . . . . 73.400000000000006 107.913 173.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.547 ' HA ' ' NE ' ' A' ' 61' ' ' ARG . 1.2 mmp_? -94.04 63.68 3.23 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 75.519999999999996 110.204 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -165.57 97.25 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.021 1.729 . . . . 74.140000000000001 106.446 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.403 ' HE1' ' O ' ' A' ' 60' ' ' VAL . 26.2 mmt -133.01 116.05 15.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 111.908 0.336 . . . . 73.239999999999995 111.908 -176.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.44 135.28 52.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.583 -0.895 . . . . 74.299999999999997 108.583 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 85.0 mtm180 -93.21 174.84 7.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.291 0.567 . . . . 74.030000000000001 111.827 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 66' ' ' LYS . 9.6 tmtt? . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 106.816 -1.55 . . . . 73.150000000000006 106.816 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.976 -0.75 . . . . 74.129999999999995 108.976 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.37 1.96 57.46 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.865 -1.061 . . . . 74.239999999999995 110.871 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 38.9 t -72.43 133.49 44.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.837 -0.431 . . . . 74.340000000000003 109.837 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -119.93 84.34 2.2 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.318 0.58 . . . . 61.049999999999997 110.409 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.18 -51.0 13.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.251 -1.759 . . . . 75.230000000000004 106.251 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 59.7 p -146.95 96.87 2.81 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.718 -1.128 . . . . 71.120000000000005 109.32 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.82 108.13 18.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.598 -0.728 . . . . 71.319999999999993 109.961 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.3 99.54 2.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.914 -0.585 . . . . 74.25 110.323 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 66.18 92.63 0.07 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.485 1.115 . . . . 73.409999999999997 112.046 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p -82.9 124.01 29.94 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.383 -0.371 . . . . 64.0 110.739 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 53.020000000000003 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.400000000000006 110.134 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.417 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 72.420000000000002 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.319999999999993 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.43 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 71.120000000000005 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 71.030000000000001 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.239999999999995 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.447 ' H ' HD22 ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.420000000000002 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.299999999999997 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.450000000000003 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.219999999999999 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 73.010000000000005 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 70.420000000000002 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.523 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.230000000000004 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.319999999999993 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 74.209999999999994 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.517 HD12 HD13 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 73.230000000000004 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 75.519999999999996 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 72.120000000000005 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.109999999999999 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.340000000000003 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 74.430000000000007 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 64.219999999999999 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.648 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.140000000000001 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 72.450000000000003 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.150000000000006 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.523 ' HB ' ' HE3' ' B' ' 225' ' ' LYS . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 74.549999999999997 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.445 ' HA ' HD11 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 72.450000000000003 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.409999999999997 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.499 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 75.420000000000002 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.530000000000001 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.584 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 75.319999999999993 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.510000000000005 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.210000000000001 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 73.030000000000001 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 75.319999999999993 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo -68.18 35.62 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 74.150000000000006 113.879 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 107.73 -1.211 . . . . 73.319999999999993 107.73 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -98.36 -51.01 4.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.175 -1.375 . . . . 64.129999999999995 112.225 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 81.2 p -98.71 0.26 44.22 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.031 -0.668 . . . . 55.200000000000003 111.811 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -112.78 102.67 10.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.167 0.803 . . . . 74.430000000000007 113.167 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.94 135.15 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.38 -1.341 . . . . 73.319999999999993 107.38 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -117.91 155.32 30.39 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.33 -0.548 . . . . 64.5 110.677 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.63 -9.37 54.44 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.621 -0.881 . . . . 74.109999999999999 108.621 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 42.0 t 73.57 -6.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.955 1.302 . . . . 74.409999999999997 110.561 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.85 -26.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.748 -0.66 . . . . 73.450000000000003 110.277 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . 0.581 ' HA ' ' HE ' ' B' ' 261' ' ' ARG . 0.7 OUTLIER -96.7 6.82 47.95 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.937 -0.477 . . . . 75.109999999999999 111.759 179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.2 m -71.52 -30.12 65.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.52 -1.659 . . . . 72.340000000000003 106.52 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.0 100.75 11.96 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.288 -2.115 . . . . 73.540000000000006 105.288 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.04 167.33 10.34 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.779 -0.452 . . . . 75.510000000000005 109.779 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -73.73 113.92 11.41 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 122.837 0.455 . . . . 75.040000000000006 111.378 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.418 -1.697 . . . . 73.329999999999998 106.418 177.52 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.213 -0.662 . . . . 74.450000000000003 109.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.63 131.17 2.46 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.608 -0.806 . . . . 70.420000000000002 111.157 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -80.51 95.1 6.38 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.35 0.595 . . . . 75.239999999999995 110.57 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.7 113.22 4.07 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.109999999999999 108.675 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.67 -22.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.951 -0.759 . . . . 61.5 108.951 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t 67.4 -178.22 0.21 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.134 0.974 . . . . 72.230000000000004 109.349 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.91 102.1 13.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.862 -1.162 . . . . 73.109999999999999 107.862 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 53.0 mtpt -121.98 135.33 54.84 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.246 -0.434 . . . . 75.120000000000005 110.62 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -94.47 72.46 3.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.012 -1.477 . . . . 74.420000000000002 107.012 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.425 ' OG1' ' HE2' ' A' ' 8' ' ' LYS . 67.9 m -115.79 124.69 51.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.88 -1.055 . . . . 75.209999999999994 112.023 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.420000000000002 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.109999999999999 109.319 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 74.239999999999995 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' CD1' ' HB ' ' B' ' 212' ' ' VAL . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 72.5 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 74.150000000000006 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 74.329999999999998 109.008 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.299999999999997 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.140000000000001 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.439999999999998 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.109999999999999 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 74.150000000000006 108.285 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.049999999999997 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.519999999999996 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.450000000000003 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' HZ1' ' HG2' ' B' ' 231' ' ' GLU . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 74.409999999999997 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 71.340000000000003 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 73.120000000000005 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 75.349999999999994 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.56 HD13 HD12 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 74.120000000000005 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.230000000000004 109.834 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' HZ2' ' B' ' 225' ' ' LYS . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.140000000000001 108.581 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 72.030000000000001 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.299999999999997 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 72.030000000000001 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.430000000000007 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.219999999999999 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.420000000000002 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.597 HD13 HD12 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.310000000000002 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.219999999999999 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 74.510000000000005 113.534 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 71.450000000000003 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 73.219999999999999 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.209999999999994 109.602 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.099999999999994 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.409999999999997 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo -77.03 39.46 0.72 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.030000000000001 111.826 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.36 56.13 3.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.275 1.036 . . . . 73.5 109.783 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.82 -47.11 2.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.351 -1.295 . . . . 73.329999999999998 109.878 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.2 m -93.55 -41.35 9.8 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.48 -0.782 . . . . 74.140000000000001 110.857 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.61 -4.77 57.0 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 114.104 1.15 . . . . 74.420000000000002 114.104 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.54 132.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.811 0.815 . . . . 74.239999999999995 112.217 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -139.96 -58.67 0.55 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 104.635 -2.357 . . . . 74.209999999999994 104.635 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -168.94 112.93 0.56 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.685 -1.598 . . . . 73.409999999999997 108.155 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -178.68 -36.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.284 -0.416 . . . . 70.150000000000006 110.724 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.85 105.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.319 -0.623 . . . . 74.109999999999999 109.319 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -132.17 117.71 18.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.6 0.714 . . . . 70.310000000000002 110.548 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.0 m -139.36 114.01 9.22 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.455 -0.793 . . . . 64.019999999999996 109.138 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.98 114.66 10.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.304 -1.739 . . . . 74.140000000000001 106.304 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -103.98 118.18 36.06 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.917 0.389 . . . . 62.439999999999998 110.754 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -84.51 -51.93 6.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.801 -0.636 . . . . 75.140000000000001 110.025 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.489 ' HB2' ' HZ1' ' A' ' 66' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.518 -0.31 . . . . 72.230000000000004 111.107 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.239 0.53 0 N-CA-C 110.326 -0.25 . . . . 74.239999999999995 110.326 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.79 28.71 1.36 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 121.362 -0.447 . . . . 63.229999999999997 112.307 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -76.48 129.81 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.338 -0.616 . . . . 74.349999999999994 109.338 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.12 100.3 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.265 0.555 . . . . 73.319999999999993 112.296 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.33 -25.9 5.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.51 -0.922 . . . . 74.209999999999994 108.51 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 28.1 t 61.96 -169.38 0.18 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.798 -1.092 . . . . 72.109999999999999 109.509 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -95.79 93.11 6.89 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.369 -0.604 . . . . 63.119999999999997 109.369 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.9 165.55 23.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.507 -0.923 . . . . 62.450000000000003 108.507 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.434 ' HB2' ' OG1' ' B' ' 254' ' ' THR . 45.8 ttp180 63.15 46.65 4.5 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 103.861 -2.644 . . . . 73.549999999999997 103.861 -164.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m -70.58 131.24 43.67 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 112.863 -1.971 . . . . 62.5 109.372 -174.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 73.530000000000001 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.497 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.200000000000003 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 72.120000000000005 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.473 HD23 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 74.219999999999999 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.310000000000002 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 61.219999999999999 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.510000000000005 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 74.409999999999997 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 64.519999999999996 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 75.5 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.209999999999994 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.299999999999997 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.340000000000003 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 71.519999999999996 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.435 ' HD2' HD11 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.219999999999999 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 75.219999999999999 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.109999999999999 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.597 HD12 HD13 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 75.040000000000006 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.099999999999994 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.435 ' HG2' ' HZ1' ' A' ' 25' ' ' LYS . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.129999999999995 108.176 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.219999999999999 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.401 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.200000000000003 108.659 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.340000000000003 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.442 ' N ' HD12 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 74.129999999999995 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.319999999999993 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 75.209999999999994 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 75.450000000000003 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.329999999999998 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.56 HD12 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.129999999999995 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.040000000000006 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.200000000000003 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 75.439999999999998 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.420000000000002 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.450000000000003 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.019999999999996 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.230000000000004 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.049999999999997 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 75.450000000000003 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.530000000000001 108.087 174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.48 36.63 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.340000000000003 112.926 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 97.4 mt-30 59.05 39.82 22.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.237 1.018 . . . . 73.400000000000006 109.05 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -99.1 -49.92 4.34 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.14 -1.391 . . . . 63.329999999999998 109.016 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' B' ' 209' ' ' ARG . 71.1 p -104.26 -24.03 13.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.922 -0.581 . . . . 71.519999999999996 109.834 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 74.9 m95 67.7 -76.32 0.05 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.455 1.102 . . . . 75.319999999999993 112.445 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.38 149.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.629 -0.508 . . . . 74.140000000000001 109.629 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -123.29 -72.78 0.67 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.717 -1.216 . . . . 74.010000000000005 107.717 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 169.89 109.45 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.98 -1.859 . . . . 73.209999999999994 105.98 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -170.89 -34.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 110.764 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.71 102.97 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.321 -0.622 . . . . 72.319999999999993 109.321 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -126.94 141.13 51.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.079 -0.711 . . . . 71.209999999999994 109.079 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -92.78 93.29 8.36 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.233 -0.654 . . . . 75.420000000000002 109.233 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 91.72 3.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.18 -1.044 . . . . 72.540000000000006 108.18 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -175.3 97.66 0.08 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.632 -2.358 . . . . 63.039999999999999 104.632 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -85.07 -32.8 22.66 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 113.992 1.108 . . . . 75.030000000000001 113.992 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.475 ' HB2' ' HZ1' ' B' ' 266' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.856 0 C-N-CA 120.081 -0.648 . . . . 73.219999999999999 111.881 -177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.568 0.223 . . . . 62.310000000000002 111.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.0 -171.19 52.03 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.898 -0.668 . . . . 65.329999999999998 111.819 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.152 0.501 . . . . 71.340000000000003 110.66 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -145.34 -55.38 0.31 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.615 -0.513 . . . . 73.129999999999995 109.615 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.55 84.62 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 122.118 0.961 . . . . 75.200000000000003 113.188 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -94.41 -35.9 12.15 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.64 -1.615 . . . . 71.239999999999995 106.64 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.71 122.33 32.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.595 -1.261 . . . . 72.310000000000002 107.595 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.22 147.5 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.59 0.233 . . . . 75.219999999999999 110.831 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -66.86 102.51 0.97 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.777 -1.564 . . . . 72.120000000000005 106.777 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -114.5 151.95 32.48 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.181 -0.918 . . . . 73.030000000000001 111.811 -169.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.150000000000006 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.230000000000004 110.567 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.129999999999995 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' HG ' HD23 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 75.219999999999999 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.219999999999999 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 HG23 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.109999999999999 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 74.129999999999995 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 74.340000000000003 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.209999999999994 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 73.340000000000003 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 62.32 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.540000000000006 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.030000000000001 111.079 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.736 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.239999999999995 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.319999999999993 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 74.439999999999998 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' CG2' ' HG2' ' A' ' 31' ' ' GLU . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.329999999999998 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 72.140000000000001 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 72.109999999999999 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.310000000000002 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 64.430000000000007 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.739 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 64.450000000000003 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.239999999999995 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.019999999999996 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.736 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 72.219999999999999 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.430000000000007 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.495 HD13 HD12 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.454 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.340000000000003 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 74.519999999999996 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.329999999999998 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.430000000000007 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.120000000000005 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.129999999999995 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 75.450000000000003 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.239999999999995 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 71.010000000000005 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.420000000000002 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 9.47 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.140000000000001 114.119 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 62.54 22.79 13.52 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.745 0.418 . . . . 65.510000000000005 111.923 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.3 -39.87 20.25 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 112.79 0.663 . . . . 38.060000000000002 112.79 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.5 p -99.43 -10.15 22.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.449 0.907 . . . . 74.349999999999994 113.449 -174.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -104.95 105.55 15.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.675 -1.232 . . . . 75.209999999999994 107.675 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.251 19.8 m -71.03 72.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 115.094 1.516 . . . . 74.530000000000001 115.094 -178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -100.71 -36.64 9.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.84 -1.541 . . . . 75.030000000000001 106.84 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -128.94 127.81 42.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 104.451 -2.426 . . . . 72.129999999999995 104.451 170.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.85 -1.7 9.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 114.083 1.142 . . . . 73.129999999999995 114.083 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.17 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.705 -0.85 . . . . 73.310000000000002 108.705 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 2.1 ptm180 -88.02 153.51 21.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.618 -0.719 . . . . 61.539999999999999 110.593 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -113.45 80.61 1.39 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-O 121.794 0.807 . . . . 72.109999999999999 109.017 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.04 -58.65 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.521 -2.029 . . . . 73.0 105.521 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' HD3' ' A' ' 61' ' ' ARG . 4.3 p-10 -123.44 144.76 49.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.46 -1.681 . . . . 72.310000000000002 106.46 173.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -134.97 -63.88 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.555 -0.535 . . . . 64.510000000000005 109.555 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 C--O 1.248 1.019 0 O-C-N 123.75 0.656 . . . . 74.430000000000007 112.057 178.396 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' B' ' 253' ' ' ALA . 34.6 m . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.131 0.967 . . . . 74.310000000000002 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -143.51 -131.2 2.47 Favored Glycine 0 C--N 1.299 -1.507 0 N-CA-C 108.857 -1.697 . . . . 70.329999999999998 108.857 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.0 m -63.22 -45.2 92.77 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.604 -1.628 . . . . 71.030000000000001 106.604 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -133.39 -46.37 0.83 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.159 -1.793 . . . . 65.450000000000003 106.159 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.89 179.4 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.435 -1.257 . . . . 74.109999999999999 107.818 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 23.2 t -149.2 89.05 1.62 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.438 -2.06 . . . . 73.540000000000006 105.438 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' B' ' 208' ' ' LYS . 14.9 t70 64.41 -161.68 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.772 -1.936 . . . . 74.400000000000006 105.772 -171.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . 0.412 ' H ' ' CG ' ' B' ' 207' ' ' ASP . 24.9 ttmm -106.58 -60.14 1.7 Allowed 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.333 -1.729 . . . . 61.32 106.333 174.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 159.11 80.92 0.0 OUTLIER 'General case' 0 C--O 1.245 0.858 0 C-N-CA 128.081 2.552 . . . . 75.030000000000001 105.862 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m -100.35 137.33 38.92 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.705 -1.134 . . . . 75.109999999999999 111.58 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 74.400000000000006 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 75.450000000000003 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.150000000000006 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.485 HD23 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.519999999999996 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.459 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.439999999999998 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.209999999999994 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.150000000000006 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.310000000000002 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.430000000000007 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.319999999999993 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.030000000000001 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.319999999999993 110.436 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 73.219999999999999 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.409999999999997 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.329999999999998 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.040000000000006 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.25 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.483 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 63.109999999999999 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.340000000000003 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.802 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.310000000000002 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 71.310000000000002 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.219999999999999 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 75.109999999999999 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 73.030000000000001 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.471 HD12 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.340000000000003 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.439 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.409999999999997 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.230000000000004 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 71.349999999999994 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.420000000000002 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.464 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.239999999999995 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 63.439999999999998 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.510000000000005 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.420000000000002 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo -75.13 41.94 0.81 Allowed 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.430000000000007 111.994 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.403 ' HB3' ' HE1' ' B' ' 255' ' ' TRP . 93.0 mt-30 57.52 50.46 11.1 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 122.278 1.037 . . . . 75.219999999999999 108.889 -174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . 0.532 ' O ' ' HB ' ' B' ' 201' ' ' VAL . . . -100.69 -53.23 3.13 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.83 -1.532 . . . . 74.140000000000001 108.556 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 58.9 p -80.55 84.75 6.08 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 122.076 0.941 . . . . 53.229999999999997 113.139 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . 0.403 ' HE1' ' HB3' ' B' ' 252' ' ' GLN . 84.8 m95 -102.74 84.69 2.44 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.359 -2.089 . . . . 75.530000000000001 105.359 168.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.86 145.43 8.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.87 -0.604 . . . . 74.239999999999995 112.018 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.37 -27.15 62.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.49 -0.93 . . . . 74.409999999999997 108.49 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.93 171.46 8.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.295 -0.866 . . . . 74.340000000000003 110.522 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.16 0.83 9.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.261 -0.427 . . . . 75.409999999999997 111.01 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.0 t 71.28 88.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.008 0.923 . . . . 73.140000000000001 108.661 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.3 104.73 16.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.501 -0.772 . . . . 73.099999999999994 112.073 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.9 t -155.7 74.69 0.88 Allowed 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 121.89 0.853 . . . . 72.040000000000006 109.611 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.34 89.94 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.299 -2.112 . . . . 74.209999999999994 105.299 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.71 168.64 10.57 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.978 -1.01 . . . . 74.299999999999997 109.179 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.37 -65.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.108 0.48 . . . . 65.420000000000002 110.631 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 65.540000000000006 109.541 -178.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.816 -0.439 . . . . 74.219999999999999 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.2 82.9 1.65 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.938 -0.648 . . . . 62.109999999999999 111.489 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 m -74.77 88.9 2.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.07 0.462 . . . . 74.540000000000006 110.592 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -147.5 -177.53 5.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.774 -1.195 . . . . 73.319999999999993 107.774 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.58 89.48 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 107.356 -1.35 . . . . 72.409999999999997 107.356 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.2 m -127.04 12.89 7.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.677 0.751 . . . . 72.129999999999995 109.422 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 91.74 7.28 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.895 -1.048 . . . . 75.219999999999999 110.219 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -99.73 127.84 45.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.083 -0.962 . . . . 64.030000000000001 109.408 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 66.74 87.89 0.12 Allowed 'General case' 0 C--O 1.249 1.039 0 C-N-CA 124.624 1.169 . . . . 75.129999999999995 107.941 -166.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m -78.71 100.06 6.9 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.971 -1.013 . . . . 74.340000000000003 109.952 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.219999999999999 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 74.239999999999995 109.212 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD21 ' HG ' ' B' ' 214' ' ' LEU . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.129999999999995 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 72.299999999999997 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.150000000000006 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 72.439999999999998 107.829 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 75.400000000000006 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.329999999999998 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 75.120000000000005 108.858 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 73.239999999999995 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 72.439999999999998 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 73.019999999999996 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HZ1' ' CD ' ' B' ' 231' ' ' GLU . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 75.439999999999998 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.340000000000003 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.540000000000006 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 74.030000000000001 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HD12 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.510000000000005 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 74.420000000000002 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 75.099999999999994 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 74.129999999999995 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 64.140000000000001 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.430000000000007 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 64.239999999999995 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 52.020000000000003 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 62.409999999999997 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 73.040000000000006 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 75.530000000000001 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 HD13 HD12 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.209999999999994 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.439999999999998 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.540000000000006 111.032 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.409999999999997 112.109 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 75.310000000000002 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 75.349999999999994 109.113 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.409999999999997 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.219999999999999 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo -71.55 19.5 0.26 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.409999999999997 113.366 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 62.69 34.06 15.08 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.9 0.88 . . . . 74.209999999999994 109.724 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.95 -48.76 11.38 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.808 1.243 . . . . 61.240000000000002 113.78 -172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -141.36 23.01 2.18 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.337 -0.986 . . . . 73.439999999999998 108.337 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -114.29 -2.43 13.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.005 0.743 . . . . 71.109999999999999 113.005 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 58' ' ' ASP . 12.6 p -115.62 -35.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 118.932 -1.107 . . . . 71.109999999999999 110.686 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 72.81 -42.66 0.54 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.561 1.544 . . . . 72.329999999999998 110.082 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 56' ' ' VAL . 24.9 t70 67.58 101.72 0.05 OUTLIER 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.665 1.186 . . . . 62.530000000000001 112.301 173.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 3.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.626 0.727 . . . . 74.310000000000002 111.55 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.43 131.17 63.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.3 -0.63 . . . . 74.239999999999995 109.3 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -86.26 -59.29 2.33 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.372 -0.931 . . . . 74.530000000000001 109.617 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 p -88.06 108.56 19.3 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.622 0.725 . . . . 54.43 112.73 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.84 100.16 10.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.578 -2.378 . . . . 63.409999999999997 104.578 170.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.69 116.23 21.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.946 -0.57 . . . . 51.009999999999998 112.15 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -123.47 99.99 6.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.28 -1.007 . . . . 72.200000000000003 108.28 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.307 -1.244 0 N-CA-C 108.762 -0.829 . . . . 71.420000000000002 108.762 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.533 -0.543 . . . . 71.0 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 110.4 80.89 1.17 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 120.469 -0.872 . . . . 73.319999999999993 111.163 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.3 p -73.45 110.33 7.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.691 0.758 . . . . 73.310000000000002 111.691 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.08 121.55 36.3 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.329 -0.851 . . . . 75.430000000000007 108.926 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.98 87.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 121.757 0.789 . . . . 75.409999999999997 109.302 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.8 m -154.71 145.11 22.1 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.216 -1.401 . . . . 72.450000000000003 107.216 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.97 145.86 51.26 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.199 0.523 . . . . 63.520000000000003 110.518 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -87.16 22.62 2.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.981 0.913 . . . . 75.329999999999998 110.701 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.96 72.64 0.5 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.45 1.5 . . . . 75.420000000000002 109.864 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m -80.55 146.6 31.19 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.961 -1.472 . . . . 70.200000000000003 110.599 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.019999999999996 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.530000000000001 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.439999999999998 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.421 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.439999999999998 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.447 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.409999999999997 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.219999999999999 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.310000000000002 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.030000000000001 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.420000000000002 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.150000000000006 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 71.230000000000004 107.613 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.420000000000002 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 72.140000000000001 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.329999999999998 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.53 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.150000000000006 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.731 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.450000000000003 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.329999999999998 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 71.109999999999999 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.239999999999995 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 73.409999999999997 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.462 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.439999999999998 112.24 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.340000000000003 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 74.140000000000001 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 74.340000000000003 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.040000000000006 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.409999999999997 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.731 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 72.230000000000004 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 64.340000000000003 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.514 HD12 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 73.5 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.140000000000001 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 74.340000000000003 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.109999999999999 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.430000000000007 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.423 HD13 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 72.129999999999995 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.230000000000004 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.549999999999997 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.340000000000003 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 55.229999999999997 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' B' ' 252' ' ' GLN . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 73.5 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.81 25.5 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.219999999999999 112.154 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' B' ' 250' ' ' ASP . 96.6 mt-30 65.84 28.88 10.71 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.483 1.113 . . . . 74.150000000000006 109.204 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.16 -46.55 7.04 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.553 -1.658 . . . . 63.130000000000003 110.043 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 26.7 m -74.63 -28.57 60.93 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.751 -0.833 . . . . 72.5 108.751 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -77.96 1.21 21.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.754 -0.657 . . . . 75.200000000000003 112.535 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.36 4.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.182 -1.044 . . . . 74.129999999999995 108.182 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -123.32 -51.09 1.87 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.198 -0.91 . . . . 75.329999999999998 110.098 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.99 -170.61 0.19 Allowed 'General case' 0 C--O 1.25 1.113 0 C-N-CA 125.455 1.502 . . . . 72.439999999999998 109.743 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.15 -22.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.956 -0.757 . . . . 73.120000000000005 108.956 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.63 159.25 43.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 62.520000000000003 110.788 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' B' ' 261' ' ' ARG . 9.1 mpt_? -89.52 -27.55 20.22 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.647 0.737 . . . . 74.230000000000004 109.388 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 29.8 p -147.04 141.01 25.93 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.065 -0.97 . . . . 64.219999999999999 108.661 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -100.74 127.26 47.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.817 -0.438 . . . . 74.230000000000004 109.817 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.58 105.54 16.23 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.137 -0.69 . . . . 70.420000000000002 109.137 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -93.23 -62.51 1.36 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.304 -0.407 . . . . 74.040000000000006 110.602 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--N 1.296 -1.739 0 N-CA-C 108.075 -1.083 . . . . 74.430000000000007 108.075 -179.801 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.236 0.375 0 N-CA-C 109.957 -0.386 . . . . 74.439999999999998 109.957 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 30.58 11.9 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.335 -0.936 . . . . 62.409999999999997 112.679 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -78.81 -36.27 42.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.11 -1.07 . . . . 63.520000000000003 108.11 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 49.87 81.79 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 124.82 1.325 . . . . 72.329999999999998 114.134 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 161.55 21.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.594 -0.891 . . . . 73.209999999999994 108.594 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -64.65 101.34 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.374 0.607 . . . . 70.120000000000005 109.515 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.693 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 20.5 t70 -88.98 85.84 6.8 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.8 -0.636 . . . . 75.010000000000005 110.719 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.693 ' HG3' ' O ' ' A' ' 7' ' ' ASP . 65.6 mttm 161.29 167.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 129.423 3.089 . . . . 72.120000000000005 106.692 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -88.1 85.86 7.02 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 107.837 -1.171 . . . . 72.530000000000001 107.837 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -82.48 129.08 34.84 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.658 -1.155 . . . . 72.439999999999998 112.002 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.310000000000002 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.510000000000005 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 64.310000000000002 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.239999999999995 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.319999999999993 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 70.310000000000002 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.230000000000004 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.230000000000004 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.319999999999993 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 74.140000000000001 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.439999999999998 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.239999999999995 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.340000000000003 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 HG22 HG21 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 73.040000000000006 110.928 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 72.420000000000002 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.230000000000004 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.567 HG23 ' CD1' ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 74.150000000000006 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 53.329999999999998 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.340000000000003 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 72.209999999999994 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.310000000000002 111.488 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.685 HD12 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.310000000000002 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.242 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD12 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 72.129999999999995 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 74.219999999999999 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.430000000000007 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.209999999999994 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.572 HD13 HD12 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.5 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.413 HG21 HG22 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.219999999999999 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.019999999999996 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.140000000000001 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.430000000000007 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.319999999999993 109.086 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.140000000000001 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 72.450000000000003 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.540000000000006 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.575 ' SG ' HD23 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 73.430000000000007 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 52' ' ' GLN . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.519999999999996 108.161 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.12 26.16 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.219999999999999 112.13 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 50' ' ' ASP . 41.8 mt-30 63.45 -88.72 0.03 OUTLIER 'General case' 0 C--O 1.25 1.102 0 C-N-CA 126.193 1.797 . . . . 65.319999999999993 112.991 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.08 -159.34 0.32 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.473 -0.936 . . . . 72.209999999999994 108.473 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 p -81.77 116.36 21.43 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 120.797 -0.361 . . . . 64.319999999999993 110.927 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.79 -10.19 29.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.938 -0.764 . . . . 74.510000000000005 108.938 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.2 t 73.61 -67.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.591 1.156 . . . . 72.219999999999999 111.643 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -146.38 -45.62 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.56 0.948 . . . . 74.519999999999996 113.56 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -74.06 125.99 29.52 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.628 -0.429 . . . . 73.219999999999999 110.409 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.15 -48.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 112.736 0.643 . . . . 75.510000000000005 112.736 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t 66.13 90.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.59 0.756 . . . . 62.039999999999999 109.674 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -135.83 151.09 49.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.343 -0.844 . . . . 73.049999999999997 109.693 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -154.88 135.3 13.33 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.374 -0.232 . . . . 63.340000000000003 110.374 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -84.5 94.24 8.51 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.38 -1.711 . . . . 62.030000000000001 106.38 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.6 153.65 23.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.973 -0.558 . . . . 62.399999999999999 109.812 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -76.33 -159.57 0.12 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 123.179 0.592 . . . . 73.549999999999997 111.492 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.313 -0.997 0 N-CA-C 108.63 -0.878 . . . . 73.209999999999994 108.63 -179.043 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.25 1.091 0 N-CA-C 110.289 -0.263 . . . . 63.310000000000002 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.56 99.45 0.18 Allowed Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.927 -0.654 . . . . 71.510000000000005 112.348 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -84.55 -21.53 30.43 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.139 -1.06 . . . . 71.129999999999995 108.139 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . 0.328 46.0 mt-10 60.42 67.42 0.84 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.132 -1.395 . . . . 71.099999999999994 113.665 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.09 144.5 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 112.622 -2.081 . . . . 70.420000000000002 106.114 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 27.1 t -97.98 113.02 24.75 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.16 -1.052 . . . . 62.119999999999997 108.16 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.29 74.87 8.27 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.941 0.877 . . . . 75.510000000000005 109.807 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -149.67 83.76 1.41 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.02 -1.445 . . . . 74.409999999999997 108.821 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -94.34 97.66 10.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.463 1.125 . . . . 73.540000000000006 108.316 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p -92.09 153.23 19.51 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 113.273 -1.785 . . . . 75.319999999999993 111.157 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 73.030000000000001 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 63.119999999999997 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.451 HD23 ' HG ' ' A' ' 14' ' ' LEU . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.239999999999995 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 73.120000000000005 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 43.43 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 72.150000000000006 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 73.140000000000001 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.219999999999999 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 72.400000000000006 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.200000000000003 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.209999999999994 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 73.450000000000003 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 74.239999999999995 110.835 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.519999999999996 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.430000000000007 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 62.130000000000003 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 74.450000000000003 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 74.540000000000006 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.310000000000002 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.439999999999998 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.450000000000003 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 62.240000000000002 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 71.409999999999997 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 228' ' ' THR . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.030000000000001 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.239999999999995 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.019999999999996 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.230000000000004 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.567 ' CD1' HG23 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.209999999999994 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.349999999999994 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.200000000000003 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.340000000000003 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 44.0 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.340000000000003 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.310000000000002 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.239999999999995 109.017 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 75.030000000000001 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 71.239999999999995 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.92 16.82 1.76 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.409999999999997 111.746 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 68.85 -76.96 0.05 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.478 1.511 . . . . 75.329999999999998 111.981 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.14 -93.37 0.04 OUTLIER 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.368 1.067 . . . . 71.409999999999997 112.285 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 23.0 p -148.53 107.49 3.86 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.337 0.655 . . . . 72.329999999999998 110.383 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -93.19 -21.15 19.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.366 -0.605 . . . . 74.209999999999994 109.366 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 57.2 t 69.22 -77.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.706 1.202 . . . . 73.310000000000002 109.291 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -158.34 17.57 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 73.329999999999998 109.846 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -123.0 104.05 8.99 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.951 -0.568 . . . . 72.230000000000004 109.94 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.74 -23.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 116.001 -0.545 . . . . 70.129999999999995 110.639 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 56.3 t 70.37 95.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.86 0.864 . . . . 74.209999999999994 109.675 -176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -120.27 100.26 7.07 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.385 -0.825 . . . . 71.319999999999993 112.312 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.6 m -87.09 100.17 12.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.325 -1.361 . . . . 51.439999999999998 107.325 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.52 106.81 0.5 Allowed 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.105 -0.498 . . . . 75.329999999999998 111.8 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.05 118.25 10.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.132 -0.94 . . . . 74.219999999999999 110.142 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.83 105.76 11.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.981 -0.554 . . . . 74.200000000000003 110.108 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? . . . . . 0 C--N 1.299 -1.622 0 N-CA-C 106.96 -1.496 . . . . 74.010000000000005 106.96 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.377 -0.601 . . . . 71.230000000000004 109.377 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.04 159.49 10.95 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 119.849 -1.167 . . . . 73.439999999999998 112.9 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -144.54 44.65 1.4 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 104.586 -2.376 . . . . 63.399999999999999 104.586 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.4 101.34 4.07 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.869 -1.968 . . . . 73.510000000000005 111.726 -171.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -122.14 95.19 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.146 -0.934 . . . . 74.239999999999995 109.25 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 m -74.33 -18.22 60.73 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.305 -0.861 . . . . 72.209999999999994 111.56 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -83.39 68.64 9.79 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.305 1.05 . . . . 64.420000000000002 111.688 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -148.7 166.05 29.54 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.217 -1.772 . . . . 70.450000000000003 106.217 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.22 111.87 18.77 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.053 -1.462 . . . . 74.510000000000005 107.053 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p -73.12 86.27 1.37 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 74.400000000000006 110.518 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.109999999999999 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 74.420000000000002 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.310000000000002 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.049999999999997 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.409999999999997 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.150000000000006 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.540000000000006 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.310000000000002 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.209999999999994 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 63.530000000000001 109.044 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.239999999999995 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.519999999999996 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 74.510000000000005 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 74.219999999999999 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.200000000000003 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 75.510000000000005 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.329999999999998 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD12 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.150000000000006 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 73.109999999999999 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.349999999999994 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.310000000000002 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD23 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 73.540000000000006 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.549999999999997 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.420000000000002 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 74.219999999999999 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.539999999999999 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.498 ' CE1' ' HE2' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.129999999999995 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HD13 HD12 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 73.540000000000006 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.030000000000001 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.430000000000007 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 74.340000000000003 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.010000000000005 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.655 HD13 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.219999999999999 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.498 ' HE2' ' CE1' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.549999999999997 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.109999999999999 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.409999999999997 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 42.420000000000002 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 52' ' ' GLN . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 74.099999999999994 112.115 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.83 34.02 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.240000000000002 109.011 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.432 ' HA ' ' NE1' ' A' ' 55' ' ' TRP . 45.1 mt-30 71.72 79.06 0.16 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.757 1.623 . . . . 73.219999999999999 111.071 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.2 -36.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.651 -1.159 . . . . 73.549999999999997 111.286 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 p -85.91 26.72 0.95 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 111.154 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.432 ' NE1' ' HA ' ' A' ' 52' ' ' GLN . 15.1 m95 -73.22 12.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.374 -0.83 . . . . 71.329999999999998 112.74 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.1 -11.3 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.102 -1.073 . . . . 75.319999999999993 108.102 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 73.59 96.1 0.07 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.215 1.406 . . . . 74.109999999999999 113.878 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -173.7 84.64 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.359 -1.292 . . . . 75.150000000000006 108.835 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.11 -37.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 75.299999999999997 109.616 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.9 t 66.08 93.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.393 -0.821 . . . . 72.239999999999995 110.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -74.8 95.37 2.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.665 -0.865 . . . . 75.439999999999998 108.665 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.8 t -87.58 90.52 8.4 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.891 -0.595 . . . . 70.439999999999998 111.381 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 mmt -147.14 102.92 3.55 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 114.409 -1.269 . . . . 63.420000000000002 108.239 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.58 -60.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.111 -0.495 . . . . 72.200000000000003 110.568 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -144.04 108.08 4.74 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.804 -0.813 . . . . 74.209999999999994 108.804 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 116.08 -0.509 . . . . 73.430000000000007 111.262 -176.653 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.243 0.723 0 CA-C-O 120.952 0.406 . . . . 71.030000000000001 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -173.08 45.29 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 109.76 -1.336 . . . . 72.439999999999998 109.76 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 49.4 m -95.2 90.98 6.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 117.545 0.672 . . . . 63.140000000000001 110.836 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -93.33 2.41 56.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.643 -0.708 . . . . 65.219999999999999 110.669 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.82 127.85 35.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.502 -0.772 . . . . 65.040000000000006 110.802 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.0 m -90.4 -20.23 23.04 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.046 -0.524 . . . . 74.25 110.75 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.38 98.84 11.48 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.599 0.714 . . . . 75.340000000000003 112.169 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -128.98 126.32 39.32 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.54 -1.209 . . . . 75.349999999999994 108.289 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' B' ' 209' ' ' ARG . 0.4 OUTLIER -92.63 105.09 17.31 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.108 -0.701 . . . . 74.010000000000005 109.108 176.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p -79.68 84.35 5.52 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 63.130000000000003 110.906 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.299999999999997 107.636 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.5 109.325 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.129999999999995 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.150000000000006 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.400000000000006 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.430000000000007 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 73.409999999999997 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.230000000000004 111.362 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.439999999999998 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.219999999999999 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.200000000000003 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.530000000000001 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.493 ' HD2' HD11 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.099999999999994 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.129999999999995 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.319999999999993 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.030000000000001 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.537 HG23 ' OE2' ' B' ' 231' ' ' GLU . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.150000000000006 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.129999999999995 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.537 ' OE2' HG23 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 73.540000000000006 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.239999999999995 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.310000000000002 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.040000000000006 109.255 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.400000000000006 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.240000000000002 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.129999999999995 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 74.519999999999996 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 74.129999999999995 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.493 HD11 ' HD2' ' B' ' 225' ' ' LYS . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 74.420000000000002 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 75.439999999999998 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 74.310000000000002 115.189 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.310000000000002 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.530000000000001 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.427 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.319999999999993 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 72.549999999999997 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.624 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.655 ' SG ' HD13 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.109999999999999 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.439999999999998 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 33.89 0.5 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.109999999999999 110.601 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 68.98 46.6 0.82 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.035 1.334 . . . . 65.549999999999997 110.202 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -146.7 -9.21 0.48 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.671 0.989 . . . . 62.030000000000001 113.671 -176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.4 p -95.66 4.36 53.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.228 0.537 . . . . 75.140000000000001 111.945 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -78.44 84.1 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 116.518 2.044 . . . . 74.219999999999999 116.518 -172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' B' ' 257' ' ' ARG . 16.8 m -118.09 -54.97 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.092 -1.447 . . . . 72.409999999999997 107.092 166.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 256' ' ' VAL . 59.0 ttp180 167.17 106.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 125.34 1.456 . . . . 73.099999999999994 108.631 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.403 ' O ' ' HB ' ' B' ' 259' ' ' VAL . 12.3 t70 -153.44 93.55 1.71 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 74.319999999999993 107.537 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.443 ' HA ' ' CZ ' ' B' ' 239' ' ' PHE . 7.7 p 175.65 -39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.754 -0.657 . . . . 70.439999999999998 111.304 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.4 t 65.27 95.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.61 -1.256 . . . . 71.120000000000005 107.61 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -59.86 113.35 2.24 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 113.786 1.032 . . . . 73.420000000000002 113.786 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.6 t -102.11 -162.4 0.92 Allowed 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.036 -1.839 . . . . 73.230000000000004 106.036 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 66.0 mtt 63.92 36.26 10.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.607 0.718 . . . . 73.510000000000005 110.116 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.0 141.72 58.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.402 -1.272 . . . . 73.400000000000006 109.653 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -57.78 121.94 11.66 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.864 0.466 . . . . 74.329999999999998 110.155 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 120.949 -0.301 . . . . 64.219999999999999 111.02 179.434 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.662 -0.495 . . . . 74.230000000000004 109.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.76 93.54 1.75 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.727 -0.749 . . . . 73.200000000000003 112.609 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -113.03 118.53 35.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.904 -1.147 . . . . 71.319999999999993 107.904 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -150.73 176.91 10.59 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.392 -0.192 . . . . 71.530000000000001 110.599 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -88.31 147.41 5.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.229 0.537 . . . . 74.150000000000006 111.929 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -95.28 118.11 31.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.581 -0.896 . . . . 60.020000000000003 108.581 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.19 160.81 19.1 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.939 -0.763 . . . . 75.030000000000001 108.939 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 79.54 -43.66 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.892 1.277 . . . . 75.319999999999993 111.174 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -138.6 85.97 2.12 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.098 0.475 . . . . 74.019999999999996 111.825 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -80.14 86.47 5.57 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.340000000000003 109.165 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.319999999999993 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 72.040000000000006 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.219999999999999 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD23 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 72.120000000000005 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.239999999999995 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.150000000000006 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' NE2' ' HG3' ' B' ' 251' ' ' PRO . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.099999999999994 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 74.030000000000001 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.219999999999999 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 74.109999999999999 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.405 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.239999999999995 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 73.319999999999993 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 74.209999999999994 112.957 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.319999999999993 106.447 176.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 23' ' ' ARG . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 75.439999999999998 110.604 -173.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 64.140000000000001 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.439999999999998 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 73.400000000000006 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 HD12 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 72.230000000000004 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.782 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.239999999999995 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.310000000000002 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.120000000000005 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.129999999999995 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.782 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 72.310000000000002 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.120000000000005 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 62.240000000000002 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 63.340000000000003 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 72.439999999999998 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 HD13 HD12 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 75.019999999999996 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.150000000000006 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 75.409999999999997 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.621 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.209999999999994 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.149999999999999 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.430000000000007 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 73.219999999999999 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 73.430000000000007 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.129999999999995 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.229999999999997 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 72.400000000000006 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.46 42.33 0.89 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.349999999999994 112.018 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 59.96 66.94 0.91 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.548 1.139 . . . . 73.109999999999999 110.963 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.98 -36.37 2.19 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.409 -1.723 . . . . 70.019999999999996 107.503 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -108.03 87.03 2.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.894 -1.048 . . . . 73.329999999999998 108.34 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -144.51 95.81 2.77 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.27 1.033 . . . . 71.239999999999995 110.294 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.05 -165.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 CA-C-N 113.708 -1.587 . . . . 73.319999999999993 107.397 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -78.78 84.88 4.82 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.031 -1.099 . . . . 73.430000000000007 108.031 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -149.13 99.35 2.94 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 114.535 -1.212 . . . . 72.010000000000005 108.65 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.49 69.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.706 1.241 . . . . 63.32 110.152 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.93 129.34 38.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 114.373 -1.285 . . . . 74.299999999999997 110.1 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 61' ' ' ARG 0.355 4.5 ppt_? -134.79 71.74 1.45 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.635 1.207 . . . . 75.140000000000001 112.924 176.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 m -92.87 120.0 32.77 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.688 -1.142 . . . . 71.409999999999997 108.834 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.9 ptm -147.32 150.19 34.29 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.554 -0.458 . . . . 72.219999999999999 110.988 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.74 157.32 18.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.295 -1.002 . . . . 71.209999999999994 108.295 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -129.17 112.08 13.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.153 -1.054 . . . . 74.450000000000003 108.153 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 C--N 1.3 -1.583 0 N-CA-C 107.432 -1.321 . . . . 75.409999999999997 107.432 179.449 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.68 0 N-CA-C 110.019 -0.363 . . . . 70.329999999999998 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -114.68 -147.66 9.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.367 -1.493 . . . . 37.219999999999999 109.367 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.7 t -79.47 89.03 5.02 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.65 -1.241 . . . . 75.099999999999994 107.65 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.15 163.0 31.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.377 -0.829 . . . . 70.040000000000006 109.594 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.2 135.21 28.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.094 0.473 . . . . 74.400000000000006 111.966 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.6 m -98.37 149.2 22.9 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.03 -0.532 . . . . 73.219999999999999 109.784 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.07 160.09 23.28 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.17 -0.307 . . . . 74.549999999999997 110.17 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' B' ' 209' ' ' ARG . 95.6 mttt 71.37 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.108 1.363 . . . . 73.140000000000001 110.101 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' B' ' 208' ' ' LYS . 0.3 OUTLIER -139.94 170.95 14.93 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.936 -1.505 . . . . 74.409999999999997 106.936 177.309 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m -109.05 105.57 15.13 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.873 -0.731 . . . . 74.310000000000002 111.12 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 74.510000000000005 110.077 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.140000000000001 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.492 HD23 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.420000000000002 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 73.409999999999997 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 75.439999999999998 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.519999999999996 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.430000000000007 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 74.109999999999999 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 65.140000000000001 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.540000000000006 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 74.340000000000003 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 60.240000000000002 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.299999999999997 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.713 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.049999999999997 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.450000000000003 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' B' ' 235' ' ' ARG . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.099999999999994 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.150000000000006 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.420000000000002 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.209999999999994 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.310000000000002 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 64.519999999999996 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 73.400000000000006 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 74.040000000000006 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.319999999999993 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.030000000000001 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.409999999999997 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.544 HD12 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 74.010000000000005 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.449 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 71.219999999999999 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.41 ' CB ' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.210000000000001 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 62.030000000000001 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.442 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.409999999999997 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.109999999999999 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.230000000000004 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 74.230000000000004 109.52 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.140000000000001 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 73.400000000000006 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -75.3 40.73 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.439999999999998 111.937 177.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 69.66 38.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.255 1.022 . . . . 74.219999999999999 109.397 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.61 -46.82 5.07 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.71 -1.132 . . . . 60.340000000000003 111.441 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' B' ' 209' ' ' ARG . 23.4 m -82.68 79.0 9.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.682 0.753 . . . . 73.030000000000001 110.899 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -127.0 -14.47 5.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.717 -0.674 . . . . 74.540000000000006 109.721 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -72.22 -25.22 23.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.286 -0.87 . . . . 71.099999999999994 109.683 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.18 98.74 7.52 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.484 -2.413 . . . . 73.430000000000007 104.484 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.84 109.19 17.35 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.321 -0.854 . . . . 71.439999999999998 110.584 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.61 -43.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.644 -0.707 . . . . 73.340000000000003 111.662 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.08 113.91 20.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 71.400000000000006 111.014 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.59 149.89 30.49 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.248 -0.649 . . . . 65.010000000000005 109.248 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 28.6 m -94.79 130.39 41.36 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.889 -1.152 . . . . 75.329999999999998 107.889 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.46 111.65 5.67 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.102 0.779 . . . . 71.120000000000005 113.102 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.21 174.13 15.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.143 -1.799 . . . . 74.140000000000001 106.143 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' B' ' 265' ' ' ARG . 4.9 tmm_? -125.42 113.77 17.96 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.113 -1.069 . . . . 64.230000000000004 108.113 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 107.335 -1.357 . . . . 72.140000000000001 107.335 -179.387 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.414 -0.587 . . . . 75.140000000000001 109.414 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.17 -11.2 61.96 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 120.292 -0.956 . . . . 62.310000000000002 112.779 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m 61.98 35.64 16.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.472 -0.936 . . . . 70.219999999999999 108.472 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -66.35 117.45 8.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.243 -1.344 . . . . 55.210000000000001 112.736 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.14 111.63 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.028 -1.842 . . . . 62.539999999999999 106.028 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 p -72.35 -67.98 0.51 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.068 0.766 . . . . 62.539999999999999 113.068 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.71 155.91 35.21 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.79 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -78.71 -32.45 46.91 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.778 0.659 . . . . 62.539999999999999 112.778 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 1.2 tmm_? -131.38 105.65 7.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.639 0.733 . . . . 73.310000000000002 110.525 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m -101.67 149.49 24.09 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.76 -1.109 . . . . 65.519999999999996 109.315 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 53.32 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 75.239999999999995 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.019999999999996 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' CG ' ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.510000000000005 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 74.230000000000004 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.129999999999995 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.439999999999998 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.119999999999997 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 74.5 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.319999999999993 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.340000000000003 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.457 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 71.349999999999994 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.310000000000002 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.425 HG22 HG21 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.519999999999996 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.329999999999998 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 74.0 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.530000000000001 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 75.340000000000003 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 HD12 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 75.010000000000005 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.746 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 63.100000000000001 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.299999999999997 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.140000000000001 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.230000000000004 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.746 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 72.239999999999995 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.200000000000003 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 34' ' ' LEU . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 61.25 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 71.239999999999995 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 75.25 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 74.329999999999998 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 HD13 HD12 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 72.400000000000006 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 73.219999999999999 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 75.019999999999996 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.140000000000001 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 73.319999999999993 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.420000000000002 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 74.310000000000002 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.554 ' SG ' ' HD3' ' A' ' 9' ' ' ARG . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.400000000000006 106.938 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.472 ' SG ' HD23 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.340000000000003 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 52' ' ' GLN . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.439999999999998 108.531 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.74 34.47 0.44 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.439999999999998 111.941 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 50' ' ' ASP . 97.4 mt-30 70.18 77.86 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.065 1.346 . . . . 63.130000000000003 110.813 -175.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.4 -55.62 0.58 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.464 -1.244 . . . . 65.219999999999999 108.637 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.7 m -88.66 -22.95 23.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.325 -0.991 . . . . 72.019999999999996 108.325 176.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 m0 66.75 36.02 4.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.73 -1.123 . . . . 74.420000000000002 111.278 174.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.33 160.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.828 -0.624 . . . . 75.319999999999993 111.358 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -142.62 166.67 24.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.381 -0.372 . . . . 75.400000000000006 110.43 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -137.71 147.09 44.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.178 -1.786 . . . . 64.420000000000002 106.178 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.05 4.68 5.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.888 -0.725 . . . . 70.519999999999996 111.88 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.57 90.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 122.453 1.12 . . . . 64.129999999999995 112.356 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -107.69 105.29 15.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.196 -0.911 . . . . 71.310000000000002 109.492 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 t -94.96 117.23 29.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.386 -0.968 . . . . 70.230000000000004 108.386 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.4 ttp -116.3 116.3 27.49 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.908 0.385 . . . . 73.439999999999998 111.012 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.45 163.54 17.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 74.310000000000002 108.134 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' B' ' 230' ' ' THR . 76.1 ttt180 -146.31 95.99 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.865 -0.42 . . . . 74.420000000000002 109.865 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HD3' ' HA2' ' B' ' 232' ' ' GLY . 63.8 tttp . . . . . 0 C--O 1.256 1.432 0 CA-C-N 116.14 -0.482 . . . . 74.200000000000003 110.279 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.244 0.774 0 N-CA-C 108.699 -0.852 . . . . 75.530000000000001 108.699 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.52 47.85 0.99 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 111.156 -0.778 . . . . 71.510000000000005 111.156 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 24.3 m -127.56 98.52 5.25 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.185 -0.672 . . . . 72.420000000000002 109.185 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.72 101.16 10.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.068 -0.515 . . . . 74.120000000000005 111.036 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.4 108.97 18.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.038 -1.097 . . . . 75.120000000000005 108.038 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 24.9 p -82.6 -52.01 7.22 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.222 0.534 . . . . 65.209999999999994 111.687 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.1 -176.52 6.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.787 -0.642 . . . . 72.519999999999996 111.186 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.08 -43.62 9.29 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -129.24 89.39 2.85 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.283 -1.006 . . . . 73.209999999999994 108.283 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m -77.8 147.2 35.36 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.667 -1.151 . . . . 75.120000000000005 112.024 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 71.549999999999997 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.340000000000003 110.284 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' SER . . . . . 0.483 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.530000000000001 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.210000000000001 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.120000000000005 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.340000000000003 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.040000000000006 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 71.349999999999994 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 74.519999999999996 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.310000000000002 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.530000000000001 109.772 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.430000000000007 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.210000000000001 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 75.319999999999993 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.549999999999997 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.120000000000005 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.200000000000003 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 62.399999999999999 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 75.439999999999998 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 70.409999999999997 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 70.549999999999997 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.099999999999994 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.549999999999997 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.120000000000005 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.299999999999997 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' CYS . . . . . 0.639 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.140000000000001 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.420000000000002 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.329999999999998 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . 0.608 HD12 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 74.140000000000001 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' THR . . . . . 0.482 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.049999999999997 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 74.340000000000003 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 74.209999999999994 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.456 ' C ' HD13 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.140000000000001 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.456 HD13 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.519999999999996 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.140000000000001 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 73.120000000000005 109.977 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 74.099999999999994 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . 0.59 ' SG ' HD23 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.209999999999994 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.409999999999997 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.99 39.35 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.340000000000003 112.173 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 68.46 73.03 0.29 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.99 1.316 . . . . 73.219999999999999 110.671 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -135.26 -56.44 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.102 -0.954 . . . . 74.030000000000001 109.329 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 66.0 m -92.27 96.23 10.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.552 0.691 . . . . 74.219999999999999 110.021 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -95.84 91.57 6.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.669 -0.696 . . . . 74.120000000000005 112.738 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.88 107.36 20.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.387 -0.968 . . . . 74.239999999999995 108.387 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.02 105.82 1.13 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.366 -0.834 . . . . 70.109999999999999 112.578 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 93.74 8.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.397 -0.594 . . . . 73.129999999999995 109.397 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.52 -7.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.934 0.873 . . . . 75.120000000000005 109.481 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.8 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.976 -1.011 . . . . 74.109999999999999 111.262 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -114.56 91.57 3.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.211 -1.403 . . . . 74.510000000000005 107.211 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.8 t -108.71 100.51 9.74 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.251 -0.648 . . . . 61.140000000000001 109.251 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 55.6 ttp -106.44 95.92 6.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.823 -0.626 . . . . 75.129999999999995 109.932 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.01 93.22 7.52 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.919 -0.582 . . . . 75.200000000000003 110.088 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.07 90.24 2.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.46 -0.941 . . . . 75.430000000000007 108.46 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--O 1.257 1.473 0 C-N-CA 124.581 1.152 . . . . 73.239999999999995 111.742 -177.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 72.52 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.53 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 63.3 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 74.03 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 62.34 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.51 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.55 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.12 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.41 112.617 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 52.21 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.13 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.42 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.24 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.02 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.32 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 44.23 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.13 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 73.35 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.03 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 70.02 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.757 HD13 HD11 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 40.12 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.32 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.4 106.943 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.33 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.05 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 64.45 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.23 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.32 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.53 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.14 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.23 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 70.32 113.378 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.21 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 34.44 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD13 HG22 ' B' ' 247' ' ' VAL . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.12 110.005 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 61.32 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.04 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 63.4 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 63.42 110.403 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.21 110.006 175.219 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.542 0.687 . . . . 74.13 109.636 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 71.21 107.443 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.22 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.04 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 54.35 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.507 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 72.12 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 63.42 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 53.34 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.33 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 220' ' ' PRO . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 44.22 109.847 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 73.21 113.211 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 64.32 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 72.22 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.52 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.44 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 65.21 110.944 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 71.33 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 72.22 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 65.54 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 53.14 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.45 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.24 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.55 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.44 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.13 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.34 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.44 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 54.43 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.727 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.21 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 72.44 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.14 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.535 HG22 HG23 ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 71.23 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.23 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 71.33 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 63.51 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.44 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 50.45 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 45' ' ' LEU . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.15 107.822 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.43 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.51 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.03 111.467 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.42 -1.963 0 N-CA-C 109.16 -0.682 . . . . 75.14 109.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.14 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.34 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.34 112.131 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' HD21 ' B' ' 214' ' ' LEU . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.12 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 54.04 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.13 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.43 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 17' ' ' GLN . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.21 110.673 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 50.54 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.01 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 40' ' ' ILE . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 64.42 109.48 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.542 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 60.31 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.41 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 HG22 ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 64.52 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 62.14 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.45 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 70.41 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 65.3 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.831 HD13 HD11 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.04 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 51.11 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.42 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.24 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 71.41 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.54 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.2 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.51 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.12 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.816 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 50.21 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.52 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 72.52 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 64.1 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.43 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 64.41 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.13 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 64.54 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.53 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HB3' HD21 ' A' ' 34' ' ' LEU . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.4 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 72.34 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.43 113.278 -177.59 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.419 -2.012 0 CA-C-O 121.364 0.602 . . . . 45.13 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.33 107.377 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 64.2 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.23 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.536 HD21 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.44 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.45 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.11 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 43.12 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' B' ' 218' ' ' ARG . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.32 111.775 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 34' ' ' LEU . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 64.04 110.266 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.44 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.42 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.33 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.44 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 71.02 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.624 ' HD3' HD12 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 41.33 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.05 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.23 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.13 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.816 HD13 HD11 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 72.3 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.44 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.22 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.21 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 52.14 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.55 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.13 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.41 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.44 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 64.21 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.52 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.831 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.3 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.603 ' HA ' HD12 ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 51.32 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 43.41 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 65.33 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.13 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 73.34 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.11 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.33 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.12 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.33 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.54 109.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 42.31 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' HD12 ' B' ' 214' ' ' LEU . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.35 110.378 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.23 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 61.35 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.467 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 70.11 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.31 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.51 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 71.3 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HD2' ' A' ' 20' ' ' PRO . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 19' ' ' LEU . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.41 112.579 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.45 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.11 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 62.32 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 64.22 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.51 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 71.23 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.754 HD13 HD11 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 70.44 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.14 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.31 111.993 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.15 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.13 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 71.04 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 73.23 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.4 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.21 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.2 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.31 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.13 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.563 ' HA ' HD12 ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.35 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 20' ' ' PRO 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 42.24 115.806 -176.949 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.12 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.02 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.54 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 63.42 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.4 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 63.33 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.32 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HG2' HD23 ' B' ' 219' ' ' LEU . 26.9 Cg_exo . . . . . 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 73.05 115.045 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.1 108.86 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.34 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.24 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.43 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.432 HD12 ' HB ' ' A' ' 12' ' ' VAL . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.54 111.988 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 61.3 110.113 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 71.33 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.53 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.24 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.02 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.35 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.51 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.1 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 71.34 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 64.52 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.612 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 52.13 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.769 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.3 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' B' ' 238' ' ' ILE . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.24 108.938 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.43 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 62.14 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.23 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.23 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.13 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 32.34 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.814 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 72.54 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 72.43 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 65.03 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 63.41 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 52.13 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.42 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 62.33 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.34 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.34 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.11 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.33 113.847 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.05 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.03 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.41 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 42.31 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.34 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.33 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.2 114.912 -172.902 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.424 -1.741 0 CA-C-O 121.478 0.656 . . . . 52.23 110.541 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.3 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.21 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 41.4 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.48 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 51.43 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 63.31 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 63.1 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 64.21 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 53.23 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.44 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.52 108.766 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' SER . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 64.34 113.298 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 63.02 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.15 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.55 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.12 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 51.3 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 54.33 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 62.24 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.43 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.21 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.4 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 65.3 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.35 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.42 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 55.52 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.51 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.713 HD11 HD13 ' B' ' 229' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 74.23 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 64.43 114.426 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.456 ' HG3' ' HE2' ' A' ' 42' ' ' LYS . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.22 112.153 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 61.25 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.13 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 71.31 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG21 HD22 ' B' ' 245' ' ' LEU . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 64.31 110.962 -173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.13 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.35 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.21 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo . . . . . 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.23 112.491 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 114.162 1.171 . . . . 72.13 114.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.14 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 50.04 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.13 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 64.33 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.456 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.01 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 71.4 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 63.52 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.34 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 64.13 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 74.42 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 62.24 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.31 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.12 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.14 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.12 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.42 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.34 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 54.01 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 64.01 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.34 110.162 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.34 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 61.42 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.11 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 64.43 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.21 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.42 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.34 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.23 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.1 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' HD12 ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 65.11 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 62.22 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.21 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.42 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 64.23 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 43.11 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.466 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 53.32 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.13 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.35 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.42 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 85.9 Cg_endo . . . . . 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 54.01 113.208 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' HB ' ' OG1' ' B' ' 216' ' ' THR . 40.1 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 120.724 0.297 . . . . 72.01 110.895 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.21 108.024 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 71.35 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.33 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 61.53 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 64.21 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.31 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.54 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.42 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.05 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 70.2 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.11 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.41 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.22 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.22 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.777 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.31 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 52.0 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.14 108.629 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 70.23 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.01 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.779 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.02 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.12 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.02 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 64.24 110.925 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 71.42 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.21 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.14 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 61.41 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.24 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.03 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.727 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 64.32 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.12 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.13 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 63.23 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.02 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 73.51 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.47 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.54 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 45.0 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 71.45 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.35 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 70.22 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo . . . . . 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 64.53 111.675 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.429 -1.51 0 CA-C-O 120.956 0.408 . . . . 73.01 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.14 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 14' ' ' LEU . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 51.4 109.677 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.3 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.33 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.4 107.777 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 10' ' ' THR . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.55 110.72 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.2 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 64.51 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.12 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.44 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 73.14 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 54.11 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.42 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 34.23 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 71.34 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 35.32 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 74.41 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.52 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.31 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 53.55 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.45 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 44.13 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.41 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.54 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.23 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.04 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 52.11 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.23 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.02 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 52.14 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.14 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 64.33 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.32 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 47' ' ' VAL . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.34 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 45' ' ' LEU . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 70.32 109.819 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.02 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.34 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 53.24 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.23 112.049 177.761 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 109.0 -0.741 . . . . 45.2 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 61.54 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.41 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 63.13 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.22 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.31 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 70.45 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 71.11 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.22 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.4 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG21 ' HZ1' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.42 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.32 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.32 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 61.54 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 65.23 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 64.11 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 38' ' ' ILE . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.52 107.83 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.43 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HD11 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 73.41 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 44.45 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 63.23 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.12 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.32 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.41 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 65.22 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.02 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 60.35 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 72.53 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 62.31 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.688 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 74.2 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 42.41 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.33 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 65.35 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.53 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 74.42 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 72.34 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 245' ' ' LEU . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 55.14 109.382 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 71.15 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.12 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.14 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.42 112.993 179.69 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.421 -1.921 0 CA-C-O 121.005 0.431 . . . . 64.43 109.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.34 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.44 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 54.33 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 72.55 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.483 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.51 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 52.33 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 61.13 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.655 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.53 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.529 ' O ' HD12 ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.23 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.42 110.681 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 74.0 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 53.11 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 241' ' ' THR . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.43 104.811 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 73.11 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.43 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.12 107.895 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.14 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.688 HD13 HD11 ' A' ' 40' ' ' ILE . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.52 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.14 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 70.24 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 61.25 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.15 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.04 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 63.34 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.53 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 63.22 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.52 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.45 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.411 ' HA ' HD12 ' B' ' 224' ' ' ILE . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 72.41 110.233 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 44.11 112.554 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 73.04 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.03 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 47' ' ' VAL . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.43 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 53.14 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 63.31 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.34 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.35 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.52 109.662 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 72.42 111.241 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.422 -1.861 0 CA-C-O 121.364 0.602 . . . . 65.13 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.05 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 62.51 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 62.5 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HG ' HD21 ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 65.03 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 74.15 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.13 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.31 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.23 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 53.33 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 72.33 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 42' ' ' LYS . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 70.33 108.329 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.52 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 53.11 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.14 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.04 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.35 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.41 108.355 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 44.2 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.628 HD13 HD11 ' B' ' 240' ' ' ILE . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 71.41 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.3 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.1 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.1 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.41 110.684 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 63.34 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.45 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.33 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 64.54 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 34.14 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 62.5 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.673 HD11 HD13 ' B' ' 229' ' ' ILE . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.24 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.55 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG22 ' A' ' 21' ' ' VAL 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.45 114.65 -179.248 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.12 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.14 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 53.11 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.31 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 61.33 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 43.44 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.4 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.42 105.949 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo . . . . . 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.54 113.368 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.23 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 64.14 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.33 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.704 HD21 ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 62.55 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.35 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.55 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.41 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.54 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 74.24 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.1 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.4 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.53 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.23 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 72.35 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.14 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.522 ' HB2' HD12 ' B' ' 238' ' ' ILE . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 74.23 108.54 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 73.14 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.32 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.01 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.14 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.34 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 71.21 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.41 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 65.01 108.76 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.698 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.13 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 72.41 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.14 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.04 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.628 HD11 HD13 ' A' ' 29' ' ' ILE . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.43 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 73.55 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 63.4 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.43 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.11 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.23 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.14 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 72.23 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.52 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.44 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.22 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.01 110.899 176.194 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 109.577 -0.527 . . . . 64.52 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 63.3 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 71.25 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.04 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.24 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 61.31 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.53 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.24 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 63.41 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.31 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 52.44 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.51 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.2 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 41' ' ' THR . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.54 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 55.1 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 71.21 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.681 HD13 HD11 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.12 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 63.42 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.23 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.34 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.22 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.44 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.32 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.21 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 64.5 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.14 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD11 HD13 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.33 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.41 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.32 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.2 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.04 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 51.43 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.43 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG21 HD22 ' B' ' 245' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.22 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.23 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.1 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.04 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 32.33 110.349 174.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 108.962 -0.755 . . . . 74.35 108.962 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.32 107.395 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.52 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.43 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' A' ' 14' ' ' LEU . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 71.04 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 60.33 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 74.41 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.42 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.3 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.504 ' H ' HD23 ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.33 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.33 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.03 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.44 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 63.45 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.02 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.13 110.76 -172.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.45 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.32 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.11 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.726 HD13 HD11 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 60.02 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 70.23 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.41 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.53 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 64.32 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' B' ' 250' ' ' ASP . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.12 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.32 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 63.33 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.13 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 71.55 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.24 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.4 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.14 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.22 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.42 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 47' ' ' VAL . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.33 111.182 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 64.22 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.31 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.45 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ASP . . . . . 0.663 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.24 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.05 108.289 168.143 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 114.712 1.375 . . . . 71.32 114.712 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 53.31 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.43 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.51 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.41 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 54.52 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.41 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.443 ' HG3' ' HD3' ' B' ' 251' ' ' PRO . 14.8 mm-40 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.23 109.201 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.01 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 64.32 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.41 114.063 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 61.41 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.44 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.12 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.23 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 65.25 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.01 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.3 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD13 HD11 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 64.14 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 64.33 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.12 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.24 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.14 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 64.5 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.05 111.053 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.44 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.24 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.54 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 73.4 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD11 HD13 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.11 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.21 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.14 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.44 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 65.51 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 52.34 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.11 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.23 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.13 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.53 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.2 110.364 174.005 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 121.363 0.601 . . . . 74.13 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.54 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 14' ' ' LEU . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 72.51 108.823 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.502 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.44 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 54.44 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.4 109.194 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 71.1 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 51.02 111.465 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 64.53 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 62.11 110.329 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 62.4 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 71.14 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.34 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.12 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 61.33 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.21 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.04 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.33 107.883 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 65.41 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.666 HD13 HD11 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 70.42 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 70.35 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' B' ' 229' ' ' ILE . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.14 106.353 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.24 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.41 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.63 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 72.44 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 64.04 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 41.55 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.2 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.32 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.04 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 29' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.42 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.514 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.31 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 62.21 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.52 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 21.43 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 62.32 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 53.41 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 54.44 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.14 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 71.32 111.536 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.43 109.46 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo . . . . . 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.22 111.698 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.641 0.734 . . . . 74.15 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 62.42 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' B' ' 214' ' ' LEU . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.4 110.455 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.23 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HG ' HD21 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.01 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.34 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.32 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.21 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.22 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.43 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.41 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.52 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.13 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.23 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 41' ' ' THR . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.51 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.54 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 63.33 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.02 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 64.05 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 70.13 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.43 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.1 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.23 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.44 111.41 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.708 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 43.41 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 62.31 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 62.13 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 60.31 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.35 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 HD13 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 71.1 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.562 HG22 HG23 ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.24 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 64.35 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 64.13 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.55 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 25.13 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.02 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' B' ' 245' ' ' LEU . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 41.12 110.504 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.43 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.708 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.34 106.992 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 71.05 112.085 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.417 -2.077 0 CA-C-O 121.226 0.536 . . . . 64.43 110.932 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.42 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.32 109.539 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.45 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.13 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.55 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.34 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 64.23 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.12 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.23 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.35 110.606 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.22 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.23 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.33 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.13 110.304 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 71.22 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.43 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 73.13 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.831 HD13 HD11 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 64.21 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.52 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.22 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.44 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.44 110.744 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.12 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.3 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 62.44 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.12 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.12 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.41 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.11 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.51 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.434 ' HD2' ' HG3' ' B' ' 243' ' ' ARG . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.434 ' HG3' ' HD2' ' B' ' 242' ' ' LYS . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 54.34 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.14 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 47' ' ' VAL . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 72.3 111.135 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.32 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.1 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 63.44 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.14 106.343 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 61.43 111.573 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.4 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.02 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 72.33 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.23 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 63.04 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.586 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.31 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.14 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 70.23 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.44 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 73.41 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.51 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.21 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.31 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.33 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.45 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 64.11 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.45 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.608 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.13 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.43 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 64.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.45 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 53.11 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.24 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.43 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 71.24 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.563 HG22 HG23 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.23 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 70.24 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 64.12 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 65.3 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.42 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 62.21 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 12' ' ' VAL . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 41.05 109.071 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.12 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 64.32 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 42.31 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 51.34 112.392 -178.888 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.418 -2.037 0 N-CA-C 108.675 -0.861 . . . . 63.44 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.14 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 55.51 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.55 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.51 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.43 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.13 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 HD13 ' B' ' 219' ' ' LEU . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.11 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.11 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.51 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.42 HD13 HG23 ' B' ' 216' ' ' THR . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 63.12 107.432 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 50.43 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.439 HG11 HG22 ' B' ' 240' ' ' ILE . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.43 110.539 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.22 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 71.22 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.24 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.11 110.477 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 72.53 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.45 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 64.24 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.43 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.427 HG22 ' HG2' ' B' ' 235' ' ' ARG . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.1 110.265 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 74.35 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 55.02 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.31 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.14 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' B' ' 230' ' ' THR . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.13 109.427 172.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.42 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.51 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 73.13 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 74.52 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 29' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.14 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.31 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.41 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.0 108.726 170.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.421 ' C ' HD12 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.21 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.421 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 71.45 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 65.12 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 42.5 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.34 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.34 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.55 112.853 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.401 -2.883 0 N-CA-C 108.896 -0.779 . . . . 53.31 108.896 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.51 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 65.2 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 64.2 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 70.53 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.02 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.01 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 71.35 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 63.34 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 65.4 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.15 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.04 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 50.33 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.45 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 41' ' ' THR . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 64.15 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 52.2 109.274 -173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 63.53 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.12 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.45 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.41 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.35 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.02 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.3 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 54.44 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.43 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 35' ' ' ARG . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.2 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.45 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 70.02 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.2 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.01 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.514 HD11 HD13 ' B' ' 229' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 71.12 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 70.31 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.33 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.34 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 52.23 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 53.11 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.45 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 64.11 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 72.42 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.33 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.21 108.183 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.54 112.799 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.413 -2.319 0 CA-C-O 122.086 0.946 . . . . 73.04 109.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 44.32 107.638 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.24 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.03 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.544 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 73.31 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.407 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.44 110.931 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.04 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.44 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 70.51 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.21 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 63.14 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.42 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 72.12 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.23 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.24 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 71.43 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.44 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.43 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 62.02 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.571 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.42 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.04 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 72.21 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 72.12 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.04 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 70.12 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.32 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.24 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 72.43 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.577 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 72.23 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.23 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.15 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.02 113.383 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 72.44 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.3 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.24 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.02 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.54 109.154 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 60.35 111.674 177.043 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 113.217 0.821 . . . . 63.54 113.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.13 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 71.14 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.11 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' B' ' 212' ' ' VAL . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.53 110.876 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.3 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.41 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.44 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.02 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.33 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 70.5 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.21 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 53.43 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.45 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.55 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 44.42 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.32 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 71.1 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.61 HD13 HD11 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.24 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 63.31 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 64.4 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 72.52 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.43 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 62.34 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.3 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.42 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.4 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 61.44 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.35 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.684 HD11 HD13 ' B' ' 229' ' ' ILE . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 55.13 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.41 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.44 113.262 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 72.25 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.43 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.41 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 72.32 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 HD22 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 42.24 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.31 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.41 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.41 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.35 111.995 177.046 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.598 0.237 . . . . 64.0 110.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 52.54 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD13 ' A' ' 14' ' ' LEU . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.4 110.134 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 43.01 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.32 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.439 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 64.43 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 33.04 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.23 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.24 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.533 ' H ' HD23 ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.42 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.3 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.45 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.22 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 63.25 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 64.44 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.581 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.23 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.32 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 64.4 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 72.35 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 73.3 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 54.35 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.11 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.21 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 60.44 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 61.24 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.14 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 61.04 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.4 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.15 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 29' ' ' ILE . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 72.45 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.548 ' HA ' HD12 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 70.31 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.41 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 71.2 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.53 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.596 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 73.21 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.51 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.21 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 60.22 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 71.15 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo . . . . . 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 53.52 113.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.422 -1.87 0 CA-C-O 120.996 0.427 . . . . 72.43 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.42 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' ' 214' ' ' LEU . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.11 109.319 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 72.33 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' B' ' 214' ' ' LEU . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 64.31 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 64.24 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.427 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 64.44 109.008 -176.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.3 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.14 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.44 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.11 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 40' ' ' ILE . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 52.51 108.285 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.05 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.52 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.45 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 73.2 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 53.51 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 70.14 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 73.32 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 HD11 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 71.0 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.23 109.834 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.14 108.581 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.23 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 49' ' ' CYS . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 63.34 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.3 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 65.33 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.43 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.22 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.42 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.778 HD11 HD13 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.31 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.22 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.55 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 61.32 113.534 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 64.14 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 70.22 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 12' ' ' VAL . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.12 109.602 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 63.14 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.1 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.41 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.03 111.826 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 109.372 -0.603 . . . . 52.23 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 71.05 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.2 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 24.43 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.515 HD21 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 72.22 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.25 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 43.54 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.51 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 71.04 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 62.33 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 73.42 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.21 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.3 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.04 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 70.23 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.58 ' HD2' HD12 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 74.24 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 72.13 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.11 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 74.33 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.1 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.13 108.176 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.22 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.2 108.659 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.34 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.45 ' N ' HD13 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 71.14 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.664 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.32 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 53.23 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 53.1 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.33 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.13 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.489 ' HA ' HD12 ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.04 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.2 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 74.11 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.42 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.45 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.02 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.12 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.05 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' B' ' 234' ' ' LEU . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 70.01 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.53 108.087 174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.34 112.926 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.806 0.336 . . . . 73.03 111.811 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.15 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' B' ' 214' ' ' LEU . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.23 110.567 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.13 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 64.12 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.22 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.11 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 72.14 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 65.54 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.21 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 62.54 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 43.13 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.22 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.54 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.03 111.079 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.745 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.24 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.32 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 55.31 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.33 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 61.44 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 63.41 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.31 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 60.53 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 63.41 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.24 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.02 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.745 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 62.32 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.43 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 HD13 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.42 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.34 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 73.32 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.33 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.43 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.12 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.13 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 74.13 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.24 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 65.33 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.42 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.14 114.119 -178.836 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.429 -1.494 0 CA-C-O 121.296 0.57 . . . . 44.54 111.58 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 73.33 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 63.1 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.15 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.02 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.44 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.32 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.21 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.15 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.31 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.43 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.42 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.32 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.03 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.32 110.436 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.773 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 60.44 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.41 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.33 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.04 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.795 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.2 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 54.24 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.34 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.14 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.31 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 61.32 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.22 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 64.22 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 72.43 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.34 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.522 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.41 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.23 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 70.14 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.42 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.48 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.24 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 61.24 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 45' ' ' LEU . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.51 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.42 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.43 111.994 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m . . . . . 0 N--CA 1.421 -1.916 0 CA-C-O 121.198 0.523 . . . . 74.34 109.952 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.22 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' B' ' 214' ' ' LEU . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 73.44 109.212 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.12 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' B' ' 212' ' ' VAL . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.13 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 71.31 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.405 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.15 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' HG3' ' A' ' 43' ' ' ARG . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 71.33 107.829 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 74.52 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.33 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 40' ' ' ILE . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 64.24 108.858 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 71.11 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 63.14 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 72.32 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 74.23 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.34 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.54 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 62.45 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.51 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 70.3 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 45.42 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 73.35 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 61.14 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.43 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 61.21 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 44.1 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 54.13 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 63.42 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 72.44 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.728 HD11 HD13 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.21 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.479 ' HA ' HD12 ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.44 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 18' ' ' ARG . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.23 111.032 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.41 112.109 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 73.21 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG21 HD22 ' B' ' 245' ' ' LEU . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 52.31 109.113 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.41 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.32 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.22 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo . . . . . 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.41 113.366 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.422 -1.873 0 CA-C-O 121.08 0.467 . . . . 70.2 110.599 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.02 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.53 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.44 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 12' ' ' VAL . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.44 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.41 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.22 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.31 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.445 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.03 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.42 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.15 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 240' ' ' ILE . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 55.34 107.613 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.42 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 55.33 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.33 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.5 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.15 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.35 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.33 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 64.22 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.728 HD13 HD11 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.24 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 43.14 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.44 112.24 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.22 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.22 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 62.23 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 71.12 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.04 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.41 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 43.53 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 63.13 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.682 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 63.23 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.524 ' HA ' HD12 ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.14 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 63.32 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.11 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.43 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.43 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 60.12 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.23 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.04 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.22 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 43.41 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ASP . . . . . 0.421 ' O ' HD22 ' B' ' 234' ' ' LEU . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 55.2 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 250' ' ' ASP . 11.8 Cg_exo . . . . . 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.22 112.154 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 112.002 0.371 . . . . 71.54 112.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.31 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.51 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 61.44 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.24 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.32 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 32.31 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.23 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.23 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.32 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 62.35 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.44 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.24 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.34 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 72.43 110.928 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 63.22 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.43 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.23 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.703 HD13 HD11 ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 71.12 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 43.11 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.34 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 15.21 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.31 111.488 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.685 HD11 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.31 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 30' ' ' THR . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.53 111.242 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD11 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 61.22 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 71.34 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.32 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.21 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.33 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.49 HG22 HG23 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.22 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.02 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.12 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.43 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD13 HG22 ' B' ' 247' ' ' VAL . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.32 109.086 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.14 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 55.14 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.54 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 62.13 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.52 108.161 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 74.4 Cg_endo . . . . . 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.22 112.13 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.412 -2.368 0 CA-C-O 120.835 0.35 . . . . 64.54 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 64.42 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 61.32 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 12' ' ' VAL . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.24 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 71.12 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 41.14 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 55.5 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 62.21 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.22 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 63.23 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.2 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.21 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' B' ' 241' ' ' THR . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 64.14 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 72.1 110.835 -173.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.52 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 53.35 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 64.34 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 41.23 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' HG22 ' B' ' 229' ' ' ILE . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.44 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.45 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 61.14 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 65.33 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.03 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.24 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.02 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.03 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.21 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.541 ' HA ' HD12 ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.35 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.2 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.34 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 31.04 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.34 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.31 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 45' ' ' LEU . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.24 109.017 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 60.15 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 54.33 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.41 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.41 111.746 179.403 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 63.42 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.11 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 70.35 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.31 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.05 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.41 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.15 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.54 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.31 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.21 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.408 HG11 HG22 ' A' ' 40' ' ' ILE . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 50.23 109.044 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.24 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.24 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 71.31 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 65.0 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.2 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 73.41 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.33 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.603 HD13 HD11 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.15 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 64.15 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.35 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.31 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 72.24 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.55 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.42 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 72.44 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.54 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.13 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.717 HD11 HD13 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 42.05 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.03 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.31 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 65.11 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.01 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.667 HD11 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.22 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.55 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.11 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.41 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.658 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 32.12 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 64.1 112.115 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.24 109.011 171.842 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 54.13 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 211' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.3 107.636 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 14' ' ' LEU . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.12 109.325 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.2 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.429 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.13 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.15 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.4 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.43 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 72.41 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.44 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.23 111.362 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.44 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.22 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.2 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.53 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.572 ' HD2' HD12 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.1 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.04 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.03 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.717 HD13 HD11 ' A' ' 40' ' ' ILE . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.15 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.13 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 70.15 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.24 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.31 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 249' ' ' CYS . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.03 109.255 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.4 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.24 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.13 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 71.13 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 73.41 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.603 HD11 HD13 ' A' ' 29' ' ' ILE . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 73.34 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 72.42 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 62.11 115.189 -175.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.31 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.53 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.13 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.32 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 71.03 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.14 109.624 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.11 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.44 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.11 110.601 174.872 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.34 109.165 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.32 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 50.55 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.22 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HG ' HD21 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 62.24 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.24 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.15 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 19' ' ' LEU . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.1 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 72.2 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.22 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 65.23 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 61.21 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 54.43 112.957 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.32 106.447 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 72.11 110.604 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 62.12 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.32 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 54.22 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.747 HD13 HD11 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 71.13 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.24 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.31 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.12 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.13 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 71.3 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.12 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 33.33 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 62.24 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 64.11 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 74.5 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.15 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 54.04 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.21 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.15 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.43 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 53.43 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 72.24 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.13 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.23 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 65.34 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.5 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.35 112.018 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.081 0.467 . . . . 74.31 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 65.41 110.077 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.14 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.539 HD21 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.42 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 53.33 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 63.22 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.52 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.43 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 73.44 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' PRO . . . . . 0.403 ' HA ' ' CB ' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 62.24 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.35 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.54 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 73.01 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 241' ' ' THR . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 45.54 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.3 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.05 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.45 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.24 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.1 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.15 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.42 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.21 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.31 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 63.42 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 72.15 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 73.12 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.32 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.03 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.41 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 73.51 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' HD12 ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 52.55 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.403 ' CB ' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.21 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 54.0 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.449 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.41 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.449 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.11 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.23 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 45' ' ' LEU . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 54.31 109.52 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.14 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 44.14 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.444 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.44 111.937 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.315 -0.624 . . . . 65.52 109.315 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 44.3 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 61.34 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.02 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.51 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 73.15 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.13 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.44 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.12 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 60.41 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.32 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.34 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 61.43 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.14 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.51 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.613 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.33 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 70.11 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.53 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 70.52 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 72.33 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 45.42 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.13 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.14 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.23 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 64.21 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.2 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 34' ' ' LEU . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 53.54 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 64.44 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 62.33 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 73.02 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.657 HD11 HD13 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 63.31 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HG23 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 64.24 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 74.44 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.14 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 63.03 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.42 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 73.31 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.4 106.938 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.34 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.44 108.531 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.1 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.44 111.941 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.181 0.515 . . . . 75.12 112.024 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 14' ' ' LEU . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.34 110.284 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.53 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.554 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.21 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.12 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.15 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.04 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 65.33 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 73.32 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.31 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.448 HG11 HG22 ' B' ' 240' ' ' ILE . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.15 109.772 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 222' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.43 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.21 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.606 HG23 HG22 ' B' ' 241' ' ' THR . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 65.4 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.55 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.12 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.2 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 51.21 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 73.41 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 63.42 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 65.11 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 232' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.1 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.21 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.12 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.3 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 236' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.34 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.42 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.33 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' ILE . . . . . 0.758 HD11 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 63.34 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' THR . . . . . 0.606 HG22 HG23 ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.05 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 73.13 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 72.11 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.14 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.464 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.12 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' LYS . . . . . 0.594 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.14 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' VAL . . . . . 0.41 HG23 HG23 ' B' ' 212' ' ' VAL . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 72.14 109.977 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 71.42 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.21 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.41 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.34 112.173 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.834 -0.432 . . . . 74.02 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.53 -140.39 6.69 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.232 -1.147 . . . . 60.25 110.232 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -85.37 -5.45 59.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.163 0.481 . . . . 60.44 112.002 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -83.87 107.0 15.99 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.524 -0.547 . . . . 74.2 109.524 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.61 89.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 121.864 0.84 . . . . 24.14 111.452 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -100.35 -16.93 17.48 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.329 -0.619 . . . . 72.54 109.329 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.68 123.38 31.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.379 -0.828 . . . . 71.1 110.449 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -146.75 166.89 25.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.24 -1.763 . . . . 65.23 106.24 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -70.45 106.52 3.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.778 -1.564 . . . . 64.42 106.778 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p -72.35 85.95 1.11 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 72.52 112.245 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.53 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 63.3 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 74.03 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 62.34 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.51 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.55 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.12 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.41 112.617 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 52.21 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.13 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.42 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.24 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.02 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.32 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 44.23 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.13 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 73.35 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.03 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 70.02 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.757 HD13 HD11 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 40.12 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.32 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.4 106.943 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.33 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.11 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.05 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 64.45 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.23 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.32 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.53 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.14 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.23 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 70.32 113.378 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.21 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 34.44 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD13 HG22 ' B' ' 247' ' ' VAL . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.12 110.005 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 61.32 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.04 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 63.4 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 52' ' ' GLN . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 63.42 110.403 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.89 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.21 110.006 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.491 ' HA ' ' HE1' ' A' ' 55' ' ' TRP 0.267 25.4 mt-30 70.75 75.22 0.19 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.252 1.821 . . . . 71.01 112.146 -176.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.29 -35.34 0.28 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.589 -1.187 . . . . 74.33 111.929 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.6 p -84.99 28.55 0.69 Allowed 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.929 0.492 . . . . 72.54 112.325 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.491 ' HE1' ' HA ' ' A' ' 52' ' ' GLN . 14.2 m95 -78.01 88.58 4.15 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 73.32 111.594 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.96 150.86 17.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.742 -1.117 . . . . 73.33 108.076 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -101.67 97.39 7.81 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.854 0.835 . . . . 72.02 113.076 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -173.82 -171.63 0.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.928 -2.249 . . . . 54.24 104.928 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t 74.18 -65.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.373 0.669 . . . . 64.1 109.466 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t 55.27 83.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.615 1.166 . . . . 73.32 110.202 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -103.28 115.62 30.9 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.248 -0.887 . . . . 63.41 111.792 -175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.3 m -77.62 125.28 29.1 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.093 -1.817 . . . . 72.54 106.093 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.2 ttt -51.06 109.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.912 0.757 . . . . 72.3 112.369 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.78 129.9 41.38 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 106.741 -1.577 . . . . 74.11 106.741 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' ARG . 27.3 tpt180 -64.93 106.7 1.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.905 0.86 . . . . 75.22 112.889 -170.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 C--N 1.299 -1.619 0 CA-C-N 114.042 -1.435 . . . . 71.12 110.151 178.819 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' VAL . . . . . 0.643 ' N ' ' HZ3' ' B' ' 208' ' ' LYS . 60.2 t . . . . . 0 C--O 1.243 0.752 0 N-CA-C 109.509 -0.552 . . . . 70.0 109.509 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -162.65 -175.49 33.74 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.796 -0.922 . . . . 62.11 110.796 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.2 m -82.43 27.88 0.49 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.632 0.729 . . . . 71.41 110.994 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -151.36 136.69 17.64 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.479 -0.934 . . . . 74.21 108.479 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.06 90.26 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 122.076 0.941 . . . . 64.1 110.292 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 50.4 m -141.85 -72.56 0.33 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.571 -0.74 . . . . 63.32 111.071 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -137.07 98.63 3.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.091 0.472 . . . . 72.4 111.099 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' LYS . . . . . 0.643 ' HZ3' ' N ' ' B' ' 201' ' ' VAL . 40.0 ttmt -95.0 -82.54 0.37 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.78 -1.563 . . . . 74.05 106.78 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.623 ' HB2' ' SG ' ' B' ' 211' ' ' CYS . 3.3 mpt_? -160.24 163.93 33.12 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.977 -2.972 . . . . 74.13 102.977 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p -83.18 85.52 7.19 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.937 -1.105 . . . . 74.13 109.636 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' B' ' 209' ' ' ARG . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 71.21 107.443 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.22 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.04 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 54.35 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.507 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 72.12 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 63.42 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 53.34 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.33 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 220' ' ' PRO . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 44.22 109.847 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 73.21 113.211 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 64.32 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 72.22 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.52 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.44 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 65.21 110.944 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 71.33 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 72.22 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 65.54 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 53.14 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.45 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.24 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.55 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.44 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.13 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.34 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.44 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 54.43 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.727 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.21 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 72.44 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.14 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.535 HG22 HG23 ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 71.23 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.23 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 71.33 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 63.51 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.44 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 50.45 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 45' ' ' LEU . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.15 107.822 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.43 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.51 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 36.21 0.6 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.03 111.467 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 68.93 34.38 3.21 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.103 0.961 . . . . 72.24 109.352 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.93 73.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 63.41 111.553 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 19.4 m -78.28 -4.27 47.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.446 0.641 . . . . 71.12 110.208 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -77.99 89.5 4.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.105 0.955 . . . . 71.53 112.291 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.7 m -121.33 -174.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.672 -1.603 . . . . 72.41 106.672 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -92.56 79.83 4.85 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.113 -1.035 . . . . 65.24 110.524 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -100.27 142.07 32.25 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.708 -1.133 . . . . 64.0 108.796 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 68.7 t 72.31 -43.43 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 62.53 112.805 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.22 95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.573 1.149 . . . . 71.03 110.271 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -83.83 148.61 26.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.512 -0.767 . . . . 71.33 111.341 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 70.6 m -152.7 114.97 4.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.95 . . . . 51.02 108.436 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -81.59 131.63 35.28 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.053 0.454 . . . . 63.12 110.932 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.9 125.68 28.15 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.55 -0.75 . . . . 74.43 110.379 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.76 117.23 10.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.303 -0.862 . . . . 75.33 112.449 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.256 1.442 0 N-CA-C 107.446 -1.316 . . . . 75.32 107.446 173.881 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 108.809 -0.812 . . . . 63.41 108.809 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.86 -149.01 11.92 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.811 -0.709 . . . . 64.23 111.6 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -86.58 127.66 34.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.932 -0.766 . . . . 54.23 108.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.03 100.65 3.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.782 -0.451 . . . . 62.04 109.782 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.7 157.59 18.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.138 -1.06 . . . . 62.04 108.138 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -126.91 159.96 32.43 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.772 -0.455 . . . . 62.14 109.772 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -86.91 79.3 8.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.969 -1.493 . . . . 71.35 106.969 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -151.99 137.48 17.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.166 -0.925 . . . . 70.24 109.3 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -82.98 136.82 34.4 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.736 -0.839 . . . . 74.15 108.736 175.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -113.09 149.07 34.0 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 109.16 -0.682 . . . . 75.14 109.16 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.14 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.34 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.34 112.131 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' HD21 ' B' ' 214' ' ' LEU . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.12 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 54.04 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.13 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.43 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 17' ' ' GLN . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.21 110.673 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 50.54 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.01 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 40' ' ' ILE . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 64.42 109.48 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.542 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 60.31 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.41 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 HG22 ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 64.52 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 62.14 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.45 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 70.41 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 65.3 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.831 HD13 HD11 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.04 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 51.11 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.42 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.24 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 71.41 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.54 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.2 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.51 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.12 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.816 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 50.21 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.52 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 72.52 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 64.1 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.43 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 64.41 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.13 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 64.54 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.53 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HB3' HD21 ' A' ' 34' ' ' LEU . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.4 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 72.34 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.12 -4.12 13.62 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.43 113.278 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 58.48 77.85 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.79 0.805 . . . . 72.45 110.909 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.45 -64.95 1.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.955 -1.02 . . . . 60.23 108.748 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.8 m -146.19 103.34 3.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.95 -0.568 . . . . 61.42 109.526 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 176.25 -27.93 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 124.072 0.857 . . . . 60.11 110.385 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.94 104.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.141 0.972 . . . . 74.24 113.166 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -132.93 92.06 2.98 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.043 -1.435 . . . . 75.44 107.636 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 59' ' ' VAL . 18.0 t70 66.19 -166.24 0.22 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 108.121 -1.066 . . . . 71.41 108.121 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 20.9 t 60.8 29.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 122.544 1.164 . . . . 70.42 108.189 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.89 115.94 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.044 -0.98 . . . . 73.24 111.63 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -137.67 110.51 7.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.188 -0.914 . . . . 74.3 109.325 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 m -145.78 135.2 23.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.828 -0.805 . . . . 64.04 108.828 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttm -83.09 94.62 7.85 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.059 -0.719 . . . . 74.52 109.059 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.49 111.07 8.05 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.926 -0.579 . . . . 75.53 110.062 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.92 93.81 2.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.534 -1.654 . . . . 73.31 106.534 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.764 -0.653 . . . . 74.23 109.531 -175.551 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.719 -0.475 . . . . 64.12 109.719 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.86 -44.67 3.38 Favored Glycine 0 C--N 1.314 -0.68 0 N-CA-C 111.144 -0.782 . . . . 42.22 111.144 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 p -74.89 128.88 36.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.465 0.706 . . . . 62.21 109.828 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.45 115.6 23.17 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.315 -0.402 . . . . 61.3 110.684 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.52 143.95 10.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.167 -0.679 . . . . 65.45 109.167 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -97.57 125.56 42.36 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 120.175 -0.61 . . . . 73.42 111.259 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -91.03 -33.98 15.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.772 -1.936 . . . . 73.2 105.772 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.93 127.06 31.57 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 113.268 -1.787 . . . . 52.23 107.273 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.526 ' NE ' ' H ' ' B' ' 209' ' ' ARG . 0.1 OUTLIER -68.95 98.41 0.95 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.524 0.678 . . . . 74.51 110.467 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p -88.41 120.47 29.81 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.555 -0.748 . . . . 45.13 110.71 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.33 107.377 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 64.2 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.23 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.536 HD21 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.44 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.45 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.11 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 43.12 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.423 ' H ' ' HD2' ' B' ' 218' ' ' ARG . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.32 111.775 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 34' ' ' LEU . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 64.04 110.266 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.44 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.42 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.33 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.44 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 71.02 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.624 ' HD3' HD12 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 41.33 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.05 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.23 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.13 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.816 HD13 HD11 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 72.3 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.44 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.22 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.21 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 52.14 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.55 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.13 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.41 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.44 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 64.21 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.52 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.831 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.3 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.603 ' HA ' HD12 ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 51.32 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 43.41 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 65.33 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.13 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 73.34 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.11 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.33 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.12 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.33 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.96 -8.92 23.85 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 51.66 32.99 10.03 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.737 1.384 . . . . 74.44 114.737 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.03 -66.62 0.8 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.293 -0.563 . . . . 72.42 110.291 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 57.3 m -156.9 91.36 1.2 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.702 0.286 . . . . 53.53 110.594 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.12 17.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.66 -0.867 . . . . 74.51 108.66 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.27 101.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.537 1.16 . . . . 63.42 113.909 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -131.73 29.12 4.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.208 -1.36 . . . . 74.31 107.478 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 259' ' ' VAL . 18.7 t70 -136.74 -153.56 0.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 104.819 -2.289 . . . . 74.25 104.819 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.437 ' H ' ' CG ' ' B' ' 258' ' ' ASP . 48.7 t 71.2 61.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 122.966 1.365 . . . . 75.03 109.898 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.68 113.16 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.833 -1.531 . . . . 52.34 107.12 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -83.0 94.88 7.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.114 0.483 . . . . 65.5 109.835 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.9 m -84.35 94.9 8.58 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.775 -0.648 . . . . 64.41 110.355 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -87.29 70.42 10.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.618 -0.882 . . . . 72.04 108.618 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -143.57 93.15 2.44 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.676 -1.147 . . . . 64.41 110.881 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -118.03 92.75 3.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.447 -1.686 . . . . 72.14 106.447 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 105.744 -1.947 . . . . 75.12 105.744 -178.667 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.115 -0.698 . . . . 60.1 109.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.95 91.38 1.5 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 108.96 -1.656 . . . . 72.53 108.96 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -71.56 95.63 1.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.983 0.735 . . . . 64.13 112.983 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.55 85.29 1.64 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.883 -1.053 . . . . 73.33 109.445 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 145.95 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.843 -0.617 . . . . 75.13 112.176 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -103.93 33.73 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.668 -1.234 . . . . 61.3 107.668 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.26 -55.68 12.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.547 -1.206 . . . . 51.44 110.854 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -102.95 -72.24 0.7 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.399 -0.593 . . . . 74.15 109.399 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -150.76 158.37 44.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.981 0.912 . . . . 71.34 108.989 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p -97.15 85.64 3.75 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.54 109.236 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 42.31 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' HD12 ' B' ' 214' ' ' LEU . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.35 110.378 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.23 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 61.35 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.467 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 70.11 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.31 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.51 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 71.3 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HD2' ' A' ' 20' ' ' PRO . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 19' ' ' LEU . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.41 112.579 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.45 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.11 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 62.32 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 64.22 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.51 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 71.23 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.754 HD13 HD11 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 70.44 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.14 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.31 111.993 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.15 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.13 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 71.04 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 73.23 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.4 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.21 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.2 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.31 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.13 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.563 ' HA ' HD12 ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.35 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 20' ' ' PRO 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 42.24 115.806 -176.949 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.12 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.02 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.54 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 63.42 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.4 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 63.33 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.32 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HG2' HD23 ' B' ' 219' ' ' LEU . 26.9 Cg_exo -63.91 2.21 1.15 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 73.05 115.045 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 49.94 27.06 2.23 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.342 1.457 . . . . 73.1 112.894 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.46 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.532 -0.758 . . . . 64.24 111.334 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 m -120.16 10.15 11.3 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.708 0.766 . . . . 65.54 109.8 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -128.51 95.03 4.02 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.771 0.656 . . . . 73.25 112.771 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t 61.61 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 115.092 1.515 . . . . 74.32 115.092 172.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.32 99.47 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.931 -0.577 . . . . 74.14 111.222 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -158.11 110.62 2.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.84 -37.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 120.823 0.344 . . . . 55.45 110.696 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.48 145.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 108.923 -0.769 . . . . 54.14 108.923 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.438 ' NH2' HG21 ' A' ' 30' ' ' THR . 68.6 mtt180 -129.63 118.23 21.64 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.605 -0.271 . . . . 73.42 110.453 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 m -84.8 74.31 10.49 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 122.207 1.003 . . . . 71.33 108.679 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.24 101.25 3.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.17 -1.789 . . . . 72.32 106.17 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.16 148.22 46.45 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.697 -1.594 . . . . 72.25 106.697 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 71.02 99.55 0.06 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.954 0.784 . . . . 64.05 110.342 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 C--N 1.308 -1.227 0 CA-C-N 115.911 -0.586 . . . . 74.24 110.02 178.757 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.081 0.467 . . . . 72.23 109.782 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.45 165.99 16.03 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 110.446 -1.062 . . . . 64.04 110.446 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.8 m 57.75 81.53 0.14 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.397 0.679 . . . . 72.13 109.902 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.44 84.57 7.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.336 1.065 . . . . 73.03 113.539 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.7 129.03 53.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.526 -1.215 . . . . 75.32 108.025 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -79.62 122.9 27.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.527 0.68 . . . . 54.42 111.701 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.71 173.0 13.04 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.838 -1.541 . . . . 74.32 106.838 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -66.75 -33.29 75.3 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.225 -1.028 . . . . 74.12 108.225 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -112.23 97.23 6.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.346 -0.843 . . . . 72.32 108.854 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p -81.23 101.96 10.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.1 108.86 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.34 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.24 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.43 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.432 HD12 ' HB ' ' A' ' 12' ' ' VAL . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.54 111.988 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 61.3 110.113 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 71.33 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.53 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.24 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.02 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.35 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.51 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.1 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 71.34 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 64.52 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.612 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 52.13 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.769 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.3 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' B' ' 238' ' ' ILE . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.24 108.938 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.43 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 62.14 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.23 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.23 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.13 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 32.34 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.814 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 72.54 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' B' ' 258' ' ' ASP . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 72.43 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 65.03 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 63.41 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 52.13 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.42 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 62.33 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.34 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.34 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.11 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.33 113.847 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.05 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.03 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.41 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 42.31 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.34 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.33 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.62 -4.48 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.2 114.912 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' B' ' 255' ' ' TRP . 12.2 pt20 52.86 1.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.969 1.841 . . . . 70.35 115.969 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.53 -55.15 19.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.108 0.48 . . . . 73.3 110.267 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 7.7 m -107.32 15.52 24.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.95 0.881 . . . . 43.52 108.664 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.495 ' HB2' ' HA ' ' B' ' 252' ' ' GLN . 67.4 m95 -126.62 22.8 6.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.996 -0.547 . . . . 75.12 111.535 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 77.1 t 78.42 119.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.908 0.883 . . . . 75.31 112.272 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -70.53 118.98 14.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.565 -0.743 . . . . 73.43 109.719 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.502 ' HB2' ' CZ ' ' B' ' 235' ' ' ARG . 28.6 t70 -86.69 73.48 10.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.92 0.867 . . . . 71.33 109.921 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.9 -28.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.682 -1.145 . . . . 63.1 108.498 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 18.2 m -88.92 87.28 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-N 114.87 -1.059 . . . . 60.3 109.585 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -118.9 104.17 10.28 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.486 -1.233 . . . . 53.0 107.734 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -76.76 72.93 3.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.908 0.861 . . . . 73.15 112.094 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.19 90.78 0.98 Allowed 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.116 -1.439 . . . . 75.14 107.116 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 264' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' ' 265' ' ' ARG . 23.8 t70 -146.29 95.3 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 103.712 -2.699 . . . . 74.31 103.712 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' B' ' 264' ' ' ASP . 70.0 ttt180 75.76 136.2 0.06 Allowed 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.64 1.213 . . . . 74.52 107.863 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp . . . . . 0 C--O 1.254 1.341 0 C-N-CA 120.259 -0.576 . . . . 64.51 109.691 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 110.124 -0.325 . . . . 62.53 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.15 35.34 1.12 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.766 -0.731 . . . . 61.25 112.506 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 m -91.69 -42.34 10.22 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.315 0.579 . . . . 62.15 110.191 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.93 107.14 8.5 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.645 0.736 . . . . 53.15 110.71 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -172.87 -45.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.945 -1.025 . . . . 51.43 108.933 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.4 p -128.38 157.04 42.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.724 -0.843 . . . . 65.21 108.724 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.49 120.41 24.98 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.751 -0.833 . . . . 73.41 108.751 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -104.13 105.02 15.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 121.293 0.568 . . . . 70.33 110.464 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -94.52 128.99 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.229 -2.137 . . . . 75.44 105.229 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m -92.11 94.6 9.31 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.457 -0.897 . . . . 52.23 110.541 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.3 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.21 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 41.4 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.48 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 51.43 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 63.31 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 63.1 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 64.21 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 53.23 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.44 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.52 108.766 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' SER . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 64.34 113.298 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 63.02 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.15 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.55 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.12 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 51.3 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 54.33 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 62.24 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.43 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.21 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.4 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 65.3 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.35 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.42 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 55.52 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.51 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.713 HD11 HD13 ' B' ' 229' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 74.23 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 64.43 114.426 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.456 ' HG3' ' HE2' ' A' ' 42' ' ' LYS . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.22 112.153 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 61.25 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.13 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 71.31 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG21 HD22 ' B' ' 245' ' ' LEU . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 64.31 110.962 -173.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.13 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.35 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.21 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo -77.77 20.85 0.68 Allowed 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.23 112.491 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 73.86 -51.67 0.69 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.577 1.551 . . . . 73.2 112.321 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 55.77 25.26 8.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 61.15 110.825 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 m 74.93 8.53 4.13 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 124.793 1.237 . . . . 74.23 112.623 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -67.1 -29.79 69.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.262 0.553 . . . . 74.23 110.607 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.82 150.47 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.816 -0.809 . . . . 70.34 108.816 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -67.64 144.37 55.56 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.512 0.508 . . . . 73.24 109.637 175.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -71.06 100.75 2.07 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.645 0.736 . . . . 72.43 110.582 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.56 -16.52 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.291 -0.633 . . . . 64.41 109.291 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.53 101.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.812 -0.81 . . . . 42.02 108.812 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 66.23 88.61 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.454 -1.313 . . . . 75.42 107.454 -171.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 p -102.76 9.78 38.88 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.727 -0.67 . . . . 52.23 111.651 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.59 98.37 0.07 Allowed 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.595 1.158 . . . . 72.32 112.934 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -131.45 158.67 40.23 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 104.931 -2.248 . . . . 73.22 104.931 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -69.21 -23.05 63.85 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.363 -0.535 . . . . 70.33 111.255 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 110.129 -0.322 . . . . 62.43 110.129 179.616 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.241 0.643 0 N-CA-C 110.232 -0.284 . . . . 55.01 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 140.27 125.57 2.2 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.171 -1.172 . . . . 61.34 110.171 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.6 m -60.75 -36.63 79.38 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.777 0.431 . . . . 75.43 111.242 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.67 153.69 42.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 113.153 0.797 . . . . 61.31 113.153 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.3 -3.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.894 -1.15 . . . . 51.31 107.894 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.2 p -159.77 166.68 29.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.023 -1.103 . . . . 75.22 108.023 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.66 86.21 6.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.342 1.067 . . . . 63.12 108.238 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' LYS . . . . . 0.501 ' HD2' ' O ' ' B' ' 209' ' ' ARG . 2.1 tmmm? -81.62 120.54 25.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 75.31 108.044 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.501 ' O ' ' HD2' ' B' ' 208' ' ' LYS . 27.6 mmm180 -77.54 140.17 39.69 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.727 -1.212 . . . . 72.05 107.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m -71.38 116.84 12.18 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.162 1.171 . . . . 72.13 114.162 -168.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.14 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 50.04 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.13 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 64.33 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.456 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.01 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 71.4 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 63.52 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.34 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 64.13 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 74.42 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 62.24 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.31 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.12 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.14 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.12 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.42 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.34 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 54.01 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 64.01 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.34 110.162 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.34 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 61.42 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.11 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 64.43 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.21 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.42 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.34 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.23 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.1 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' HD12 ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 65.11 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 62.22 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.21 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.42 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 64.23 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 43.11 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.466 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 53.32 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.13 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.35 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.42 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 85.9 Cg_endo -80.19 6.11 5.56 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 54.01 113.208 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 58.76 -83.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.866 1.266 . . . . 63.25 112.777 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 52.13 84.24 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.943 1.297 . . . . 74.42 112.929 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 39.7 m 72.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.262 1.025 . . . . 73.43 112.982 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -50.01 -49.44 50.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 73.15 112.021 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.23 135.09 59.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.927 -0.768 . . . . 70.32 108.927 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -99.8 158.07 16.06 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.09 -1.078 . . . . 71.01 108.09 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -126.63 144.66 50.84 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.078 -0.649 . . . . 75.54 112.229 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.9 p 51.82 17.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.14 2.176 . . . . 64.43 113.907 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.67 105.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.002 0.906 . . . . 72.33 109.949 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -122.89 94.44 4.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.286 -0.87 . . . . 72.2 111.492 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 58.0 p -147.98 94.01 2.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.314 -0.857 . . . . 71.54 109.177 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.03 102.82 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.43 0.633 . . . . 53.3 109.974 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -137.56 165.04 27.27 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.775 -1.194 . . . . 73.3 107.775 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -65.77 -23.19 66.66 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.366 0.506 . . . . 74.11 112.366 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.872 -0.585 . . . . 74.31 109.635 177.804 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.575 0.226 . . . . 63.52 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.08 1.71 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.028 -1.229 . . . . 64.12 110.028 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -146.98 77.74 1.47 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.605 0.717 . . . . 54.3 110.621 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.87 112.84 26.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.093 -1.447 . . . . 72.31 107.093 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -67.85 146.81 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 115.136 1.532 . . . . 60.44 115.136 -171.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 t -158.71 156.97 30.87 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.37 -2.455 . . . . 70.01 104.37 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -93.61 -169.68 2.17 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.562 -1.255 . . . . 72.22 108.04 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HE2' HG23 ' A' ' 54' ' ' THR . 33.3 mtmm -82.21 -43.55 17.5 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.52 -0.919 . . . . 64.3 108.52 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.594 ' HD3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -97.53 134.54 40.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.094 -1.076 . . . . 70.12 108.094 176.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' HB ' ' OG1' ' B' ' 216' ' ' THR . 40.1 p -100.51 114.54 28.24 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.572 -0.451 . . . . 72.01 110.895 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.21 108.024 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 71.35 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.33 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 61.53 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 64.21 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.31 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.54 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.42 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.05 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 70.2 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.11 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.41 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.22 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.22 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.777 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.31 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 52.0 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.14 108.629 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 70.23 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.01 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.779 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.02 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.12 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.02 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.564 ' HA ' ' NE2' ' A' ' 52' ' ' GLN . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 64.24 110.925 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 71.42 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.21 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.14 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 61.41 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.24 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.03 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.727 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 64.32 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.12 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.13 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 63.23 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.02 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 73.51 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.54 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 45.0 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 71.45 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.35 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 70.22 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo -77.06 37.46 0.59 Allowed 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 64.53 111.675 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' NE2' ' HA ' ' A' ' 33' ' ' SER . 77.9 mt-30 60.21 38.93 19.8 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.904 0.859 . . . . 73.2 110.408 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.28 -37.37 12.08 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.396 -1.335 . . . . 62.14 107.396 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HB ' HG23 ' A' ' 56' ' ' VAL . 12.7 m -98.39 -28.74 13.51 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.039 -0.982 . . . . 74.21 109.292 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.2 m95 64.37 41.85 5.56 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.981 -1.118 . . . . 70.34 107.981 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 54' ' ' THR . 35.1 t -55.09 112.89 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.332 -1.303 . . . . 72.53 112.611 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -111.95 134.19 53.66 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.294 -1.743 . . . . 70.42 106.294 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -115.25 140.65 48.92 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.072 -0.651 . . . . 74.23 111.033 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 m -82.8 -13.95 12.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.279 -1.008 . . . . 53.31 108.279 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.8 t -72.22 102.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.574 -1.639 . . . . 73.03 106.574 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -83.13 143.46 30.52 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.142 -0.481 . . . . 64.2 111.037 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.4 t -87.23 138.72 31.24 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.447 -0.946 . . . . 74.24 108.447 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 ptp -106.27 -171.95 1.99 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.6 -0.889 . . . . 64.54 108.6 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.6 149.66 46.84 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.255 -0.578 . . . . 65.04 109.682 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.74 -23.3 63.09 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.924 0.89 . . . . 74.24 112.501 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 tptp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.203 -0.295 . . . . 64.42 110.203 175.854 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.245 0.85 0 CA-C-O 120.832 0.349 . . . . 62.34 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -139.44 105.99 0.49 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.483 -1.447 . . . . 62.4 109.483 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.0 m -144.42 101.82 3.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.142 0.496 . . . . 75.32 110.991 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.59 143.88 35.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.145 -1.057 . . . . 63.1 108.145 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.76 140.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.15 0.5 . . . . 63.12 111.012 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 22.9 t -89.05 -170.28 2.84 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.128 -1.064 . . . . 73.11 108.128 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.16 157.53 19.3 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.727 -0.842 . . . . 70.41 108.727 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.7 -28.6 68.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.971 0.415 . . . . 74.02 110.043 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 103.16 6.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.525 -1.287 . . . . 74.5 107.525 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m -100.52 117.13 34.05 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.278 -0.569 . . . . 73.01 111.43 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.14 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 14' ' ' LEU . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 51.4 109.677 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.3 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.33 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.4 107.777 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 10' ' ' THR . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.55 110.72 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.2 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 64.51 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.12 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.44 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 73.14 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 54.11 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.42 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 34.23 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 71.34 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 35.32 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 74.41 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.52 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.31 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 53.55 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.45 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 44.13 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.41 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.54 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.23 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.04 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 52.11 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.23 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.02 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 52.14 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.14 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 64.33 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.32 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 47' ' ' VAL . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.34 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 45' ' ' LEU . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 70.32 109.819 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.02 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.34 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 53.24 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -84.78 18.12 1.62 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.23 112.049 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.448 ' O ' HG23 ' B' ' 256' ' ' VAL . 74.4 mt-30 61.79 24.32 14.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.28 1.032 . . . . 71.32 111.749 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.73 -34.11 70.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.487 0.715 . . . . 60.11 112.179 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 38.8 m -108.78 -8.78 15.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.675 0.75 . . . . 73.42 109.664 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -90.04 -10.68 43.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.913 0.709 . . . . 73.42 112.913 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 252' ' ' GLN . 58.7 t -79.42 94.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.603 -1.999 . . . . 64.33 105.603 168.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -138.87 145.67 40.25 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.068 -0.969 . . . . 63.42 110.708 -169.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -140.22 153.67 46.65 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.026 -1.842 . . . . 75.23 106.026 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.9 -1.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 117.886 0.312 . . . . 73.25 111.271 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 70.38 64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.353 -1.721 . . . . 71.34 106.353 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -60.63 150.31 32.3 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.769 -2.014 . . . . 74.11 112.094 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.2 t -140.13 129.15 23.51 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.123 -1.065 . . . . 63.33 108.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.04 156.97 34.67 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.31 -0.626 . . . . 64.13 109.31 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.01 156.11 39.2 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.796 -0.362 . . . . 63.43 110.227 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -56.37 -37.11 69.62 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.303 1.041 . . . . 75.15 110.375 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 118.073 -0.965 . . . . 65.12 110.341 177.555 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.643 -0.873 . . . . 71.02 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.79 88.55 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 119.565 -1.302 . . . . 50.24 113.723 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -71.52 -23.33 61.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.063 -1.458 . . . . 71.01 107.063 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.39 92.41 4.58 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.362 -1.718 . . . . 61.51 106.362 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.21 -37.43 12.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.422 -0.808 . . . . 62.03 110.663 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 p -150.6 -67.76 0.19 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.332 -0.988 . . . . 74.22 108.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.19 89.4 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.157 0.983 . . . . 65.31 113.256 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -102.31 -61.71 1.36 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.762 -0.654 . . . . 71.41 109.73 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -143.06 106.59 4.61 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.538 -0.755 . . . . 72.14 109.43 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m -98.93 133.02 43.81 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.0 -0.741 . . . . 45.2 109.0 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 61.54 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.41 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 63.13 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.22 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.31 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 70.45 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 71.11 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.22 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.4 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG21 ' HZ1' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.42 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.32 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.32 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 61.54 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 65.23 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 64.11 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 38' ' ' ILE . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.52 107.83 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.43 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HD11 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 73.41 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 44.45 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 63.23 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.12 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.32 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.41 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 65.22 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.02 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 60.35 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 72.53 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 62.31 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.688 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 74.2 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 42.41 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.33 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 65.35 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.53 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 74.42 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 72.34 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 245' ' ' LEU . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 55.14 109.382 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 71.15 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.12 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.14 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.85 -11.2 21.75 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.42 112.993 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' TRP . 87.7 mt-30 59.34 17.6 6.0 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.401 1.08 . . . . 75.21 113.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.61 94.22 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.44 0.533 . . . . 51.25 112.44 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.0 p -86.29 -0.45 55.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.977 0.732 . . . . 75.03 112.977 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.527 ' CD1' ' HA ' ' A' ' 52' ' ' GLN . 4.5 p-90 -139.85 69.32 1.36 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.624 1.202 . . . . 73.01 110.835 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.8 11.6 4.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.367 -1.288 . . . . 71.43 110.679 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -82.24 74.01 9.24 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.629 1.204 . . . . 63.34 111.727 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -177.77 78.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 112.967 -1.924 . . . . 73.31 107.088 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.02 -18.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.215 -0.902 . . . . 51.31 110.604 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.62 77.93 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 122.127 0.965 . . . . 55.02 109.015 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -147.13 161.7 40.34 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.547 -1.649 . . . . 62.01 106.547 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -115.47 91.74 3.7 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.258 -0.645 . . . . 70.22 109.258 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.5 ttm -159.72 128.51 5.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 75.51 110.208 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.86 144.41 8.55 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.827 -0.805 . . . . 74.51 108.827 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -120.14 132.95 55.6 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.529 -0.545 . . . . 65.15 109.529 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--N 1.301 -1.518 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 -179.232 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.243 0.736 0 CA-C-O 121.048 0.451 . . . . 70.25 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -153.46 75.86 0.23 Allowed Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.859 -0.686 . . . . 40.2 111.821 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 33.5 t -76.4 -45.89 29.66 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.795 -1.557 . . . . 75.23 106.795 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.57 90.78 3.12 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.521 -1.659 . . . . 64.53 106.521 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.8 -27.36 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.433 -0.803 . . . . 54.45 112.225 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 30.4 p -134.23 -84.91 0.43 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 121.005 -0.278 . . . . 72.45 111.005 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 53.81 86.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.11 0.964 . . . . 72.04 113.304 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.98 -55.9 3.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.418 -0.81 . . . . 54.42 110.802 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.437 ' HA ' ' CZ ' ' B' ' 209' ' ' ARG . 1.7 tpm_? -141.86 81.68 1.77 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.793 0.806 . . . . 74.23 109.134 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m -92.7 119.06 31.71 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.833 -1.076 . . . . 64.43 109.877 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.34 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.44 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 54.33 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 72.55 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.483 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.51 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 52.33 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 61.13 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.655 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.53 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.529 ' O ' HD12 ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.23 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.42 110.681 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 74.0 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 53.11 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 241' ' ' THR . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.43 104.811 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 73.11 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.43 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.12 107.895 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.14 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.688 HD13 HD11 ' A' ' 40' ' ' ILE . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.52 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.14 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 70.24 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 61.25 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.15 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.04 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 63.34 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.53 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 63.22 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.52 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.45 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.411 ' HA ' HD12 ' B' ' 224' ' ' ILE . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 72.41 110.233 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 44.11 112.554 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 73.04 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.03 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 47' ' ' VAL . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.43 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 53.14 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 63.31 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.34 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.35 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.52 109.662 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo -76.88 38.26 0.63 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 72.42 111.241 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.517 ' HA ' ' CD1' ' B' ' 255' ' ' TRP . 95.0 mt-30 65.23 72.76 0.42 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.435 1.094 . . . . 72.41 111.309 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -140.41 -45.0 0.41 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.464 -1.244 . . . . 65.3 110.702 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 74.7 p -116.01 -1.86 12.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.583 0.586 . . . . 74.32 112.583 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' B' ' 252' ' ' GLN . 5.6 p-90 -65.05 -25.26 67.74 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 111.579 0.214 . . . . 75.53 111.579 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 47.3 t 67.85 -80.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.694 1.198 . . . . 73.1 110.235 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -165.24 29.87 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.301 -0.629 . . . . 72.52 109.301 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.59 140.2 47.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.014 -0.993 . . . . 45.03 111.837 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.73 18.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.3 1.048 . . . . 73.0 108.532 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 85.8 t -93.18 91.19 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.205 -0.907 . . . . 61.52 111.905 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' B' ' 261' ' ' ARG . 3.1 mmp_? -153.43 82.27 1.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.82 1.248 . . . . 61.24 110.144 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.9 p -79.43 96.16 5.97 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.331 -0.988 . . . . 70.1 108.331 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 45.4 ttm -128.77 145.46 51.18 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.051 -0.977 . . . . 74.24 109.616 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.55 134.22 53.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.693 -1.595 . . . . 74.4 106.693 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -149.52 132.14 15.85 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.095 -0.705 . . . . 73.12 109.095 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 C--N 1.293 -1.88 0 O-C-N 123.668 0.605 . . . . 73.35 110.691 -177.669 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 2' ' ' GLY . 14.9 m . . . . . 0 C--O 1.217 -0.642 0 CA-C-O 119.787 -0.149 . . . . 72.1 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 1' ' ' VAL . . . -99.23 53.06 1.05 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 106.616 -2.594 . . . . 23.44 106.616 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -111.83 25.69 11.37 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.035 -1.082 . . . . 70.42 109.885 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.69 98.3 2.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.036 -0.529 . . . . 44.43 111.301 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.92 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.363 -0.835 . . . . 60.33 109.726 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 m -95.12 91.2 6.21 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.962 -1.125 . . . . 70.41 107.962 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.94 92.32 7.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.462 -1.245 . . . . 72.32 107.774 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 38.1 ttpt -118.97 142.94 47.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.565 -0.743 . . . . 53.44 111.574 -171.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HG2' ' HG2' ' A' ' 8' ' ' LYS . 28.2 mmm180 64.91 14.17 9.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.222 1.409 . . . . 73.54 112.026 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -85.21 129.83 34.73 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.348 -0.842 . . . . 65.13 112.468 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.05 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 62.51 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 62.5 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HG ' HD21 ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 65.03 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 74.15 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.13 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.31 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.23 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 53.33 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 72.33 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 42' ' ' LYS . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 70.33 108.329 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.52 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 53.11 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.14 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.04 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.35 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.41 108.355 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 44.2 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.628 HD13 HD11 ' B' ' 240' ' ' ILE . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 71.41 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.3 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.1 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.1 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.503 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.41 110.684 -173.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 63.34 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.45 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.33 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 64.54 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 34.14 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 62.5 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.673 HD11 HD13 ' B' ' 229' ' ' ILE . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.24 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.55 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG22 ' A' ' 21' ' ' VAL 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.45 114.65 -179.248 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.12 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.14 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 53.11 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.31 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 61.33 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 43.44 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.4 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD1' HG22 ' A' ' 54' ' ' THR . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.42 105.949 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo -68.31 32.88 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.54 113.368 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 54.0 mt-30 56.77 38.58 29.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.595 1.188 . . . . 61.55 110.232 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.89 -50.31 7.2 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 113.116 -1.856 . . . . 60.33 108.525 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' OD1' ' A' ' 50' ' ' ASP . 15.3 t -99.23 -17.84 17.91 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.808 -0.757 . . . . 62.43 109.747 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -83.99 76.82 10.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.651 0.739 . . . . 75.34 112.503 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.8 m -97.23 137.81 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 107.358 -1.349 . . . . 64.43 107.358 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -132.45 152.61 51.45 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.379 -0.528 . . . . 72.14 110.129 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.99 109.71 2.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.386 -0.968 . . . . 73.31 108.386 174.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.98 3.36 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.251 0.548 . . . . 75.14 110.635 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.39 146.31 11.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.84 -1.17 . . . . 63.44 107.84 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -124.97 148.54 48.36 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.557 -0.457 . . . . 74.45 109.961 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.9 t -83.53 -17.25 42.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.186 -1.042 . . . . 71.13 108.186 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.7 tmm? 74.12 114.68 0.06 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.113 1.365 . . . . 52.35 111.907 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -140.18 -168.68 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.819 -1.919 . . . . 73.55 105.819 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 65' ' ' ARG . 6.5 mpt_? -114.33 142.57 46.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 118.739 0.7 . . . . 75.34 110.353 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.293 179.175 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.339 0.59 . . . . 74.14 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.45 -101.59 2.02 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.024 -1.23 . . . . 72.25 110.024 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 45.7 m 63.9 16.53 9.92 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.033 0.921 . . . . 64.34 112.491 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.74 16.56 20.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.018 -0.992 . . . . 71.41 109.308 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.1 97.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.645 -1.161 . . . . 62.23 112.306 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 32.5 m -86.61 87.75 7.51 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.83 -1.544 . . . . 70.3 106.83 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.59 127.46 32.86 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.454 -0.793 . . . . 53.31 112.105 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -99.48 101.13 12.28 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.444 -0.798 . . . . 71.33 109.529 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 67.13 97.63 0.05 Allowed 'General case' 0 C--O 1.251 1.182 0 C-N-CA 125.162 1.385 . . . . 65.45 112.816 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m -79.54 85.78 5.26 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.23 109.535 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 64.14 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.33 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.704 HD21 ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 62.55 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.35 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.55 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.41 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.54 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 74.24 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.1 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.4 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.53 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.23 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 72.35 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.14 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.522 ' HB2' HD12 ' B' ' 238' ' ' ILE . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 74.23 108.54 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 73.14 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.32 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.01 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.14 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.34 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 71.21 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.41 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 65.01 108.76 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.698 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.13 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 72.41 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.14 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.04 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.628 HD11 HD13 ' A' ' 29' ' ' ILE . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.43 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 73.55 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 63.4 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.43 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.11 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.23 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.14 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 72.23 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.52 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.44 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.22 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.53 15.59 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.01 110.899 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' B' ' 255' ' ' TRP . 50.8 mt-30 67.31 -97.3 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.878 1.671 . . . . 74.41 112.497 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.51 -72.6 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 114.687 1.365 . . . . 73.23 114.687 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 9.9 t -78.66 -3.21 42.92 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.473 0.709 . . . . 73.1 112.365 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.4 ' HD1' ' HA ' ' B' ' 252' ' ' GLN . 96.4 m95 -82.36 103.41 11.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 112.507 0.558 . . . . 74.01 112.507 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.18 82.41 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 122.463 1.125 . . . . 73.43 109.059 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -140.41 116.59 10.55 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.717 -1.129 . . . . 63.31 109.226 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.06 175.66 5.68 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.324 -0.991 . . . . 34.03 108.324 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.09 -2.16 9.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 122.123 -0.361 . . . . 75.35 110.993 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.42 127.67 13.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 123.936 0.772 . . . . 44.12 112.739 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ARG . . . . . 0.484 ' NH1' ' HB3' ' B' ' 264' ' ' ASP . 41.2 ptt180 -155.71 163.04 40.4 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.476 -1.305 . . . . 74.41 107.476 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.3 t -73.54 -64.88 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.039 -0.726 . . . . 71.21 109.039 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 48.0 ttm -173.32 112.02 0.21 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.884 -0.598 . . . . 72.1 109.77 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' ASP . . . . . 0.484 ' HB3' ' NH1' ' B' ' 261' ' ' ARG . 29.3 t70 -120.29 127.18 52.13 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.492 -1.299 . . . . 75.12 107.492 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -71.2 -78.76 0.07 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.765 0.654 . . . . 72.14 112.765 -173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 57.7 pttt . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.237 -0.887 . . . . 74.43 111.199 -178.084 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 111.849 0.314 . . . . 64.25 111.849 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.05 160.54 23.13 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.418 -1.073 . . . . 51.2 110.418 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -78.02 113.57 16.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.873 0.336 . . . . 71.23 110.147 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -74.09 112.71 10.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.678 -1.23 . . . . 65.41 107.678 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.74 122.45 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.212 0.529 . . . . 74.31 111.158 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -89.13 154.04 20.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.437 -1.32 . . . . 64.22 107.437 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.28 82.72 4.56 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.244 0.545 . . . . 64.13 110.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -78.31 -70.32 0.5 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.409 -0.96 . . . . 73.21 108.409 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -85.33 98.95 10.83 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.025 -1.472 . . . . 63.44 107.025 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m -95.72 132.31 41.06 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 109.577 -0.527 . . . . 64.52 109.577 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 63.3 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 71.25 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.04 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.24 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 61.31 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.53 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.24 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 63.41 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.31 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 52.44 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.51 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.13 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.2 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 41' ' ' THR . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.54 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 55.1 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 71.21 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 HD13 HD11 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.12 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 63.42 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.23 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.34 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.22 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.44 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.32 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.21 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.44 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 64.5 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.14 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD11 HD13 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.33 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.41 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.32 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.2 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.04 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 51.43 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.43 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG21 HD22 ' B' ' 245' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.22 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.23 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.1 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.04 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.53 33.17 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 32.33 110.349 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 78.41 -43.42 0.36 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.881 1.672 . . . . 73.12 111.643 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.51 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 117.408 2.373 . . . . 74.32 117.408 166.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.9 m 68.36 88.96 0.11 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.882 0.849 . . . . 64.53 112.971 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -170.45 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.073 -0.967 . . . . 74.42 109.67 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.3 m -56.82 -24.24 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.512 -0.767 . . . . 55.32 111.296 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 72.23 -63.07 0.44 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 124.69 1.196 . . . . 64.54 112.579 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.2 141.49 46.89 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.449 -0.574 . . . . 70.51 109.449 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.61 18.85 7.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.737 0.78 . . . . 62.21 109.92 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t 74.7 -81.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 124.522 1.129 . . . . 51.41 110.647 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 173.01 156.42 0.1 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.792 -1.559 . . . . 71.44 106.792 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 m -73.84 96.7 2.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.383 -0.969 . . . . 73.35 108.383 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.66 177.72 4.74 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.702 -0.681 . . . . 62.41 111.798 -176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.86 107.22 2.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.044 -0.525 . . . . 74.34 111.133 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -155.06 114.53 3.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.715 -0.846 . . . . 72.52 108.715 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.295 -1.783 0 CA-C-N 115.668 -0.696 . . . . 75.32 110.466 -179.073 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.635 -0.876 . . . . 62.31 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 134.59 69.17 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.579 -0.82 . . . . 75.33 111.398 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 28.3 m 68.87 155.68 0.13 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.575 1.15 . . . . 61.24 111.958 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -80.43 104.09 10.73 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 73.31 108.731 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.35 101.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.913 0.863 . . . . 73.55 110.861 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 31.7 t -100.92 -164.42 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.08 -0.964 . . . . 71.23 109.284 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.46 74.83 0.77 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.365 0.666 . . . . 73.54 112.679 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' B' ' 255' ' ' TRP . 52.6 mtmt -104.67 -39.91 6.19 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.417 -1.697 . . . . 75.34 106.417 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -135.92 144.9 45.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 71.15 107.337 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m -102.05 121.7 42.69 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.962 -0.755 . . . . 74.35 108.962 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.32 107.395 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.52 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.43 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' A' ' 14' ' ' LEU . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 71.04 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 60.33 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 74.41 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.42 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.3 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.504 ' H ' HD23 ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.33 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.33 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.03 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.44 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 63.45 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.02 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.13 110.76 -172.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.45 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.32 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.11 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.726 HD13 HD11 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 60.02 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 70.23 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.41 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.53 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 64.32 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' B' ' 250' ' ' ASP . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.12 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.32 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 63.33 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.13 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 71.55 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.24 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.4 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.14 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.22 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.42 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 47' ' ' VAL . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.33 111.182 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 64.22 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.31 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.45 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.663 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.24 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.58 -0.15 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.05 108.289 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' B' ' 250' ' ' ASP . 70.1 mt-30 73.19 -80.8 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.3 2.24 . . . . 72.14 109.2 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.07 -85.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 115.248 1.573 . . . . 74.12 115.248 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 21.3 p -97.2 -52.04 3.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 114.659 1.355 . . . . 73.25 114.659 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.4 ' CB ' ' HB3' ' B' ' 208' ' ' LYS . 11.4 p-90 -60.69 -24.49 65.66 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.871 1.063 . . . . 74.32 113.871 -168.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.1 m -57.16 -32.32 40.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 112.384 0.513 . . . . 61.24 112.384 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 68.99 -42.11 0.48 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.412 1.085 . . . . 63.04 113.045 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.19 145.93 28.9 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 124.106 0.963 . . . . 71.5 109.629 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.1 25.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 122.435 1.112 . . . . 73.52 108.81 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.81 153.01 11.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.782 -0.821 . . . . 53.33 108.782 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -73.23 154.4 40.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.149 -0.685 . . . . 61.15 109.149 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 40.9 m -68.51 123.19 20.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.525 -0.546 . . . . 53.35 109.525 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.7 173.11 6.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.524 -0.307 . . . . 73.42 110.732 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.88 127.43 43.82 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.707 -0.479 . . . . 75.22 109.707 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -125.76 138.61 53.87 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.624 -0.51 . . . . 62.23 109.624 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.715 -0.846 . . . . 61.2 108.715 178.729 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.702 -0.481 . . . . 74.31 109.702 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.69 140.08 6.17 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 119.696 -1.24 . . . . 72.14 112.419 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -80.39 114.47 19.31 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 120.779 0.323 . . . . 71.35 110.158 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -79.2 130.33 35.37 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.439 -0.578 . . . . 74.34 109.439 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.36 92.46 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.235 1.017 . . . . 72.13 111.911 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -122.49 150.37 42.63 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.575 -1.193 . . . . 73.13 108.864 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -78.83 113.96 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.433 -0.951 . . . . 61.32 108.433 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 9' ' ' ARG . 87.0 tttt -98.36 -72.79 0.64 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.732 0.641 . . . . 74.25 112.732 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 22.2 mmm180 -127.28 112.16 14.75 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.635 -0.876 . . . . 72.51 108.635 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m -115.51 118.34 32.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 114.712 1.375 . . . . 71.32 114.712 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 53.31 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.43 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.51 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.41 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 54.52 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.41 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' HG3' ' HD3' ' B' ' 251' ' ' PRO . 14.8 mm-40 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.23 109.201 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.01 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 64.32 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.41 114.063 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 61.41 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.44 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.12 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.23 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 65.25 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.01 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.3 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD13 HD11 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 64.14 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 64.33 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.12 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.24 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.14 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 64.5 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' NH2' ' HB2' ' A' ' 61' ' ' ARG . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.05 111.053 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.44 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.24 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.54 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 73.4 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD11 HD13 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.11 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.21 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.14 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.44 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 65.51 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 52.34 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.11 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.23 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.13 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.53 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.45 6.54 5.73 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.2 110.364 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 71.68 -44.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.548 1.939 . . . . 72.41 111.157 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' HA ' HD21 ' B' ' 219' ' ' LEU . . . 63.84 -86.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.369 1.468 . . . . 74.22 112.962 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.3 m -147.1 13.82 1.13 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.759 -0.83 . . . . 54.03 108.759 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -78.31 99.63 6.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.682 0.754 . . . . 62.01 109.703 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.67 133.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 114.937 1.458 . . . . 44.31 114.937 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 58' ' ' ASP . 18.0 ttp180 -162.56 -173.57 3.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 103.126 -2.916 . . . . 73.34 103.126 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 15.1 m-20 -57.52 -26.02 60.73 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.75 1.159 . . . . 74.42 112.156 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.8 t 75.36 -45.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.037 1.335 . . . . 72.45 111.093 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.4 135.05 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 122.181 0.991 . . . . 51.35 112.466 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 1.9 tmt_? -129.11 47.6 2.46 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 102.382 -3.192 . . . . 72.43 102.382 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 79.08 1.53 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.085 -1.416 . . . . 64.14 113.619 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 tmm? 176.36 94.61 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 102.649 -3.093 . . . . 61.04 102.649 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -146.77 177.75 8.85 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.369 -0.533 . . . . 71.3 111.454 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -57.27 107.53 0.43 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.981 1.313 . . . . 74.13 111.318 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.734 -0.469 . . . . 73.23 109.734 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.764 -0.458 . . . . 73.01 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -119.1 128.69 7.75 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.962 -1.114 . . . . 73.23 112.723 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 54.5 m -95.86 102.43 14.23 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.318 -0.623 . . . . 73.32 109.318 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.43 149.41 21.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.448 -0.945 . . . . 72.13 108.448 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 137.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.049 0.759 . . . . 72.45 113.049 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 33.6 p -163.24 96.09 0.87 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.211 -0.904 . . . . 74.53 110.325 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -105.58 92.88 4.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.164 0.507 . . . . 73.52 110.805 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -93.06 -27.58 16.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.728 -1.212 . . . . 62.14 107.728 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.544 HH22 ' HB2' ' B' ' 250' ' ' ASP . 17.3 mmm180 -118.43 100.17 7.3 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.536 -2.024 . . . . 74.32 105.536 170.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m -95.34 101.28 12.99 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.363 0.601 . . . . 74.13 110.888 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.54 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 14' ' ' LEU . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 72.51 108.823 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.502 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.44 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 54.44 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.4 109.194 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 71.1 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 51.02 111.465 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 64.53 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.47 HD21 ' HA ' ' A' ' 53' ' ' ALA . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 62.11 110.329 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 62.4 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 71.14 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.34 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.12 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 61.33 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.21 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.04 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.33 107.883 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 65.41 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.666 HD13 HD11 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 70.42 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 70.35 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' B' ' 229' ' ' ILE . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.14 106.353 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.24 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.41 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.63 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 72.44 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 64.04 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 41.55 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.2 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.32 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.04 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 29' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.42 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.514 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.31 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 62.21 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.52 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 21.43 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 62.32 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 53.41 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 54.44 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.14 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 71.32 111.536 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.544 ' HB2' HH22 ' B' ' 209' ' ' ARG . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.43 109.46 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo -83.62 19.85 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.22 111.698 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 66.75 -66.05 0.19 Allowed 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.033 1.333 . . . . 73.34 112.236 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 46.0 -99.0 0.04 OUTLIER 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.135 1.374 . . . . 33.1 113.701 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 63.1 m -157.93 95.51 1.41 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.775 -0.824 . . . . 64.21 108.775 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -129.06 101.33 6.0 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.028 -0.987 . . . . 75.43 109.185 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.3 m -85.99 113.65 24.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.73 0.776 . . . . 71.22 110.924 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -157.9 -57.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.056 -0.975 . . . . 74.34 108.476 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -123.18 -63.23 1.27 Allowed 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.838 -0.619 . . . . 73.44 109.808 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 70.0 t 70.61 -57.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.302 1.041 . . . . 74.2 110.48 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.37 83.33 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 122.473 1.13 . . . . 62.33 111.637 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.05 93.26 4.33 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.117 -2.179 . . . . 63.54 105.117 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 36.9 m -106.47 101.1 10.58 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.431 -0.804 . . . . 62.22 112.492 -172.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.06 108.18 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.41 -2.07 . . . . 53.24 105.41 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.12 153.59 18.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.502 -0.479 . . . . 73.31 109.793 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -141.51 154.22 45.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.638 -0.504 . . . . 62.51 109.638 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.369 -0.974 . . . . 74.53 108.369 176.587 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.115 0.413 . . . . 72.41 112.115 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.91 9.27 37.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.397 -0.906 . . . . 61.43 113.028 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 p -98.94 108.74 21.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.392 -0.475 . . . . 70.04 110.056 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -118.57 98.83 6.44 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.638 -0.425 . . . . 71.32 112.077 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.41 90.56 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.213 -1.032 . . . . 74.32 108.213 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -146.38 -25.42 0.43 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.84 -0.618 . . . . 75.55 110.279 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -90.24 148.22 23.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.449 -1.315 . . . . 53.43 107.449 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.37 -15.65 35.03 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 111.894 0.331 . . . . 73.2 111.894 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' HE ' ' HB2' ' A' ' 50' ' ' ASP . 69.9 ttt180 -144.42 99.39 3.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.641 -0.874 . . . . 51.41 108.641 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t -73.52 126.72 30.87 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.641 0.734 . . . . 74.15 112.42 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 62.42 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' B' ' 214' ' ' LEU . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.4 110.455 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.23 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HG ' HD21 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.01 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.34 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.32 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.21 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.22 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.43 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.41 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.52 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.13 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.23 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 41' ' ' THR . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.51 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.54 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 63.33 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.02 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 64.05 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 70.13 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.43 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.1 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.23 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.565 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.44 111.41 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 43.41 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 62.31 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 62.13 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 60.31 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.35 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 HD13 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 71.1 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.562 HG22 HG23 ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.24 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 64.35 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 64.13 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.55 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 25.13 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.02 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' B' ' 245' ' ' LEU . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 41.12 110.504 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.43 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.708 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' HB2' ' HE ' ' A' ' 9' ' ' ARG . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.34 106.992 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo -83.21 34.38 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 71.05 112.085 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 46.8 mt-30 67.22 43.05 2.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 124.073 0.949 . . . . 73.45 111.198 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 104.35 2.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.271 -0.877 . . . . 65.3 108.903 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.4 m 76.43 -0.17 3.11 Favored 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 124.106 0.962 . . . . 54.03 110.934 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 28.52 2.3 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.185 -0.672 . . . . 72.42 109.185 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.08 -17.93 12.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.06 -0.518 . . . . 74.32 111.507 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -67.24 -59.01 3.78 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.195 -0.457 . . . . 63.54 109.871 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.1 113.38 26.48 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 109.394 -0.595 . . . . 62.35 109.394 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG12 HE22 ' A' ' 52' ' ' GLN . 33.4 m -99.8 13.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.814 -0.63 . . . . 72.35 111.425 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t 62.64 90.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 121.619 0.723 . . . . 63.13 109.532 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -77.16 86.85 3.62 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.68 0.752 . . . . 75.53 110.846 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 t -171.95 39.49 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.701 -3.074 . . . . 62.11 102.701 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -107.85 15.67 24.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.026 -1.897 . . . . 61.22 112.641 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -81.63 87.28 6.29 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.534 -0.866 . . . . 74.53 109.398 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -176.72 129.85 0.19 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.561 1.145 . . . . 73.33 108.143 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 C--O 1.252 1.19 0 O-C-N 123.394 0.434 . . . . 70.21 110.833 179.796 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.806 0.813 . . . . 74.04 110.509 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.48 41.6 1.86 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 115.263 -0.881 . . . . 72.12 111.059 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 58.5 p -76.39 104.33 6.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.454 -0.573 . . . . 72.32 109.454 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -123.11 107.53 11.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 119.83 -0.748 . . . . 72.13 112.209 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.32 99.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 105.378 -2.082 . . . . 73.43 105.378 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.4 t -72.32 97.53 2.04 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.49 0.662 . . . . 60.22 111.425 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.76 95.08 3.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.396 -1.335 . . . . 74.54 107.396 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 90.61 1.01 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.348 0.87 . . . . 74.21 113.348 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -92.43 88.04 6.23 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.359 -2.089 . . . . 74.44 105.359 168.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -102.83 137.05 41.55 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.233 -0.894 . . . . 64.43 110.932 -171.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.42 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.32 109.539 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.45 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.13 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.55 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.34 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 64.23 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.12 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.23 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.35 110.606 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.22 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.23 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.33 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.13 110.304 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 71.22 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.43 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 73.13 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.831 HD13 HD11 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 64.21 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.52 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.22 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.44 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.593 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.44 110.744 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.12 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.3 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 62.44 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.12 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.12 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.41 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.11 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.51 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.434 ' HD2' ' HG3' ' B' ' 243' ' ' ARG . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.434 ' HG3' ' HD2' ' B' ' 242' ' ' LYS . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 54.34 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.14 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 47' ' ' VAL . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 72.3 111.135 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.32 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.1 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 63.44 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' B' ' 252' ' ' GLN . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.14 106.343 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo -73.34 24.35 0.31 Allowed 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 61.43 111.573 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.593 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 49.9 mt-30 63.33 68.71 0.6 Allowed 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 125.478 1.511 . . . . 75.4 110.621 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -111.98 127.92 56.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.434 -1.712 . . . . 55.15 109.591 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 12.8 m 75.05 20.4 2.15 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.505 1.145 . . . . 63.11 109.533 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -82.54 69.56 9.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.125 0.964 . . . . 71.15 111.739 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.53 -6.39 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 113.807 -1.542 . . . . 65.01 107.154 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.38 106.31 10.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.352 -1.749 . . . . 74.44 109.52 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.6 t0 64.57 166.79 0.16 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.083 0.864 . . . . 54.54 113.286 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.37 22.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 124.182 0.993 . . . . 74.51 108.493 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 86.0 t 77.54 106.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.199 1.399 . . . . 62.12 110.447 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -74.32 79.2 1.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.81 -0.632 . . . . 73.4 110.841 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.7 t -177.7 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.843 -1.54 . . . . 75.15 106.843 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.37 72.21 1.31 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.901 0.858 . . . . 74.22 111.815 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -137.65 82.34 1.92 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.79 -1.096 . . . . 64.12 109.195 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -165.01 134.0 3.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.666 -0.697 . . . . 70.42 110.045 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 115.318 -0.855 . . . . 53.45 109.816 178.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 108.406 -0.961 . . . . 65.45 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.73 96.32 1.02 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.491 -0.862 . . . . 70.04 111.167 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -147.8 112.22 5.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.944 0.402 . . . . 75.42 111.158 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -91.28 154.27 19.37 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.488 -0.93 . . . . 73.14 108.488 174.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.24 141.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.744 -0.782 . . . . 34.54 111.284 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.0 m -89.71 123.43 33.72 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.586 -0.734 . . . . 54.01 109.292 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.51 -52.22 66.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.783 -0.821 . . . . 72.24 108.783 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -144.52 -176.03 4.88 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.824 -1.176 . . . . 60.25 107.824 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -61.94 110.86 1.68 Allowed 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.53 0.681 . . . . 63.11 112.452 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m -85.58 109.6 18.65 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.4 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.02 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 72.33 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.23 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 63.04 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.586 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.31 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.14 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 70.23 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.44 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 73.41 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.51 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.21 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.31 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.33 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.45 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 64.11 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.45 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.608 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.13 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.43 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 64.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.45 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.33 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 62.21 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 53.11 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.24 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.43 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 71.24 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.563 HG22 HG23 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.23 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 70.24 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 64.12 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 65.3 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.42 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 62.21 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 12' ' ' VAL . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 41.05 109.071 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.12 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 64.32 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 42.31 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.25 -1.95 12.07 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 51.34 112.392 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 67.55 -63.44 0.3 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.677 1.191 . . . . 71.35 111.799 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 66.73 -57.69 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.646 1.578 . . . . 70.24 113.05 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.2 m -110.25 92.84 4.21 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.122 -1.066 . . . . 71.22 108.122 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -139.83 -26.25 0.8 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.181 0.437 . . . . 74.44 112.181 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.19 122.29 11.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.664 0.745 . . . . 63.34 110.843 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -156.75 -42.93 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.66 -1.607 . . . . 62.33 106.66 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -125.94 -177.88 4.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 104.889 -2.263 . . . . 74.34 104.889 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.06 -5.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 107.523 -1.288 . . . . 72.25 107.523 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.1 t 78.55 75.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 113.016 -1.902 . . . . 70.44 110.461 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -91.07 99.86 12.81 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.786 -1.097 . . . . 74.42 109.293 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -142.98 -17.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.438 -0.801 . . . . 75.21 111.417 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.1 tmm? 65.69 96.77 0.05 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.056 0.943 . . . . 71.22 110.621 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.84 127.78 29.51 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.774 -0.648 . . . . 71.34 111.589 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -135.53 142.94 45.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.185 -0.672 . . . . 60.55 109.185 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 109.314 -0.624 . . . . 74.34 109.314 177.761 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -127.83 -71.95 0.16 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.037 -0.825 . . . . 75.42 111.037 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.9 t -156.29 81.51 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.333 -0.988 . . . . 75.24 108.333 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.73 91.56 2.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.871 0.843 . . . . 74.1 111.312 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.35 159.17 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.494 -0.775 . . . . 62.4 110.311 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.405 ' O ' ' HB ' ' B' ' 254' ' ' THR . 19.5 m -84.95 80.26 9.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.063 0.935 . . . . 50.41 109.27 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -144.87 -46.37 0.23 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.875 -1.898 . . . . 62.31 105.875 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -94.63 123.75 38.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.964 -1.495 . . . . 65.11 106.964 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -95.86 100.84 12.49 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.648 0.737 . . . . 73.11 112.985 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -82.79 132.06 35.18 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.782 -1.099 . . . . 63.44 108.675 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.14 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 55.51 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.55 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.51 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.43 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.13 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 HD13 ' B' ' 219' ' ' LEU . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.11 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.11 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.51 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.42 HD13 HG23 ' B' ' 216' ' ' THR . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 63.12 107.432 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 50.43 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.439 HG11 HG22 ' B' ' 240' ' ' ILE . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.43 110.539 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.22 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 71.22 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.24 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.11 110.477 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 72.53 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.45 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 64.24 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.43 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.427 HG22 ' HG2' ' B' ' 235' ' ' ARG . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.1 110.265 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 74.35 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 55.02 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.31 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.14 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' B' ' 230' ' ' THR . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.13 109.427 172.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.42 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.51 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 73.13 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 74.52 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 29' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.14 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.31 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.41 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.0 108.726 170.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.421 ' C ' HD12 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.21 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.421 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 71.45 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 65.12 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 42.5 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.34 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.34 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo -77.89 14.8 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.55 112.853 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.439 ' HB3' ' NE1' ' B' ' 255' ' ' TRP . 95.8 mt-30 68.24 -75.36 0.07 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 73.04 112.159 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 35.83 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 74.44 116.424 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 206' ' ' SER . 16.6 m -69.1 -3.46 13.38 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.712 1.205 . . . . 74.43 112.755 -173.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.439 ' NE1' ' HB3' ' B' ' 252' ' ' GLN . 0.2 OUTLIER -81.51 -0.62 42.75 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.329 -0.857 . . . . 64.34 109.805 178.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.19 126.72 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.53 -1.214 . . . . 73.21 112.56 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 172.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.365 -2.087 . . . . 72.24 105.365 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.82 168.52 19.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.628 -1.99 . . . . 74.01 105.628 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.02 -16.71 16.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.24 0.543 . . . . 73.41 109.681 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 68.53 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.051 1.34 . . . . 64.01 111.892 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 124.29 16.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.8 -1.926 . . . . 54.1 105.8 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.6 m -146.6 -78.12 0.17 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 122.499 -0.126 . . . . 70.44 110.884 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -103.53 -57.48 2.03 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.835 -1.172 . . . . 70.02 107.835 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.1 136.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.2 1.926 . . . . 71.21 116.2 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -132.19 147.99 52.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.366 -1.346 . . . . 75.21 107.366 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 120.624 -0.43 . . . . 60.22 110.054 -177.885 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 109.292 -0.633 . . . . 63.54 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 32.1 2.45 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.453 -0.88 . . . . 53.04 111.269 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -101.2 102.72 13.68 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.782 0.325 . . . . 74.14 111.119 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.28 90.55 8.44 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.477 -1.305 . . . . 73.21 107.477 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.56 164.45 2.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.441 -0.8 . . . . 61.05 111.968 -172.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 m -86.27 138.59 31.73 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.921 -1.511 . . . . 73.42 106.921 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -123.62 144.25 49.73 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.629 -0.828 . . . . 74.41 110.477 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -55.57 131.64 46.74 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.158 0.983 . . . . 61.42 108.917 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -50.71 128.88 21.73 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 112.869 0.692 . . . . 63.32 112.869 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -94.94 122.82 37.99 Favored 'General case' 0 N--CA 1.401 -2.883 0 CA-C-N 115.163 -0.926 . . . . 53.31 108.896 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.51 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 65.2 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 64.2 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 70.53 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.02 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.01 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 71.35 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 63.34 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 65.4 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.15 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.04 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 50.33 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.45 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 41' ' ' THR . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 64.15 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 52.2 109.274 -173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 63.53 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.12 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.45 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.41 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.35 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.02 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.3 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 54.44 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.43 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 35' ' ' ARG . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.2 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.45 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 70.02 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.2 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.01 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.514 HD11 HD13 ' B' ' 229' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 71.12 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 70.31 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.33 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.34 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 52.23 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 53.11 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.45 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 64.11 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 72.42 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.33 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.21 108.183 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.49 28.84 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.54 112.799 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 69.65 21.44 6.6 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.834 1.254 . . . . 75.24 110.119 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.72 -25.51 35.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.261 -0.881 . . . . 62.12 109.74 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.3 m -101.14 11.21 39.9 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.474 1.13 . . . . 75.33 108.484 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -117.28 -55.44 2.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.021 -0.991 . . . . 74.51 109.834 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t 56.96 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.429 1.092 . . . . 72.12 112.011 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 68.85 94.85 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.448 1.099 . . . . 75.22 110.014 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -117.75 153.49 33.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.313 -0.403 . . . . 74.11 111.167 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -85.16 -16.59 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.4 0.68 . . . . 65.5 111.852 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.8 t -86.69 103.88 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.999 0.905 . . . . 75.44 110.336 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -86.81 150.65 23.99 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.603 -1.181 . . . . 72.33 108.548 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -67.75 93.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.398 0.618 . . . . 73.1 111.006 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 50.6 ttm -102.48 34.77 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.578 -1.638 . . . . 74.44 106.578 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.26 -37.79 86.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.967 -1.47 . . . . 70.13 111.203 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 50.18 85.08 0.03 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.149 0.98 . . . . 72.2 111.333 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.456 1.102 . . . . 74.2 111.68 -176.72 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.369 -0.604 . . . . 75.13 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 127.22 54.3 0.14 Allowed Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.741 -0.742 . . . . 73.33 111.266 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 30.4 m -143.04 87.48 1.98 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.476 0.655 . . . . 73.33 109.523 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -110.2 130.69 55.5 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.729 -1.212 . . . . 75.4 107.729 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 23.8 m -103.09 103.12 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.199 0.523 . . . . 75.32 110.478 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 69.1 p -73.66 102.46 3.93 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.191 -0.459 . . . . 53.24 110.234 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.87 108.24 10.97 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.817 -0.808 . . . . 54.41 108.817 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.62 -54.95 3.92 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.172 -0.922 . . . . 71.32 109.525 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -124.16 126.12 45.61 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.245 -1.02 . . . . 72.25 108.245 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t -95.82 97.75 9.9 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.086 0.946 . . . . 73.04 109.052 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 44.32 107.638 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.24 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.03 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.544 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 73.31 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.407 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.44 110.931 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.04 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.44 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 70.51 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.21 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 63.14 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.12 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.42 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 72.12 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.23 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.24 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 71.43 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.44 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.43 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 62.02 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.571 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.42 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.34 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.04 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 72.21 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 72.12 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.04 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 70.12 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.32 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.24 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 72.43 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.577 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 72.23 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.23 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.15 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.02 113.383 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 72.44 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.3 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.24 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.02 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.425 ' OD2' ' HD1' ' B' ' 255' ' ' TRP . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.54 109.154 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.14 33.5 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 60.35 111.674 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.419 ' HG2' ' HE ' ' B' ' 235' ' ' ARG . 42.5 mt-30 67.67 44.06 1.72 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.661 1.185 . . . . 65.02 110.128 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.39 -43.01 7.85 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 113.494 -1.684 . . . . 53.35 108.122 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.8 m -85.55 -35.63 20.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.539 -0.755 . . . . 64.15 109.098 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.425 ' HD1' ' OD2' ' B' ' 250' ' ' ASP . 82.5 m95 -79.65 -41.85 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.586 -0.734 . . . . 72.33 110.996 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 59.9 t 67.4 -64.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.476 1.111 . . . . 63.23 112.412 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -108.51 161.09 15.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.421 -0.955 . . . . 61.21 108.421 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.09 80.26 1.24 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.274 -1.01 . . . . 74.24 108.274 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.29 -11.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.001 -1.0 . . . . 72.41 110.757 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 52.1 t -76.28 97.66 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.179 -1.045 . . . . 64.43 108.179 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -103.11 106.4 16.91 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.947 -1.131 . . . . 74.24 107.947 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -140.48 86.9 2.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.339 0.59 . . . . 65.44 110.539 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -106.5 116.44 31.93 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.855 -0.795 . . . . 62.44 108.855 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.46 -25.74 23.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.043 -0.526 . . . . 73.33 110.963 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 71.05 166.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.157 0.983 . . . . 53.42 113.585 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 C--O 1.266 1.956 0 CA-C-N 115.277 -0.874 . . . . 72.13 109.993 178.977 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 120.561 0.22 . . . . 65.03 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.82 31.19 8.45 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.314 -0.946 . . . . 74.11 111.795 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -118.05 139.37 51.3 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.919 -0.771 . . . . 45.31 108.919 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.97 101.34 7.71 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.295 -0.632 . . . . 75.13 109.295 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.63 -50.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.924 0.869 . . . . 73.32 109.194 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 p -137.74 27.86 2.7 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.225 -1.398 . . . . 54.01 107.225 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.02 160.08 14.6 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.302 -1.317 . . . . 70.54 112.434 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -163.46 157.1 19.38 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.832 -2.284 . . . . 75.53 104.832 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -79.01 93.42 5.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.591 -2.003 . . . . 71.41 105.591 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m -90.81 121.86 33.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.01 -0.995 . . . . 63.54 113.217 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.13 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 71.14 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.11 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' B' ' 212' ' ' VAL . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.53 110.876 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.3 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.41 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.44 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.02 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.33 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 70.5 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.21 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 53.43 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.45 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.55 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 44.42 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.32 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 71.1 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.61 HD13 HD11 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.24 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 63.31 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 64.4 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 72.52 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.43 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 62.34 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.3 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.42 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.4 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 61.44 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.35 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.684 HD11 HD13 ' B' ' 229' ' ' ILE . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 55.13 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.41 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.44 113.262 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 72.25 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.43 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.41 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 72.32 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 HD22 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 42.24 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.31 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.41 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.41 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 -22.8 30.88 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.35 111.995 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 63.51 26.84 14.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.147 0.979 . . . . 73.3 112.16 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.74 97.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 75.42 110.526 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.1 p -103.93 12.45 34.3 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.914 -0.585 . . . . 72.24 110.208 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -133.68 33.88 3.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.982 -0.553 . . . . 62.41 110.28 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.21 106.18 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.949 0.881 . . . . 65.33 110.393 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -112.89 -164.16 0.9 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.435 -0.802 . . . . 72.33 109.695 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -72.28 -47.98 45.97 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 116.064 -0.516 . . . . 72.43 109.808 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.5 72.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.938 0.875 . . . . 73.12 110.586 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.76 -27.4 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.277 -1.329 . . . . 73.4 107.913 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 61' ' ' ARG . 1.2 mmp_? -94.04 63.68 3.23 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 75.52 110.204 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -165.57 97.25 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.021 1.729 . . . . 74.14 106.446 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.2 mmt -133.01 116.05 15.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 111.908 0.336 . . . . 64.13 111.908 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.44 135.28 52.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.583 -0.895 . . . . 74.3 108.583 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 85.0 mtm180 -93.21 174.84 7.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.291 0.567 . . . . 74.03 111.827 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' C ' ' HD3' ' A' ' 66' ' ' LYS . 9.6 tmtt? . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 106.816 -1.55 . . . . 73.15 106.816 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.976 -0.75 . . . . 73.21 108.976 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.37 1.96 57.46 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.865 -1.061 . . . . 63.24 110.871 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 38.9 t -72.43 133.49 44.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.837 -0.431 . . . . 74.34 109.837 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -119.93 84.34 2.2 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.318 0.58 . . . . 61.05 110.409 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.18 -51.0 13.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.251 -1.759 . . . . 75.1 106.251 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 59.7 p -146.95 96.87 2.81 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.718 -1.128 . . . . 71.12 109.32 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.82 108.13 18.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.598 -0.728 . . . . 70.32 109.961 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.3 99.54 2.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.914 -0.585 . . . . 74.25 110.323 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 66.18 92.63 0.07 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.485 1.115 . . . . 65.15 112.046 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p -82.9 124.01 29.94 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.383 -0.371 . . . . 64.0 110.739 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 52.54 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD13 ' A' ' 14' ' ' LEU . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.4 110.134 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 43.01 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.32 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.439 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 64.43 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 33.04 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.23 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.24 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.533 ' H ' HD23 ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.42 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.3 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.45 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.22 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 63.25 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 64.44 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.581 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.23 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.32 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 64.4 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 72.35 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 73.3 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 54.35 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.11 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.21 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 60.44 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 61.24 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.14 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 61.04 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.4 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.15 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 29' ' ' ILE . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 72.45 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.548 ' HA ' HD12 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 70.31 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.41 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 71.2 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.53 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.596 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 73.21 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.51 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.21 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 60.22 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 71.15 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo -68.18 35.62 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 53.52 113.879 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 107.73 -1.211 . . . . 73.32 107.73 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -98.36 -51.01 4.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.175 -1.375 . . . . 53.24 112.225 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 81.2 p -98.71 0.26 44.22 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.031 -0.668 . . . . 51.44 111.811 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -112.78 102.67 10.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.167 0.803 . . . . 74.43 113.167 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.94 135.15 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.38 -1.341 . . . . 63.3 107.38 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -117.91 155.32 30.39 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.33 -0.548 . . . . 64.41 110.677 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' B' ' 260' ' ' VAL . 10.4 m-20 -87.63 -9.37 54.44 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.621 -0.881 . . . . 74.11 108.621 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 42.0 t 73.57 -6.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.955 1.302 . . . . 74.34 110.561 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' B' ' 258' ' ' ASP . 14.5 p -71.85 -26.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.748 -0.66 . . . . 70.33 110.277 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' ARG . . . . . 0.651 ' HE ' ' HA ' ' B' ' 261' ' ' ARG . 0.7 OUTLIER -96.7 6.82 47.95 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.937 -0.477 . . . . 72.51 111.759 179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.2 m -71.52 -30.12 65.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.52 -1.659 . . . . 61.1 106.52 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.0 100.75 11.96 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.288 -2.115 . . . . 71.54 105.288 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.04 167.33 10.34 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.779 -0.452 . . . . 74.43 109.779 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 265' ' ' ARG . 15.3 ttm180 -73.73 113.92 11.41 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 122.837 0.455 . . . . 75.04 111.378 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.418 -1.697 . . . . 72.01 106.418 177.52 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.213 -0.662 . . . . 73.21 109.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.63 131.17 2.46 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.608 -0.806 . . . . 44.33 111.157 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -80.51 95.1 6.38 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.35 0.595 . . . . 72.25 110.57 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.7 113.22 4.07 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.11 108.675 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.67 -22.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.951 -0.759 . . . . 61.5 108.951 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t 67.4 -178.22 0.21 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.134 0.974 . . . . 72.23 109.349 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.91 102.1 13.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.862 -1.162 . . . . 73.11 107.862 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 53.0 mtpt -121.98 135.33 54.84 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.246 -0.434 . . . . 75.12 110.62 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -94.47 72.46 3.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.012 -1.477 . . . . 74.42 107.012 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.439 ' OG1' ' HE2' ' A' ' 8' ' ' LYS . 67.9 m -115.79 124.69 51.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.88 -1.055 . . . . 72.43 112.023 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.42 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' ' 214' ' ' LEU . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.11 109.319 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 72.33 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' B' ' 214' ' ' LEU . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 64.31 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 64.24 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.427 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 64.44 109.008 -176.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.3 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.14 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.44 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.11 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 40' ' ' ILE . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 52.51 108.285 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.05 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.52 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.45 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 73.2 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 53.51 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 70.14 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 73.32 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 HD11 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 71.0 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.23 109.834 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.14 108.581 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.23 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 49' ' ' CYS . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 63.34 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.3 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 65.33 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.43 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.22 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.42 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.778 HD11 HD13 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.31 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.22 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.55 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 61.32 113.534 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 64.14 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 70.22 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 12' ' ' VAL . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.12 109.602 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 63.14 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.1 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.41 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo -77.03 39.46 0.72 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.03 111.826 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.36 56.13 3.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.275 1.036 . . . . 73.5 109.783 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.82 -47.11 2.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.351 -1.295 . . . . 72.14 109.878 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.2 m -93.55 -41.35 9.8 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.48 -0.782 . . . . 74.14 110.857 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.61 -4.77 57.0 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 114.104 1.15 . . . . 74.21 114.104 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.54 132.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.811 0.815 . . . . 74.13 112.217 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -139.96 -58.67 0.55 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 104.635 -2.357 . . . . 62.41 104.635 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -168.94 112.93 0.56 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.685 -1.598 . . . . 73.41 108.155 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 60' ' ' VAL . 12.2 p -178.68 -36.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.284 -0.416 . . . . 64.12 110.724 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 59' ' ' VAL . 61.0 t -96.85 105.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.319 -0.623 . . . . 74.11 109.319 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -132.17 117.71 18.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.6 0.714 . . . . 65.34 110.548 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.0 m -139.36 114.01 9.22 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.455 -0.793 . . . . 64.02 109.138 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.98 114.66 10.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.304 -1.739 . . . . 74.14 106.304 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -103.98 118.18 36.06 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.917 0.389 . . . . 62.44 110.754 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -84.51 -51.93 6.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.801 -0.636 . . . . 73.41 110.025 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.518 -0.31 . . . . 72.02 111.107 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.239 0.53 0 N-CA-C 110.326 -0.25 . . . . 63.42 110.326 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.79 28.71 1.36 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 121.362 -0.447 . . . . 63.23 112.307 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -76.48 129.81 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.338 -0.616 . . . . 74.35 109.338 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.12 100.3 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.265 0.555 . . . . 72.35 112.296 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.33 -25.9 5.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.51 -0.922 . . . . 74.21 108.51 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 28.1 t 61.96 -169.38 0.18 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.798 -1.092 . . . . 72.11 109.509 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -95.79 93.11 6.89 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.369 -0.604 . . . . 53.33 109.369 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.9 165.55 23.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.507 -0.923 . . . . 62.45 108.507 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' B' ' 250' ' ' ASP . 45.8 ttp180 63.15 46.65 4.5 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 103.861 -2.644 . . . . 73.54 103.861 -164.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m -70.58 131.24 43.67 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 112.863 -1.971 . . . . 52.23 109.372 -174.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 71.05 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.2 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 24.43 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.515 HD21 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 72.22 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.25 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 43.54 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.51 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 71.04 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 62.33 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 73.42 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.21 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.3 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.04 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 70.23 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.58 ' HD2' HD12 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 74.24 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 72.13 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.11 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 74.33 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.1 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.13 108.176 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.22 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.2 108.659 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.34 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.45 ' N ' HD13 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 71.14 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.664 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.32 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 53.23 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 53.1 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.33 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.13 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.489 ' HA ' HD12 ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.04 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.2 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 74.11 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.42 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.45 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.02 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.12 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.05 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' B' ' 234' ' ' LEU . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 70.01 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' B' ' 209' ' ' ARG . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.53 108.087 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 8.1 Cg_exo -73.48 36.63 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.34 112.926 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 97.4 mt-30 59.05 39.82 22.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.237 1.018 . . . . 72.33 109.05 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -99.1 -49.92 4.34 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.14 -1.391 . . . . 63.33 109.016 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' B' ' 209' ' ' ARG . 71.1 p -104.26 -24.03 13.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.922 -0.581 . . . . 63.22 109.834 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 74.9 m95 67.7 -76.32 0.05 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.455 1.102 . . . . 75.32 112.445 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.38 149.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.629 -0.508 . . . . 74.14 109.629 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -123.29 -72.78 0.67 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.717 -1.216 . . . . 74.01 107.717 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 169.89 109.45 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.98 -1.859 . . . . 73.21 105.98 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -170.89 -34.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.213 0.53 . . . . 73.52 110.764 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.71 102.97 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.321 -0.622 . . . . 71.11 109.321 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -126.94 141.13 51.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.079 -0.711 . . . . 63.44 109.079 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -92.78 93.29 8.36 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.233 -0.654 . . . . 75.42 109.233 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 91.72 3.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.18 -1.044 . . . . 72.54 108.18 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -175.3 97.66 0.08 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.632 -2.358 . . . . 63.04 104.632 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -85.07 -32.8 22.66 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 113.992 1.108 . . . . 75.03 113.992 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.856 0 C-N-CA 120.081 -0.648 . . . . 73.22 111.881 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.568 0.223 . . . . 62.02 111.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.0 -171.19 52.03 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.898 -0.668 . . . . 65.33 111.819 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.152 0.501 . . . . 60.41 110.66 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -145.34 -55.38 0.31 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.615 -0.513 . . . . 54.32 109.615 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.55 84.62 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 122.118 0.961 . . . . 61.03 113.188 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -94.41 -35.9 12.15 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.64 -1.615 . . . . 54.12 106.64 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.71 122.33 32.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.595 -1.261 . . . . 72.31 107.595 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.22 147.5 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.59 0.233 . . . . 75.22 110.831 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HG3' ' HE1' ' A' ' 55' ' ' TRP . 1.4 tmt_? -66.86 102.51 0.97 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.777 -1.564 . . . . 72.12 106.777 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -114.5 151.95 32.48 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.181 -0.918 . . . . 73.03 111.811 -169.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.15 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' B' ' 214' ' ' LEU . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.23 110.567 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.13 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 64.12 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.22 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.11 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 72.14 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 65.54 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.21 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 62.54 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 43.13 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.22 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.54 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.03 111.079 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.745 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.24 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.32 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 55.31 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.33 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 61.44 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 63.41 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.31 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 60.53 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 63.41 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.24 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.02 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.745 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 62.32 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.43 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 HD13 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.42 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.34 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 73.32 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.33 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.43 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.12 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.13 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 74.13 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.24 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 65.33 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.42 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 9.47 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.14 114.119 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 62.54 22.79 13.52 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.745 0.418 . . . . 64.55 111.923 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.3 -39.87 20.25 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 112.79 0.663 . . . . 22.3 112.79 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.5 p -99.43 -10.15 22.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.449 0.907 . . . . 74.35 113.449 -174.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 9' ' ' ARG . 36.0 m95 -104.95 105.55 15.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.675 -1.232 . . . . 75.11 107.675 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.251 19.8 m -71.03 72.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 115.094 1.516 . . . . 62.23 115.094 -178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -100.71 -36.64 9.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.84 -1.541 . . . . 74.1 106.84 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -128.94 127.81 42.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 104.451 -2.426 . . . . 72.13 104.451 170.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.85 -1.7 9.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 114.083 1.142 . . . . 44.44 114.083 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.17 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.705 -0.85 . . . . 62.51 108.705 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 2.1 ptm180 -88.02 153.51 21.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.618 -0.719 . . . . 61.54 110.593 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -113.45 80.61 1.39 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-O 121.794 0.807 . . . . 53.51 109.017 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.04 -58.65 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.521 -2.029 . . . . 63.31 105.521 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' ' 61' ' ' ARG . 4.3 p-10 -123.44 144.76 49.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.46 -1.681 . . . . 64.11 106.46 173.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -134.97 -63.88 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.555 -0.535 . . . . 64.51 109.555 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 C--O 1.248 1.019 0 O-C-N 123.75 0.656 . . . . 74.43 112.057 178.396 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' B' ' 253' ' ' ALA . 34.6 m . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.131 0.967 . . . . 74.31 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -143.51 -131.2 2.47 Favored Glycine 0 C--N 1.299 -1.507 0 N-CA-C 108.857 -1.697 . . . . 70.33 108.857 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.0 m -63.22 -45.2 92.77 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.604 -1.628 . . . . 71.03 106.604 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -133.39 -46.37 0.83 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.159 -1.793 . . . . 62.41 106.159 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.89 179.4 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.435 -1.257 . . . . 74.11 107.818 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 23.2 t -149.2 89.05 1.62 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.438 -2.06 . . . . 73.54 105.438 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 14.9 t70 64.41 -161.68 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.772 -1.936 . . . . 73.11 105.772 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -106.58 -60.14 1.7 Allowed 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.333 -1.729 . . . . 54.22 106.333 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 159.11 80.92 0.0 OUTLIER 'General case' 0 C--O 1.245 0.858 0 C-N-CA 128.081 2.552 . . . . 62.01 105.862 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m -100.35 137.33 38.92 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.705 -1.134 . . . . 44.54 111.58 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 73.33 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 63.1 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.15 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.02 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.44 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.32 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.21 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.15 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.31 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.43 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.42 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.32 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.03 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.32 110.436 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.773 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 60.44 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.41 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.33 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.04 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.795 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.2 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 54.24 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.34 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.14 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.31 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 61.32 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.22 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 64.22 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 72.43 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.34 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.522 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.41 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.23 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 70.14 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.42 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.48 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.24 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 61.24 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 45' ' ' LEU . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.51 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.42 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo -75.13 41.94 0.81 Allowed 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.43 111.994 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.454 ' HB3' ' HE1' ' B' ' 255' ' ' TRP . 93.0 mt-30 57.52 50.46 11.1 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 122.278 1.037 . . . . 75.22 108.889 -174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' B' ' 201' ' ' VAL . . . -100.69 -53.23 3.13 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.83 -1.532 . . . . 74.14 108.556 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 58.9 p -80.55 84.75 6.08 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 122.076 0.941 . . . . 34.34 113.139 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' TRP . . . . . 0.454 ' HE1' ' HB3' ' B' ' 252' ' ' GLN . 84.8 m95 -102.74 84.69 2.44 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.359 -2.089 . . . . 75.21 105.359 168.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.86 145.43 8.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.87 -0.604 . . . . 74.24 112.018 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.37 -27.15 62.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.93 171.46 8.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.295 -0.866 . . . . 74.34 110.522 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.16 0.83 9.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.261 -0.427 . . . . 51.23 111.01 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.0 t 71.28 88.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.008 0.923 . . . . 64.54 108.661 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.3 104.73 16.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.501 -0.772 . . . . 72.41 112.073 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.9 t -155.7 74.69 0.88 Allowed 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 121.89 0.853 . . . . 72.04 109.611 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.34 89.94 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.299 -2.112 . . . . 74.21 105.299 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.71 168.64 10.57 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.978 -1.01 . . . . 74.3 109.179 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.37 -65.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.108 0.48 . . . . 65.42 110.631 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 63.54 109.541 -178.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.816 -0.439 . . . . 74.22 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.2 82.9 1.65 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.938 -0.648 . . . . 62.11 111.489 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 m -74.77 88.9 2.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.07 0.462 . . . . 61.32 110.592 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -147.5 -177.53 5.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.774 -1.195 . . . . 73.32 107.774 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.58 89.48 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 107.356 -1.35 . . . . 64.25 107.356 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.2 m -127.04 12.89 7.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.677 0.751 . . . . 71.43 109.422 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 91.74 7.28 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.895 -1.048 . . . . 75.22 110.219 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -99.73 127.84 45.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.083 -0.962 . . . . 60.24 109.408 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 66.74 87.89 0.12 Allowed 'General case' 0 C--O 1.249 1.039 0 C-N-CA 124.624 1.169 . . . . 73.3 107.941 -166.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m -78.71 100.06 6.9 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.971 -1.013 . . . . 74.34 109.952 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.22 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' B' ' 214' ' ' LEU . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 73.44 109.212 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.12 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' B' ' 212' ' ' VAL . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.13 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 71.31 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.405 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.15 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' HG3' ' A' ' 43' ' ' ARG . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 71.33 107.829 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 74.52 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.33 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 40' ' ' ILE . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 64.24 108.858 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 71.11 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 63.14 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 72.32 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 74.23 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.34 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.54 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 62.45 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.51 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 70.3 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 45.42 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 73.35 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 61.14 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.43 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 61.21 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 44.1 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 54.13 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 63.42 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 72.44 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.728 HD11 HD13 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.21 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.479 ' HA ' HD12 ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.44 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 18' ' ' ARG . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.23 111.032 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.41 112.109 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 73.21 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG21 HD22 ' B' ' 245' ' ' LEU . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 52.31 109.113 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.41 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.32 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.22 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo -71.55 19.5 0.26 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.41 113.366 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 62.69 34.06 15.08 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.9 0.88 . . . . 74.21 109.724 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.95 -48.76 11.38 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.808 1.243 . . . . 45.1 113.78 -172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -141.36 23.01 2.18 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.337 -0.986 . . . . 71.3 108.337 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -114.29 -2.43 13.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.005 0.743 . . . . 71.11 113.005 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -115.62 -35.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 118.932 -1.107 . . . . 71.11 110.686 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 72.81 -42.66 0.54 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.561 1.544 . . . . 72.33 110.082 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 67.58 101.72 0.05 OUTLIER 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.665 1.186 . . . . 62.53 112.301 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 3.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.626 0.727 . . . . 73.14 111.55 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.43 131.17 63.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.3 -0.63 . . . . 74.24 109.3 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -86.26 -59.29 2.33 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.372 -0.931 . . . . 74.44 109.617 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 p -88.06 108.56 19.3 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.622 0.725 . . . . 54.43 112.73 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.84 100.16 10.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.578 -2.378 . . . . 63.41 104.578 170.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.69 116.23 21.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.946 -0.57 . . . . 51.01 112.15 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -123.47 99.99 6.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.28 -1.007 . . . . 62.33 108.28 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.307 -1.244 0 N-CA-C 108.762 -0.829 . . . . 71.42 108.762 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.533 -0.543 . . . . 70.33 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 110.4 80.89 1.17 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 120.469 -0.872 . . . . 73.32 111.163 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.3 p -73.45 110.33 7.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.691 0.758 . . . . 73.31 111.691 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.08 121.55 36.3 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.329 -0.851 . . . . 75.43 108.926 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.98 87.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 121.757 0.789 . . . . 75.41 109.302 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.8 m -154.71 145.11 22.1 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.216 -1.401 . . . . 65.53 107.216 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.97 145.86 51.26 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.199 0.523 . . . . 60.52 110.518 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -87.16 22.62 2.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.981 0.913 . . . . 74.35 110.701 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.96 72.64 0.5 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.45 1.5 . . . . 54.21 109.864 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m -80.55 146.6 31.19 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.961 -1.472 . . . . 70.2 110.599 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.02 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.53 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.44 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 12' ' ' VAL . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.44 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.41 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.22 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.31 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.445 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.03 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.42 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.15 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 240' ' ' ILE . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 55.34 107.613 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.42 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 55.33 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.33 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.5 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.15 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.35 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.33 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 64.22 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.728 HD13 HD11 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.24 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 43.14 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.44 112.24 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.22 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.22 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 62.23 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 71.12 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.04 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.41 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 43.53 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 63.13 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.682 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 63.23 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.524 ' HA ' HD12 ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.14 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 63.32 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.11 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.43 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.43 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 60.12 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.23 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.04 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.22 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 43.41 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ASP . . . . . 0.421 ' O ' HD22 ' B' ' 234' ' ' LEU . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 55.2 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 250' ' ' ASP . 11.8 Cg_exo -73.81 25.5 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.22 112.154 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' B' ' 250' ' ' ASP . 96.6 mt-30 65.84 28.88 10.71 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.483 1.113 . . . . 74.15 109.204 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.16 -46.55 7.04 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.553 -1.658 . . . . 60.13 110.043 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 26.7 m -74.63 -28.57 60.93 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.751 -0.833 . . . . 53.15 108.751 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -77.96 1.21 21.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.754 -0.657 . . . . 74.43 112.535 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.36 4.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -123.32 -51.09 1.87 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.098 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.99 -170.61 0.19 Allowed 'General case' 0 C--O 1.25 1.113 0 C-N-CA 125.455 1.502 . . . . 72.23 109.743 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.15 -22.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.956 -0.757 . . . . 73.12 108.956 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.63 159.25 43.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 61.12 110.788 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' B' ' 261' ' ' ARG . 9.1 mpt_? -89.52 -27.55 20.22 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.647 0.737 . . . . 72.44 109.388 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 29.8 p -147.04 141.01 25.93 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.065 -0.97 . . . . 55.31 108.661 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -100.74 127.26 47.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.817 -0.438 . . . . 74.21 109.817 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.58 105.54 16.23 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.137 -0.69 . . . . 70.42 109.137 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -93.23 -62.51 1.36 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.304 -0.407 . . . . 73.03 110.602 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--N 1.296 -1.739 0 N-CA-C 108.075 -1.083 . . . . 62.35 108.075 -179.801 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.236 0.375 0 N-CA-C 109.957 -0.386 . . . . 73.14 109.957 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 30.58 11.9 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.335 -0.936 . . . . 62.41 112.679 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -78.81 -36.27 42.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.11 -1.07 . . . . 43.35 108.11 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 49.87 81.79 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 124.82 1.325 . . . . 72.33 114.134 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 161.55 21.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.594 -0.891 . . . . 73.21 108.594 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -64.65 101.34 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.374 0.607 . . . . 70.02 109.515 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.689 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 20.5 t70 -88.98 85.84 6.8 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.8 -0.636 . . . . 75.01 110.719 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 7' ' ' ASP . 65.6 mttm 161.29 167.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 129.423 3.089 . . . . 70.41 106.692 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -88.1 85.86 7.02 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 107.837 -1.171 . . . . 72.24 107.837 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -82.48 129.08 34.84 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.658 -1.155 . . . . 71.54 112.002 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.31 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.51 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 61.44 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.24 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.32 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 32.31 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.23 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.23 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.32 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 62.35 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.44 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.24 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.34 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 72.43 110.928 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 63.22 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.43 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.23 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.703 HD13 HD11 ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 71.12 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 43.11 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.34 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 15.21 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.31 111.488 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.685 HD11 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.31 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 30' ' ' THR . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.53 111.242 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD11 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 61.22 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 71.34 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.32 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.21 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.33 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.49 HG22 HG23 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.22 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.02 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.12 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.43 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD13 HG22 ' B' ' 247' ' ' VAL . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.32 109.086 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.14 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 55.14 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.54 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 62.13 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 52' ' ' GLN . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.52 108.161 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 74.4 Cg_endo -74.12 26.16 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.22 112.13 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 50' ' ' ASP . 47.2 mt-30 63.45 -88.72 0.03 OUTLIER 'General case' 0 C--O 1.25 1.102 0 C-N-CA 126.193 1.797 . . . . 64.15 112.991 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.08 -159.34 0.32 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.473 -0.936 . . . . 72.21 108.473 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 p -81.77 116.36 21.43 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 120.797 -0.361 . . . . 62.13 110.927 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.79 -10.19 29.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.938 -0.764 . . . . 73.45 108.938 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.2 t 73.61 -67.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.591 1.156 . . . . 72.22 111.643 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -146.38 -45.62 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.56 0.948 . . . . 74.52 113.56 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -74.06 125.99 29.52 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.628 -0.429 . . . . 73.22 110.409 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.15 -48.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 112.736 0.643 . . . . 75.51 112.736 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t 66.13 90.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.59 0.756 . . . . 60.44 109.674 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -135.83 151.09 49.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.343 -0.844 . . . . 73.05 109.693 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -154.88 135.3 13.33 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.374 -0.232 . . . . 63.34 110.374 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -84.5 94.24 8.51 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.38 -1.711 . . . . 62.03 106.38 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.6 153.65 23.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.973 -0.558 . . . . 62.4 109.812 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -76.33 -159.57 0.12 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 123.179 0.592 . . . . 72.35 111.492 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.313 -0.997 0 N-CA-C 108.63 -0.878 . . . . 73.21 108.63 -179.043 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.25 1.091 0 N-CA-C 110.289 -0.263 . . . . 54.21 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.56 99.45 0.18 Allowed Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.927 -0.654 . . . . 71.51 112.348 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -84.55 -21.53 30.43 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.139 -1.06 . . . . 71.13 108.139 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . 0.328 46.0 mt-10 60.42 67.42 0.84 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.132 -1.395 . . . . 71.1 113.665 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.09 144.5 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 112.622 -2.081 . . . . 70.42 106.114 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 27.1 t -97.98 113.02 24.75 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.16 -1.052 . . . . 62.12 108.16 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.29 74.87 8.27 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.941 0.877 . . . . 75.51 109.807 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -149.67 83.76 1.41 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.02 -1.445 . . . . 74.41 108.821 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -94.34 97.66 10.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.463 1.125 . . . . 63.31 108.316 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p -92.09 153.23 19.51 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 113.273 -1.785 . . . . 64.54 111.157 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 64.42 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 61.32 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 12' ' ' VAL . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.24 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 71.12 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 41.14 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 55.5 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 62.21 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.22 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 63.23 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.2 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.21 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' B' ' 241' ' ' THR . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 64.14 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 72.1 110.835 -173.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.52 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 53.35 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 64.34 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 41.23 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' HG22 ' B' ' 229' ' ' ILE . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.44 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.45 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 61.14 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 65.33 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.03 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.24 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.02 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.03 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.21 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.541 ' HA ' HD12 ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.35 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.2 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.34 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 31.04 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.34 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.31 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 45' ' ' LEU . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.24 109.017 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 60.15 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 54.33 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.41 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.92 16.82 1.76 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.41 111.746 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 68.85 -76.96 0.05 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.478 1.511 . . . . 72.34 111.981 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.14 -93.37 0.04 OUTLIER 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.368 1.067 . . . . 63.21 112.285 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 23.0 p -148.53 107.49 3.86 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.337 0.655 . . . . 72.25 110.383 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -93.19 -21.15 19.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.366 -0.605 . . . . 74.21 109.366 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 57.2 t 69.22 -77.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.706 1.202 . . . . 54.44 109.291 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -158.34 17.57 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 73.33 109.846 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -123.0 104.05 8.99 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.951 -0.568 . . . . 72.23 109.94 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.74 -23.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 116.001 -0.545 . . . . 55.42 110.639 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 56.3 t 70.37 95.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.86 0.864 . . . . 74.21 109.675 -176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -120.27 100.26 7.07 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.385 -0.825 . . . . 71.32 112.312 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.6 m -87.09 100.17 12.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.325 -1.361 . . . . 51.44 107.325 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.52 106.81 0.5 Allowed 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.105 -0.498 . . . . 74.14 111.8 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.05 118.25 10.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.132 -0.94 . . . . 74.22 110.142 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.83 105.76 11.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.981 -0.554 . . . . 74.2 110.108 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? . . . . . 0 C--N 1.299 -1.622 0 N-CA-C 106.96 -1.496 . . . . 65.01 106.96 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.377 -0.601 . . . . 71.23 109.377 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.04 159.49 10.95 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 119.849 -1.167 . . . . 73.44 112.9 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -144.54 44.65 1.4 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 104.586 -2.376 . . . . 31.02 104.586 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.4 101.34 4.07 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.869 -1.968 . . . . 73.51 111.726 -171.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -122.14 95.19 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.146 -0.934 . . . . 74.24 109.25 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 m -74.33 -18.22 60.73 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.305 -0.861 . . . . 72.21 111.56 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -83.39 68.64 9.79 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.305 1.05 . . . . 61.41 111.688 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -148.7 166.05 29.54 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.217 -1.772 . . . . 70.45 106.217 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.22 111.87 18.77 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.053 -1.462 . . . . 74.41 107.053 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p -73.12 86.27 1.37 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 63.42 110.518 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.11 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 70.35 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.31 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.05 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.41 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.15 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.54 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.31 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.21 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.408 HG11 HG22 ' A' ' 40' ' ' ILE . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 50.23 109.044 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.24 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.24 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 71.31 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 65.0 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.2 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 73.41 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.33 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.603 HD13 HD11 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.15 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 64.15 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.35 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.31 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 72.24 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.55 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.42 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 72.44 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.54 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.13 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.717 HD11 HD13 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 42.05 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.03 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.31 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 65.11 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.01 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.667 HD11 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.22 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.55 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.11 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.41 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.658 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 32.12 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 52' ' ' GLN . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 64.1 112.115 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.83 34.02 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.24 109.011 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HA ' ' NE1' ' A' ' 55' ' ' TRP . 45.1 mt-30 71.72 79.06 0.16 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.757 1.623 . . . . 73.22 111.071 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.2 -36.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.651 -1.159 . . . . 73.55 111.286 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 p -85.91 26.72 0.95 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.727 0.775 . . . . 75.12 111.154 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.478 ' NE1' ' HA ' ' A' ' 52' ' ' GLN . 15.1 m95 -73.22 12.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.374 -0.83 . . . . 70.45 112.74 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.1 -11.3 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.102 -1.073 . . . . 74.12 108.102 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 73.59 96.1 0.07 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.215 1.406 . . . . 74.11 113.878 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -173.7 84.64 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.359 -1.292 . . . . 71.51 108.835 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.11 -37.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 75.3 109.616 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.9 t 66.08 93.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.393 -0.821 . . . . 53.24 110.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -74.8 95.37 2.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.665 -0.865 . . . . 71.21 108.665 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.8 t -87.58 90.52 8.4 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.891 -0.595 . . . . 70.44 111.381 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 mmt -147.14 102.92 3.55 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 114.409 -1.269 . . . . 63.42 108.239 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.58 -60.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.111 -0.495 . . . . 72.2 110.568 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -144.04 108.08 4.74 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.804 -0.813 . . . . 74.01 108.804 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 116.08 -0.509 . . . . 63.32 111.262 -176.653 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.243 0.723 0 CA-C-O 120.952 0.406 . . . . 45.55 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -173.08 45.29 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 109.76 -1.336 . . . . 72.44 109.76 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 49.4 m -95.2 90.98 6.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 117.545 0.672 . . . . 34.33 110.836 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -93.33 2.41 56.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.643 -0.708 . . . . 63.45 110.669 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.82 127.85 35.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.502 -0.772 . . . . 65.04 110.802 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.0 m -90.4 -20.23 23.04 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.046 -0.524 . . . . 74.25 110.75 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.38 98.84 11.48 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.599 0.714 . . . . 75.34 112.169 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -128.98 126.32 39.32 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.54 -1.209 . . . . 75.35 108.289 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' B' ' 209' ' ' ARG . 0.4 OUTLIER -92.63 105.09 17.31 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.108 -0.701 . . . . 62.51 109.108 176.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p -79.68 84.35 5.52 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 54.13 110.906 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.3 107.636 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 14' ' ' LEU . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.12 109.325 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.2 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.429 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.13 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.15 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.4 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.43 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 72.41 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.44 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.23 111.362 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.44 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.22 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.2 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.53 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.572 ' HD2' HD12 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.1 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.04 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.03 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.717 HD13 HD11 ' A' ' 40' ' ' ILE . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.15 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.13 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 70.15 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.24 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.31 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 249' ' ' CYS . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.03 109.255 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.4 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.24 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.13 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 71.13 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 73.41 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.603 HD11 HD13 ' A' ' 29' ' ' ILE . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 73.34 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 72.42 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 62.11 115.189 -175.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.31 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.53 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.13 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.32 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 71.03 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.14 109.624 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.11 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.44 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 33.89 0.5 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.11 110.601 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 68.98 46.6 0.82 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.035 1.334 . . . . 60.44 110.202 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -146.7 -9.21 0.48 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.671 0.989 . . . . 44.31 113.671 -176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.4 p -95.66 4.36 53.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.228 0.537 . . . . 73.3 111.945 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -78.44 84.1 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 116.518 2.044 . . . . 71.4 116.518 -172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' VAL . . . . . 0.414 HG23 ' H ' ' B' ' 257' ' ' ARG . 16.8 m -118.09 -54.97 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.092 -1.447 . . . . 72.41 107.092 166.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' ARG . . . . . 0.414 ' H ' HG23 ' B' ' 256' ' ' VAL . 59.0 ttp180 167.17 106.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 125.34 1.456 . . . . 73.1 108.631 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' B' ' 259' ' ' VAL . 12.3 t70 -153.44 93.55 1.71 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 73.41 107.537 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 239' ' ' PHE . 7.7 p 175.65 -39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.754 -0.657 . . . . 52.42 111.304 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.4 t 65.27 95.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.61 -1.256 . . . . 71.12 107.61 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -59.86 113.35 2.24 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 113.786 1.032 . . . . 71.33 113.786 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.6 t -102.11 -162.4 0.92 Allowed 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.036 -1.839 . . . . 73.23 106.036 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 66.0 mtt 63.92 36.26 10.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.607 0.718 . . . . 63.31 110.116 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.0 141.72 58.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.402 -1.272 . . . . 73.4 109.653 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -57.78 121.94 11.66 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.864 0.466 . . . . 74.33 110.155 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 120.949 -0.301 . . . . 64.22 111.02 179.434 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.662 -0.495 . . . . 70.14 109.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.76 93.54 1.75 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.727 -0.749 . . . . 73.2 112.609 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -113.03 118.53 35.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.904 -1.147 . . . . 71.32 107.904 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -150.73 176.91 10.59 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.392 -0.192 . . . . 71.53 110.599 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -88.31 147.41 5.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.229 0.537 . . . . 41.43 111.929 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -95.28 118.11 31.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.581 -0.896 . . . . 53.13 108.581 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.19 160.81 19.1 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.939 -0.763 . . . . 75.03 108.939 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 79.54 -43.66 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.892 1.277 . . . . 72.11 111.174 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -138.6 85.97 2.12 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.098 0.475 . . . . 74.02 111.825 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -80.14 86.47 5.57 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.34 109.165 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.32 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 50.55 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.22 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HG ' HD21 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 62.24 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.24 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.15 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 19' ' ' LEU . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.1 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 72.2 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.22 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 65.23 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.24 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 61.21 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 54.43 112.957 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.32 106.447 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 72.11 110.604 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 62.12 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.32 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 54.22 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.747 HD13 HD11 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 71.13 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.24 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.31 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.12 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.13 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 71.3 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.12 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 33.33 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 62.24 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 64.11 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 74.5 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.15 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 54.04 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.21 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.15 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.43 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 53.43 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 72.24 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.13 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.23 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 65.34 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.5 Cg_endo -75.46 42.33 0.89 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.35 112.018 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 59.96 66.94 0.91 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.548 1.139 . . . . 61.3 110.963 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.98 -36.37 2.19 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.409 -1.723 . . . . 70.02 107.503 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -108.03 87.03 2.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.894 -1.048 . . . . 73.33 108.34 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -144.51 95.81 2.77 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.27 1.033 . . . . 71.24 110.294 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.05 -165.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 CA-C-N 113.708 -1.587 . . . . 51.21 107.397 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -78.78 84.88 4.82 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.031 -1.099 . . . . 73.12 108.031 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -149.13 99.35 2.94 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 114.535 -1.212 . . . . 72.01 108.65 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.49 69.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.706 1.241 . . . . 63.32 110.152 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.93 129.34 38.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 114.373 -1.285 . . . . 52.23 110.1 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 61' ' ' ARG 0.355 4.5 ppt_? -134.79 71.74 1.45 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.635 1.207 . . . . 75.14 112.924 176.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 m -92.87 120.0 32.77 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.688 -1.142 . . . . 65.53 108.834 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.9 ptm -147.32 150.19 34.29 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.554 -0.458 . . . . 65.04 110.988 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.74 157.32 18.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.295 -1.002 . . . . 71.21 108.295 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -129.17 112.08 13.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.153 -1.054 . . . . 73.15 108.153 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 C--N 1.3 -1.583 0 N-CA-C 107.432 -1.321 . . . . 50.51 107.432 179.449 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.68 0 N-CA-C 110.019 -0.363 . . . . 70.33 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -114.68 -147.66 9.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.367 -1.493 . . . . 30.02 109.367 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.7 t -79.47 89.03 5.02 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.65 -1.241 . . . . 75.1 107.65 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.15 163.0 31.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.377 -0.829 . . . . 70.04 109.594 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.2 135.21 28.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.094 0.473 . . . . 74.31 111.966 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.6 m -98.37 149.2 22.9 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.03 -0.532 . . . . 65.51 109.784 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.07 160.09 23.28 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.17 -0.307 . . . . 70.32 110.17 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' B' ' 209' ' ' ARG . 95.6 mttt 71.37 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.108 1.363 . . . . 73.14 110.101 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' B' ' 208' ' ' LYS . 0.3 OUTLIER -139.94 170.95 14.93 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.936 -1.505 . . . . 64.21 106.936 177.309 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m -109.05 105.57 15.13 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.873 -0.731 . . . . 74.31 111.12 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 65.41 110.077 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.14 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.539 HD21 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.42 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 53.33 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 63.22 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.52 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.43 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 73.44 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' PRO . . . . . 0.403 ' HA ' ' CB ' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 62.24 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.35 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.54 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 73.01 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 241' ' ' THR . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 45.54 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.3 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.05 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.45 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.24 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.1 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.15 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.42 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.21 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.31 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 63.42 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 72.15 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 73.12 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.32 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.03 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.41 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 73.51 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' HD12 ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 52.55 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.403 ' CB ' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.21 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 54.0 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.449 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.41 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.449 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.11 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.23 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 45' ' ' LEU . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 54.31 109.52 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.14 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 44.14 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.444 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -75.3 40.73 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.44 111.937 177.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 69.66 38.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.255 1.022 . . . . 72.2 109.397 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.61 -46.82 5.07 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.71 -1.132 . . . . 54.43 111.441 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' B' ' 209' ' ' ARG . 23.4 m -82.68 79.0 9.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.682 0.753 . . . . 73.03 110.899 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -127.0 -14.47 5.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.717 -0.674 . . . . 74.32 109.721 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -72.22 -25.22 23.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.286 -0.87 . . . . 71.1 109.683 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.18 98.74 7.52 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.484 -2.413 . . . . 73.43 104.484 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.84 109.19 17.35 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.321 -0.854 . . . . 71.44 110.584 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.61 -43.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.644 -0.707 . . . . 73.34 111.662 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.08 113.91 20.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 71.4 111.014 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.59 149.89 30.49 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.248 -0.649 . . . . 64.43 109.248 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 28.6 m -94.79 130.39 41.36 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.889 -1.152 . . . . 75.33 107.889 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.46 111.65 5.67 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.102 0.779 . . . . 71.12 113.102 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.21 174.13 15.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.143 -1.799 . . . . 74.14 106.143 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' ARG . . . . . 0.407 ' HD2' ' C ' ' B' ' 265' ' ' ARG . 4.9 tmm_? -125.42 113.77 17.96 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.113 -1.069 . . . . 64.23 108.113 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 107.335 -1.357 . . . . 72.14 107.335 -179.387 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.414 -0.587 . . . . 63.22 109.414 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.17 -11.2 61.96 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 120.292 -0.956 . . . . 62.31 112.779 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m 61.98 35.64 16.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.472 -0.936 . . . . 62.34 108.472 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -66.35 117.45 8.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.243 -1.344 . . . . 55.21 112.736 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.14 111.63 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.028 -1.842 . . . . 62.54 106.028 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 p -72.35 -67.98 0.51 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.068 0.766 . . . . 62.41 113.068 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.71 155.91 35.21 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.79 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -78.71 -32.45 46.91 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.778 0.659 . . . . 62.54 112.778 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 1.2 tmm_? -131.38 105.65 7.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.639 0.733 . . . . 64.45 110.525 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m -101.67 149.49 24.09 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.76 -1.109 . . . . 65.52 109.315 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 44.3 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 61.34 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.02 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.51 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 73.15 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.13 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.44 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.12 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 60.41 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.32 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.34 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 61.43 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.14 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.51 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.613 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.33 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 70.11 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.53 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 70.52 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 72.33 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 45.42 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.13 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.14 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.23 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 64.21 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.2 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 34' ' ' LEU . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 53.54 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 64.44 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 62.33 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 73.02 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.657 HD11 HD13 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 63.31 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HG23 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 64.24 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 74.44 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.14 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 63.03 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.42 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 73.31 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 9' ' ' ARG . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.4 106.938 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.34 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.44 108.531 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.1 Cg_endo -76.74 34.47 0.44 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.44 111.941 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 70.18 77.86 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.065 1.346 . . . . 63.13 110.813 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.4 -55.62 0.58 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.464 -1.244 . . . . 65.22 108.637 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.7 m -88.66 -22.95 23.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.325 -0.991 . . . . 72.02 108.325 176.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 m0 66.75 36.02 4.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.73 -1.123 . . . . 74.42 111.278 174.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.33 160.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.828 -0.624 . . . . 75.32 111.358 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -142.62 166.67 24.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.381 -0.372 . . . . 75.4 110.43 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -137.71 147.09 44.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.178 -1.786 . . . . 64.42 106.178 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.05 4.68 5.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.888 -0.725 . . . . 65.14 111.88 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.57 90.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 122.453 1.12 . . . . 55.04 112.356 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -107.69 105.29 15.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.196 -0.911 . . . . 71.31 109.492 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 t -94.96 117.23 29.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.386 -0.968 . . . . 65.43 108.386 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.4 ttp -116.3 116.3 27.49 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.908 0.385 . . . . 64.44 111.012 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.45 163.54 17.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 44.34 108.134 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -146.31 95.99 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.865 -0.42 . . . . 73.25 109.865 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HD3' ' HA2' ' B' ' 232' ' ' GLY . 63.8 tttp . . . . . 0 C--O 1.256 1.432 0 CA-C-N 116.14 -0.482 . . . . 53.13 110.279 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.244 0.774 0 N-CA-C 108.699 -0.852 . . . . 50.34 108.699 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.52 47.85 0.99 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 111.156 -0.778 . . . . 64.12 111.156 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 24.3 m -127.56 98.52 5.25 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.185 -0.672 . . . . 60.12 109.185 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.72 101.16 10.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.068 -0.515 . . . . 74.12 111.036 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.4 108.97 18.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.038 -1.097 . . . . 75.12 108.038 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 24.9 p -82.6 -52.01 7.22 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.222 0.534 . . . . 65.21 111.687 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.1 -176.52 6.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.787 -0.642 . . . . 72.33 111.186 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.08 -43.62 9.29 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.352 0.501 . . . . 75.43 112.352 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -129.24 89.39 2.85 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.283 -1.006 . . . . 73.1 108.283 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m -77.8 147.2 35.36 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.667 -1.151 . . . . 75.12 112.024 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 14' ' ' LEU . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.34 110.284 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.53 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.554 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.21 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.12 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.15 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.04 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 65.33 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 73.32 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.31 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.448 HG11 HG22 ' B' ' 240' ' ' ILE . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.15 109.772 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.43 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.21 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.606 HG23 HG22 ' B' ' 241' ' ' THR . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 65.4 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.55 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.12 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.2 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 51.21 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 73.41 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 63.42 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 65.11 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 232' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.1 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.21 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.12 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.3 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.34 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.42 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.33 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' ILE . . . . . 0.758 HD11 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 63.34 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' THR . . . . . 0.606 HG22 HG23 ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.05 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 73.13 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 72.11 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.14 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.464 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.12 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' LYS . . . . . 0.594 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.14 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' VAL . . . . . 0.41 HG23 HG23 ' B' ' 212' ' ' VAL . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 72.14 109.977 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 71.42 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.21 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.41 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 92.0 Cg_endo -76.99 39.35 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.34 112.173 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 68.46 73.03 0.29 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.99 1.316 . . . . 73.21 110.671 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -135.26 -56.44 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.102 -0.954 . . . . 63.11 109.329 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 66.0 m -92.27 96.23 10.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.552 0.691 . . . . 74.22 110.021 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -95.84 91.57 6.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.669 -0.696 . . . . 73.55 112.738 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.88 107.36 20.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.387 -0.968 . . . . 72.21 108.387 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.02 105.82 1.13 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.366 -0.834 . . . . 70.11 112.578 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 93.74 8.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.397 -0.594 . . . . 73.13 109.397 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.52 -7.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.934 0.873 . . . . 75.12 109.481 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.8 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.976 -1.011 . . . . 71.12 111.262 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -114.56 91.57 3.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.211 -1.403 . . . . 74.51 107.211 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.8 t -108.71 100.51 9.74 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.251 -0.648 . . . . 61.14 109.251 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 55.6 ttp -106.44 95.92 6.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.823 -0.626 . . . . 75.13 109.932 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.01 93.22 7.52 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.919 -0.582 . . . . 75.2 110.088 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.07 90.24 2.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.46 -0.941 . . . . 72.44 108.46 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--O 1.257 1.473 0 C-N-CA 124.581 1.152 . . . . 71.33 111.742 -177.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 72.519999999999996 112.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.530000000000001 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 63.299999999999997 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 74.030000000000001 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 62.340000000000003 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.510000000000005 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.55 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.120000000000005 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.416 HE22 ' HD3' ' B' ' 251' ' ' PRO . 95.8 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.409999999999997 112.617 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 52.210000000000001 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.129999999999995 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.420000000000002 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.020000000000003 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.319999999999993 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 44.229999999999997 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.129999999999995 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 73.349999999999994 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.030000000000001 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 70.019999999999996 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.757 HD13 HD11 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 40.119999999999997 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.319999999999993 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.400000000000006 106.943 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.329999999999998 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.109999999999999 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.049999999999997 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 64.450000000000003 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.230000000000004 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.319999999999993 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.530000000000001 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.140000000000001 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.230000000000004 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 70.319999999999993 113.378 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.209999999999994 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 34.439999999999998 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.499 HD13 HG22 ' B' ' 247' ' ' VAL . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.120000000000005 110.005 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 61.32 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.040000000000006 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 63.399999999999999 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 63.420000000000002 110.403 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.209999999999994 110.006 175.219 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.542 0.687 . . . . 74.129999999999995 109.636 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 71.209999999999994 107.443 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.219999999999999 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 54.350000000000001 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.507 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 72.120000000000005 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 63.420000000000002 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 53.340000000000003 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.329999999999998 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 220' ' ' PRO . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 44.219999999999999 109.847 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 73.209999999999994 113.211 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 64.319999999999993 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 72.219999999999999 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.519999999999996 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.439999999999998 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 110.944 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 71.329999999999998 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 72.219999999999999 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 65.540000000000006 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 53.140000000000001 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.450000000000003 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.239999999999995 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.549999999999997 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.129999999999995 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.340000000000003 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.439999999999998 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 54.43 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.727 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.209999999999994 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 72.439999999999998 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.140000000000001 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.535 HG22 HG23 ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 71.230000000000004 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.230000000000004 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 71.329999999999998 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 63.509999999999998 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.439999999999998 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 50.450000000000003 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 45' ' ' LEU . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.150000000000006 107.822 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.510000000000005 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' HE22 ' A' ' 17' ' ' GLN . 91.4 Cg_endo . . . . . 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.030000000000001 111.467 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.42 -1.963 0 N-CA-C 109.16 -0.682 . . . . 75.140000000000001 109.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.140000000000001 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.340000000000003 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' HD21 ' B' ' 214' ' ' LEU . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.120000000000005 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 54.039999999999999 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.129999999999995 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.430000000000007 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 17' ' ' GLN . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.209999999999994 110.673 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 50.539999999999999 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.010000000000005 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 40' ' ' ILE . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 64.420000000000002 109.48 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.542 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 60.310000000000002 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.409999999999997 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 HG22 ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 64.519999999999996 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 62.140000000000001 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.450000000000003 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 70.409999999999997 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 65.299999999999997 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.831 HD13 HD11 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.040000000000006 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 51.109999999999999 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.420000000000002 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.240000000000002 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 71.409999999999997 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.540000000000006 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.200000000000003 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.510000000000005 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.120000000000005 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.816 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 50.210000000000001 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.519999999999996 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 72.519999999999996 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 64.099999999999994 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.430000000000007 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 64.409999999999997 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.129999999999995 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 64.540000000000006 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.530000000000001 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HB3' HD21 ' A' ' 34' ' ' LEU . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.400000000000006 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 72.340000000000003 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.430000000000007 113.278 -177.59 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 N--CA 1.419 -2.012 0 CA-C-O 121.364 0.602 . . . . 45.130000000000003 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.329999999999998 107.377 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 64.200000000000003 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.230000000000004 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.536 HD21 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.439999999999998 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.450000000000003 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.109999999999999 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 43.119999999999997 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.423 ' HD2' ' H ' ' B' ' 218' ' ' ARG . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.319999999999993 111.775 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 34' ' ' LEU . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 64.040000000000006 110.266 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.439999999999998 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.420000000000002 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.329999999999998 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 71.019999999999996 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.624 ' HD3' HD12 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 41.329999999999998 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.049999999999997 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.230000000000004 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.129999999999995 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.816 HD13 HD11 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 72.299999999999997 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.439999999999998 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.219999999999999 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.209999999999994 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 52.140000000000001 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.549999999999997 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.129999999999995 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.409999999999997 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.439999999999998 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 64.209999999999994 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.519999999999996 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.831 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.299999999999997 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.603 ' HA ' HD12 ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 51.32 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 43.409999999999997 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 65.329999999999998 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.129999999999995 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.109999999999999 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.329999999999998 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.119999999999997 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.329999999999998 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.539999999999999 109.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 42.310000000000002 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' HD12 ' B' ' 214' ' ' LEU . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.349999999999994 110.378 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.229999999999997 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 61.350000000000001 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.467 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 70.109999999999999 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.510000000000005 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 71.299999999999997 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HD2' ' A' ' 20' ' ' PRO . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 19' ' ' LEU . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.409999999999997 112.579 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.450000000000003 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.109999999999999 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 62.32 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 64.219999999999999 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.510000000000005 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 71.230000000000004 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.754 HD13 HD11 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 70.439999999999998 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.140000000000001 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.310000000000002 111.993 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.150000000000006 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 71.040000000000006 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 73.230000000000004 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.400000000000006 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.209999999999994 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.200000000000003 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.129999999999995 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.563 ' HA ' HD12 ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.349999999999994 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 20' ' ' PRO 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 42.240000000000002 115.806 -176.949 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.120000000000005 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.019999999999996 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.540000000000006 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 63.420000000000002 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.399999999999999 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 63.329999999999998 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.319999999999993 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HG2' HD23 ' B' ' 219' ' ' LEU . 26.9 Cg_exo . . . . . 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 73.049999999999997 115.045 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.099999999999994 108.86 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.430000000000007 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.432 HD12 ' HB ' ' A' ' 12' ' ' VAL . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.540000000000006 111.988 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 61.299999999999997 110.113 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 71.329999999999998 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.530000000000001 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.239999999999995 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.019999999999996 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.349999999999994 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.510000000000005 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 71.340000000000003 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 64.519999999999996 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.612 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 52.130000000000003 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.769 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.299999999999997 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' B' ' 238' ' ' ILE . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.239999999999995 108.938 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 62.140000000000001 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.229999999999997 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.230000000000004 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.129999999999995 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 32.340000000000003 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.814 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 72.540000000000006 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 72.430000000000007 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 65.030000000000001 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 63.409999999999997 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 52.130000000000003 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.420000000000002 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 62.329999999999998 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.340000000000003 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.340000000000003 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.109999999999999 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.329999999999998 113.847 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.049999999999997 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.030000000000001 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.409999999999997 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 42.310000000000002 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.340000000000003 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.329999999999998 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 114.912 -172.902 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.424 -1.741 0 CA-C-O 121.478 0.656 . . . . 52.229999999999997 110.541 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.299999999999997 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.209999999999994 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 41.399999999999999 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.48 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 51.43 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 63.310000000000002 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 63.100000000000001 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 64.209999999999994 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 53.229999999999997 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.439999999999998 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.519999999999996 108.766 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' SER . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 64.340000000000003 113.298 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 63.020000000000003 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.150000000000006 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.549999999999997 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.120000000000005 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 51.299999999999997 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 54.329999999999998 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 62.240000000000002 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.430000000000007 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.210000000000001 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.400000000000006 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 65.299999999999997 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.349999999999994 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.420000000000002 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 55.520000000000003 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.510000000000005 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.713 HD11 HD13 ' B' ' 229' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 74.230000000000004 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 64.430000000000007 114.426 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.456 ' HG3' ' HE2' ' A' ' 42' ' ' LYS . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.219999999999999 112.153 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 61.25 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.129999999999995 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 71.310000000000002 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG21 HD22 ' B' ' 245' ' ' LEU . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 64.310000000000002 110.962 -173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.130000000000003 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.349999999999994 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.209999999999994 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo . . . . . 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.230000000000004 112.491 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 114.162 1.171 . . . . 72.129999999999995 114.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.140000000000001 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 50.039999999999999 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.130000000000003 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 64.329999999999998 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.456 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.010000000000005 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 71.400000000000006 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 63.520000000000003 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.340000000000003 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 64.129999999999995 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 74.420000000000002 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 62.240000000000002 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.310000000000002 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.120000000000005 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.140000000000001 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.120000000000005 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.420000000000002 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 54.009999999999998 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 64.010000000000005 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.340000000000003 110.162 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.340000000000003 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 61.420000000000002 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.109999999999999 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 64.430000000000007 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.210000000000001 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.420000000000002 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.340000000000003 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.230000000000004 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.099999999999994 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' HD12 ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 65.109999999999999 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 62.219999999999999 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.209999999999994 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.420000000000002 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 64.230000000000004 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 43.109999999999999 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.466 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 53.32 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.129999999999995 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.349999999999994 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.420000000000002 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 85.9 Cg_endo . . . . . 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 54.009999999999998 113.208 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' HB ' ' OG1' ' B' ' 216' ' ' THR . 40.1 p . . . . . 0 N--CA 1.426 -1.641 0 CA-C-O 120.724 0.297 . . . . 72.010000000000005 110.895 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.209999999999994 108.024 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 71.349999999999994 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.329999999999998 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 61.530000000000001 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 64.209999999999994 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.310000000000002 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.540000000000006 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.049999999999997 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 70.200000000000003 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.109999999999999 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.409999999999997 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.219999999999999 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.219999999999999 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.777 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.310000000000002 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 52.0 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.140000000000001 108.629 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 70.230000000000004 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.010000000000005 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.779 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.019999999999996 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.120000000000005 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.019999999999996 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 64.239999999999995 110.925 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 71.420000000000002 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.209999999999994 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.140000000000001 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 61.409999999999997 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.239999999999995 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.030000000000001 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.727 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 64.319999999999993 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.120000000000005 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.129999999999995 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 63.229999999999997 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.019999999999996 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 73.510000000000005 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.47 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.540000000000006 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 45.0 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 71.450000000000003 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.349999999999994 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 70.219999999999999 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo . . . . . 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 64.530000000000001 111.675 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.429 -1.51 0 CA-C-O 120.956 0.408 . . . . 73.010000000000005 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.140000000000001 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 14' ' ' LEU . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 51.399999999999999 109.677 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.299999999999997 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.329999999999998 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.400000000000006 107.777 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 10' ' ' THR . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.549999999999997 110.72 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.200000000000003 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 64.510000000000005 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.439999999999998 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 73.140000000000001 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 54.109999999999999 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.420000000000002 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 34.229999999999997 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 71.340000000000003 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 35.32 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 74.409999999999997 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.519999999999996 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.310000000000002 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 53.549999999999997 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.450000000000003 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 44.130000000000003 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.409999999999997 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.539999999999999 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.230000000000004 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.039999999999999 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 52.109999999999999 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.230000000000004 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.019999999999996 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 52.140000000000001 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.140000000000001 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 64.329999999999998 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.319999999999993 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 47' ' ' VAL . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 45' ' ' LEU . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 70.319999999999993 109.819 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.019999999999996 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.340000000000003 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 53.240000000000002 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.230000000000004 112.049 177.761 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.426 -1.646 0 N-CA-C 109.0 -0.741 . . . . 45.200000000000003 109.0 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 61.539999999999999 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.409999999999997 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.219999999999999 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.310000000000002 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 70.450000000000003 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 71.109999999999999 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.400000000000006 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG21 ' HZ1' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.319999999999993 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 61.539999999999999 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 65.230000000000004 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 64.109999999999999 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 38' ' ' ILE . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.519999999999996 107.83 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.430000000000007 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HD11 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 73.409999999999997 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 44.450000000000003 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 63.229999999999997 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.120000000000005 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.319999999999993 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 65.219999999999999 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.019999999999996 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 60.350000000000001 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 72.530000000000001 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 62.310000000000002 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.688 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 74.200000000000003 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 42.409999999999997 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.329999999999998 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 65.349999999999994 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.530000000000001 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 74.420000000000002 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 72.340000000000003 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 245' ' ' LEU . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 55.140000000000001 109.382 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 71.150000000000006 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.120000000000005 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.140000000000001 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.420000000000002 112.993 179.69 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.421 -1.921 0 CA-C-O 121.005 0.431 . . . . 64.430000000000007 109.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.340000000000003 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.439999999999998 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 54.329999999999998 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 72.549999999999997 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.483 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.510000000000005 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 61.130000000000003 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.655 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.530000000000001 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.529 ' O ' HD12 ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.230000000000004 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.420000000000002 110.681 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 74.0 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.319999999999993 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 53.109999999999999 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 241' ' ' THR . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.430000000000007 104.811 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 73.109999999999999 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.430000000000007 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.120000000000005 107.895 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.140000000000001 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.688 HD13 HD11 ' A' ' 40' ' ' ILE . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.519999999999996 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.140000000000001 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 70.239999999999995 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 61.25 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.150000000000006 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.040000000000006 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 63.340000000000003 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.530000000000001 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.519999999999996 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.450000000000003 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.411 ' HA ' HD12 ' B' ' 224' ' ' ILE . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 72.409999999999997 110.233 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 44.109999999999999 112.554 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 73.040000000000006 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.030000000000001 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 47' ' ' VAL . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.430000000000007 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 53.140000000000001 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 63.310000000000002 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.340000000000003 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.350000000000001 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.519999999999996 109.662 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 72.420000000000002 111.241 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.422 -1.861 0 CA-C-O 121.364 0.602 . . . . 65.129999999999995 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.049999999999997 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 62.509999999999998 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 62.5 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HG ' HD21 ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 65.030000000000001 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 74.150000000000006 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.129999999999995 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.310000000000002 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.230000000000004 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 53.329999999999998 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 72.329999999999998 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 42' ' ' LYS . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 70.329999999999998 108.329 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.519999999999996 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 53.109999999999999 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.140000000000001 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.040000000000006 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.349999999999994 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.409999999999997 108.355 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 44.200000000000003 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.628 HD13 HD11 ' B' ' 240' ' ' ILE . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 71.409999999999997 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.299999999999997 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.099999999999994 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.099999999999994 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.409999999999997 110.684 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 63.340000000000003 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.450000000000003 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.329999999999998 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 64.540000000000006 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 34.140000000000001 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 62.5 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.673 HD11 HD13 ' B' ' 229' ' ' ILE . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.239999999999995 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.549999999999997 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG22 ' A' ' 21' ' ' VAL 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.450000000000003 114.65 -179.248 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.120000000000005 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.140000000000001 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 53.109999999999999 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.310000000000002 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 61.329999999999998 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 43.439999999999998 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.400000000000006 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.420000000000002 105.949 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo . . . . . 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.540000000000006 113.368 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 64.140000000000001 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.329999999999998 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.704 HD21 ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 62.549999999999997 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.349999999999994 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.549999999999997 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.409999999999997 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.540000000000006 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 74.239999999999995 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.099999999999994 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.399999999999999 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.530000000000001 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.230000000000004 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 72.349999999999994 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.140000000000001 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.522 ' HB2' HD12 ' B' ' 238' ' ' ILE . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 74.230000000000004 108.54 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 73.140000000000001 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.319999999999993 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.010000000000005 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.140000000000001 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.340000000000003 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 71.209999999999994 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.409999999999997 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 65.010000000000005 108.76 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.698 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.130000000000003 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 72.409999999999997 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.040000000000006 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.628 HD11 HD13 ' A' ' 29' ' ' ILE . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.430000000000007 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 73.549999999999997 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 63.399999999999999 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.430000000000007 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.109999999999999 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.230000000000004 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.140000000000001 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 72.230000000000004 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.519999999999996 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.439999999999998 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.219999999999999 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.010000000000005 110.899 176.194 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 109.577 -0.527 . . . . 64.519999999999996 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 63.299999999999997 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 71.25 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.040000000000006 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.239999999999995 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 61.310000000000002 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.530000000000001 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.239999999999995 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 63.409999999999997 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.310000000000002 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 52.439999999999998 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.510000000000005 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.129999999999995 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.200000000000003 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 41' ' ' THR . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.540000000000006 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 55.100000000000001 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 71.209999999999994 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.681 HD13 HD11 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.120000000000005 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 63.420000000000002 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.230000000000004 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.340000000000003 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.219999999999999 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.439999999999998 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.319999999999993 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.209999999999994 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.439999999999998 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 64.5 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.140000000000001 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.726 HD11 HD13 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.329999999999998 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.409999999999997 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.319999999999993 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.200000000000003 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.039999999999999 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 51.43 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.430000000000007 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG21 HD22 ' B' ' 245' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.219999999999999 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.229999999999997 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.099999999999994 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.040000000000006 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 32.329999999999998 110.349 174.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.319999999999993 107.395 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.519999999999996 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.430000000000007 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' A' ' 14' ' ' LEU . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 71.040000000000006 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 60.329999999999998 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 74.409999999999997 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.420000000000002 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.299999999999997 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.329999999999998 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.030000000000001 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.439999999999998 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 63.450000000000003 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.019999999999996 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.76 -172.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.450000000000003 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.319999999999993 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.109999999999999 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.726 HD13 HD11 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 60.020000000000003 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 70.230000000000004 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.409999999999997 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 64.319999999999993 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' B' ' 250' ' ' ASP . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.119999999999997 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.319999999999993 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 63.329999999999998 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.129999999999995 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 71.549999999999997 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.239999999999995 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.400000000000006 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.140000000000001 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.219999999999999 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.420000000000002 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 47' ' ' VAL . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.329999999999998 111.182 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 64.219999999999999 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.310000000000002 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.340000000000003 107.391 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.450000000000003 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . 0.663 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.239999999999995 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.049999999999997 108.289 168.143 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.438 -1.049 0 N-CA-C 114.712 1.375 . . . . 71.319999999999993 114.712 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 53.310000000000002 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.510000000000005 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.409999999999997 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 54.520000000000003 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.409999999999997 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.706 HE21 ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 109.201 -177.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.010000000000005 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 64.319999999999993 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 114.063 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 61.409999999999997 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.439999999999998 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.120000000000005 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.230000000000004 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 65.25 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.009999999999998 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.299999999999997 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.709 HD13 HD11 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 64.140000000000001 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 64.329999999999998 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.119999999999997 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.240000000000002 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.140000000000001 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 64.5 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.049999999999997 111.053 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.439999999999998 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.239999999999995 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.540000000000006 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 73.400000000000006 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.666 HD11 HD13 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.109999999999999 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.210000000000001 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.140000000000001 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.439999999999998 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 65.510000000000005 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 52.340000000000003 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.109999999999999 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.230000000000004 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.129999999999995 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.530000000000001 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.200000000000003 110.364 174.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 121.363 0.601 . . . . 74.129999999999995 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.540000000000006 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 14' ' ' LEU . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 72.510000000000005 108.823 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.502 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.439999999999998 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 54.439999999999998 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.400000000000006 109.194 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 71.099999999999994 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . 0.747 HE21 ' HA ' ' B' ' 217' ' ' GLN . 0.0 OUTLIER 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 51.020000000000003 111.465 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 64.530000000000001 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 62.109999999999999 110.329 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 62.399999999999999 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.340000000000003 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.120000000000005 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 61.329999999999998 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.210000000000001 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.329999999999998 107.883 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 65.409999999999997 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.666 HD13 HD11 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 70.420000000000002 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 70.349999999999994 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' B' ' 229' ' ' ILE . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.140000000000001 106.353 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.240000000000002 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.409999999999997 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.63 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 72.439999999999998 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 64.040000000000006 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 41.549999999999997 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.200000000000003 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.319999999999993 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.040000000000006 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 29' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.420000000000002 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.514 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.310000000000002 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 62.210000000000001 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.519999999999996 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 21.43 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 62.32 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 53.409999999999997 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 54.439999999999998 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.140000000000001 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 71.319999999999993 111.536 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.430000000000007 109.46 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo . . . . . 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.219999999999999 111.698 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 121.641 0.734 . . . . 74.150000000000006 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 62.420000000000002 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' B' ' 214' ' ' LEU . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.400000000000006 110.455 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.230000000000004 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HG ' HD21 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.010000000000005 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.340000000000003 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.319999999999993 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.209999999999994 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.430000000000007 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.409999999999997 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.519999999999996 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.129999999999995 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.230000000000004 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 41' ' ' THR . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.510000000000005 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.540000000000006 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 63.329999999999998 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.019999999999996 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 64.049999999999997 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 70.129999999999995 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.100000000000001 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.230000000000004 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.439999999999998 111.41 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.708 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 43.409999999999997 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 62.310000000000002 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 62.130000000000003 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 60.310000000000002 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.349999999999994 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 HD13 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 71.099999999999994 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.562 HG22 HG23 ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.239999999999995 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 64.349999999999994 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 64.129999999999995 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.549999999999997 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 25.129999999999999 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.019999999999996 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' B' ' 245' ' ' LEU . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 41.119999999999997 110.504 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.430000000000007 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.708 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.340000000000003 106.992 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 71.049999999999997 112.085 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.417 -2.077 0 CA-C-O 121.226 0.536 . . . . 64.430000000000007 110.932 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.420000000000002 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.319999999999993 109.539 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.450000000000003 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.129999999999995 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.340000000000003 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 64.230000000000004 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.120000000000005 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.230000000000004 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.349999999999994 110.606 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.219999999999999 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.230000000000004 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.329999999999998 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.130000000000003 110.304 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 71.219999999999999 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.430000000000007 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 73.129999999999995 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.831 HD13 HD11 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 64.209999999999994 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.520000000000003 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.219999999999999 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.439999999999998 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.439999999999998 110.744 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.120000000000005 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.299999999999997 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 62.439999999999998 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.120000000000005 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.120000000000005 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.409999999999997 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.109999999999999 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.510000000000005 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.434 ' HD2' ' HG3' ' B' ' 243' ' ' ARG . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.434 ' HG3' ' HD2' ' B' ' 242' ' ' LYS . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 54.340000000000003 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.140000000000001 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 47' ' ' VAL . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 72.299999999999997 111.135 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.319999999999993 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.100000000000001 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 63.439999999999998 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.140000000000001 106.343 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 61.43 111.573 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.400000000000006 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.019999999999996 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 72.329999999999998 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.230000000000004 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 63.039999999999999 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.586 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.310000000000002 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.140000000000001 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 70.230000000000004 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.439999999999998 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 73.409999999999997 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.510000000000005 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.209999999999994 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.329999999999998 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.450000000000003 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 64.109999999999999 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.450000000000003 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.608 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.129999999999995 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 64.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.450000000000003 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 62.210000000000001 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 53.109999999999999 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.239999999999995 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.430000000000007 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 71.239999999999995 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.563 HG22 HG23 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.230000000000004 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 70.239999999999995 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 64.120000000000005 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 65.299999999999997 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.420000000000002 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 62.210000000000001 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 12' ' ' VAL . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 41.049999999999997 109.071 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.120000000000005 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 64.319999999999993 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 42.310000000000002 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 51.340000000000003 112.392 -178.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.418 -2.037 0 N-CA-C 108.675 -0.861 . . . . 63.439999999999998 108.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.140000000000001 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 55.509999999999998 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.55 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.510000000000005 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.129999999999995 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 HD13 ' B' ' 219' ' ' LEU . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.109999999999999 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.109999999999999 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.510000000000005 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.42 HD13 HG23 ' B' ' 216' ' ' THR . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 63.119999999999997 107.432 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 50.43 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.439 HG11 HG22 ' B' ' 240' ' ' ILE . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.430000000000007 110.539 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.219999999999999 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 71.219999999999999 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.239999999999995 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.109999999999999 110.477 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 72.530000000000001 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.450000000000003 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 64.239999999999995 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.430000000000007 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.427 HG22 ' HG2' ' B' ' 235' ' ' ARG . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.099999999999994 110.265 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 74.349999999999994 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 55.020000000000003 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.310000000000002 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.140000000000001 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' B' ' 230' ' ' THR . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.129999999999995 109.427 172.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.420000000000002 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.510000000000005 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 73.129999999999995 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 74.519999999999996 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 29' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.140000000000001 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.310000000000002 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.409999999999997 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.0 108.726 170.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.421 ' C ' HD12 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.210000000000001 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.421 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 71.450000000000003 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 65.120000000000005 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 42.5 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.340000000000003 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.340000000000003 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.549999999999997 112.853 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.401 -2.883 0 N-CA-C 108.896 -0.779 . . . . 53.310000000000002 108.896 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.510000000000005 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 65.200000000000003 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 64.200000000000003 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 70.530000000000001 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.019999999999996 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.010000000000005 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 71.349999999999994 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 63.340000000000003 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 65.400000000000006 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.150000000000006 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.040000000000006 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 50.329999999999998 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.450000000000003 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 41' ' ' THR . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 64.150000000000006 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 52.200000000000003 109.274 -173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 63.530000000000001 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.120000000000005 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.450000000000003 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.409999999999997 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.349999999999994 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.019999999999996 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.299999999999997 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 54.439999999999998 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.430000000000007 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 35' ' ' ARG . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.200000000000003 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.450000000000003 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 70.019999999999996 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.200000000000003 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.010000000000005 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.514 HD11 HD13 ' B' ' 229' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 71.120000000000005 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 70.310000000000002 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.329999999999998 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.340000000000003 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 52.229999999999997 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 53.109999999999999 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.450000000000003 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 64.109999999999999 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 72.420000000000002 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.329999999999998 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.209999999999994 108.183 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.540000000000006 112.799 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.413 -2.319 0 CA-C-O 122.086 0.946 . . . . 73.040000000000006 109.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 44.32 107.638 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.240000000000002 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.030000000000001 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.544 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 73.310000000000002 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.407 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.439999999999998 110.931 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.040000000000006 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.439999999999998 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 70.510000000000005 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 63.140000000000001 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.420000000000002 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 72.120000000000005 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.230000000000004 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 71.430000000000007 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.129999999999995 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.439999999999998 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.430000000000007 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 62.020000000000003 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.571 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.420000000000002 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.040000000000006 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 72.209999999999994 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 72.120000000000005 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.040000000000006 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 70.120000000000005 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.319999999999993 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.239999999999995 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 72.430000000000007 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.577 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 72.230000000000004 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.230000000000004 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.150000000000006 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.019999999999996 113.383 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 72.439999999999998 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.299999999999997 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.239999999999995 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.019999999999996 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.539999999999999 109.154 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 60.350000000000001 111.674 177.043 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 113.217 0.821 . . . . 63.539999999999999 113.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.129999999999995 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 71.140000000000001 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.109999999999999 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' B' ' 212' ' ' VAL . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.530000000000001 110.876 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.409999999999997 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.439999999999998 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.019999999999996 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 70.5 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.120000000000005 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.210000000000001 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 53.43 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.450000000000003 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.549999999999997 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 44.420000000000002 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.319999999999993 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 71.099999999999994 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.61 HD13 HD11 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.239999999999995 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 63.310000000000002 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 64.400000000000006 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 72.519999999999996 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.430000000000007 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 62.340000000000003 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.299999999999997 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.420000000000002 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.400000000000006 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 61.439999999999998 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.349999999999994 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.684 HD11 HD13 ' B' ' 229' ' ' ILE . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 55.130000000000003 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.409999999999997 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.439999999999998 113.262 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 72.25 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.430000000000007 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 72.319999999999993 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 HD22 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 42.240000000000002 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.310000000000002 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.409999999999997 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.409999999999997 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.349999999999994 111.995 177.046 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-O 120.598 0.237 . . . . 64.0 110.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 52.539999999999999 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD13 ' A' ' 14' ' ' LEU . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.400000000000006 110.134 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 43.009999999999998 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.319999999999993 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.439 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 64.430000000000007 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 33.039999999999999 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.239999999999995 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.533 HD23 ' H ' ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.420000000000002 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.299999999999997 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.450000000000003 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.219999999999999 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 63.25 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 64.439999999999998 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.581 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.230000000000004 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.319999999999993 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 64.400000000000006 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 72.349999999999994 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 73.299999999999997 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 54.350000000000001 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.109999999999999 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.209999999999994 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 60.439999999999998 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 61.240000000000002 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.140000000000001 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 61.039999999999999 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.150000000000006 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 29' ' ' ILE . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 72.450000000000003 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.548 ' HA ' HD12 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 70.310000000000002 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.409999999999997 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 71.200000000000003 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.530000000000001 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.596 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 73.209999999999994 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.510000000000005 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.210000000000001 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 60.219999999999999 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 71.150000000000006 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo . . . . . 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 53.520000000000003 113.879 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.422 -1.87 0 CA-C-O 120.996 0.427 . . . . 72.430000000000007 112.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.420000000000002 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' ' 214' ' ' LEU . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.109999999999999 109.319 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 72.329999999999998 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' B' ' 214' ' ' LEU . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 64.310000000000002 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 64.239999999999995 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.427 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 64.439999999999998 109.008 -176.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.299999999999997 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.140000000000001 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.439999999999998 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.109999999999999 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 40' ' ' ILE . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 52.509999999999998 108.285 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.049999999999997 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.519999999999996 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.450000000000003 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 73.200000000000003 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 53.509999999999998 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 70.140000000000001 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 73.319999999999993 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 HD11 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 71.0 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.230000000000004 109.834 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.140000000000001 108.581 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 49' ' ' CYS . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 63.340000000000003 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.299999999999997 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 65.329999999999998 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.430000000000007 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.219999999999999 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.420000000000002 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.778 HD11 HD13 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.310000000000002 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.219999999999999 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 61.32 113.534 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 64.140000000000001 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 70.219999999999999 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 12' ' ' VAL . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.602 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 63.140000000000001 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.099999999999994 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.409999999999997 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo . . . . . 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.030000000000001 111.826 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 109.372 -0.603 . . . . 52.229999999999997 109.372 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 71.049999999999997 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.200000000000003 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 24.43 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.515 HD21 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 72.219999999999999 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.25 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 43.539999999999999 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.510000000000005 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 71.040000000000006 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 62.329999999999998 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 73.420000000000002 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.209999999999994 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.299999999999997 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.040000000000006 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 70.230000000000004 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.58 ' HD2' HD12 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.219999999999999 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 72.129999999999995 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.109999999999999 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 74.329999999999998 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.099999999999994 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.129999999999995 108.176 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.219999999999999 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.200000000000003 108.659 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.340000000000003 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.45 ' N ' HD13 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 71.140000000000001 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.664 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.319999999999993 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 53.229999999999997 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 53.100000000000001 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.329999999999998 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.129999999999995 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.489 ' HA ' HD12 ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.040000000000006 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.200000000000003 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 74.109999999999999 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.420000000000002 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.450000000000003 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.019999999999996 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.120000000000005 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.049999999999997 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' B' ' 234' ' ' LEU . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 70.010000000000005 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.530000000000001 108.087 174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 8.1 Cg_exo . . . . . 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.340000000000003 112.926 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 120.806 0.336 . . . . 73.030000000000001 111.811 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.150000000000006 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' B' ' 214' ' ' LEU . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.230000000000004 110.567 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.129999999999995 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 64.120000000000005 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.219999999999999 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.109999999999999 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 72.140000000000001 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 65.540000000000006 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.209999999999994 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 62.539999999999999 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 43.130000000000003 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.540000000000006 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.030000000000001 111.079 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.745 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.239999999999995 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.319999999999993 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 55.310000000000002 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.329999999999998 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 61.439999999999998 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 63.409999999999997 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.310000000000002 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 60.530000000000001 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 63.409999999999997 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.239999999999995 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.019999999999996 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.745 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 62.32 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.430000000000007 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 HD13 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.340000000000003 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 73.319999999999993 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.329999999999998 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.430000000000007 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.120000000000005 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.129999999999995 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 74.129999999999995 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.239999999999995 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 65.329999999999998 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.420000000000002 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.140000000000001 114.119 -178.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.429 -1.494 0 CA-C-O 121.296 0.57 . . . . 44.539999999999999 111.58 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 73.329999999999998 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 63.100000000000001 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.150000000000006 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.019999999999996 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.439999999999998 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.209999999999994 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.150000000000006 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.310000000000002 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.430000000000007 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.319999999999993 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.030000000000001 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.319999999999993 110.436 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.773 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 60.439999999999998 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.409999999999997 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.329999999999998 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.040000000000006 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.795 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.200000000000003 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 54.240000000000002 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.340000000000003 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.310000000000002 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 61.32 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.219999999999999 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 64.219999999999999 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 72.430000000000007 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.340000000000003 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.522 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.409999999999997 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.230000000000004 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 70.140000000000001 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.420000000000002 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.48 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.239999999999995 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 61.240000000000002 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 45' ' ' LEU . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.510000000000005 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.420000000000002 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo . . . . . 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.430000000000007 111.994 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m . . . . . 0 N--CA 1.421 -1.916 0 CA-C-O 121.198 0.523 . . . . 74.340000000000003 109.952 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.219999999999999 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' B' ' 214' ' ' LEU . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 73.439999999999998 109.212 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' B' ' 212' ' ' VAL . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.129999999999995 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 71.310000000000002 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.405 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.150000000000006 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' HG3' ' A' ' 43' ' ' ARG . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 71.329999999999998 107.829 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 74.519999999999996 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.329999999999998 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 40' ' ' ILE . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 64.239999999999995 108.858 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 71.109999999999999 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 63.140000000000001 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 72.319999999999993 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 74.230000000000004 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.340000000000003 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.540000000000006 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 62.450000000000003 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.510000000000005 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 70.299999999999997 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 45.420000000000002 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 73.349999999999994 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 61.140000000000001 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.430000000000007 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 61.210000000000001 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 44.100000000000001 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 54.130000000000003 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 63.420000000000002 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 72.439999999999998 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.728 HD11 HD13 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.209999999999994 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.479 ' HA ' HD12 ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.439999999999998 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 18' ' ' ARG . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.230000000000004 111.032 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.409999999999997 112.109 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 73.209999999999994 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG21 HD22 ' B' ' 245' ' ' LEU . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 52.310000000000002 109.113 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.409999999999997 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.219999999999999 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo . . . . . 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.409999999999997 113.366 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.422 -1.873 0 CA-C-O 121.08 0.467 . . . . 70.200000000000003 110.599 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.019999999999996 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.530000000000001 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.439999999999998 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 12' ' ' VAL . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.439999999999998 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.409999999999997 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.219999999999999 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.310000000000002 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.445 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.030000000000001 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.420000000000002 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.150000000000006 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 240' ' ' ILE . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 55.340000000000003 107.613 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.420000000000002 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 55.329999999999998 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.329999999999998 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.5 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.150000000000006 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.349999999999994 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.329999999999998 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 64.219999999999999 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.728 HD13 HD11 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.239999999999995 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 43.140000000000001 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.439999999999998 112.24 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.219999999999999 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 62.229999999999997 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 71.120000000000005 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.040000000000006 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.409999999999997 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 43.530000000000001 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 63.130000000000003 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.682 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 63.229999999999997 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.524 ' HA ' HD12 ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.140000000000001 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 63.32 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.109999999999999 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.430000000000007 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.43 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 60.119999999999997 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.230000000000004 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.040000000000006 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.219999999999999 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 43.409999999999997 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . 0.421 ' O ' HD22 ' B' ' 234' ' ' LEU . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 55.200000000000003 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 250' ' ' ASP . 11.8 Cg_exo . . . . . 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.219999999999999 112.154 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 112.002 0.371 . . . . 71.540000000000006 112.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.310000000000002 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.510000000000005 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 61.439999999999998 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.239999999999995 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.319999999999993 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 32.310000000000002 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.230000000000004 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.230000000000004 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.319999999999993 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 62.350000000000001 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.439999999999998 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.239999999999995 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.340000000000003 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 72.430000000000007 110.928 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 63.219999999999999 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.230000000000004 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.703 HD13 HD11 ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 71.120000000000005 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 43.109999999999999 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.340000000000003 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 15.210000000000001 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.310000000000002 111.488 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.685 HD11 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.310000000000002 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 30' ' ' THR . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.242 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD11 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 61.219999999999999 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 71.340000000000003 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.319999999999993 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.209999999999994 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.329999999999998 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.49 HG22 HG23 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.219999999999999 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.019999999999996 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.120000000000005 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.430000000000007 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD13 HG22 ' B' ' 247' ' ' VAL . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.319999999999993 109.086 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.140000000000001 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 55.140000000000001 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.540000000000006 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 62.130000000000003 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.519999999999996 108.161 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 74.4 Cg_endo . . . . . 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.219999999999999 112.13 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.412 -2.368 0 CA-C-O 120.835 0.35 . . . . 64.540000000000006 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 64.420000000000002 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 61.32 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 12' ' ' VAL . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.239999999999995 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 71.120000000000005 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 41.140000000000001 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 55.5 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 62.210000000000001 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.219999999999999 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 63.229999999999997 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.200000000000003 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.209999999999994 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' B' ' 241' ' ' THR . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 64.140000000000001 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 72.099999999999994 110.835 -173.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.519999999999996 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.430000000000007 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 53.350000000000001 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 64.340000000000003 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 41.229999999999997 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' HG22 ' B' ' 229' ' ' ILE . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.310000000000002 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.439999999999998 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.450000000000003 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 61.140000000000001 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 65.329999999999998 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.030000000000001 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.239999999999995 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.019999999999996 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.030000000000001 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.209999999999994 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.541 ' HA ' HD12 ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.349999999999994 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.200000000000003 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.340000000000003 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 31.039999999999999 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.340000000000003 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.310000000000002 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 45' ' ' LEU . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.239999999999995 109.017 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 60.149999999999999 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 54.329999999999998 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.409999999999997 111.746 179.403 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 63.420000000000002 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.109999999999999 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 70.349999999999994 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.310000000000002 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.049999999999997 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.409999999999997 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.150000000000006 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.540000000000006 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.310000000000002 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.209999999999994 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.408 HG11 HG22 ' A' ' 40' ' ' ILE . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 50.229999999999997 109.044 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.239999999999995 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.239999999999995 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 71.310000000000002 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 65.0 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.200000000000003 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 73.409999999999997 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.329999999999998 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.603 HD13 HD11 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.150000000000006 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 64.150000000000006 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.349999999999994 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.310000000000002 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 72.239999999999995 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.549999999999997 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.420000000000002 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 72.439999999999998 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.539999999999999 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.129999999999995 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.717 HD11 HD13 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 42.049999999999997 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.030000000000001 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.310000000000002 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 65.109999999999999 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.010000000000005 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.667 HD11 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.219999999999999 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.549999999999997 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.109999999999999 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.409999999999997 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.658 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 32.119999999999997 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 64.099999999999994 112.115 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.240000000000002 109.011 171.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 54.130000000000003 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.299999999999997 107.636 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 14' ' ' LEU . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.120000000000005 109.325 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.429 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.129999999999995 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.150000000000006 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.400000000000006 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.430000000000007 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 72.409999999999997 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.230000000000004 111.362 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.439999999999998 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.219999999999999 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.200000000000003 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.530000000000001 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.572 ' HD2' HD12 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.099999999999994 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.040000000000006 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.319999999999993 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.030000000000001 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.717 HD13 HD11 ' A' ' 40' ' ' ILE . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.150000000000006 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.129999999999995 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 70.150000000000006 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.239999999999995 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.310000000000002 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 249' ' ' CYS . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.030000000000001 109.255 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.400000000000006 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.240000000000002 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.129999999999995 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 71.129999999999995 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 73.409999999999997 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.603 HD11 HD13 ' A' ' 29' ' ' ILE . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 73.340000000000003 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 72.420000000000002 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 62.109999999999999 115.189 -175.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.310000000000002 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.530000000000001 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.319999999999993 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 71.030000000000001 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.624 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.109999999999999 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.439999999999998 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.109999999999999 110.601 174.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.340000000000003 109.165 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.319999999999993 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 50.549999999999997 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.219999999999999 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HG ' HD21 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 62.240000000000002 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.239999999999995 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.150000000000006 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 19' ' ' LEU . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.099999999999994 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 72.200000000000003 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.219999999999999 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 65.230000000000004 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.239999999999995 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 61.210000000000001 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 54.43 112.957 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.319999999999993 106.447 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 72.109999999999999 110.604 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 62.119999999999997 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.319999999999993 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 54.219999999999999 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.747 HD13 HD11 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 71.129999999999995 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.239999999999995 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.310000000000002 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.120000000000005 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.129999999999995 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 71.299999999999997 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.120000000000005 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 33.329999999999998 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 62.240000000000002 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 64.109999999999999 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 74.5 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.150000000000006 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 54.039999999999999 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.209999999999994 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.149999999999999 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.430000000000007 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 53.43 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 72.239999999999995 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.129999999999995 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.229999999999997 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 65.340000000000003 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.5 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.349999999999994 112.018 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.12 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 65.409999999999997 110.077 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.140000000000001 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.539 HD21 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.420000000000002 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 53.329999999999998 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 63.219999999999999 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.519999999999996 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.430000000000007 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 73.439999999999998 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 62.240000000000002 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.540000000000006 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 73.010000000000005 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 241' ' ' THR . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 45.539999999999999 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.299999999999997 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.049999999999997 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.450000000000003 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.099999999999994 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.150000000000006 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.420000000000002 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.209999999999994 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.310000000000002 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 63.420000000000002 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 72.150000000000006 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 73.120000000000005 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.319999999999993 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.030000000000001 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.409999999999997 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 73.510000000000005 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' HD12 ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 52.549999999999997 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.210000000000001 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 54.0 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.449 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.409999999999997 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.449 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.109999999999999 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.230000000000004 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 45' ' ' LEU . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 54.310000000000002 109.52 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.140000000000001 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 44.140000000000001 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.444 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.439999999999998 111.937 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.315 -0.624 . . . . 65.519999999999996 109.315 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 44.299999999999997 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 61.340000000000003 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.019999999999996 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.510000000000005 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 73.150000000000006 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.129999999999995 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.439999999999998 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.119999999999997 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 60.409999999999997 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.319999999999993 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.340000000000003 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 61.43 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.140000000000001 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.510000000000005 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.329999999999998 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 70.109999999999999 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.530000000000001 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 70.519999999999996 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 72.329999999999998 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 45.420000000000002 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.129999999999995 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.140000000000001 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.230000000000004 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 64.209999999999994 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.200000000000003 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 53.539999999999999 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 64.439999999999998 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 62.329999999999998 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 73.019999999999996 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.657 HD11 HD13 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 63.310000000000002 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HG23 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 64.239999999999995 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 74.439999999999998 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.140000000000001 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 63.030000000000001 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.420000000000002 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 73.310000000000002 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.400000000000006 106.938 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.340000000000003 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.439999999999998 108.531 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.1 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.439999999999998 111.941 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.439 -0.991 0 CA-C-O 121.181 0.515 . . . . 75.120000000000005 112.024 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 70.319999999999993 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 14' ' ' LEU . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.340000000000003 110.284 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.530000000000001 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.554 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.210000000000001 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.120000000000005 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.150000000000006 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.040000000000006 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 65.329999999999998 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 73.319999999999993 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.310000000000002 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.448 HG11 HG22 ' B' ' 240' ' ' ILE . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.150000000000006 109.772 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.430000000000007 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.210000000000001 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.606 HG23 HG22 ' B' ' 241' ' ' THR . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 65.400000000000006 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.549999999999997 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.120000000000005 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.200000000000003 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 51.210000000000001 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 73.409999999999997 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 63.420000000000002 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 65.109999999999999 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.099999999999994 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.209999999999994 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.120000000000005 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.299999999999997 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.140000000000001 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.420000000000002 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.329999999999998 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' ILE . . . . . 0.758 HD11 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 63.340000000000003 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' THR . . . . . 0.606 HG22 HG23 ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.049999999999997 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 73.129999999999995 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 72.109999999999999 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.140000000000001 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.464 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.120000000000005 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . 0.594 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.140000000000001 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' VAL . . . . . 0.41 HG23 HG23 ' B' ' 212' ' ' VAL . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 72.140000000000001 109.977 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 71.420000000000002 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.209999999999994 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.409999999999997 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.340000000000003 112.173 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 109.834 -0.432 . . . . 74.019999999999996 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.53 -140.39 6.69 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.232 -1.147 . . . . 60.25 110.232 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -85.37 -5.45 59.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.163 0.481 . . . . 60.439999999999998 112.002 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -83.87 107.0 15.99 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.524 -0.547 . . . . 74.200000000000003 109.524 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.61 89.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 121.864 0.84 . . . . 24.140000000000001 111.452 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -100.35 -16.93 17.48 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.329 -0.619 . . . . 72.540000000000006 109.329 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.68 123.38 31.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.379 -0.828 . . . . 71.099999999999994 110.449 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -146.75 166.89 25.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 106.24 -1.763 . . . . 65.230000000000004 106.24 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -70.45 106.52 3.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.778 -1.564 . . . . 64.420000000000002 106.778 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.5 p -72.35 85.95 1.11 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.939 0.876 . . . . 72.519999999999996 112.245 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 m -134.53 144.48 48.03 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.352 -1.721 . . . . 75.530000000000001 106.352 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.01 132.09 51.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.976 -0.75 . . . . 63.299999999999997 108.976 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.51 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 25.0 p -132.85 144.2 50.04 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 113.006 0.743 . . . . 74.030000000000001 113.006 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' B' ' 212' ' ' VAL . 58.7 mt -140.69 142.68 34.86 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 114.91 -1.041 . . . . 62.340000000000003 111.064 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 p -99.58 126.39 45.55 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.584 -0.735 . . . . 75.510000000000005 109.986 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.55 ' H ' ' HA2' ' A' ' 44' ' ' GLY . 11.5 t -148.88 151.26 34.39 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.261 -1.015 . . . . 74.120000000000005 108.261 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.416 HE22 ' HD3' ' B' ' 251' ' ' PRO . 95.8 mt-30 66.75 176.08 0.24 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.959 0.903 . . . . 74.409999999999997 112.617 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -149.98 14.32 0.81 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.091 -0.504 . . . . 52.210000000000001 111.457 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.23 139.68 42.13 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 110.135 -0.32 . . . . 74.129999999999995 110.135 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.66 140.4 62.03 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.871 1.714 . . . . 70.420000000000002 111.306 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.24 162.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -69.76 -38.35 76.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.987 -0.375 . . . . 42.020000000000003 109.987 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.23 135.69 7.15 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.255 -1.387 . . . . 74.319999999999993 107.255 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG23 HG22 ' A' ' 41' ' ' THR . 43.7 mm -67.29 102.32 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 N-CA-C 105.026 -2.213 . . . . 44.229999999999997 105.026 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -119.14 162.1 19.21 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 115.708 -0.678 . . . . 73.129999999999995 111.523 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.73 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 15.8 p -126.88 132.02 51.03 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.186 -0.915 . . . . 73.349999999999994 111.945 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.53 130.13 55.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.501 -1.296 . . . . 75.030000000000001 107.501 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m -108.34 124.87 51.01 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 108.669 -0.863 . . . . 70.019999999999996 108.669 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.757 HD13 HD11 ' B' ' 240' ' ' ILE . 83.4 mt -101.68 139.33 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.622 -1.251 . . . . 40.119999999999997 107.622 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.8 p -135.59 92.41 2.83 Favored 'General case' 0 C--N 1.255 -3.531 0 N-CA-C 108.337 -0.986 . . . . 75.319999999999993 108.337 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.36 125.38 45.81 Favored 'General case' 0 N--CA 1.407 -2.606 0 N-CA-C 106.943 -1.503 . . . . 74.400000000000006 106.943 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.61 -117.42 9.38 Favored Glycine 0 N--CA 1.432 -1.572 0 N-CA-C 109.608 -1.397 . . . . 71.329999999999998 109.608 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 m -116.7 22.34 12.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.465 -0.939 . . . . 54.109999999999999 108.465 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -111.94 129.27 56.23 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.116 -0.947 . . . . 75.049999999999997 110.554 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 50.0 mtp180 -107.71 146.58 31.9 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 107.72 -1.215 . . . . 64.450000000000003 107.72 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -140.76 147.78 39.65 Favored 'General case' 0 C--N 1.273 -2.733 0 C-N-CA 119.587 -0.845 . . . . 75.230000000000004 109.124 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.4 t -128.44 125.73 64.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.131 -1.062 . . . . 74.25 108.131 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.9 mt -116.38 120.38 64.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 116.45 -0.341 . . . . 71.319999999999993 110.198 -176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 35.8 m-85 -98.62 121.8 41.02 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 122.863 0.465 . . . . 73.530000000000001 109.902 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 8.4 mt -98.84 118.14 44.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.037 -1.468 . . . . 73.140000000000001 107.037 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.537 HG22 HG23 ' A' ' 24' ' ' ILE . 39.4 p -123.01 162.82 21.62 Favored 'General case' 0 N--CA 1.412 -2.339 0 C-N-CA 119.395 -0.922 . . . . 71.230000000000004 108.833 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -69.95 -3.78 17.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.378 0.881 . . . . 70.319999999999993 113.378 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.46 17.29 2.03 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.133 0.42 . . . . 75.209999999999994 112.133 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 16' ' ' THR . . . 173.74 171.44 38.21 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 118.97 -1.586 . . . . 34.439999999999998 113.916 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.499 HD13 HG22 ' B' ' 247' ' ' VAL . 73.9 mt -135.43 131.77 36.64 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 123.136 0.574 . . . . 72.120000000000005 110.005 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -116.78 123.02 46.12 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.426 -0.806 . . . . 74.25 109.236 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.54 116.26 51.26 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-O 121.979 0.895 . . . . 61.32 109.802 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -121.82 98.11 5.8 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.797 -0.638 . . . . 70.040000000000006 110.292 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 81.5 m -92.26 134.53 34.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.763 0.792 . . . . 63.399999999999999 111.863 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 52' ' ' GLN . 18.0 t70 -126.15 108.7 24.4 Favored Pre-proline 0 C--N 1.297 -1.704 0 C-N-CA 125.67 1.588 . . . . 63.420000000000002 110.403 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.89 29.96 0.49 Allowed 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 123.087 2.524 . . . . 64.209999999999994 110.006 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.491 ' HA ' ' HE1' ' A' ' 55' ' ' TRP 0.267 25.4 mt-30 70.75 75.22 0.19 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.252 1.821 . . . . 71.010000000000005 112.146 -176.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.29 -35.34 0.28 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.589 -1.187 . . . . 74.329999999999998 111.929 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.6 p -84.99 28.55 0.69 Allowed 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.929 0.492 . . . . 72.540000000000006 112.325 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.491 ' HE1' ' HA ' ' A' ' 52' ' ' GLN . 14.2 m95 -78.01 88.58 4.15 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.49 0.662 . . . . 73.319999999999993 111.594 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.96 150.86 17.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.742 -1.117 . . . . 73.329999999999998 108.076 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -101.67 97.39 7.81 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.854 0.835 . . . . 72.019999999999996 113.076 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -173.82 -171.63 0.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.928 -2.249 . . . . 54.240000000000002 104.928 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.5 t 74.18 -65.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.373 0.669 . . . . 64.099999999999994 109.466 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.2 t 55.27 83.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.615 1.166 . . . . 73.319999999999993 110.202 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -103.28 115.62 30.9 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.248 -0.887 . . . . 63.409999999999997 111.792 -175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.3 m -77.62 125.28 29.1 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.093 -1.817 . . . . 72.540000000000006 106.093 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.2 ttt -51.06 109.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.912 0.757 . . . . 72.299999999999997 112.369 -174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.78 129.9 41.38 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 106.741 -1.577 . . . . 74.109999999999999 106.741 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 65' ' ' ARG . 27.3 tpt180 -64.93 106.7 1.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.905 0.86 . . . . 75.219999999999999 112.889 -170.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt . . . . . 0 C--N 1.299 -1.619 0 CA-C-N 114.042 -1.435 . . . . 71.120000000000005 110.151 178.819 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . 0.643 ' N ' ' HZ3' ' B' ' 208' ' ' LYS . 60.2 t . . . . . 0 C--O 1.243 0.752 0 N-CA-C 109.509 -0.552 . . . . 70.0 109.509 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -162.65 -175.49 33.74 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.796 -0.922 . . . . 62.109999999999999 110.796 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 42.2 m -82.43 27.88 0.49 Allowed 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.632 0.729 . . . . 71.409999999999997 110.994 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -151.36 136.69 17.64 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.479 -0.934 . . . . 74.209999999999994 108.479 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.06 90.26 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 122.076 0.941 . . . . 64.099999999999994 110.292 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 50.4 m -141.85 -72.56 0.33 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.571 -0.74 . . . . 63.32 111.071 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -137.07 98.63 3.79 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.091 0.472 . . . . 72.400000000000006 111.099 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . 0.643 ' HZ3' ' N ' ' B' ' 201' ' ' VAL . 40.0 ttmt -95.0 -82.54 0.37 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.78 -1.563 . . . . 74.049999999999997 106.78 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.623 ' HB2' ' SG ' ' B' ' 211' ' ' CYS . 3.3 mpt_? -160.24 163.93 33.12 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 102.977 -2.972 . . . . 74.129999999999995 102.977 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 30.0 p -83.18 85.52 7.19 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.937 -1.105 . . . . 74.129999999999995 109.636 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' B' ' 209' ' ' ARG . 21.0 m -123.14 144.89 49.04 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.443 -1.318 . . . . 71.209999999999994 107.443 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.6 m -124.35 139.21 51.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 C-N-CA 120.153 -0.619 . . . . 72.219999999999999 109.694 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 37.4 p -122.78 117.91 26.77 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.32 0.581 . . . . 73.040000000000006 110.397 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.15 125.94 54.03 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.251 -0.886 . . . . 54.350000000000001 110.631 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.507 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 19.4 p -94.15 124.32 38.09 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 115.509 -0.769 . . . . 72.120000000000005 111.46 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.8 t -143.89 137.16 27.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.336 -0.847 . . . . 63.420000000000002 108.74 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 64.48 -177.59 0.17 Allowed 'General case' 0 C--O 1.239 0.502 0 O-C-N 124.212 0.945 . . . . 53.340000000000003 113.287 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -148.12 19.13 1.1 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.617 -1.174 . . . . 65.329999999999998 107.853 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' B' ' 220' ' ' PRO . 6.9 mp -83.79 138.39 40.61 Favored Pre-proline 0 N--CA 1.437 -1.106 0 CA-C-N 114.669 -1.15 . . . . 44.219999999999999 109.847 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 24.7 Cg_exo -64.4 141.16 73.25 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.179 1.919 . . . . 73.209999999999994 113.211 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.53 162.84 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 114.934 -1.03 . . . . 64.319999999999993 108.349 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 17.2 m -65.36 -40.96 94.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 123.464 0.478 . . . . 72.219999999999999 111.278 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.27 145.69 4.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.494 -2.039 . . . . 64.519999999999996 105.494 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 32.6 mm -71.57 97.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.55 -1.648 . . . . 70.439999999999998 106.55 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.45 155.45 20.57 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 110.944 -173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.5 p -120.29 130.7 54.58 Favored 'General case' 0 N--CA 1.425 -1.679 0 O-C-N 123.617 0.573 . . . . 71.329999999999998 111.549 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 74.9 m-85 -108.05 137.99 45.09 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.518 -0.765 . . . . 72.219999999999999 109.47 176.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 11.5 p -109.61 126.38 53.56 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.362 0.601 . . . . 65.540000000000006 111.711 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 70.8 mt -102.96 137.04 32.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 107.001 -1.481 . . . . 53.140000000000001 107.001 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 28.3 p -135.09 96.56 3.53 Favored 'General case' 0 C--N 1.266 -3.063 0 C-N-CA 123.244 0.618 . . . . 71.450000000000003 109.722 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.659 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -137.27 122.4 19.15 Favored 'General case' 0 C--O 1.2 -1.544 0 C-N-CA 119.538 -0.865 . . . . 65.239999999999995 109.386 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.85 99.74 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.225 -0.512 . . . . 44.549999999999997 113.142 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 44.9 m 67.12 19.08 10.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 111.089 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.659 ' HB3' ' O ' ' B' ' 231' ' ' GLU . 1.9 tm? -111.21 128.87 56.06 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.905 -0.776 . . . . 74.129999999999995 108.905 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 83.2 mtt180 -105.12 144.55 31.77 Favored 'General case' 0 C--O 1.189 -2.09 0 N-CA-C 109.046 -0.724 . . . . 64.340000000000003 109.046 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.6 t -139.73 135.1 32.79 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 108.516 -0.92 . . . . 72.439999999999998 108.516 175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.6 t -117.95 129.36 74.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.23 -0.655 . . . . 54.43 109.23 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.727 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.5 mp -117.39 118.77 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 O-C-N 123.221 0.325 . . . . 75.209999999999994 110.217 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.533 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 48.1 m-85 -95.74 116.48 28.94 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.937 -0.764 . . . . 72.439999999999998 108.937 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -97.09 117.66 42.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.888 -1.152 . . . . 75.140000000000001 107.888 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.535 HG22 HG23 ' B' ' 224' ' ' ILE . 27.6 p -121.25 166.33 14.16 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.572 -0.899 . . . . 71.230000000000004 108.572 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.86 1.82 11.75 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.054 0.761 . . . . 65.230000000000004 113.054 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.57 1.0 5.56 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 120.693 -0.403 . . . . 71.329999999999998 111.401 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 159.47 -176.57 36.23 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 119.932 -1.127 . . . . 63.509999999999998 112.851 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' B' ' 240' ' ' ILE . 5.5 mp -131.35 150.1 52.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.164 0.507 . . . . 75.439999999999998 111.577 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 34.4 ttmt -115.15 127.88 55.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.422 -1.325 . . . . 50.450000000000003 107.422 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.499 HG22 HD13 ' A' ' 45' ' ' LEU . 8.8 p -122.08 124.51 71.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 107.822 -1.177 . . . . 71.150000000000006 107.822 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 49.7 t -133.57 103.47 5.93 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 111.518 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 94.3 m -91.89 134.84 34.41 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.264 0.554 . . . . 74.510000000000005 110.525 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -135.41 117.43 12.31 Favored Pre-proline 0 C--N 1.311 -1.084 0 C-N-CA 123.869 0.867 . . . . 73.25 109.485 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' HE22 ' A' ' 17' ' ' GLN . 91.4 Cg_endo -83.13 36.21 0.6 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.561 2.841 . . . . 45.030000000000001 111.467 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 68.93 34.38 3.21 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.103 0.961 . . . . 72.239999999999995 109.352 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.93 73.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.742 -1.117 . . . . 63.409999999999997 111.553 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 19.4 m -78.28 -4.27 47.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.446 0.641 . . . . 71.120000000000005 110.208 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -77.99 89.5 4.15 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.105 0.955 . . . . 71.530000000000001 112.291 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.7 m -121.33 -174.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 106.672 -1.603 . . . . 72.409999999999997 106.672 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -92.56 79.83 4.85 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.113 -1.035 . . . . 65.239999999999995 110.524 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -100.27 142.07 32.25 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.708 -1.133 . . . . 64.0 108.796 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 68.7 t 72.31 -43.43 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 124.267 1.027 . . . . 62.530000000000001 112.805 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.22 95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.573 1.149 . . . . 71.030000000000001 110.271 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -83.83 148.61 26.9 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.512 -0.767 . . . . 71.329999999999998 111.341 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 70.6 m -152.7 114.97 4.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.436 -0.95 . . . . 51.020000000000003 108.436 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.6 ttt -81.59 131.63 35.28 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.053 0.454 . . . . 63.119999999999997 110.932 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.9 125.68 28.15 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.55 -0.75 . . . . 74.430000000000007 110.379 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -68.76 117.23 10.2 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.303 -0.862 . . . . 75.329999999999998 112.449 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.256 1.442 0 N-CA-C 107.446 -1.316 . . . . 75.319999999999993 107.446 173.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 108.809 -0.812 . . . . 63.409999999999997 108.809 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.86 -149.01 11.92 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.811 -0.709 . . . . 64.230000000000004 111.6 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.5 m -86.58 127.66 34.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.932 -0.766 . . . . 54.229999999999997 108.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.03 100.65 3.04 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.782 -0.451 . . . . 62.039999999999999 109.782 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.7 157.59 18.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.138 -1.06 . . . . 62.039999999999999 108.138 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 p -126.91 159.96 32.43 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.772 -0.455 . . . . 62.140000000000001 109.772 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -86.91 79.3 8.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 106.969 -1.493 . . . . 71.349999999999994 106.969 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -151.99 137.48 17.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.166 -0.925 . . . . 70.239999999999995 109.3 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -82.98 136.82 34.4 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.736 -0.839 . . . . 74.150000000000006 108.736 175.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -113.09 149.07 34.0 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 109.16 -0.682 . . . . 75.140000000000001 109.16 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.6 m -120.3 145.04 47.48 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.669 -1.234 . . . . 75.140000000000001 107.669 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.69 140.55 42.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.791 -0.818 . . . . 73.340000000000003 108.791 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 34.3 p -139.66 143.15 37.01 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HG ' HD21 ' B' ' 214' ' ' LEU . 73.7 mt -135.44 144.14 46.31 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.906 -0.588 . . . . 73.120000000000005 111.928 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.4 m -102.18 137.26 40.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.755 -0.831 . . . . 54.039999999999999 108.755 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -115.27 164.21 14.57 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.929 -0.397 . . . . 75.129999999999995 109.929 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 18' ' ' ARG . 14.3 mm-40 -62.66 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.833 1.049 . . . . 74.430000000000007 113.833 -174.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 17' ' ' GLN . 5.6 mpt_? -123.47 95.54 4.63 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 120.897 0.379 . . . . 73.209999999999994 110.673 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 64.2 tp -126.04 98.4 33.33 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.144 -0.48 . . . . 50.539999999999999 111.032 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.17 141.01 10.13 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.0 1.8 . . . . 70.010000000000005 110.249 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG11 HG22 ' A' ' 40' ' ' ILE . 33.3 m -132.69 159.54 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 109.48 -0.563 . . . . 64.420000000000002 109.48 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.542 ' HB2' ' OE1' ' B' ' 231' ' ' GLU . 20.6 m -83.53 -26.21 30.35 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.75 0.31 . . . . 60.310000000000002 110.709 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -164.25 160.64 21.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.269 -1.011 . . . . 75.409999999999997 108.269 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 HG22 ' A' ' 41' ' ' THR . 34.8 mm -87.91 100.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.289 -2.115 . . . . 64.519999999999996 105.289 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.679 ' HD3' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -117.55 154.42 31.53 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.247 -0.981 . . . . 62.140000000000001 110.401 -176.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 24.6 p -115.7 134.39 55.08 Favored 'General case' 0 N--CA 1.422 -1.866 0 O-C-N 123.954 0.784 . . . . 74.450000000000003 111.4 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -108.77 136.67 47.95 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.881 -1.155 . . . . 70.409999999999997 107.881 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.3 m -111.64 126.78 55.38 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 120.3 -0.56 . . . . 65.299999999999997 110.21 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.831 HD13 HD11 ' B' ' 240' ' ' ILE . 28.8 mt -103.02 140.12 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 107.298 -1.371 . . . . 75.040000000000006 107.298 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 42.5 p -133.59 88.2 2.46 Favored 'General case' 0 C--N 1.259 -3.34 0 N-CA-C 106.61 -1.626 . . . . 51.109999999999999 106.61 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 4.1 tp10 -140.35 106.59 5.25 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 114.277 -1.329 . . . . 75.420000000000002 110.887 -169.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.79 40.16 15.46 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.248 -0.887 . . . . 61.32 111.879 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.6 m 60.38 27.78 17.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 122.126 0.965 . . . . 62.240000000000002 108.987 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 2.1 tm? -119.83 127.24 52.58 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 113.971 -1.468 . . . . 71.409999999999997 108.598 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 99.0 mtt180 -105.71 113.27 26.73 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.277 -0.638 . . . . 74.540000000000006 109.277 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 3.4 t -112.0 147.08 36.71 Favored 'General case' 0 C--N 1.283 -2.326 0 C-N-CA 119.536 -0.866 . . . . 74.200000000000003 109.755 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -129.98 132.49 65.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.0 mt -116.8 120.9 66.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.887 -0.597 . . . . 64.510000000000005 109.401 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 49.5 m-85 -101.65 113.39 26.49 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.43 -0.581 . . . . 74.120000000000005 109.43 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.816 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -97.9 118.15 43.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 106.418 -1.697 . . . . 50.210000000000001 106.418 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 24' ' ' ILE . 29.8 p -121.87 171.2 9.08 Favored 'General case' 0 N--CA 1.421 -1.913 0 C-N-CA 119.186 -1.006 . . . . 75.519999999999996 110.176 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER -73.51 78.27 1.44 Allowed 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.368 -0.833 . . . . 72.519999999999996 112.344 173.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 19' ' ' LEU 0.317 61.2 mtt180 111.11 7.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.108 2.163 . . . . 64.099999999999994 114.8 171.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 154.06 25.67 Favored Glycine 0 C--N 1.297 -1.61 0 C-N-CA 119.754 -1.212 . . . . 73.430000000000007 111.59 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -130.59 129.2 42.45 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.334 0.588 . . . . 64.409999999999997 110.187 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 15.6 ttmm -119.97 125.67 48.97 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.332 -0.849 . . . . 75.129999999999995 108.941 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.4 127.47 75.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 121.267 0.556 . . . . 64.540000000000006 109.755 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.0 t -133.85 114.37 13.26 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.064 -0.397 . . . . 64.530000000000001 110.178 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.67 ' HB3' HD21 ' A' ' 34' ' ' LEU . 83.5 m -106.84 134.63 49.71 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.071 -0.652 . . . . 73.400000000000006 110.835 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -116.76 110.8 41.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 108.013 -1.106 . . . . 72.340000000000003 108.013 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.12 -4.12 13.62 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 123.568 2.845 . . . . 75.430000000000007 113.278 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 58.48 77.85 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.79 0.805 . . . . 72.450000000000003 110.909 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.45 -64.95 1.07 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.955 -1.02 . . . . 60.229999999999997 108.748 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.8 m -146.19 103.34 3.71 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.95 -0.568 . . . . 61.420000000000002 109.526 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 176.25 -27.93 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 124.072 0.857 . . . . 60.109999999999999 110.385 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.94 104.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.141 0.972 . . . . 74.239999999999995 113.166 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -132.93 92.06 2.98 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.043 -1.435 . . . . 75.439999999999998 107.636 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 59' ' ' VAL . 18.0 t70 66.19 -166.24 0.22 Allowed 'General case' 0 CA--C 1.557 1.24 0 N-CA-C 108.121 -1.066 . . . . 71.409999999999997 108.121 -176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 20.9 t 60.8 29.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 122.544 1.164 . . . . 70.420000000000002 108.189 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.89 115.94 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.044 -0.98 . . . . 73.239999999999995 111.63 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -137.67 110.51 7.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.188 -0.914 . . . . 74.299999999999997 109.325 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 m -145.78 135.2 23.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.828 -0.805 . . . . 64.040000000000006 108.828 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttm -83.09 94.62 7.85 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.059 -0.719 . . . . 74.519999999999996 109.059 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -137.49 111.07 8.05 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.926 -0.579 . . . . 75.530000000000001 110.062 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.92 93.81 2.6 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.534 -1.654 . . . . 73.310000000000002 106.534 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 115.764 -0.653 . . . . 74.230000000000004 109.531 -175.551 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.244 0.791 0 N-CA-C 109.719 -0.475 . . . . 64.120000000000005 109.719 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.86 -44.67 3.38 Favored Glycine 0 C--N 1.314 -0.68 0 N-CA-C 111.144 -0.782 . . . . 42.219999999999999 111.144 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 23.1 p -74.89 128.88 36.63 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 123.465 0.706 . . . . 62.210000000000001 109.828 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.45 115.6 23.17 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.315 -0.402 . . . . 61.299999999999997 110.684 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.2 m -86.52 143.95 10.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.167 -0.679 . . . . 65.450000000000003 109.167 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.8 p -97.57 125.56 42.36 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 120.175 -0.61 . . . . 73.420000000000002 111.259 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -91.03 -33.98 15.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.772 -1.936 . . . . 73.200000000000003 105.772 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.93 127.06 31.57 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 113.268 -1.787 . . . . 52.229999999999997 107.273 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.526 ' H ' ' NE ' ' B' ' 209' ' ' ARG . 0.1 OUTLIER -68.95 98.41 0.95 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.524 0.678 . . . . 74.510000000000005 110.467 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 31.2 p -88.41 120.47 29.81 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.555 -0.748 . . . . 45.130000000000003 110.71 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 45.3 m -121.18 144.92 48.33 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.377 -1.342 . . . . 74.329999999999998 107.377 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 25.2 m -98.96 136.26 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 119.166 -1.014 . . . . 64.200000000000003 110.283 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 58.7 p -127.38 133.09 50.05 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.997 0.427 . . . . 64.230000000000004 111.579 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.536 HD21 ' HG ' ' A' ' 14' ' ' LEU . 46.0 mt -119.79 144.68 47.17 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.669 -0.696 . . . . 75.439999999999998 111.599 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.0 m -109.41 139.07 44.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.61 -0.515 . . . . 74.450000000000003 109.61 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.4 t -123.36 165.76 16.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.579 -0.526 . . . . 74.109999999999999 109.579 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -55.87 159.72 3.04 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.319 0.648 . . . . 43.119999999999997 109.987 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.423 ' HD2' ' H ' ' B' ' 218' ' ' ARG . 9.3 mpt_? -51.37 105.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.421 0.451 . . . . 73.319999999999993 111.775 -174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 34' ' ' LEU . 65.6 tp -126.14 105.8 25.19 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 115.0 -1.0 . . . . 64.040000000000006 110.266 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.92 140.22 34.61 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.237 1.291 . . . . 65.439999999999998 111.418 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 33.7 m -129.87 163.32 35.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.273 -1.01 . . . . 75.420000000000002 108.273 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 13.5 m -77.6 -50.53 12.34 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.382 0.61 . . . . 61.329999999999998 110.473 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.76 150.8 39.13 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 109.778 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' B' ' 241' ' ' THR . 27.3 mm -82.86 109.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 105.417 -2.068 . . . . 71.019999999999996 105.417 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.624 ' HD3' HD12 ' B' ' 240' ' ' ILE . 0.0 OUTLIER -123.95 163.7 20.8 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 120.17 -0.612 . . . . 41.329999999999998 110.174 -176.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 37.8 p -116.38 136.31 53.1 Favored 'General case' 0 N--CA 1.407 -2.606 0 O-C-N 123.917 0.76 . . . . 74.049999999999997 110.274 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 77.3 m-85 -108.07 129.48 55.14 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.867 -1.16 . . . . 75.230000000000004 107.867 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 24.5 m -110.41 121.66 45.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 C-N-CA 119.985 -0.686 . . . . 72.129999999999995 110.021 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.816 HD13 HD11 ' A' ' 40' ' ' ILE . 70.1 mt -101.58 130.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 107.365 -1.346 . . . . 72.299999999999997 107.365 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 30.0 p -134.23 99.69 4.47 Favored 'General case' 0 C--N 1.251 -3.708 0 CA-C-N 115.485 -0.78 . . . . 74.439999999999998 109.008 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 22' ' ' SER . 0.7 OUTLIER -136.67 116.96 13.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.793 -0.763 . . . . 71.219999999999999 111.101 -176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 54.96 43.85 82.54 Favored Glycine 0 N--CA 1.461 0.354 0 CA-C-N 115.864 -0.607 . . . . 72.209999999999994 113.295 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 33.7 t 66.64 69.14 0.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.188 0.994 . . . . 52.140000000000001 110.252 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.732 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -159.87 125.05 4.02 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 106.437 -1.69 . . . . 75.549999999999997 106.437 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 67.7 mtm180 -118.17 114.32 22.87 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 120.245 -0.582 . . . . 74.129999999999995 110.036 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' B' ' 228' ' ' THR . 1.7 t -115.53 132.4 56.64 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.54 -0.541 . . . . 65.409999999999997 109.54 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 34.3 t -117.73 127.67 75.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.39 -0.596 . . . . 75.439999999999998 109.39 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' B' ' 226' ' ' THR . 4.4 mp -116.63 119.63 62.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 123.17 0.294 . . . . 64.209999999999994 110.516 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 53.3 m-85 -95.41 125.06 39.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.871 -0.788 . . . . 73.519999999999996 108.871 175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.831 HD11 HD13 ' A' ' 29' ' ' ILE . 7.2 mt -110.32 118.27 56.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.281 -1.007 . . . . 72.299999999999997 108.281 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.603 ' HA ' HD12 ' B' ' 224' ' ' ILE . 33.8 p -115.89 174.98 5.75 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 108.618 -0.882 . . . . 51.32 108.618 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 19.0 0.33 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 114.252 1.204 . . . . 43.409999999999997 114.252 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -160.3 -25.88 0.06 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.766 0.317 . . . . 65.329999999999998 111.471 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -143.32 158.03 27.13 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.082 -1.532 . . . . 70.129999999999995 113.185 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.7 140.09 53.26 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.889 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 20.0 ttmm -115.35 132.03 56.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.98 -1.118 . . . . 73.109999999999999 107.98 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.57 118.98 48.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-O 121.85 0.833 . . . . 74.329999999999998 109.911 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.8 t -126.43 104.96 8.44 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.874 -0.603 . . . . 62.32 110.961 -174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -96.35 135.0 38.8 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.005 0.431 . . . . 61.119999999999997 111.346 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -116.48 104.68 51.37 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 107.662 -1.236 . . . . 70.329999999999998 107.662 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.96 -8.92 23.85 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.634 2.889 . . . . 73.25 114.771 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 51.66 32.99 10.03 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.737 1.384 . . . . 74.439999999999998 114.737 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -77.03 -66.62 0.8 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.293 -0.563 . . . . 72.420000000000002 110.291 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 57.3 m -156.9 91.36 1.2 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.702 0.286 . . . . 53.530000000000001 110.594 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.12 17.74 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.66 -0.867 . . . . 74.510000000000005 108.66 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.27 101.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.537 1.16 . . . . 63.420000000000002 113.909 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -131.73 29.12 4.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.208 -1.36 . . . . 74.310000000000002 107.478 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 259' ' ' VAL . 18.7 t70 -136.74 -153.56 0.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 104.819 -2.289 . . . . 74.25 104.819 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.437 ' H ' ' CG ' ' B' ' 258' ' ' ASP . 48.7 t 71.2 61.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 122.966 1.365 . . . . 75.030000000000001 109.898 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.68 113.16 19.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.833 -1.531 . . . . 52.340000000000003 107.12 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -83.0 94.88 7.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.114 0.483 . . . . 65.5 109.835 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.9 m -84.35 94.9 8.58 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.775 -0.648 . . . . 64.409999999999997 110.355 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -87.29 70.42 10.04 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.618 -0.882 . . . . 72.040000000000006 108.618 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -143.57 93.15 2.44 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.676 -1.147 . . . . 64.409999999999997 110.881 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -118.03 92.75 3.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.447 -1.686 . . . . 72.140000000000001 106.447 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 105.744 -1.947 . . . . 75.120000000000005 105.744 -178.667 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.115 -0.698 . . . . 60.100000000000001 109.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.95 91.38 1.5 Allowed Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 108.96 -1.656 . . . . 72.530000000000001 108.96 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -71.56 95.63 1.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.983 0.735 . . . . 64.129999999999995 112.983 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.55 85.29 1.64 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.883 -1.053 . . . . 73.329999999999998 109.445 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 145.95 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.843 -0.617 . . . . 75.129999999999995 112.176 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -103.93 33.73 3.32 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.668 -1.234 . . . . 61.299999999999997 107.668 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.26 -55.68 12.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.547 -1.206 . . . . 51.439999999999998 110.854 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -102.95 -72.24 0.7 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.399 -0.593 . . . . 74.150000000000006 109.399 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -150.76 158.37 44.06 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.981 0.912 . . . . 71.340000000000003 108.989 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.3 p -97.15 85.64 3.75 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.236 -0.653 . . . . 63.539999999999999 109.236 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.0 m -125.32 144.25 50.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.176 -1.787 . . . . 42.310000000000002 106.176 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HB ' HD12 ' B' ' 214' ' ' LEU . 35.2 m -123.35 141.77 42.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 120.287 -0.565 . . . . 65.349999999999994 110.378 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -123.66 124.44 42.78 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.202 0.525 . . . . 62.229999999999997 110.58 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' B' ' 212' ' ' VAL . 84.7 mt -122.68 123.08 40.31 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.385 -0.825 . . . . 61.350000000000001 110.879 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.467 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 20.2 p -94.15 135.63 35.31 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 116.061 -0.518 . . . . 70.109999999999999 110.631 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -148.25 136.21 21.0 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 109.771 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 58.7 -171.62 0.11 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 124.095 0.958 . . . . 72.510000000000005 113.068 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -154.73 74.79 0.95 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.615 -0.72 . . . . 71.299999999999997 110.402 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.47 HD12 ' HD2' ' A' ' 20' ' ' PRO . 32.2 tp -127.71 122.32 22.49 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 105.826 -1.916 . . . . 74.5 105.826 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 19' ' ' LEU . 17.9 Cg_endo -60.25 140.52 92.47 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.307 1.338 . . . . 62.409999999999997 112.579 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -93.26 163.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.229 -0.896 . . . . 73.450000000000003 110.228 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.5 t -72.5 -27.57 62.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.549 -0.296 . . . . 51.109999999999999 110.869 -176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -162.1 158.59 24.99 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.144 -0.687 . . . . 62.32 109.144 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 41' ' ' THR . 44.0 mm -96.66 109.11 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 104.912 -2.255 . . . . 64.219999999999999 104.912 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -128.22 157.22 41.46 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.364 -0.606 . . . . 75.510000000000005 109.364 -173.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 12.4 p -117.04 133.61 55.79 Favored 'General case' 0 N--CA 1.415 -2.189 0 O-C-N 124.149 0.906 . . . . 63.0 111.527 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -108.81 130.91 55.4 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.825 -1.176 . . . . 71.230000000000004 107.825 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 16.0 m -108.59 122.04 46.24 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 107.709 -1.219 . . . . 63.43 107.709 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.754 HD13 HD11 ' B' ' 240' ' ' ILE . 70.9 mt -102.72 126.61 56.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.2 -1.037 . . . . 70.439999999999998 108.2 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.7 p -135.87 95.8 3.29 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.553 -0.749 . . . . 64.140000000000001 110.3 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.54 110.14 16.11 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.727 0.775 . . . . 72.310000000000002 111.993 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.65 -82.87 0.92 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.32 -1.112 . . . . 64.150000000000006 110.32 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.3 m -149.54 80.87 1.4 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.939 -1.134 . . . . 65.129999999999995 107.939 175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.6 tp -159.85 136.34 9.02 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.481 -0.933 . . . . 71.040000000000006 108.481 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -120.8 113.24 19.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.572 -0.529 . . . . 73.230000000000004 109.572 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 28' ' ' THR . 3.3 t -121.01 141.42 50.75 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.55 -0.86 . . . . 73.400000000000006 109.501 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -128.08 126.04 65.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.905 -0.776 . . . . 75.209999999999994 108.905 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 64.0 mt -117.98 118.73 59.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 116.534 -0.303 . . . . 65.200000000000003 111.338 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.6 m-85 -96.08 107.27 19.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.11 174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 229' ' ' ILE . 3.1 mt -95.5 117.58 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 N-CA-C 106.643 -1.614 . . . . 74.129999999999995 106.643 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.563 ' HA ' HD12 ' A' ' 24' ' ' ILE . 71.8 p -114.26 178.57 4.24 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 120.147 -0.621 . . . . 75.349999999999994 109.972 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 20' ' ' PRO 0.251 0.0 OUTLIER -69.78 -10.4 58.24 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 115.806 1.78 . . . . 42.240000000000002 115.806 -176.949 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -138.59 16.02 2.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 113.023 0.749 . . . . 71.120000000000005 113.023 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 168.46 175.01 37.7 Favored Glycine 0 CA--C 1.475 -2.43 0 C-N-CA 118.243 -1.932 . . . . 74.019999999999996 112.935 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -128.76 144.32 51.14 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.57 0.7 . . . . 74.540000000000006 111.424 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 53.0 tttt -115.06 121.09 41.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.441 -1.254 . . . . 63.420000000000002 107.929 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.499 HG23 HG12 ' A' ' 38' ' ' ILE . 7.5 p -124.88 133.67 68.86 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 116.015 -0.539 . . . . 61.399999999999999 110.069 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 t -136.97 100.35 4.27 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.36 -0.536 . . . . 63.329999999999998 109.833 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.8 m -97.53 134.1 41.21 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.583 -0.447 . . . . 74.0 110.097 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.3 123.26 15.39 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.531 -0.914 . . . . 70.319999999999993 108.531 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HG2' HD23 ' B' ' 219' ' ' LEU . 26.9 Cg_exo -63.91 2.21 1.15 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 124.171 3.247 . . . . 73.049999999999997 115.045 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 49.94 27.06 2.23 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 125.342 1.457 . . . . 73.099999999999994 112.894 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.4 -36.46 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.532 -0.758 . . . . 64.239999999999995 111.334 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.9 m -120.16 10.15 11.3 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.708 0.766 . . . . 65.540000000000006 109.8 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -128.51 95.03 4.02 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.771 0.656 . . . . 73.25 112.771 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t 61.61 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 115.092 1.515 . . . . 74.319999999999993 115.092 172.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -76.32 99.47 4.81 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.931 -0.577 . . . . 74.140000000000001 111.222 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -158.11 110.62 2.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.322 -0.992 . . . . 75.420000000000002 108.322 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.84 -37.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-O 120.823 0.344 . . . . 55.450000000000003 110.696 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.48 145.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 108.923 -0.769 . . . . 54.140000000000001 108.923 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.438 ' NH2' HG21 ' A' ' 30' ' ' THR . 68.6 mtt180 -129.63 118.23 21.64 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.605 -0.271 . . . . 73.420000000000002 110.453 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 m -84.8 74.31 10.49 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 122.207 1.003 . . . . 71.329999999999998 108.679 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.24 101.25 3.48 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.17 -1.789 . . . . 72.319999999999993 106.17 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.16 148.22 46.45 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.697 -1.594 . . . . 72.25 106.697 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 71.02 99.55 0.06 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.954 0.784 . . . . 64.049999999999997 110.342 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 C--N 1.308 -1.227 0 CA-C-N 115.911 -0.586 . . . . 74.239999999999995 110.02 178.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.081 0.467 . . . . 72.230000000000004 109.782 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.45 165.99 16.03 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 110.446 -1.062 . . . . 64.040000000000006 110.446 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 21.8 m 57.75 81.53 0.14 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.397 0.679 . . . . 72.129999999999995 109.902 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.44 84.57 7.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.336 1.065 . . . . 73.030000000000001 113.539 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.3 m -101.7 129.03 53.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 114.526 -1.215 . . . . 75.319999999999993 108.025 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -79.62 122.9 27.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.527 0.68 . . . . 54.420000000000002 111.701 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.71 173.0 13.04 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.838 -1.541 . . . . 74.319999999999993 106.838 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -66.75 -33.29 75.3 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.225 -1.028 . . . . 74.120000000000005 108.225 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -112.23 97.23 6.5 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 115.346 -0.843 . . . . 72.319999999999993 108.854 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 47.5 p -81.23 101.96 10.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.86 -0.793 . . . . 75.099999999999994 108.86 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 28.5 m -121.27 147.37 45.73 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 109.997 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 14' ' ' LEU . 28.0 m -113.35 132.12 63.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 27.1 p -141.39 135.79 30.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.538 0.94 . . . . 64.430000000000007 113.538 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.432 HD12 ' HB ' ' A' ' 12' ' ' VAL . 66.6 mt -132.74 144.57 50.37 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.203 -0.908 . . . . 73.540000000000006 111.988 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 21.0 p -97.82 132.09 43.74 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.484 -0.78 . . . . 61.299999999999997 110.113 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 140.5 24.61 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.067 -0.716 . . . . 71.329999999999998 109.067 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 64.5 178.64 0.18 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 75.530000000000001 111.976 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -146.83 13.59 1.16 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.584 0.706 . . . . 74.239999999999995 109.181 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 51' ' ' PRO . 33.3 tp -88.83 110.52 38.14 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 107.804 -1.184 . . . . 70.019999999999996 107.804 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 57.8 Cg_exo -54.19 141.48 69.8 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.568 2.845 . . . . 74.349999999999994 116.363 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 31.8 m -89.24 163.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 113.492 -1.685 . . . . 75.510000000000005 109.022 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -65.81 -29.86 70.4 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 112.086 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -163.92 161.19 22.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.711 -0.477 . . . . 71.340000000000003 109.711 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 38.0 mm -95.94 114.9 33.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 104.796 -2.298 . . . . 64.519999999999996 104.796 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.612 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -136.34 158.19 45.01 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.84 -0.744 . . . . 52.130000000000003 109.846 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.769 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 8.8 p -118.48 131.39 56.25 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 124.808 1.317 . . . . 73.299999999999997 111.579 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' B' ' 238' ' ' ILE . 95.7 m-85 -111.75 141.33 45.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.457 -0.792 . . . . 74.239999999999995 108.938 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 3.9 p -109.14 121.17 44.57 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 111.028 176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 40' ' ' ILE . 89.4 mt -102.37 129.11 54.35 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.178 0 N-CA-C 107.332 -1.358 . . . . 62.140000000000001 107.332 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.3 p -134.74 86.36 2.25 Favored 'General case' 0 C--N 1.256 -3.493 0 CA-C-O 121.384 0.611 . . . . 63.229999999999997 109.508 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.78 52.78 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 108.71 -0.848 . . . . 73.230000000000004 108.71 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.84 -88.08 0.04 OUTLIER Glycine 0 C--O 1.237 0.321 0 O-C-N 123.89 0.744 . . . . 72.129999999999995 111.577 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 61.5 m -149.99 71.46 1.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.406 -0.961 . . . . 32.340000000000003 108.406 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.814 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -160.19 131.13 5.67 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.053 -0.976 . . . . 72.540000000000006 108.648 -177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' B' ' 258' ' ' ASP . 91.2 mtt180 -104.78 143.64 32.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 107.47 -1.307 . . . . 72.430000000000007 107.47 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.7 OUTLIER -141.14 141.63 34.14 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 109.114 -0.698 . . . . 65.030000000000001 109.114 172.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.6 t -122.19 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.582 -1.266 . . . . 63.409999999999997 107.582 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' B' ' 226' ' ' THR . 57.1 mt -116.54 118.28 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.664 -0.495 . . . . 52.130000000000003 109.664 -175.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.669 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 49.2 m-85 -101.74 106.44 17.45 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.976 -0.75 . . . . 74.420000000000002 108.976 175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 29' ' ' ILE . 5.0 mt -96.27 117.38 40.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 106.167 -1.79 . . . . 62.329999999999998 106.167 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.525 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 64.6 p -117.02 175.1 5.74 Favored 'General case' 0 N--CA 1.42 -1.932 0 C-N-CA 119.326 -0.95 . . . . 72.340000000000003 109.825 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 220' ' ' PRO 0.255 0.0 OUTLIER -83.5 2.21 38.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 114.457 1.281 . . . . 74.340000000000003 114.457 -177.258 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -137.9 4.28 2.52 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 112.564 0.579 . . . . 72.109999999999999 112.564 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -179.76 177.2 48.03 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 118.517 -1.801 . . . . 73.329999999999998 113.847 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 59.4 mt -131.03 126.65 36.47 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.75 0.785 . . . . 72.049999999999997 110.027 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 69.7 tttt -115.32 122.55 46.25 Favored 'General case' 0 C--N 1.255 -3.5 0 CA-C-N 114.316 -1.311 . . . . 73.030000000000001 109.603 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 45' ' ' LEU . 14.9 p -125.92 135.42 63.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 109.22 -0.659 . . . . 74.409999999999997 109.22 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.4 t -136.49 101.03 4.52 Favored 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.834 -0.747 . . . . 42.310000000000002 110.86 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 56.5 m -94.22 134.21 36.92 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.646 0.736 . . . . 70.340000000000003 111.083 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -130.35 115.94 17.45 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 106.798 -1.556 . . . . 65.329999999999998 106.798 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -70.62 -4.48 14.7 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 114.912 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' B' ' 255' ' ' TRP . 12.2 pt20 52.86 1.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.969 1.841 . . . . 70.349999999999994 115.969 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -65.53 -55.15 19.37 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.108 0.48 . . . . 73.299999999999997 110.267 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 7.7 m -107.32 15.52 24.91 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.95 0.881 . . . . 43.520000000000003 108.664 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.495 ' HB2' ' HA ' ' B' ' 252' ' ' GLN . 67.4 m95 -126.62 22.8 6.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.996 -0.547 . . . . 75.120000000000005 111.535 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 77.1 t 78.42 119.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.908 0.883 . . . . 75.310000000000002 112.272 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -70.53 118.98 14.02 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.565 -0.743 . . . . 73.430000000000007 109.719 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.502 ' HB2' ' CZ ' ' B' ' 235' ' ' ARG . 28.6 t70 -86.69 73.48 10.02 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.92 0.867 . . . . 71.329999999999998 109.921 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.1 p -101.9 -28.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.682 -1.145 . . . . 63.100000000000001 108.498 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 18.2 m -88.92 87.28 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-N 114.87 -1.059 . . . . 60.299999999999997 109.585 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -118.9 104.17 10.28 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.486 -1.233 . . . . 53.0 107.734 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.8 m -76.76 72.93 3.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.908 0.861 . . . . 73.150000000000006 112.094 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.19 90.78 0.98 Allowed 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 107.116 -1.439 . . . . 75.140000000000001 107.116 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' B' ' 265' ' ' ARG . 23.8 t70 -146.29 95.3 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 103.712 -2.699 . . . . 74.310000000000002 103.712 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' B' ' 264' ' ' ASP . 70.0 ttt180 75.76 136.2 0.06 Allowed 'General case' 0 C--O 1.238 0.478 0 O-C-N 124.64 1.213 . . . . 74.519999999999996 107.863 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp . . . . . 0 C--O 1.254 1.341 0 C-N-CA 120.259 -0.576 . . . . 64.510000000000005 109.691 -179.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 110.124 -0.325 . . . . 62.530000000000001 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.15 35.34 1.12 Allowed Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.766 -0.731 . . . . 61.25 112.506 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.1 m -91.69 -42.34 10.22 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.315 0.579 . . . . 62.149999999999999 110.191 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.93 107.14 8.5 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 121.645 0.736 . . . . 53.149999999999999 110.71 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -172.87 -45.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.945 -1.025 . . . . 51.43 108.933 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.4 p -128.38 157.04 42.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.724 -0.843 . . . . 65.209999999999994 108.724 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.49 120.41 24.98 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.751 -0.833 . . . . 73.409999999999997 108.751 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -104.13 105.02 15.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 121.293 0.568 . . . . 70.329999999999998 110.464 -175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -94.52 128.99 41.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.229 -2.137 . . . . 75.439999999999998 105.229 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 m -92.11 94.6 9.31 Favored 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.457 -0.897 . . . . 52.229999999999997 110.541 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.91 144.67 48.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.139 -1.06 . . . . 65.299999999999997 108.139 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.37 149.88 34.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 O-C-N 122.153 -0.342 . . . . 74.209999999999994 110.169 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -132.33 132.6 43.09 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 120.078 -0.649 . . . . 41.399999999999999 111.953 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.48 HD11 ' HG ' ' B' ' 214' ' ' LEU . 53.4 mt -114.32 121.05 42.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.401 -0.818 . . . . 51.43 110.088 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 p -94.0 116.12 28.53 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 115.853 -0.612 . . . . 63.310000000000002 110.113 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.0 t -147.53 150.56 34.75 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 108.293 -1.003 . . . . 63.100000000000001 108.293 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 69.14 -179.98 0.24 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.594 0.758 . . . . 64.209999999999994 111.141 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -153.9 21.83 0.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.835 -0.62 . . . . 53.229999999999997 109.391 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.14 138.77 21.58 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.942 -0.572 . . . . 72.439999999999998 110.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.39 141.41 81.19 Favored 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 122.658 2.239 . . . . 70.25 113.094 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.02 159.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 37.9 t -81.77 94.4 7.01 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.766 -0.827 . . . . 71.519999999999996 108.766 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 22' ' ' SER . 15.0 ptt180 61.03 161.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 127.638 2.375 . . . . 64.340000000000003 113.298 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 30.4 mm -79.75 103.98 7.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 104.614 -2.365 . . . . 63.020000000000003 104.614 172.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 14.9 ptpt -106.14 153.62 21.84 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.348 -0.387 . . . . 64.150000000000006 110.506 -173.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.2 p -116.06 129.63 56.44 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 112.9 0.704 . . . . 73.549999999999997 112.9 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -111.68 137.96 48.88 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.036 -1.098 . . . . 75.120000000000005 108.036 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 12.4 m -112.31 127.85 56.11 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 109.344 -0.613 . . . . 51.299999999999997 109.344 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 83.3 mt -103.63 132.01 50.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.462 -0.94 . . . . 54.329999999999998 108.462 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.5 p -134.33 108.29 8.11 Favored 'General case' 0 C--N 1.262 -3.237 0 N-CA-C 108.712 -0.848 . . . . 62.240000000000002 108.712 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.72 123.8 20.32 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.887 -0.725 . . . . 74.430000000000007 110.23 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.04 -83.34 0.17 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.14 -0.482 . . . . 62.210000000000001 112.555 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 m -148.08 20.0 1.11 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.526 -0.916 . . . . 72.400000000000006 108.526 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.9 tm? -111.48 131.43 55.23 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.285 -0.871 . . . . 65.299999999999997 109.783 -174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -114.42 140.77 48.42 Favored 'General case' 0 C--O 1.192 -1.923 0 N-CA-C 108.602 -0.888 . . . . 71.349999999999994 108.602 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -139.94 145.42 37.89 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 119.719 -0.792 . . . . 74.25 109.448 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -126.42 130.46 71.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.905 -1.146 . . . . 70.420000000000002 107.905 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 26' ' ' THR . 62.9 mt -116.5 119.06 60.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 116.163 -0.471 . . . . 55.520000000000003 109.986 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.556 ' CD1' ' HD2' ' A' ' 46' ' ' LYS . 40.5 m-85 -100.61 110.74 22.9 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.736 -0.839 . . . . 74.510000000000005 108.736 174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.713 HD11 HD13 ' B' ' 229' ' ' ILE . 6.2 mt -92.15 118.33 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 107.764 -1.199 . . . . 74.230000000000004 107.764 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 35.1 p -113.19 163.03 15.28 Favored 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 109.025 -0.731 . . . . 71.25 109.025 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HE2' ' HG3' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -67.58 -2.22 6.32 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 114.426 1.269 . . . . 64.430000000000007 114.426 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.456 ' HG3' ' HE2' ' A' ' 42' ' ' LYS . 31.4 mtp85 -131.19 23.81 4.86 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 112.153 0.427 . . . . 75.219999999999999 112.153 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.1 -169.87 24.3 Favored Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 119.547 -1.311 . . . . 61.25 112.34 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 HG21 ' B' ' 247' ' ' VAL . 5.3 mp -123.95 144.59 49.7 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.814 -0.754 . . . . 64.129999999999995 111.394 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HD2' ' CD1' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -114.84 120.84 41.36 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.023 -1.843 . . . . 71.310000000000002 106.023 175.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG21 HD22 ' B' ' 245' ' ' LEU . 13.7 p -127.39 136.02 61.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-O 121.25 0.547 . . . . 64.310000000000002 110.962 -173.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 t -133.43 107.76 8.26 Favored 'General case' 0 N--CA 1.423 -1.805 0 C-N-CA 120.589 -0.444 . . . . 61.130000000000003 110.634 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.566 ' SG ' HD21 ' B' ' 245' ' ' LEU . 68.8 m -99.06 135.99 39.68 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.197 0.522 . . . . 74.349999999999994 110.242 175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -136.95 115.35 10.23 Favored Pre-proline 0 N--CA 1.423 -1.804 0 N-CA-C 108.868 -0.79 . . . . 75.209999999999994 108.868 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 73.9 Cg_endo -77.77 20.85 0.68 Allowed 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.491 2.794 . . . . 74.230000000000004 112.491 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 73.86 -51.67 0.69 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.577 1.551 . . . . 73.200000000000003 112.321 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 55.77 25.26 8.15 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.075 0.95 . . . . 61.149999999999999 110.825 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.3 m 74.93 8.53 4.13 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 124.793 1.237 . . . . 74.230000000000004 112.623 177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -67.1 -29.79 69.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.262 0.553 . . . . 74.230000000000004 110.607 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.82 150.47 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.816 -0.809 . . . . 70.340000000000003 108.816 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -67.64 144.37 55.56 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.512 0.508 . . . . 73.239999999999995 109.637 175.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -71.06 100.75 2.07 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.645 0.736 . . . . 72.430000000000007 110.582 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.56 -16.52 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.291 -0.633 . . . . 64.409999999999997 109.291 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.53 101.85 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.812 -0.81 . . . . 42.020000000000003 108.812 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 66.23 88.61 0.11 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 107.454 -1.313 . . . . 75.420000000000002 107.454 -171.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.9 p -102.76 9.78 38.88 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.727 -0.67 . . . . 52.229999999999997 111.651 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.59 98.37 0.07 Allowed 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 124.595 1.158 . . . . 72.319999999999993 112.934 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -131.45 158.67 40.23 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 104.931 -2.248 . . . . 73.219999999999999 104.931 173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -69.21 -23.05 63.85 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.363 -0.535 . . . . 70.329999999999998 111.255 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 110.129 -0.322 . . . . 62.43 110.129 179.616 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.241 0.643 0 N-CA-C 110.232 -0.284 . . . . 55.009999999999998 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 140.27 125.57 2.2 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.171 -1.172 . . . . 61.340000000000003 110.171 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.6 m -60.75 -36.63 79.38 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.777 0.431 . . . . 75.430000000000007 111.242 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.67 153.69 42.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 113.153 0.797 . . . . 61.310000000000002 113.153 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.3 -3.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.894 -1.15 . . . . 51.310000000000002 107.894 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.2 p -159.77 166.68 29.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.023 -1.103 . . . . 75.219999999999999 108.023 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.66 86.21 6.88 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.342 1.067 . . . . 63.119999999999997 108.238 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . 0.501 ' HD2' ' O ' ' B' ' 209' ' ' ARG . 2.1 tmmm? -81.62 120.54 25.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.112 -1.858 . . . . 75.310000000000002 108.044 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.501 ' O ' ' HD2' ' B' ' 208' ' ' LYS . 27.6 mmm180 -77.54 140.17 39.69 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.727 -1.212 . . . . 72.049999999999997 107.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 m -71.38 116.84 12.18 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.162 1.171 . . . . 72.129999999999995 114.162 -168.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 34.6 m -123.56 144.7 49.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.497 -1.297 . . . . 73.140000000000001 107.497 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.61 142.01 42.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.226 -0.657 . . . . 50.039999999999999 109.226 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 8.9 p -143.46 136.87 28.14 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.148 0.795 . . . . 53.130000000000003 113.148 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HG ' HD11 ' A' ' 14' ' ' LEU . 65.5 mt -125.51 143.47 50.99 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 121.13 0.49 . . . . 64.329999999999998 112.166 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.456 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 25.4 p -102.13 127.62 48.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.304 -0.862 . . . . 75.010000000000005 109.397 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -147.92 140.19 24.32 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.466 -0.568 . . . . 71.400000000000006 109.466 -175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 66.47 -179.74 0.21 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.18 0.992 . . . . 63.520000000000003 112.125 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -142.01 19.52 2.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.711 -0.677 . . . . 74.25 110.036 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -92.04 121.73 66.3 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.68 -0.691 . . . . 75.340000000000003 109.412 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.95 141.62 54.1 Favored 'Trans proline' 0 C--O 1.244 0.78 0 C-N-CA 122.82 2.346 . . . . 64.129999999999995 114.812 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.31 165.25 2.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.117 -1.401 . . . . 74.420000000000002 109.267 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.4 t -58.88 -44.27 91.09 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 117.573 0.169 . . . . 62.240000000000002 111.189 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.03 -179.09 6.85 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.985 -0.746 . . . . 74.310000000000002 108.985 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' B' ' 241' ' ' THR . 30.8 mm -94.82 124.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.033 -2.21 . . . . 74.120000000000005 105.033 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -138.9 154.79 48.4 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.045 -0.724 . . . . 73.140000000000001 109.045 -177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.0 p -115.45 130.95 57.05 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 124.025 0.828 . . . . 75.120000000000005 112.428 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -109.46 136.9 48.13 Favored 'General case' 0 CA--C 1.485 -1.519 0 CA-C-N 115.622 -0.717 . . . . 71.420000000000002 109.825 175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.1 p -108.59 126.72 53.26 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.063 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 40' ' ' ILE . 93.8 mt -102.32 129.72 53.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.81 -1.552 . . . . 54.009999999999998 106.81 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.9 p -133.56 91.45 2.85 Favored 'General case' 0 C--N 1.248 -3.845 0 N-CA-C 108.734 -0.839 . . . . 64.010000000000005 108.734 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.54 126.08 41.53 Favored 'General case' 0 N--CA 1.411 -2.392 0 C-N-CA 119.499 -0.88 . . . . 74.340000000000003 110.162 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 68.36 -89.7 0.22 Allowed Glycine 0 C--N 1.321 -0.301 0 N-CA-C 111.6 -0.6 . . . . 54.340000000000003 111.6 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m -141.46 19.09 2.21 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.027 . . . . 61.420000000000002 108.226 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -110.89 125.55 53.76 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.255 -0.884 . . . . 72.109999999999999 110.343 -172.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 82.8 mtt180 -105.96 141.86 36.65 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.375 -0.972 . . . . 64.430000000000007 108.375 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.8 t -139.93 146.87 39.75 Favored 'General case' 0 C--N 1.273 -2.744 0 C-N-CA 119.552 -0.859 . . . . 63.210000000000001 109.247 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.42 125.47 63.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.508 -1.293 . . . . 74.420000000000002 107.508 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' B' ' 226' ' ' THR . 62.5 mt -117.03 118.42 58.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.58 -0.282 . . . . 73.340000000000003 110.725 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 61.1 m-85 -98.29 106.82 19.16 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.055 0.942 . . . . 75.230000000000004 108.857 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 2.8 mt -95.32 117.95 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 106.295 -1.742 . . . . 75.099999999999994 106.295 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.508 ' HA ' HD12 ' B' ' 224' ' ' ILE . 52.3 p -110.32 175.41 5.44 Favored 'General case' 0 N--CA 1.415 -2.218 0 C-N-CA 119.547 -0.861 . . . . 65.109999999999999 110.332 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.02 -2.37 20.86 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.797 1.406 . . . . 62.219999999999999 114.797 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -146.21 25.95 1.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.22 0.452 . . . . 74.209999999999994 112.22 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 158.68 179.31 33.44 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 118.346 -1.883 . . . . 72.420000000000002 113.013 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.566 HD21 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -129.99 140.98 50.81 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.819 0.819 . . . . 64.230000000000004 111.831 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 44.1 tttp -117.51 121.15 40.22 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 114.15 -1.387 . . . . 43.109999999999999 108.838 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.466 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -119.8 134.74 62.38 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.848 0 CA-C-O 121.591 0.71 . . . . 53.32 110.456 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 34.6 t -135.05 97.92 3.86 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 120.374 -0.531 . . . . 70.129999999999995 109.883 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.9 m -96.56 134.5 39.71 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.476 0.655 . . . . 73.349999999999994 110.833 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.86 110.22 22.22 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.132 -1.062 . . . . 73.420000000000002 108.132 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 85.9 Cg_endo -80.19 6.11 5.56 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 123.453 2.769 . . . . 54.009999999999998 113.208 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 58.76 -83.7 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.866 1.266 . . . . 63.25 112.777 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 52.13 84.24 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.943 1.297 . . . . 74.420000000000002 112.929 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 39.7 m 72.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.262 1.025 . . . . 73.430000000000007 112.982 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -50.01 -49.44 50.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 73.150000000000006 112.021 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.23 135.09 59.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.927 -0.768 . . . . 70.319999999999993 108.927 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -99.8 158.07 16.06 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.09 -1.078 . . . . 71.010000000000005 108.09 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -126.63 144.66 50.84 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.078 -0.649 . . . . 75.540000000000006 112.229 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.9 p 51.82 17.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.14 2.176 . . . . 64.430000000000007 113.907 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.7 p -82.67 105.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 122.002 0.906 . . . . 72.329999999999998 109.949 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -122.89 94.44 4.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.286 -0.87 . . . . 72.200000000000003 111.492 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 58.0 p -147.98 94.01 2.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.314 -0.857 . . . . 71.540000000000006 109.177 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.03 102.82 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.43 0.633 . . . . 53.299999999999997 109.974 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -137.56 165.04 27.27 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.775 -1.194 . . . . 73.299999999999997 107.775 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -65.77 -23.19 66.66 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.366 0.506 . . . . 74.109999999999999 112.366 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.872 -0.585 . . . . 74.310000000000002 109.635 177.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.242 0.672 0 CA-C-O 120.575 0.226 . . . . 63.520000000000003 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.08 1.71 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.028 -1.229 . . . . 64.120000000000005 110.028 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -146.98 77.74 1.47 Allowed 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.605 0.717 . . . . 54.299999999999997 110.621 175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.87 112.84 26.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.093 -1.447 . . . . 72.310000000000002 107.093 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.1 m -67.85 146.81 12.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 115.136 1.532 . . . . 60.439999999999998 115.136 -171.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 t -158.71 156.97 30.87 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.37 -2.455 . . . . 70.010000000000005 104.37 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -93.61 -169.68 2.17 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.562 -1.255 . . . . 72.219999999999999 108.04 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HE2' HG23 ' A' ' 54' ' ' THR . 33.3 mtmm -82.21 -43.55 17.5 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.52 -0.919 . . . . 64.299999999999997 108.52 -178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.594 ' HD3' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -97.53 134.54 40.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.094 -1.076 . . . . 70.120000000000005 108.094 176.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' HB ' ' OG1' ' B' ' 216' ' ' THR . 40.1 p -100.51 114.54 28.24 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.572 -0.451 . . . . 72.010000000000005 110.895 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 14.1 m -120.92 143.96 48.69 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.024 -1.102 . . . . 64.209999999999994 108.024 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 30.0 m -140.81 154.5 21.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.897 -0.408 . . . . 71.349999999999994 109.897 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.4 p -131.78 126.34 34.15 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.361 -0.212 . . . . 73.329999999999998 111.122 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 57.4 mt -120.96 122.36 39.99 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.146 0.578 . . . . 61.530000000000001 111.641 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 43' ' ' ARG . 55.2 m -94.82 131.5 40.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.413 -0.358 . . . . 64.209999999999994 110.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -147.57 142.1 26.5 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 108.722 -0.844 . . . . 74.310000000000002 108.722 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.66 171.58 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.79 0.805 . . . . 75.540000000000006 112.999 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.4 ptp180 -130.24 11.14 5.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.706 -0.679 . . . . 74.420000000000002 109.539 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.52 127.5 67.88 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 115.309 -0.86 . . . . 73.049999999999997 109.923 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.7 140.77 82.55 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.22 1.946 . . . . 70.200000000000003 112.545 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -94.45 164.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.25 -0.886 . . . . 64.109999999999999 110.935 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 t -53.28 -43.04 67.16 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.767 0.827 . . . . 73.409999999999997 111.252 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -171.1 171.94 5.58 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 106.103 -1.814 . . . . 75.219999999999999 106.103 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 41' ' ' THR . 35.1 mm -88.81 118.84 34.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 105.629 -1.989 . . . . 74.219999999999999 105.629 172.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.777 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.72 150.71 51.51 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.282 -1.007 . . . . 71.310000000000002 108.282 -174.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 1.7 p -119.15 133.04 56.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 123.949 0.781 . . . . 52.0 112.394 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -108.23 134.37 51.17 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.185 -0.916 . . . . 73.140000000000001 108.629 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 17.7 p -109.2 124.46 50.89 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.358 0.599 . . . . 70.230000000000004 110.809 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 82.5 mt -102.11 128.64 54.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.714 -1.217 . . . . 73.010000000000005 107.714 177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.779 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 49.0 p -134.07 88.87 2.5 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 115.82 -0.627 . . . . 65.019999999999996 109.726 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 42.2 mm-40 -116.2 99.41 7.2 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.206 -0.598 . . . . 74.120000000000005 110.638 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.43 68.44 1.69 Allowed Glycine 0 C--O 1.244 0.754 0 O-C-N 123.66 0.6 . . . . 73.019999999999996 112.964 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.564 ' HA ' ' NE2' ' A' ' 52' ' ' GLN . 38.6 m 62.47 69.76 0.59 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.63 0.729 . . . . 64.239999999999995 110.925 -177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.7 tm? -159.88 132.37 6.52 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.402 -1.332 . . . . 71.420000000000002 107.402 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.91 112.87 18.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.783 -0.451 . . . . 72.209999999999994 109.783 174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.8 t -118.72 133.47 55.83 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.634 -0.876 . . . . 63.140000000000001 108.634 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 45.3 t -118.68 125.11 74.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.558 -0.534 . . . . 61.409999999999997 109.558 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 26' ' ' THR . 63.2 mt -116.87 117.91 57.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 123.602 0.564 . . . . 75.239999999999995 110.207 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 47.3 m-85 -99.22 111.46 23.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.05 -1.093 . . . . 74.030000000000001 108.05 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.727 ' HB ' ' NZ ' ' A' ' 25' ' ' LYS . 1.8 mt -97.02 117.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 105.307 -2.109 . . . . 64.319999999999993 105.307 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 ' HA ' HD12 ' A' ' 24' ' ' ILE . 52.3 p -113.31 172.67 6.81 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.841 -0.744 . . . . 73.120000000000005 110.185 -176.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -25.17 22.59 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.763 1.023 . . . . 75.129999999999995 113.763 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 54.6 mtp180 -141.74 68.39 1.33 Allowed 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.903 0.705 . . . . 63.229999999999997 112.903 170.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.25 165.75 11.37 Favored Glycine 0 CA--C 1.478 -2.258 0 C-N-CA 118.878 -1.63 . . . . 71.019999999999996 113.545 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HG ' HG23 ' A' ' 40' ' ' ILE . 5.6 mp -119.86 135.08 55.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.111 0.481 . . . . 73.510000000000005 110.46 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' C ' ' HE2' ' A' ' 46' ' ' LYS . 1.5 tmpt? -116.91 120.53 38.72 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.703 -1.592 . . . . 74.540000000000006 106.703 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 7.5 p -128.5 136.93 58.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.039 0.447 . . . . 45.0 111.976 -172.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.1 t -138.36 113.04 8.96 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.505 -0.478 . . . . 71.450000000000003 110.774 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -101.5 134.14 45.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.906 0.384 . . . . 74.349999999999994 110.88 176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.82 114.0 17.71 Favored Pre-proline 0 C--O 1.212 -0.911 0 C-N-CA 123.363 0.665 . . . . 70.219999999999999 109.232 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 80.4 Cg_endo -77.06 37.46 0.59 Allowed 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.631 2.887 . . . . 64.530000000000001 111.675 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.564 ' NE2' ' HA ' ' A' ' 33' ' ' SER . 77.9 mt-30 60.21 38.93 19.8 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.904 0.859 . . . . 73.200000000000003 110.408 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.28 -37.37 12.08 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.396 -1.335 . . . . 62.140000000000001 107.396 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HB ' HG23 ' A' ' 56' ' ' VAL . 12.7 m -98.39 -28.74 13.51 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.039 -0.982 . . . . 74.209999999999994 109.292 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.2 m95 64.37 41.85 5.56 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 107.981 -1.118 . . . . 70.340000000000003 107.981 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 54' ' ' THR . 35.1 t -55.09 112.89 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.332 -1.303 . . . . 72.530000000000001 112.611 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -111.95 134.19 53.66 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.294 -1.743 . . . . 70.420000000000002 106.294 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -115.25 140.65 48.92 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.072 -0.651 . . . . 74.230000000000004 111.033 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 m -82.8 -13.95 12.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.279 -1.008 . . . . 53.310000000000002 108.279 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.8 t -72.22 102.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.574 -1.639 . . . . 73.030000000000001 106.574 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -83.13 143.46 30.52 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.142 -0.481 . . . . 64.200000000000003 111.037 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.4 t -87.23 138.72 31.24 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.447 -0.946 . . . . 74.239999999999995 108.447 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 ptp -106.27 -171.95 1.99 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.6 -0.889 . . . . 64.540000000000006 108.6 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.6 149.66 46.84 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.255 -0.578 . . . . 65.040000000000006 109.682 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.74 -23.3 63.09 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.924 0.89 . . . . 74.239999999999995 112.501 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 tptp . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 110.203 -0.295 . . . . 64.420000000000002 110.203 175.854 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.245 0.85 0 CA-C-O 120.832 0.349 . . . . 62.340000000000003 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -139.44 105.99 0.49 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.483 -1.447 . . . . 62.399999999999999 109.483 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 41.0 m -144.42 101.82 3.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.142 0.496 . . . . 75.319999999999993 110.991 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.59 143.88 35.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.145 -1.057 . . . . 63.100000000000001 108.145 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -81.76 140.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-O 121.15 0.5 . . . . 63.119999999999997 111.012 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 22.9 t -89.05 -170.28 2.84 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.128 -1.064 . . . . 73.109999999999999 108.128 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.16 157.53 19.3 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.727 -0.842 . . . . 70.409999999999997 108.727 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.7 -28.6 68.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.971 0.415 . . . . 74.019999999999996 110.043 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 103.16 6.09 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.525 -1.287 . . . . 74.5 107.525 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 54.3 m -100.52 117.13 34.05 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 120.278 -0.569 . . . . 73.010000000000005 111.43 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 38.5 m -120.73 144.95 47.98 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.738 -1.579 . . . . 75.140000000000001 106.738 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.413 ' HB ' HD13 ' A' ' 14' ' ' LEU . 27.9 m -122.34 133.6 68.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 109.677 -0.49 . . . . 51.399999999999999 109.677 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 38.4 p -136.81 122.35 19.63 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.436 0.902 . . . . 63.299999999999997 113.436 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 48.5 mt -114.78 131.91 56.64 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 121.667 0.746 . . . . 73.329999999999998 112.14 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 18.3 m -94.98 121.39 36.55 Favored 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 114.468 -1.242 . . . . 74.400000000000006 107.777 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.405 ' OG1' ' HB ' ' A' ' 10' ' ' THR . 7.0 t -148.05 138.59 22.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 116.701 -0.227 . . . . 74.549999999999997 110.72 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' B' ' 219' ' ' LEU . 34.3 tt0 77.08 163.52 0.23 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.131 0.972 . . . . 72.200000000000003 111.462 175.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -127.52 15.1 7.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.074 0.464 . . . . 64.510000000000005 111.275 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 217' ' ' GLN . 87.6 mt -97.67 130.16 29.76 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.638 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.63 141.87 74.82 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.825 2.35 . . . . 70.439999999999998 113.514 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' B' ' 242' ' ' LYS . 16.5 m -104.52 164.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.844 . . . . 73.140000000000001 109.536 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 37.6 t -43.13 -54.92 4.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.963 1.305 . . . . 54.109999999999999 112.849 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -177.04 157.16 1.37 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.224 -1.028 . . . . 73.420000000000002 108.224 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 23.9 mm -70.48 109.52 2.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 106.631 -1.618 . . . . 34.229999999999997 106.631 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -128.96 159.32 36.25 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 120.718 -0.393 . . . . 71.340000000000003 110.373 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 17.4 p -122.14 130.42 53.22 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 113.344 0.868 . . . . 35.32 113.344 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -112.32 136.77 51.37 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.288 -0.869 . . . . 74.409999999999997 109.263 173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 26.2 m -112.4 130.53 55.94 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.361 -0.536 . . . . 74.519999999999996 110.691 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 40' ' ' ILE . 66.1 mt -107.94 142.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.0 -1.111 . . . . 64.310000000000002 108.0 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.5 p -134.94 100.08 4.48 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 122.358 0.263 . . . . 53.549999999999997 110.725 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -111.4 100.08 8.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 75.450000000000003 109.085 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 66.3 -94.78 0.23 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.258 -0.972 . . . . 44.130000000000003 112.635 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 40.3 m -118.66 21.41 12.54 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.564 0.746 . . . . 75.409999999999997 109.519 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' B' ' 230' ' ' THR . 30.0 tp -111.57 126.94 55.53 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.984 -0.553 . . . . 62.539999999999999 109.868 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -117.53 112.84 21.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.122 -1.066 . . . . 75.230000000000004 108.122 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 4.5 t -112.38 140.67 46.91 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 120.014 -0.675 . . . . 60.039999999999999 109.524 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 33.5 t -124.48 132.03 71.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.097 -1.075 . . . . 52.109999999999999 108.097 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' B' ' 226' ' ' THR . 59.4 mt -115.99 118.6 59.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 109.644 -0.502 . . . . 72.230000000000004 109.644 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 50.5 m-85 -99.85 111.03 23.37 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 123.941 0.896 . . . . 72.019999999999996 108.931 175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' B' ' 224' ' ' ILE . 7.1 mt -91.57 117.92 35.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.252 -1.759 . . . . 52.140000000000001 106.252 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.513 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 55.7 p -113.7 163.21 15.31 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 119.098 -1.041 . . . . 64.140000000000001 109.525 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.299 0.0 OUTLIER -69.93 -0.76 7.95 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.55 2.056 . . . . 64.329999999999998 116.55 -173.328 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -146.67 21.3 1.3 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 122.55 0.34 . . . . 73.25 111.888 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.04 178.27 42.91 Favored Glycine 0 CA--C 1.479 -2.157 0 C-N-CA 118.14 -1.981 . . . . 71.319999999999993 112.963 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 47' ' ' VAL . 6.4 mp -131.35 137.34 48.71 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.763 0.792 . . . . 73.340000000000003 111.889 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 66.8 tttt -117.15 120.88 39.67 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.236 -1.347 . . . . 73.5 108.627 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 45' ' ' LEU . 14.6 p -125.24 135.84 62.76 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-O 121.5 0.667 . . . . 70.319999999999993 109.819 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 16.7 t -131.33 98.97 4.69 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 109.651 -0.5 . . . . 73.019999999999996 109.651 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.9 m -89.88 133.53 34.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.169 -0.613 . . . . 64.340000000000003 109.698 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -125.34 113.37 25.83 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.985 -0.552 . . . . 53.240000000000002 111.238 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -84.78 18.12 1.62 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.195 2.597 . . . . 64.230000000000004 112.049 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.448 ' O ' HG23 ' B' ' 256' ' ' VAL . 74.4 mt-30 61.79 24.32 14.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.28 1.032 . . . . 71.319999999999993 111.749 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.73 -34.11 70.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.487 0.715 . . . . 60.109999999999999 112.179 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 38.8 m -108.78 -8.78 15.28 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.675 0.75 . . . . 73.420000000000002 109.664 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -90.04 -10.68 43.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.913 0.709 . . . . 73.420000000000002 112.913 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . 0.448 HG23 ' O ' ' B' ' 252' ' ' GLN . 58.7 t -79.42 94.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 105.603 -1.999 . . . . 64.329999999999998 105.603 168.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -138.87 145.67 40.25 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.068 -0.969 . . . . 63.420000000000002 110.708 -169.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -140.22 153.67 46.65 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.026 -1.842 . . . . 75.230000000000004 106.026 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.9 -1.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 117.886 0.312 . . . . 73.25 111.271 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 70.38 64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 106.353 -1.721 . . . . 71.340000000000003 106.353 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -60.63 150.31 32.3 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.769 -2.014 . . . . 74.109999999999999 112.094 -175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.2 t -140.13 129.15 23.51 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.123 -1.065 . . . . 63.329999999999998 108.123 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 23.2 ptp -67.04 156.97 34.67 Favored 'General case' 0 C--O 1.251 1.18 0 N-CA-C 109.31 -0.626 . . . . 64.129999999999995 109.31 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.01 156.11 39.2 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.796 -0.362 . . . . 63.43 110.227 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -56.37 -37.11 69.62 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 124.303 1.041 . . . . 75.150000000000006 110.375 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.1 tttp . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 118.073 -0.965 . . . . 65.120000000000005 110.341 177.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 108.643 -0.873 . . . . 71.019999999999996 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.79 88.55 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 119.565 -1.302 . . . . 50.240000000000002 113.723 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -71.52 -23.33 61.76 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.063 -1.458 . . . . 71.010000000000005 107.063 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.39 92.41 4.58 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 106.362 -1.718 . . . . 61.509999999999998 106.362 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.21 -37.43 12.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.422 -0.808 . . . . 62.030000000000001 110.663 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 p -150.6 -67.76 0.19 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.332 -0.988 . . . . 74.219999999999999 108.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.19 89.4 0.05 OUTLIER 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.157 0.983 . . . . 65.310000000000002 113.256 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -102.31 -61.71 1.36 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.762 -0.654 . . . . 71.409999999999997 109.73 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -143.06 106.59 4.61 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.538 -0.755 . . . . 72.140000000000001 109.43 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m -98.93 133.02 43.81 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.0 -0.741 . . . . 45.200000000000003 109.0 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m -120.31 143.36 48.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.35 -1.722 . . . . 61.539999999999999 106.35 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' HD12 ' B' ' 214' ' ' LEU . 31.0 m -132.26 133.51 60.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-O 121.143 0.497 . . . . 65.409999999999997 110.349 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 30.3 p -123.95 125.05 43.92 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.735 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 ' HG ' ' B' ' 214' ' ' LEU . 37.5 mt -114.58 130.69 56.8 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.001 -0.68 . . . . 74.219999999999999 111.9 174.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.47 125.22 39.93 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.768 -1.106 . . . . 74.310000000000002 109.852 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.7 t -144.77 136.66 25.81 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.662 -1.236 . . . . 70.450000000000003 107.662 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 58.55 -177.79 0.08 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.662 0.744 . . . . 64.25 111.877 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -135.12 98.78 4.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.302 -1.74 . . . . 71.109999999999999 106.302 169.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.6 pt? -126.09 106.04 25.3 Favored Pre-proline 0 C--N 1.284 -2.245 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 110.175 -174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.26 139.53 90.88 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 121.378 1.386 . . . . 70.400000000000006 109.883 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG21 ' HZ1' ' A' ' 25' ' ' LYS . 12.0 p -127.18 144.79 36.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 m -56.74 -40.18 75.31 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.042 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -161.63 164.38 29.35 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 115.601 -0.727 . . . . 74.319999999999993 109.328 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 41' ' ' THR . 27.1 mm -92.67 136.95 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 104.546 -2.39 . . . . 61.539999999999999 104.546 173.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -139.76 153.32 47.14 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.295 -1.002 . . . . 65.230000000000004 108.295 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.5 p -115.42 133.51 55.97 Favored 'General case' 0 N--CA 1.415 -2.208 0 O-C-N 124.047 0.842 . . . . 64.109999999999999 112.7 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HB2' HD12 ' A' ' 38' ' ' ILE . 90.1 m-85 -109.6 133.53 53.0 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.83 -1.174 . . . . 73.519999999999996 107.83 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 23.8 m -110.19 130.62 55.51 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 120.066 -0.654 . . . . 74.430000000000007 110.007 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.718 HD13 HD11 ' B' ' 240' ' ' ILE . 92.0 mt -102.39 135.2 40.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.142 -0.936 . . . . 73.409999999999997 108.954 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.1 p -135.35 92.79 2.89 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 124.038 0.935 . . . . 44.450000000000003 110.359 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -143.49 118.89 10.27 Favored 'General case' 0 C--O 1.201 -1.456 0 C-N-CA 119.09 -1.044 . . . . 63.229999999999997 113.495 -177.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.43 42.87 93.56 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.97 -0.559 . . . . 71.120000000000005 112.45 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.8 m 66.17 20.84 11.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.743 0.817 . . . . 75.319999999999993 111.182 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 1.2 tm? -111.32 131.72 54.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.057 -0.974 . . . . 71.409999999999997 108.908 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 68.9 mtt85 -116.83 138.37 51.55 Favored 'General case' 0 C--O 1.189 -2.091 0 CA-C-N 116.3 -0.409 . . . . 65.219999999999999 110.97 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.591 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.7 t -139.77 146.18 39.16 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.79 -0.764 . . . . 75.019999999999996 109.775 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.09 133.38 68.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.051 -0.722 . . . . 60.350000000000001 109.051 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.3 mt -117.87 120.58 65.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.064 0.546 . . . . 72.530000000000001 110.542 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 41.1 m-85 -105.81 116.19 31.51 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.154 -0.684 . . . . 62.310000000000002 109.154 175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.688 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -97.31 117.4 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.504 0 N-CA-C 107.324 -1.362 . . . . 74.200000000000003 107.324 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.582 ' HA ' HD12 ' A' ' 24' ' ' ILE . 32.5 p -118.36 174.68 6.1 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 120.313 -0.555 . . . . 42.409999999999997 110.352 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -0.8 6.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 114.977 1.473 . . . . 74.329999999999998 114.977 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 74.2 ttt180 -139.3 18.69 2.58 Favored 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 119.474 -0.891 . . . . 65.349999999999994 110.325 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.87 -165.85 25.8 Favored Glycine 0 CA--C 1.487 -1.694 0 C-N-CA 118.729 -1.7 . . . . 70.530000000000001 112.343 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.98 152.87 43.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.64 -0.824 . . . . 74.420000000000002 112.621 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 16.9 ttmm -115.3 125.56 53.41 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.768 -1.567 . . . . 72.340000000000003 106.768 173.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 245' ' ' LEU . 12.5 p -120.7 135.63 60.31 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 C-N-CA 119.911 -0.716 . . . . 55.140000000000001 109.382 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.5 t -138.52 109.73 6.88 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.591 -0.444 . . . . 71.150000000000006 110.568 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 91.1 m -103.28 140.32 37.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.281 0.562 . . . . 72.120000000000005 112.347 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -128.66 105.32 18.91 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.481 -1.303 . . . . 74.140000000000001 107.481 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.85 -11.2 21.75 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 123.619 2.879 . . . . 74.420000000000002 112.993 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' TRP . 87.7 mt-30 59.34 17.6 6.0 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.401 1.08 . . . . 75.209999999999994 113.148 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.92 -44.61 94.22 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 112.44 0.533 . . . . 51.25 112.44 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.0 p -86.29 -0.45 55.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.977 0.732 . . . . 75.030000000000001 112.977 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.527 ' CD1' ' HA ' ' A' ' 52' ' ' GLN . 4.5 p-90 -139.85 69.32 1.36 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.624 1.202 . . . . 73.010000000000005 110.835 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.0 m -94.8 11.6 4.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.367 -1.288 . . . . 71.430000000000007 110.679 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -82.24 74.01 9.24 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.629 1.204 . . . . 63.340000000000003 111.727 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -177.77 78.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 112.967 -1.924 . . . . 73.310000000000002 107.088 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -109.02 -18.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.215 -0.902 . . . . 51.310000000000002 110.604 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -81.62 77.93 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 122.127 0.965 . . . . 55.020000000000003 109.015 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -147.13 161.7 40.34 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.547 -1.649 . . . . 62.009999999999998 106.547 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 p -115.47 91.74 3.7 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.258 -0.645 . . . . 70.219999999999999 109.258 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.5 ttm -159.72 128.51 5.08 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.816 -0.629 . . . . 75.510000000000005 110.208 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -163.86 144.41 8.55 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.827 -0.805 . . . . 74.510000000000005 108.827 177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -120.14 132.95 55.6 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.529 -0.545 . . . . 65.150000000000006 109.529 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--N 1.301 -1.518 0 N-CA-C 109.467 -0.568 . . . . 74.25 109.467 -179.232 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.243 0.736 0 CA-C-O 121.048 0.451 . . . . 70.25 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -153.46 75.86 0.23 Allowed Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.859 -0.686 . . . . 40.200000000000003 111.821 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 33.5 t -76.4 -45.89 29.66 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.795 -1.557 . . . . 75.230000000000004 106.795 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -128.57 90.78 3.12 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.521 -1.659 . . . . 64.530000000000001 106.521 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.8 -27.36 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.433 -0.803 . . . . 54.450000000000003 112.225 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 30.4 p -134.23 -84.91 0.43 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 121.005 -0.278 . . . . 72.450000000000003 111.005 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 53.81 86.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.11 0.964 . . . . 72.040000000000006 113.304 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -83.98 -55.9 3.97 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.418 -0.81 . . . . 54.420000000000002 110.802 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.437 ' CZ ' ' HA ' ' B' ' 209' ' ' ARG . 1.7 tpm_? -141.86 81.68 1.77 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.793 0.806 . . . . 74.230000000000004 109.134 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 33.4 m -92.7 119.06 31.71 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.833 -1.076 . . . . 64.430000000000007 109.877 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 47.7 m -135.9 145.54 46.41 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.969 -1.493 . . . . 75.340000000000003 106.969 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 14' ' ' LEU . 32.2 m -112.61 144.1 21.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 120.511 -0.476 . . . . 72.439999999999998 109.998 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.528 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 40.5 p -141.23 146.38 36.8 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.278 -0.569 . . . . 54.329999999999998 111.758 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.486 HD12 ' HB ' ' A' ' 12' ' ' VAL . 63.5 mt -129.86 134.05 47.29 Favored 'General case' 0 CA--C 1.494 -1.201 0 CA-C-O 121.581 0.705 . . . . 72.549999999999997 111.577 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.483 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 39.2 p -103.2 130.42 50.4 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.883 -1.053 . . . . 74.510000000000005 109.783 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.8 t -147.3 138.75 23.97 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.282 -0.417 . . . . 52.329999999999998 109.886 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' B' ' 218' ' ' ARG . 40.8 tp60 59.79 -161.58 0.27 Allowed 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.121 0.888 . . . . 61.130000000000003 109.819 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.655 ' H ' ' HG3' ' B' ' 217' ' ' GLN . 33.5 ptt180 -147.68 29.77 0.92 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.43 -1.322 . . . . 63.530000000000001 107.43 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.529 ' O ' HD12 ' B' ' 219' ' ' LEU . 3.0 pp -76.42 133.56 71.04 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 115.588 -0.733 . . . . 73.230000000000004 112.84 -170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 21.7 Cg_exo -65.53 142.29 70.8 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.1 1.867 . . . . 55.420000000000002 110.681 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.62 159.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.931 -1.137 . . . . 74.0 107.931 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 44.7 m -74.44 -21.02 59.81 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 111.998 0.37 . . . . 73.319999999999993 111.998 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 178.13 172.37 0.66 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.455 1.102 . . . . 53.109999999999999 108.258 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' B' ' 241' ' ' THR . 29.7 mm -97.5 131.44 44.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 104.811 -2.292 . . . . 71.430000000000007 104.811 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.558 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -145.09 161.96 38.18 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.058 -1.09 . . . . 73.109999999999999 108.058 -179.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 24.9 p -120.43 148.61 43.57 Favored 'General case' 0 N--CA 1.411 -2.409 0 O-C-N 124.082 0.863 . . . . 73.430000000000007 111.009 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -119.18 123.85 45.36 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.895 -1.15 . . . . 74.120000000000005 107.895 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 47.9 m -108.9 120.46 42.58 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.776 -0.824 . . . . 74.140000000000001 108.776 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.688 HD13 HD11 ' A' ' 40' ' ' ILE . 67.0 mt -103.7 133.8 46.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.008 -1.108 . . . . 75.519999999999996 108.008 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 26.2 p -132.35 98.88 4.51 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.702 -0.681 . . . . 71.140000000000001 109.631 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' B' ' 234' ' ' LEU 0.277 1.9 pp20? -144.5 110.46 5.4 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 114.284 1.216 . . . . 70.239999999999995 114.284 -178.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.62 47.76 8.53 Favored Glycine 0 N--CA 1.439 -1.161 0 CA-C-N 114.952 -1.022 . . . . 61.25 112.067 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 51.0 m 58.89 53.72 5.55 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.766 0.793 . . . . 70.150000000000006 108.921 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -144.66 137.34 26.56 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.836 -1.074 . . . . 74.040000000000006 109.528 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -127.63 112.31 14.71 Favored 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 120.855 0.359 . . . . 63.340000000000003 111.947 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 69.7 m -113.6 131.58 56.06 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 109.121 -0.696 . . . . 54.530000000000001 109.121 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 26.5 t -124.88 126.32 71.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.767 -0.827 . . . . 73.0 108.767 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.7 mt -117.36 127.0 74.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 116.176 -0.465 . . . . 63.219999999999999 110.946 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 40.5 m-85 -104.18 115.47 30.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.591 -0.892 . . . . 72.519999999999996 108.591 176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.718 HD11 HD13 ' A' ' 29' ' ' ILE . 3.7 mt -98.08 117.68 43.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.605 -1.628 . . . . 73.450000000000003 106.605 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.411 ' HA ' HD12 ' B' ' 224' ' ' ILE . 32.4 p -121.3 174.53 6.66 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 119.834 -0.746 . . . . 72.409999999999997 110.233 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -74.57 1.35 12.26 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.357 -0.838 . . . . 44.109999999999999 112.554 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -132.85 6.1 3.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.774 -0.579 . . . . 73.040000000000006 111.439 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 145.18 -167.85 27.25 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.595 -0.812 . . . . 44.030000000000001 111.657 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 47' ' ' VAL . 5.0 mp -130.6 149.89 52.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.325 0.584 . . . . 72.430000000000007 111.923 -177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.6 ttmm -115.38 137.24 52.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.059 -1.089 . . . . 53.140000000000001 108.059 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.94 116.37 42.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-O 122.399 1.095 . . . . 63.310000000000002 110.185 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 24.8 t -120.66 119.14 31.97 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 107.041 -1.466 . . . . 71.340000000000003 107.041 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.491 ' SG ' HD21 ' B' ' 234' ' ' LEU . 18.9 t -133.45 144.72 49.66 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 118.347 -1.341 . . . . 61.350000000000001 110.858 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -139.24 115.68 8.51 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.242 -0.89 . . . . 73.519999999999996 109.662 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 76.4 Cg_endo -76.88 38.26 0.63 Allowed 'Trans proline' 0 N--CA 1.481 0.764 0 C-N-CA 123.609 2.873 . . . . 72.420000000000002 111.241 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.517 ' HA ' ' CD1' ' B' ' 255' ' ' TRP . 95.0 mt-30 65.23 72.76 0.42 Allowed 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 124.435 1.094 . . . . 72.409999999999997 111.309 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -140.41 -45.0 0.41 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.464 -1.244 . . . . 65.299999999999997 110.702 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 74.7 p -116.01 -1.86 12.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.583 0.586 . . . . 74.319999999999993 112.583 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' B' ' 252' ' ' GLN . 5.6 p-90 -65.05 -25.26 67.74 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 111.579 0.214 . . . . 75.530000000000001 111.579 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 47.3 t 67.85 -80.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.694 1.198 . . . . 73.099999999999994 110.235 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -165.24 29.87 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.301 -0.629 . . . . 72.519999999999996 109.301 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.59 140.2 47.4 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.014 -0.993 . . . . 45.030000000000001 111.837 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.73 18.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.3 1.048 . . . . 73.0 108.532 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 85.8 t -93.18 91.19 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.205 -0.907 . . . . 61.520000000000003 111.905 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' B' ' 261' ' ' ARG . 3.1 mmp_? -153.43 82.27 1.18 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.82 1.248 . . . . 61.240000000000002 110.144 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.9 p -79.43 96.16 5.97 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.331 -0.988 . . . . 70.099999999999994 108.331 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 45.4 ttm -128.77 145.46 51.18 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.051 -0.977 . . . . 74.239999999999995 109.616 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -124.55 134.22 53.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.693 -1.595 . . . . 74.400000000000006 106.693 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -149.52 132.14 15.85 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.095 -0.705 . . . . 73.120000000000005 109.095 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 C--N 1.293 -1.88 0 O-C-N 123.668 0.605 . . . . 73.349999999999994 110.691 -177.669 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 2' ' ' GLY . 14.9 m . . . . . 0 C--O 1.217 -0.642 0 CA-C-O 119.787 -0.149 . . . . 72.099999999999994 111.321 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 1' ' ' VAL . . . -99.23 53.06 1.05 Allowed Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 106.616 -2.594 . . . . 23.440000000000001 106.616 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -111.83 25.69 11.37 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.035 -1.082 . . . . 70.420000000000002 109.885 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.69 98.3 2.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.036 -0.529 . . . . 44.43 111.301 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.92 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 115.363 -0.835 . . . . 60.329999999999998 109.726 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.5 m -95.12 91.2 6.21 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.962 -1.125 . . . . 70.409999999999997 107.962 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.94 92.32 7.79 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.462 -1.245 . . . . 72.319999999999993 107.774 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 38.1 ttpt -118.97 142.94 47.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.565 -0.743 . . . . 53.439999999999998 111.574 -171.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.445 ' HG2' ' HG2' ' A' ' 8' ' ' LYS . 28.2 mmm180 64.91 14.17 9.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.222 1.409 . . . . 73.540000000000006 112.026 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -85.21 129.83 34.73 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.348 -0.842 . . . . 65.129999999999995 112.468 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m -124.02 144.87 49.58 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.083 -1.451 . . . . 71.049999999999997 107.083 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' B' ' 214' ' ' LEU . 31.4 m -117.06 139.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.8 -0.444 . . . . 62.509999999999998 109.8 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -143.48 137.65 28.68 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.686 0.624 . . . . 62.5 112.686 -175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.704 ' HG ' HD21 ' B' ' 214' ' ' LEU . 35.2 mt -123.91 144.16 49.94 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.776 -0.647 . . . . 65.030000000000001 112.038 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -94.47 134.17 37.29 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.331 -1.359 . . . . 74.150000000000006 107.331 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 t -113.83 166.01 11.99 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.846 -0.427 . . . . 74.129999999999995 109.846 -173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 72.1 mt-30 -55.21 139.66 41.41 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.621 -1.622 . . . . 73.310000000000002 106.621 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -53.68 101.75 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.978 0.732 . . . . 74.230000000000004 112.978 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 17' ' ' GLN . 95.4 mt -117.73 110.64 40.13 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 107.872 -1.159 . . . . 53.329999999999998 107.872 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.39 141.26 50.72 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.898 1.732 . . . . 72.329999999999998 111.914 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 42' ' ' LYS . 27.1 m -128.35 159.76 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.329 -0.989 . . . . 70.329999999999998 108.329 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.4 t -66.75 -37.84 85.44 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.422 0.451 . . . . 72.519999999999996 111.064 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -161.09 176.9 10.82 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.137 -0.69 . . . . 53.109999999999999 109.137 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 41' ' ' THR . 30.3 mm -94.23 122.3 45.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.677 -1.971 . . . . 71.140000000000001 105.677 176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -136.66 157.36 46.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.216 -0.594 . . . . 73.040000000000006 109.842 -176.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 19.0 p -119.45 132.23 55.76 Favored 'General case' 0 N--CA 1.426 -1.669 0 O-C-N 124.13 0.893 . . . . 73.349999999999994 111.625 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -109.33 139.65 44.01 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.355 -0.979 . . . . 73.409999999999997 108.355 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.9 m -115.7 120.74 40.35 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 109.211 -0.663 . . . . 44.200000000000003 109.211 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.628 HD13 HD11 ' B' ' 240' ' ' ILE . 83.6 mt -102.12 128.91 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 107.462 -1.31 . . . . 71.409999999999997 107.462 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.1 p -134.26 95.98 3.52 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.017 -0.992 . . . . 71.299999999999997 108.544 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.9 pp20? -141.77 124.36 15.88 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.856 1.058 . . . . 73.099999999999994 113.856 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.7 92.19 Favored Glycine 0 C--O 1.246 0.859 0 CA-C-N 115.727 -0.67 . . . . 73.099999999999994 111.773 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.503 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 51.5 m 63.5 75.96 0.37 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.065 0.936 . . . . 74.409999999999997 110.684 -173.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.784 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.7 tm? -160.72 125.51 3.7 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.059 -1.428 . . . . 63.340000000000003 108.502 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 21.9 ttt180 -113.71 121.14 43.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 C-N-CA 122.65 0.38 . . . . 65.450000000000003 110.175 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 66.2 m -134.36 130.99 37.76 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 122.16 0.184 . . . . 73.329999999999998 111.203 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.64 129.57 72.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.19 -1.041 . . . . 64.540000000000006 108.19 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 26' ' ' THR . 61.7 mt -116.48 119.45 62.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 O-C-N 123.383 0.427 . . . . 34.140000000000001 111.347 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 53.5 m-85 -96.86 107.09 19.52 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 124.236 1.014 . . . . 62.5 109.116 175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.673 HD11 HD13 ' B' ' 229' ' ' ILE . 1.5 mt -100.23 117.3 45.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 106.678 -1.601 . . . . 74.239999999999995 106.678 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 24' ' ' ILE . 53.2 p -110.45 177.88 4.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.204 -1.036 . . . . 75.549999999999997 108.204 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG22 ' A' ' 21' ' ' VAL 0.282 0.0 OUTLIER -82.19 4.85 21.78 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.65 1.352 . . . . 75.450000000000003 114.65 -179.248 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -139.7 -15.84 1.03 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.792 0.664 . . . . 75.120000000000005 112.792 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.07 165.72 31.8 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 119.236 -1.459 . . . . 43.140000000000001 113.011 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD21 ' SG ' ' B' ' 249' ' ' CYS . 6.3 mp -127.31 131.99 50.36 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.68 0.753 . . . . 53.109999999999999 111.481 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.587 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 64.0 tttt -121.25 129.58 53.24 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 114.674 -1.148 . . . . 65.310000000000002 110.556 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.95 133.58 65.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.592 0.71 . . . . 61.329999999999998 110.845 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.0 t -121.08 122.16 39.46 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.35 -0.982 . . . . 43.439999999999998 108.35 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 83.6 m -126.41 141.39 51.91 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.459 1.281 . . . . 72.400000000000006 114.459 -173.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD1' HG22 ' A' ' 54' ' ' THR . 25.4 t70 -139.82 123.26 10.57 Favored Pre-proline 0 C--O 1.188 -2.154 0 N-CA-C 105.949 -1.871 . . . . 75.420000000000002 105.949 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 31.1 Cg_exo -68.31 32.88 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.748 0 C-N-CA 123.084 2.522 . . . . 74.540000000000006 113.368 178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 54.0 mt-30 56.77 38.58 29.59 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.595 1.188 . . . . 61.549999999999997 110.232 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.89 -50.31 7.2 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 113.116 -1.856 . . . . 60.329999999999998 108.525 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' OD1' ' A' ' 50' ' ' ASP . 15.3 t -99.23 -17.84 17.91 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.808 -0.757 . . . . 62.43 109.747 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -83.99 76.82 10.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.651 0.739 . . . . 75.340000000000003 112.503 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.8 m -97.23 137.81 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.844 0 N-CA-C 107.358 -1.349 . . . . 64.430000000000007 107.358 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -132.45 152.61 51.45 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.379 -0.528 . . . . 72.140000000000001 110.129 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -64.99 109.71 2.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.386 -0.968 . . . . 73.310000000000002 108.386 174.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.98 3.36 10.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.251 0.548 . . . . 75.140000000000001 110.635 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.2 p -72.39 146.31 11.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.84 -1.17 . . . . 63.439999999999998 107.84 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -124.97 148.54 48.36 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.557 -0.457 . . . . 74.450000000000003 109.961 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.9 t -83.53 -17.25 42.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.186 -1.042 . . . . 71.129999999999995 108.186 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.7 tmm? 74.12 114.68 0.06 Allowed 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.113 1.365 . . . . 52.350000000000001 111.907 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -140.18 -168.68 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 105.819 -1.919 . . . . 73.549999999999997 105.819 174.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 65' ' ' ARG . 6.5 mpt_? -114.33 142.57 46.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 118.739 0.7 . . . . 75.340000000000003 110.353 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt . . . . . 0 C--O 1.25 1.121 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.293 179.175 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.339 0.59 . . . . 74.140000000000001 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.45 -101.59 2.02 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.024 -1.23 . . . . 72.25 110.024 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 45.7 m 63.9 16.53 9.92 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 122.033 0.921 . . . . 64.340000000000003 112.491 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.74 16.56 20.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.018 -0.992 . . . . 71.409999999999997 109.308 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 67.9 t 70.1 97.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 114.645 -1.161 . . . . 62.229999999999997 112.306 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 32.5 m -86.61 87.75 7.51 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 106.83 -1.544 . . . . 70.299999999999997 106.83 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.59 127.46 32.86 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.454 -0.793 . . . . 53.310000000000002 112.105 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -99.48 101.13 12.28 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.444 -0.798 . . . . 71.329999999999998 109.529 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 67.13 97.63 0.05 Allowed 'General case' 0 C--O 1.251 1.182 0 C-N-CA 125.162 1.385 . . . . 65.450000000000003 112.816 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.6 m -79.54 85.78 5.26 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 109.535 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 27.3 m -129.45 144.73 51.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.4 -1.333 . . . . 63.43 107.4 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 20.8 m -122.56 150.63 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.516 -0.55 . . . . 64.140000000000001 109.516 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 52.3 p -127.31 131.4 50.47 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.205 0.526 . . . . 61.329999999999998 111.447 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.704 HD21 ' HG ' ' A' ' 14' ' ' LEU . 48.1 mt -112.86 118.83 36.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.094 -0.706 . . . . 62.549999999999997 109.094 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 7.5 m -104.95 141.88 35.78 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.902 -1.045 . . . . 64.349999999999994 110.405 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -141.79 164.31 30.54 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 106.638 -1.616 . . . . 71.549999999999997 106.638 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -63.42 151.99 39.5 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.268 -0.973 . . . . 71.409999999999997 110.02 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -43.83 120.15 1.94 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 115.218 1.562 . . . . 73.540000000000006 115.218 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 96.9 mt -125.1 104.48 29.4 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 107.072 -1.455 . . . . 74.239999999999995 107.072 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.83 139.97 77.4 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.545 1.497 . . . . 71.099999999999994 111.73 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.13 156.86 42.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.048 -0.723 . . . . 63.399999999999999 109.048 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.3 t -64.33 -50.58 67.22 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.233 0.333 . . . . 73.530000000000001 110.189 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -148.14 169.55 19.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.636 -0.256 . . . . 73.230000000000004 110.409 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 241' ' ' THR . 33.3 mm -100.25 122.64 52.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 105.93 -1.878 . . . . 73.0 105.93 176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -134.58 160.5 37.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.667 -0.494 . . . . 72.349999999999994 109.667 -175.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 33.5 p -120.41 133.57 55.41 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 124.006 0.816 . . . . 73.140000000000001 112.393 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.522 ' HB2' HD12 ' B' ' 238' ' ' ILE . 80.2 m-85 -108.6 141.49 40.45 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.912 -1.04 . . . . 74.230000000000004 108.54 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 17.3 p -112.52 124.78 53.28 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-O 121.894 0.854 . . . . 73.140000000000001 111.596 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 92.2 mt -101.78 131.32 49.93 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.933 -1.506 . . . . 74.319999999999993 106.933 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 36.2 p -132.75 106.96 8.06 Favored 'General case' 0 C--N 1.254 -3.549 0 N-CA-C 108.63 -0.878 . . . . 71.010000000000005 108.63 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -140.83 122.22 14.97 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.113 -0.635 . . . . 71.140000000000001 109.507 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.11 42.49 99.81 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.347 -0.388 . . . . 73.340000000000003 113.315 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 41.3 m 69.54 20.51 7.09 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.9 0.88 . . . . 71.209999999999994 111.592 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.4 tm? -112.2 134.58 53.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.023 -0.989 . . . . 73.409999999999997 109.053 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.11 147.95 27.36 Favored 'General case' 0 C--O 1.188 -2.153 0 N-CA-C 108.76 -0.83 . . . . 65.010000000000005 108.76 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.698 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 1.8 t -140.43 136.8 33.41 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 107.692 -1.225 . . . . 62.130000000000003 107.692 171.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 25.2 t -116.5 132.43 66.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.443 -0.947 . . . . 72.409999999999997 108.443 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.2 mt -117.04 118.98 60.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.108 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 54.2 m-85 -103.23 108.62 19.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 123.495 0.718 . . . . 74.040000000000006 109.207 175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.628 HD11 HD13 ' A' ' 29' ' ' ILE . 2.1 mt -98.41 117.51 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.28 -1.748 . . . . 75.430000000000007 106.28 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.492 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.9 p -121.26 174.89 6.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 120.211 -0.596 . . . . 73.549999999999997 110.592 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -80.05 2.41 23.97 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 115.139 1.533 . . . . 63.399999999999999 115.139 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -125.31 5.24 7.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.06 0.457 . . . . 75.430000000000007 111.169 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 147.56 -163.82 28.76 Favored Glycine 0 N--CA 1.42 -2.397 0 C-N-CA 119.382 -1.389 . . . . 72.109999999999999 111.831 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.52 152.22 47.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.541 0.686 . . . . 71.230000000000004 112.354 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.6 tttt -128.61 131.18 48.11 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.779 -1.101 . . . . 74.140000000000001 108.8 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.81 135.68 56.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 109.369 -0.604 . . . . 72.230000000000004 109.369 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 38.8 t -137.54 103.45 5.05 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.485 -0.486 . . . . 72.519999999999996 110.911 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 95.5 m -87.91 133.99 33.8 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.963 -0.695 . . . . 65.439999999999998 109.896 175.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.69 111.3 9.62 Favored Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 115.205 -0.907 . . . . 75.219999999999999 110.754 -173.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.53 15.59 1.88 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.46 2.773 . . . . 65.010000000000005 110.899 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' B' ' 255' ' ' TRP . 50.8 mt-30 67.31 -97.3 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 125.878 1.671 . . . . 74.409999999999997 112.497 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 58.51 -72.6 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 114.687 1.365 . . . . 73.230000000000004 114.687 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 9.9 t -78.66 -3.21 42.92 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.473 0.709 . . . . 73.099999999999994 112.365 -174.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.4 ' HD1' ' HA ' ' B' ' 252' ' ' GLN . 96.4 m95 -82.36 103.41 11.91 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 112.507 0.558 . . . . 74.010000000000005 112.507 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.18 82.41 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 122.463 1.125 . . . . 73.430000000000007 109.059 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -140.41 116.59 10.55 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.717 -1.129 . . . . 63.310000000000002 109.226 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -100.06 175.66 5.68 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.324 -0.991 . . . . 34.030000000000001 108.324 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.09 -2.16 9.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 122.123 -0.361 . . . . 75.349999999999994 110.993 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 8.0 p -54.42 127.67 13.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 123.936 0.772 . . . . 44.119999999999997 112.739 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . 0.484 ' NH1' ' HB3' ' B' ' 264' ' ' ASP . 41.2 ptt180 -155.71 163.04 40.4 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.476 -1.305 . . . . 74.409999999999997 107.476 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.3 t -73.54 -64.88 0.9 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.039 -0.726 . . . . 71.209999999999994 109.039 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 48.0 ttm -173.32 112.02 0.21 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.884 -0.598 . . . . 72.099999999999994 109.77 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . 0.484 ' HB3' ' NH1' ' B' ' 261' ' ' ARG . 29.3 t70 -120.29 127.18 52.13 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.492 -1.299 . . . . 75.120000000000005 107.492 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -71.2 -78.76 0.07 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.765 0.654 . . . . 72.140000000000001 112.765 -173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 57.7 pttt . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.237 -0.887 . . . . 74.430000000000007 111.199 -178.084 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 111.849 0.314 . . . . 64.25 111.849 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.05 160.54 23.13 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.418 -1.073 . . . . 51.200000000000003 110.418 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 m -78.02 113.57 16.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 116.873 0.336 . . . . 71.230000000000004 110.147 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -74.09 112.71 10.49 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 107.678 -1.23 . . . . 65.409999999999997 107.678 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.74 122.45 56.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.212 0.529 . . . . 74.310000000000002 111.158 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -89.13 154.04 20.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.437 -1.32 . . . . 64.219999999999999 107.437 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.28 82.72 4.56 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.244 0.545 . . . . 64.129999999999995 110.127 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -78.31 -70.32 0.5 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.409 -0.96 . . . . 73.209999999999994 108.409 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -85.33 98.95 10.83 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.025 -1.472 . . . . 63.439999999999998 107.025 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.3 m -95.72 132.31 41.06 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 109.577 -0.527 . . . . 64.519999999999996 109.577 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 6.7 m -120.34 143.8 48.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.948 -1.13 . . . . 63.299999999999997 107.948 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' B' ' 214' ' ' LEU . 5.5 m -135.58 139.07 47.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 C-N-CA 123.811 0.844 . . . . 71.25 109.075 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.547 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.3 p -136.85 134.54 37.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.634 0.605 . . . . 71.040000000000006 112.634 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HG ' HD21 ' B' ' 214' ' ' LEU . 31.1 mt -123.76 134.01 53.74 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-N 115.818 -0.628 . . . . 74.239999999999995 110.761 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -100.11 112.78 25.08 Favored 'General case' 0 N--CA 1.406 -2.674 0 N-CA-C 106.551 -1.648 . . . . 61.310000000000002 106.551 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -143.33 136.57 28.05 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 110.388 -0.227 . . . . 71.530000000000001 110.388 -173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 62.8 176.46 0.15 Allowed 'General case' 0 CA--C 1.558 1.254 0 O-C-N 123.676 0.61 . . . . 75.239999999999995 110.883 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -124.2 87.73 2.78 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-O 122.085 0.945 . . . . 63.409999999999997 109.52 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -96.89 121.97 57.91 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.453 -1.249 . . . . 71.310000000000002 108.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 11.1 Cg_exo -70.86 139.5 36.53 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 120.871 1.047 . . . . 52.439999999999998 110.218 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.82 141.22 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-O 121.163 0.506 . . . . 72.510000000000005 110.794 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.5 p -68.23 -19.64 64.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.985 -0.552 . . . . 70.129999999999995 110.953 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -176.67 142.84 0.43 Allowed 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.084 -1.08 . . . . 72.200000000000003 108.084 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.481 HG23 HG22 ' A' ' 41' ' ' THR . 43.5 mm -67.37 99.52 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 105.306 -2.109 . . . . 72.540000000000006 105.306 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.1 ptpt -112.17 158.76 19.26 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.027 -0.533 . . . . 55.100000000000001 111.147 -171.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 10.5 p -123.15 131.22 53.6 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 115.597 -0.729 . . . . 75.0 112.499 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 50.8 m-85 -108.17 143.91 36.31 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.139 -1.06 . . . . 71.25 108.139 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 26.6 m -122.57 120.95 35.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.553 0.692 . . . . 71.209999999999994 110.374 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 HD13 HD11 ' B' ' 240' ' ' ILE . 90.1 mt -102.85 137.29 31.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.472 -0.936 . . . . 73.120000000000005 108.472 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.6 p -131.5 94.7 3.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.828 -0.434 . . . . 63.420000000000002 109.828 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -115.11 98.89 7.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.74 -0.784 . . . . 75.230000000000004 110.291 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.39 64.86 2.99 Favored Glycine 0 C--N 1.311 -0.816 0 CA-C-N 115.956 -0.566 . . . . 74.340000000000003 113.677 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.6 m 66.14 21.06 11.18 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.735 0.778 . . . . 73.219999999999999 111.687 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.714 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -112.87 141.75 46.32 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.17 -0.923 . . . . 75.439999999999998 109.02 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -126.07 111.1 14.3 Favored 'General case' 0 C--O 1.199 -1.557 0 CA-C-N 118.31 0.505 . . . . 74.319999999999993 110.014 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 34' ' ' LEU . 55.8 m -111.82 131.75 55.14 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.171 -0.677 . . . . 65.209999999999994 109.171 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 42.0 t -118.5 129.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.727 -0.842 . . . . 73.439999999999998 108.727 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 26' ' ' THR . 51.9 mt -117.06 119.19 61.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 116.447 -0.342 . . . . 64.5 110.435 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 25.0 m-85 -96.3 116.17 28.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.048 -0.723 . . . . 72.140000000000001 109.048 176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.726 HD11 HD13 ' B' ' 229' ' ' ILE . 3.5 mt -93.29 118.6 39.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.976 -1.49 . . . . 70.329999999999998 106.976 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 24' ' ' ILE . 33.8 p -117.69 163.5 16.39 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.47 -0.892 . . . . 75.409999999999997 109.354 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.17 -4.65 3.8 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.981 1.845 . . . . 75.319999999999993 115.981 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -135.54 14.23 3.45 Favored 'General case' 0 C--O 1.207 -1.149 0 O-C-N 121.901 -0.5 . . . . 71.200000000000003 112.193 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.34 -164.88 31.17 Favored Glycine 0 CA--C 1.499 -0.964 0 C-N-CA 119.774 -1.203 . . . . 40.039999999999999 111.649 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 247' ' ' VAL . 5.0 mp -140.71 151.25 44.37 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 117.476 0.638 . . . . 51.43 112.238 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 26.9 ttmt -118.94 125.95 50.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.214 -1.032 . . . . 74.430000000000007 108.214 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG21 HD22 ' B' ' 245' ' ' LEU . 13.4 p -112.21 129.59 67.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 C-N-CA 118.778 -1.169 . . . . 74.219999999999999 109.118 171.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 34.4 t -121.18 127.01 51.1 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.924 -1.51 . . . . 62.229999999999997 106.924 176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -129.09 139.18 52.1 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.376 -1.73 . . . . 71.099999999999994 112.013 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -131.07 110.6 15.5 Favored Pre-proline 0 C--N 1.29 -2.015 0 CA-C-N 113.573 -1.648 . . . . 71.040000000000006 111.08 -174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -86.53 33.17 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.81 2.34 . . . . 32.329999999999998 110.349 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 78.41 -43.42 0.36 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.881 1.672 . . . . 73.120000000000005 111.643 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.51 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 117.408 2.373 . . . . 74.319999999999993 117.408 166.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.9 m 68.36 88.96 0.11 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.882 0.849 . . . . 64.530000000000001 112.971 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -170.45 -24.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.073 -0.967 . . . . 74.420000000000002 109.67 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.3 m -56.82 -24.24 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.512 -0.767 . . . . 55.32 111.296 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 72.23 -63.07 0.44 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 124.69 1.196 . . . . 64.540000000000006 112.579 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -113.2 141.49 46.89 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.449 -0.574 . . . . 70.510000000000005 109.449 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.61 18.85 7.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.737 0.78 . . . . 62.210000000000001 109.92 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t 74.7 -81.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 124.522 1.129 . . . . 51.409999999999997 110.647 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 173.01 156.42 0.1 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.792 -1.559 . . . . 71.439999999999998 106.792 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 m -73.84 96.7 2.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.383 -0.969 . . . . 73.349999999999994 108.383 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.66 177.72 4.74 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.702 -0.681 . . . . 62.409999999999997 111.798 -176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.86 107.22 2.55 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.044 -0.525 . . . . 74.340000000000003 111.133 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -155.06 114.53 3.68 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.715 -0.846 . . . . 72.519999999999996 108.715 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--N 1.295 -1.783 0 CA-C-N 115.668 -0.696 . . . . 75.319999999999993 110.466 -179.073 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.635 -0.876 . . . . 62.310000000000002 108.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 134.59 69.17 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.579 -0.82 . . . . 75.329999999999998 111.398 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 28.3 m 68.87 155.68 0.13 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.575 1.15 . . . . 61.240000000000002 111.958 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -80.43 104.09 10.73 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 73.310000000000002 108.731 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.35 101.81 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.913 0.863 . . . . 73.549999999999997 110.861 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 31.7 t -100.92 -164.42 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.08 -0.964 . . . . 71.230000000000004 109.284 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.46 74.83 0.77 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.365 0.666 . . . . 73.540000000000006 112.679 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' B' ' 255' ' ' TRP . 52.6 mtmt -104.67 -39.91 6.19 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.417 -1.697 . . . . 75.340000000000003 106.417 173.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -135.92 144.9 45.75 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 71.150000000000006 107.337 172.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.4 m -102.05 121.7 42.69 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 19.6 m -120.59 143.57 48.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.395 -1.335 . . . . 74.319999999999993 107.395 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.44 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.7 m -137.61 153.03 27.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.599 -0.519 . . . . 72.519999999999996 109.599 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' B' ' 246' ' ' LYS . 37.1 p -123.6 136.59 54.6 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.959 0.409 . . . . 72.430000000000007 111.023 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.657 HD21 ' HG ' ' A' ' 14' ' ' LEU . 95.5 mt -114.42 118.41 33.74 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 108.118 -1.067 . . . . 71.040000000000006 108.118 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 31.9 p -96.68 114.96 26.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.625 -0.716 . . . . 60.329999999999998 111.342 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.8 t -143.35 134.53 25.8 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.816 -0.809 . . . . 74.409999999999997 108.816 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 60.48 154.78 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.467 1.107 . . . . 73.420000000000002 112.846 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -118.15 84.71 2.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.369 -0.974 . . . . 75.299999999999997 108.369 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 219' ' ' LEU . 2.0 pt? -127.2 139.42 35.08 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 115.403 -0.817 . . . . 64.329999999999998 110.84 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.57 140.39 43.26 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 108.892 -1.234 . . . . 75.329999999999998 108.892 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.63 154.27 19.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 116.433 -0.349 . . . . 75.030000000000001 110.942 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.7 m -52.81 -36.01 57.84 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 70.439999999999998 111.851 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -178.57 151.25 0.57 Allowed 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.048 -1.464 . . . . 63.450000000000003 107.048 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 41.0 mm -73.63 94.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 105.363 -2.088 . . . . 74.019999999999996 105.363 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.408 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 15.3 ptpt -105.95 162.31 13.7 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 116.147 -0.479 . . . . 73.129999999999995 110.76 -172.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.6 p -123.69 136.72 54.63 Favored 'General case' 0 N--CA 1.412 -2.339 0 O-C-N 123.889 0.743 . . . . 75.450000000000003 111.937 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -115.92 140.1 49.58 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.213 -0.903 . . . . 74.319999999999993 108.672 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 15.8 p -112.25 122.53 48.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.494 0.664 . . . . 74.109999999999999 112.072 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.726 HD13 HD11 ' A' ' 40' ' ' ILE . 97.1 mt -102.77 137.45 30.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.147 -1.427 . . . . 60.020000000000003 107.147 176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.2 p -133.56 91.9 2.91 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.076 0.465 . . . . 70.230000000000004 110.923 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 30.9 mm-40 -111.39 99.21 8.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 119.604 -0.839 . . . . 54.409999999999997 110.389 -176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 60.16 67.1 2.31 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 114.21 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.2 m 67.41 14.1 9.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.691 0.796 . . . . 63.32 112.101 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' B' ' 230' ' ' THR . 0.9 OUTLIER -113.76 136.68 52.59 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.982 0.913 . . . . 64.319999999999993 108.913 178.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' B' ' 250' ' ' ASP . 97.9 mtt180 -116.54 148.53 40.76 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 107.999 -1.112 . . . . 63.119999999999997 107.999 173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 65.9 m -138.57 129.49 26.7 Favored 'General case' 0 C--N 1.262 -3.218 0 N-CA-C 107.832 -1.173 . . . . 74.319999999999993 107.832 171.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 19.6 t -110.17 129.15 65.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.852 -1.166 . . . . 63.329999999999998 107.852 -177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.784 ' O ' ' HA ' ' B' ' 226' ' ' THR . 50.2 mt -116.53 117.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.314 -0.625 . . . . 75.129999999999995 109.314 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 36.2 m-85 -99.17 116.03 30.43 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.425 -0.954 . . . . 71.549999999999997 108.425 176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.681 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.11 118.55 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 106.998 -1.482 . . . . 64.239999999999995 106.998 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 47.5 p -119.22 168.33 10.99 Favored 'General case' 0 N--CA 1.411 -2.396 0 C-N-CA 119.69 -0.804 . . . . 73.400000000000006 110.9 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.97 5.32 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.655 1.354 . . . . 75.140000000000001 114.655 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -135.75 20.9 3.31 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.89 -0.507 . . . . 75.219999999999999 112.366 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 139.53 -162.03 26.15 Favored Glycine 0 CA--C 1.486 -1.742 0 C-N-CA 119.475 -1.345 . . . . 62.420000000000002 112.158 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 47' ' ' VAL . 5.3 mp -125.25 143.15 51.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.351 0.596 . . . . 74.329999999999998 111.182 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 57.9 tttt -114.68 125.97 54.34 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 114.95 -1.023 . . . . 64.219999999999999 109.286 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 45' ' ' LEU . 7.3 p -118.92 135.47 59.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 121.238 0.542 . . . . 71.310000000000002 109.775 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 20.9 t -133.03 117.57 17.76 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.391 -1.337 . . . . 74.340000000000003 107.391 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 85.5 m -102.68 140.2 37.26 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.933 1.086 . . . . 73.450000000000003 113.933 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.663 ' HB2' ' HB2' ' B' ' 235' ' ' ARG . 1.9 m-20 -116.36 99.79 52.99 Favored Pre-proline 0 N--CA 1.432 -1.338 0 CA-C-N 114.437 -1.256 . . . . 73.239999999999995 109.15 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.58 -0.15 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.261 1.974 . . . . 73.049999999999997 108.289 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' B' ' 250' ' ' ASP . 70.1 mt-30 73.19 -80.8 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.3 2.24 . . . . 72.140000000000001 109.2 -177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 47.07 -85.9 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 115.248 1.573 . . . . 74.120000000000005 115.248 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 21.3 p -97.2 -52.04 3.98 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 114.659 1.355 . . . . 73.25 114.659 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.4 ' CB ' ' HB3' ' B' ' 208' ' ' LYS . 11.4 p-90 -60.69 -24.49 65.66 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.871 1.063 . . . . 74.319999999999993 113.871 -168.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.1 m -57.16 -32.32 40.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 112.384 0.513 . . . . 61.240000000000002 112.384 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 68.99 -42.11 0.48 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.412 1.085 . . . . 63.039999999999999 113.045 175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -83.19 145.93 28.9 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 124.106 0.963 . . . . 71.5 109.629 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.1 25.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 122.435 1.112 . . . . 73.519999999999996 108.81 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.81 153.01 11.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.782 -0.821 . . . . 53.329999999999998 108.782 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -73.23 154.4 40.24 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.149 -0.685 . . . . 61.149999999999999 109.149 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 40.9 m -68.51 123.19 20.15 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 109.525 -0.546 . . . . 53.350000000000001 109.525 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.7 173.11 6.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.524 -0.307 . . . . 73.420000000000002 110.732 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.88 127.43 43.82 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.707 -0.479 . . . . 75.219999999999999 109.707 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -125.76 138.61 53.87 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.624 -0.51 . . . . 62.229999999999997 109.624 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.715 -0.846 . . . . 61.200000000000003 108.715 178.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.241 0.636 0 N-CA-C 109.702 -0.481 . . . . 74.310000000000002 109.702 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.69 140.08 6.17 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 119.696 -1.24 . . . . 72.140000000000001 112.419 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 p -80.39 114.47 19.31 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 120.779 0.323 . . . . 71.349999999999994 110.158 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -79.2 130.33 35.37 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.439 -0.578 . . . . 74.340000000000003 109.439 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 m -79.36 92.46 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.235 1.017 . . . . 72.129999999999995 111.911 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 p -122.49 150.37 42.63 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.575 -1.193 . . . . 73.129999999999995 108.864 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -78.83 113.96 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.433 -0.951 . . . . 61.32 108.433 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 9' ' ' ARG . 87.0 tttt -98.36 -72.79 0.64 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.732 0.641 . . . . 74.25 112.732 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 22.2 mmm180 -127.28 112.16 14.75 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.635 -0.876 . . . . 72.510000000000005 108.635 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.0 m -115.51 118.34 32.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 114.712 1.375 . . . . 71.319999999999993 114.712 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 29.6 m -121.81 144.35 48.87 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.52 -2.029 . . . . 53.310000000000002 105.52 169.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.38 140.43 48.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 24.7 t -123.79 137.77 54.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.764 -0.374 . . . . 74.510000000000005 110.201 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' B' ' 214' ' ' LEU . 73.0 mt -127.55 134.66 49.74 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.507 -0.77 . . . . 72.409999999999997 111.931 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.7 p -98.42 118.03 34.18 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.769 -0.651 . . . . 54.520000000000003 112.392 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -132.93 135.96 45.85 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.316 -1.364 . . . . 71.409999999999997 107.316 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.706 HE21 ' HA ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER 57.0 -164.93 0.15 Allowed 'General case' 0 CA--C 1.556 1.202 0 O-C-N 123.893 0.746 . . . . 73.230000000000004 109.201 -177.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -162.38 15.52 0.08 Allowed 'General case' 0 C--O 1.245 0.85 0 N-CA-C 111.939 0.348 . . . . 74.010000000000005 111.939 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.5 124.9 85.33 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 107.018 -1.475 . . . . 64.319999999999993 107.018 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 26.0 Cg_endo -61.5 140.29 86.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 114.063 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.54 162.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.68 -1.146 . . . . 61.409999999999997 109.775 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -79.35 91.33 5.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 110.332 -0.247 . . . . 72.439999999999998 110.332 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 73.56 140.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.468 1.107 . . . . 75.120000000000005 113.673 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 40.0 mm -78.86 116.23 22.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 105.926 -1.879 . . . . 74.230000000000004 105.926 174.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 10.4 ptpt -129.42 158.77 38.25 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.388 -0.525 . . . . 65.25 111.098 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 23.9 p -121.23 129.54 53.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 123.761 0.663 . . . . 63.009999999999998 112.629 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -109.73 144.03 38.69 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.642 -1.244 . . . . 75.25 107.642 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -120.15 123.62 43.76 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.983 -0.687 . . . . 74.299999999999997 111.056 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.709 HD13 HD11 ' B' ' 240' ' ' ILE . 90.7 mt -108.1 129.92 61.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.295 -1.002 . . . . 64.140000000000001 108.295 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 69.0 p -128.74 99.16 5.23 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 110.074 -0.343 . . . . 64.329999999999998 110.074 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 20.0 mm-40 -116.36 98.73 6.74 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 121.056 -0.258 . . . . 63.119999999999997 110.788 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.95 69.34 1.29 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 123.3 0.375 . . . . 53.240000000000002 113.658 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.6 m 66.91 14.15 9.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.544 0.738 . . . . 74.140000000000001 112.213 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.8 tm? -111.4 125.15 53.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.595 -1.261 . . . . 64.5 107.595 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' NH2' ' HB2' ' A' ' 61' ' ' ARG . 78.1 mtt180 -122.16 110.78 16.16 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.169 0.509 . . . . 72.049999999999997 111.053 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.619 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 56.6 m -111.21 135.2 52.08 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.855 -0.612 . . . . 70.439999999999998 109.849 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.74 132.54 71.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.792 -1.559 . . . . 75.239999999999995 106.792 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 26' ' ' THR . 52.8 mt -116.78 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 116.268 -0.424 . . . . 73.540000000000006 110.342 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.697 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 58.2 m-85 -98.19 111.71 23.94 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.721 -0.844 . . . . 73.400000000000006 108.721 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.666 HD11 HD13 ' B' ' 229' ' ' ILE . 4.9 mt -91.28 118.84 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 106.11 -1.811 . . . . 75.109999999999999 106.11 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 49.0 p -120.35 164.19 16.7 Favored 'General case' 0 N--CA 1.41 -2.426 0 C-N-CA 119.381 -0.928 . . . . 63.210000000000001 110.866 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -73.1 9.35 1.24 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 114.827 1.418 . . . . 71.25 114.827 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.2 2.84 4.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 74.140000000000001 110.975 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 145.34 -152.9 24.91 Favored Glycine 0 N--CA 1.425 -2.047 0 C-N-CA 120.215 -0.993 . . . . 72.439999999999998 110.929 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.01 144.77 50.58 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.895 -0.722 . . . . 65.510000000000005 111.583 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 45.4 tttp -120.03 119.91 34.75 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.496 -1.229 . . . . 52.340000000000003 107.809 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.44 134.43 56.2 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 N-CA-C 109.16 -0.681 . . . . 73.109999999999999 109.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 29.3 t -127.74 117.97 22.89 Favored 'General case' 0 C--N 1.258 -3.407 0 N-CA-C 106.958 -1.497 . . . . 73.230000000000004 106.958 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.5 t -129.26 139.68 51.72 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 117.556 -1.658 . . . . 75.129999999999995 112.108 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.45 104.67 31.23 Favored Pre-proline 0 N--CA 1.428 -1.55 0 CA-C-N 114.394 -1.275 . . . . 73.530000000000001 110.899 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.45 6.54 5.73 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 123.042 2.494 . . . . 71.200000000000003 110.364 174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 71.68 -44.49 0.59 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.548 1.939 . . . . 72.409999999999997 111.157 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.47 ' HA ' HD21 ' B' ' 219' ' ' LEU . . . 63.84 -86.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.369 1.468 . . . . 74.219999999999999 112.962 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.3 m -147.1 13.82 1.13 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.759 -0.83 . . . . 54.030000000000001 108.759 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -78.31 99.63 6.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.682 0.754 . . . . 62.009999999999998 109.703 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.67 133.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 114.937 1.458 . . . . 44.310000000000002 114.937 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 58' ' ' ASP . 18.0 ttp180 -162.56 -173.57 3.6 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 103.126 -2.916 . . . . 73.340000000000003 103.126 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 15.1 m-20 -57.52 -26.02 60.73 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.75 1.159 . . . . 74.420000000000002 112.156 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.8 t 75.36 -45.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.037 1.335 . . . . 72.450000000000003 111.093 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.4 135.05 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 122.181 0.991 . . . . 51.350000000000001 112.466 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 1.9 tmt_? -129.11 47.6 2.46 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 102.382 -3.192 . . . . 72.430000000000007 102.382 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 m -73.68 79.08 1.53 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.085 -1.416 . . . . 64.140000000000001 113.619 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 tmm? 176.36 94.61 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 102.649 -3.093 . . . . 61.039999999999999 102.649 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -146.77 177.75 8.85 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 120.369 -0.533 . . . . 71.299999999999997 111.454 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -57.27 107.53 0.43 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.981 1.313 . . . . 74.129999999999995 111.318 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp . . . . . 0 C--N 1.303 -1.439 0 N-CA-C 109.734 -0.469 . . . . 73.230000000000004 109.734 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.764 -0.458 . . . . 73.010000000000005 109.764 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -119.1 128.69 7.75 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.962 -1.114 . . . . 73.230000000000004 112.723 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 54.5 m -95.86 102.43 14.23 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.318 -0.623 . . . . 73.319999999999993 109.318 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.43 149.41 21.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.448 -0.945 . . . . 72.129999999999995 108.448 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.21 137.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.049 0.759 . . . . 72.450000000000003 113.049 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 33.6 p -163.24 96.09 0.87 Allowed 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.211 -0.904 . . . . 74.530000000000001 110.325 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -105.58 92.88 4.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.164 0.507 . . . . 73.519999999999996 110.805 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -93.06 -27.58 16.89 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.728 -1.212 . . . . 62.140000000000001 107.728 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.544 HH22 ' HB2' ' B' ' 250' ' ' ASP . 17.3 mmm180 -118.43 100.17 7.3 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 105.536 -2.024 . . . . 74.319999999999993 105.536 170.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 19.0 m -95.34 101.28 12.99 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.363 0.601 . . . . 74.129999999999995 110.888 -173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 4.9 m -121.02 144.87 48.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.443 -1.318 . . . . 74.540000000000006 107.443 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 14' ' ' LEU . 17.1 m -128.11 147.05 32.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.823 -0.806 . . . . 72.510000000000005 108.823 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.502 ' HB2' ' HG3' ' B' ' 246' ' ' LYS . 11.8 t -144.06 138.16 28.11 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.467 -0.893 . . . . 72.439999999999998 111.358 -173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.533 ' HG ' HD21 ' A' ' 14' ' ' LEU . 57.3 mt -132.07 143.65 50.18 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.481 0.658 . . . . 54.439999999999998 112.516 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 23.2 p -94.71 129.63 41.54 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 114.652 -1.158 . . . . 75.400000000000006 109.194 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.4 t -147.67 139.01 23.68 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.486 -0.561 . . . . 71.099999999999994 109.486 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.747 HE21 ' HA ' ' B' ' 217' ' ' GLN . 0.0 OUTLIER 71.56 149.55 0.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.766 1.226 . . . . 51.020000000000003 111.465 179.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -110.41 17.28 20.98 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.074 -0.512 . . . . 64.530000000000001 111.004 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.47 HD21 ' HA ' ' A' ' 53' ' ' ALA . 6.4 mp -105.47 117.52 57.94 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.688 -0.687 . . . . 62.109999999999999 110.329 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' B' ' 242' ' ' LYS . 36.2 Cg_endo -65.16 145.72 85.11 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.114 2.543 . . . . 62.399999999999999 113.702 -176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' B' ' 242' ' ' LYS . 18.4 m -93.6 164.54 2.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.006 -0.997 . . . . 71.140000000000001 109.144 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 39.7 t -57.3 -55.72 31.08 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 123.069 0.231 . . . . 73.340000000000003 111.367 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -155.66 148.54 24.3 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 121.085 -0.246 . . . . 71.120000000000005 111.047 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 22.9 mm -67.47 123.96 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 106.691 -1.596 . . . . 61.329999999999998 106.691 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -136.51 158.23 44.93 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 116.217 -0.447 . . . . 61.210000000000001 110.152 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 4.4 p -124.93 131.99 53.35 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.74 0.781 . . . . 73.040000000000006 112.631 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -114.38 129.45 56.65 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.883 -1.154 . . . . 72.329999999999998 107.883 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 35.5 m -109.61 121.56 45.49 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 108.92 -0.771 . . . . 65.409999999999997 108.92 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.666 HD13 HD11 ' A' ' 40' ' ' ILE . 86.5 mt -101.35 129.39 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 N-CA-C 107.464 -1.31 . . . . 70.420000000000002 107.464 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 41.0 p -124.09 85.9 2.49 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-N 115.465 -0.789 . . . . 70.349999999999994 110.831 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' B' ' 229' ' ' ILE . 60.1 mm-40 -96.57 150.2 20.91 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.353 -1.721 . . . . 73.140000000000001 106.353 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.7 111.95 0.13 Allowed Glycine 0 CA--C 1.534 1.224 0 O-C-N 123.712 0.633 . . . . 60.240000000000002 114.401 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 42.1 m 67.19 25.65 8.91 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 73.409999999999997 112.012 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.63 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.3 tm? -144.94 126.15 14.72 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.937 -0.477 . . . . 72.439999999999998 111.36 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -122.62 111.56 16.91 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 121.173 -0.211 . . . . 64.040000000000006 110.587 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' B' ' 234' ' ' LEU . 54.1 m -112.07 138.7 48.37 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.637 0.375 . . . . 41.549999999999997 110.391 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 35.1 t -124.38 127.35 73.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 108.163 -1.051 . . . . 74.200000000000003 108.163 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' B' ' 226' ' ' THR . 61.5 mt -117.44 120.97 66.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.117 -0.492 . . . . 71.319999999999993 110.556 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 28.5 m-85 -98.71 116.13 30.25 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.608 -0.886 . . . . 75.040000000000006 108.608 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 29' ' ' ILE . 9.2 mt -92.71 118.0 37.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.263 -1.755 . . . . 74.420000000000002 106.263 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.514 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 71.0 p -112.09 170.44 8.15 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 119.916 -0.714 . . . . 73.310000000000002 109.374 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.51 ' HA ' HG22 ' B' ' 221' ' ' VAL 0.3 0.0 OUTLIER -65.9 -10.66 40.68 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.718 1.747 . . . . 62.210000000000001 115.718 -175.06 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -149.34 34.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.675 0.274 . . . . 74.519999999999996 111.532 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 166.27 177.04 38.0 Favored Glycine 0 CA--C 1.493 -1.3 0 C-N-CA 119.033 -1.556 . . . . 21.43 113.032 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.5 mp -134.23 143.24 47.7 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.67 -0.493 . . . . 62.32 109.67 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.1 ttmm -114.44 124.89 53.07 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.922 -1.14 . . . . 53.409999999999997 107.922 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.7 118.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-O 122.061 0.934 . . . . 54.439999999999998 110.393 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 41.7 t -120.46 134.69 55.23 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 106.181 -1.785 . . . . 74.140000000000001 106.181 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.1 t -147.09 141.97 26.9 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 117.129 -1.829 . . . . 71.319999999999993 111.536 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.544 ' HB2' HH22 ' B' ' 209' ' ' ARG . 18.4 t70 -127.63 106.94 20.79 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.817 -1.083 . . . . 75.430000000000007 109.46 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 94.9 Cg_endo -83.62 19.85 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.85 0 C-N-CA 123.559 2.839 . . . . 65.219999999999999 111.698 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 66.75 -66.05 0.19 Allowed 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.033 1.333 . . . . 73.340000000000003 112.236 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 46.0 -99.0 0.04 OUTLIER 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.135 1.374 . . . . 33.100000000000001 113.701 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 63.1 m -157.93 95.51 1.41 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.775 -0.824 . . . . 64.209999999999994 108.775 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -129.06 101.33 6.0 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.028 -0.987 . . . . 75.430000000000007 109.185 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 31.3 m -85.99 113.65 24.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 121.73 0.776 . . . . 71.219999999999999 110.924 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -157.9 -57.21 0.08 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.056 -0.975 . . . . 74.340000000000003 108.476 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -123.18 -63.23 1.27 Allowed 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 115.838 -0.619 . . . . 73.439999999999998 109.808 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 70.0 t 70.61 -57.44 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.302 1.041 . . . . 74.200000000000003 110.48 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.5 m -80.37 83.33 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 122.473 1.13 . . . . 62.329999999999998 111.637 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.05 93.26 4.33 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.117 -2.179 . . . . 63.539999999999999 105.117 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 36.9 m -106.47 101.1 10.58 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.431 -0.804 . . . . 62.219999999999999 112.492 -172.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.06 108.18 19.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.41 -2.07 . . . . 53.240000000000002 105.41 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.12 153.59 18.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.502 -0.479 . . . . 73.310000000000002 109.793 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -141.51 154.22 45.38 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.638 -0.504 . . . . 62.509999999999998 109.638 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.369 -0.974 . . . . 74.530000000000001 108.369 176.587 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.115 0.413 . . . . 72.409999999999997 112.115 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.91 9.27 37.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.397 -0.906 . . . . 61.43 113.028 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 p -98.94 108.74 21.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.392 -0.475 . . . . 70.040000000000006 110.056 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -118.57 98.83 6.44 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.638 -0.425 . . . . 71.319999999999993 112.077 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.41 90.56 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.213 -1.032 . . . . 74.319999999999993 108.213 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -146.38 -25.42 0.43 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.84 -0.618 . . . . 75.549999999999997 110.279 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -90.24 148.22 23.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.449 -1.315 . . . . 53.43 107.449 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.671 ' HD2' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.37 -15.65 35.03 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 111.894 0.331 . . . . 73.200000000000003 111.894 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' HE ' ' HB2' ' A' ' 50' ' ' ASP . 69.9 ttt180 -144.42 99.39 3.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.641 -0.874 . . . . 51.409999999999997 108.641 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 t -73.52 126.72 30.87 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.641 0.734 . . . . 74.150000000000006 112.42 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.3 m -121.2 147.27 45.84 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.612 -1.625 . . . . 62.420000000000002 106.612 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' B' ' 214' ' ' LEU . 17.1 m -123.17 138.42 53.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 120.748 0.308 . . . . 72.400000000000006 110.455 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 p -139.16 130.54 26.98 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.56 0.578 . . . . 71.230000000000004 112.56 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' HG ' HD21 ' B' ' 214' ' ' LEU . 52.1 mt -117.99 141.34 48.56 Favored 'General case' 0 CA--C 1.494 -1.196 0 CA-C-O 121.464 0.649 . . . . 75.010000000000005 111.85 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 p -107.02 141.35 38.37 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 114.951 -1.022 . . . . 75.340000000000003 110.559 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.7 t -126.67 165.01 20.02 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.58 -1.637 . . . . 75.319999999999993 106.58 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -50.25 131.63 23.94 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.585 0.553 . . . . 74.209999999999994 110.322 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.02 98.29 0.02 OUTLIER 'General case' 0 C--O 1.243 0.723 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 113.421 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -125.42 136.0 27.67 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.847 -1.168 . . . . 75.430000000000007 107.847 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.24 141.3 25.81 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 121.94 1.76 . . . . 73.409999999999997 114.532 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.28 163.73 10.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.23 -1.767 . . . . 73.519999999999996 106.23 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' B' ' 231' ' ' GLU . 37.0 t -71.62 -54.91 8.87 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.859 -0.737 . . . . 65.129999999999995 110.435 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -141.31 143.73 34.21 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 120.124 -0.631 . . . . 72.230000000000004 110.694 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 41' ' ' THR . 42.1 mm -73.11 101.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 106.477 -1.675 . . . . 73.510000000000005 106.477 175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.7 ptpt -122.16 162.72 20.81 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.228 -0.442 . . . . 73.540000000000006 111.915 -171.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 20.0 p -124.64 129.96 51.53 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 124.062 0.851 . . . . 63.329999999999998 112.439 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.14 127.58 54.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.372 -0.973 . . . . 75.019999999999996 108.372 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.2 m -109.36 121.0 44.23 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.129 -0.693 . . . . 64.049999999999997 109.129 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.731 HD13 HD11 ' B' ' 240' ' ' ILE . 94.0 mt -105.15 136.7 37.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-N 115.487 -0.779 . . . . 70.129999999999995 109.223 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 34.9 p -133.5 82.74 2.0 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 110.513 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 28.9 mm-40 -112.31 99.68 8.21 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.048 -0.661 . . . . 63.100000000000001 112.327 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.3 72.58 0.54 Allowed Glycine 0 C--N 1.332 0.357 0 O-C-N 123.846 0.716 . . . . 72.230000000000004 112.724 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.565 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 46.8 m 60.56 67.19 0.85 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.745 0.818 . . . . 71.439999999999998 111.41 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD11 ' SG ' ' A' ' 49' ' ' CYS . 62.0 tp -160.06 139.88 11.36 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.226 -0.897 . . . . 43.409999999999997 110.033 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.7 109.93 10.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.333 -0.617 . . . . 62.310000000000002 109.333 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 89.3 m -115.9 138.09 51.5 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.911 -0.774 . . . . 62.130000000000003 108.911 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.35 127.12 68.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.023 -1.103 . . . . 60.310000000000002 108.023 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' A' ' 26' ' ' THR . 55.1 mt -116.78 122.18 69.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 116.302 -0.408 . . . . 73.25 110.137 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.2 m-85 -98.62 116.74 31.52 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 124.103 0.961 . . . . 75.349999999999994 109.864 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.831 HD11 HD13 ' B' ' 229' ' ' ILE . 8.7 mt -92.78 117.92 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 106.956 -1.498 . . . . 71.099999999999994 106.956 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.562 HG22 HG23 ' A' ' 24' ' ' ILE . 31.7 p -126.68 161.63 27.65 Favored 'General case' 0 N--CA 1.413 -2.304 0 C-N-CA 119.109 -1.036 . . . . 73.239999999999995 109.897 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.292 0.4 OUTLIER -76.1 2.12 13.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.4 1.259 . . . . 64.349999999999994 114.4 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -112.42 -4.7 14.19 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.595 -0.442 . . . . 64.129999999999995 110.587 173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 149.55 -159.38 28.05 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 119.824 -1.179 . . . . 74.549999999999997 112.868 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.24 143.12 49.79 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.648 0.737 . . . . 25.129999999999999 111.497 -174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 39.2 tttp -127.31 121.46 31.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.595 -1.184 . . . . 73.019999999999996 108.959 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG21 ' HG ' ' B' ' 245' ' ' LEU . 7.4 p -123.01 128.63 75.21 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-O 122.019 0.914 . . . . 41.119999999999997 110.504 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.6 t -124.37 128.42 49.05 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.942 -1.503 . . . . 74.430000000000007 106.942 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.708 ' SG ' HD11 ' A' ' 34' ' ' LEU . 31.0 t -138.66 145.62 40.66 Favored 'General case' 0 N--CA 1.42 -1.939 0 C-N-CA 117.972 -1.491 . . . . 61.25 111.664 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' HB2' ' HE ' ' A' ' 9' ' ' ARG . 9.9 t0 -137.24 121.31 12.1 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 106.992 -1.485 . . . . 71.340000000000003 106.992 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 35.7 Cg_endo -83.21 34.38 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 123.203 2.602 . . . . 71.049999999999997 112.085 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' OE1' ' HA ' ' A' ' 33' ' ' SER . 46.8 mt-30 67.22 43.05 2.14 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 124.073 0.949 . . . . 73.450000000000003 111.198 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 104.35 2.94 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.271 -0.877 . . . . 65.299999999999997 108.903 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.4 m 76.43 -0.17 3.11 Favored 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 124.106 0.962 . . . . 54.030000000000001 110.934 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 28.52 2.3 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.185 -0.672 . . . . 72.420000000000002 109.185 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.8 m -80.08 -17.93 12.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 116.06 -0.518 . . . . 74.319999999999993 111.507 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -67.24 -59.01 3.78 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.195 -0.457 . . . . 63.539999999999999 109.871 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -108.1 113.38 26.48 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 109.394 -0.595 . . . . 62.350000000000001 109.394 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG12 HE22 ' A' ' 52' ' ' GLN . 33.4 m -99.8 13.79 5.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.814 -0.63 . . . . 72.349999999999994 111.425 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t 62.64 90.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.91 0 CA-C-O 121.619 0.723 . . . . 63.130000000000003 109.532 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -77.16 86.85 3.62 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.68 0.752 . . . . 75.530000000000001 110.846 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 t -171.95 39.49 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 102.701 -3.074 . . . . 62.109999999999999 102.701 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -107.85 15.67 24.27 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.026 -1.897 . . . . 61.219999999999999 112.641 -170.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -81.63 87.28 6.29 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.534 -0.866 . . . . 74.530000000000001 109.398 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -176.72 129.85 0.19 Allowed 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.561 1.145 . . . . 73.329999999999998 108.143 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 C--O 1.252 1.19 0 O-C-N 123.394 0.434 . . . . 70.209999999999994 110.833 179.796 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.806 0.813 . . . . 74.040000000000006 110.509 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.48 41.6 1.86 Allowed Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 115.263 -0.881 . . . . 72.120000000000005 111.059 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 58.5 p -76.39 104.33 6.85 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.454 -0.573 . . . . 72.319999999999993 109.454 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -123.11 107.53 11.86 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 119.83 -0.748 . . . . 72.129999999999995 112.209 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.32 99.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 105.378 -2.082 . . . . 73.430000000000007 105.378 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 34.4 t -72.32 97.53 2.04 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.49 0.662 . . . . 60.219999999999999 111.425 -173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.76 95.08 3.88 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.396 -1.335 . . . . 74.540000000000006 107.396 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 90.61 1.01 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.348 0.87 . . . . 74.209999999999994 113.348 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -92.43 88.04 6.23 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.359 -2.089 . . . . 74.439999999999998 105.359 168.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.9 t -102.83 137.05 41.55 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.233 -0.894 . . . . 64.430000000000007 110.932 -171.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 9.8 m -120.74 143.02 49.01 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 106.438 -1.69 . . . . 64.420000000000002 106.438 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 33.0 m -129.05 140.35 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 109.539 -0.541 . . . . 72.319999999999993 109.539 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 45.4 p -123.3 130.44 52.74 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 116.276 -0.42 . . . . 50.450000000000003 110.981 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 14' ' ' LEU . 27.6 mt -113.79 120.94 42.51 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-O 121.786 0.803 . . . . 74.129999999999995 110.878 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.424 HG23 ' O ' ' B' ' 243' ' ' ARG . 19.2 m -99.27 113.24 25.42 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 114.82 -1.082 . . . . 72.549999999999997 109.306 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 8.9 t -102.41 164.22 11.79 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 106.507 -1.664 . . . . 71.340000000000003 106.507 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' B' ' 219' ' ' LEU . 12.3 mm100 -52.01 120.05 4.96 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.753 -0.832 . . . . 64.230000000000004 108.753 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -39.22 106.49 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.688 1.366 . . . . 74.120000000000005 114.688 -171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 217' ' ' GLN . 79.7 mt -108.63 133.04 20.77 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.022 -1.473 . . . . 71.230000000000004 107.022 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 219' ' ' LEU . 7.4 Cg_exo -72.6 139.9 31.88 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 121.004 1.136 . . . . 72.349999999999994 110.606 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.3 162.36 39.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.974 -0.751 . . . . 73.219999999999999 108.974 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.2 m -96.37 89.49 5.09 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.137 -0.625 . . . . 63.25 111.539 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 72.52 141.49 0.06 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.137 1.375 . . . . 75.230000000000004 113.817 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 26.8 mm -75.72 124.3 33.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 106.956 -1.498 . . . . 75.329999999999998 106.956 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.9 ptpt -143.63 160.7 40.2 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.757 -0.377 . . . . 63.130000000000003 110.304 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.749 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.5 p -122.44 130.24 52.88 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 113.281 0.845 . . . . 71.219999999999999 113.281 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -110.9 144.07 40.53 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.011 -1.107 . . . . 73.430000000000007 108.011 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . . . . . . . . . 25.6 m -118.25 124.76 48.65 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.312 0.577 . . . . 73.129999999999995 110.346 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.831 HD13 HD11 ' A' ' 40' ' ' ILE . 83.5 mt -103.2 137.71 30.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.969 -0.752 . . . . 64.209999999999994 108.969 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 24.6 p -123.5 102.7 8.02 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.45 -0.795 . . . . 63.520000000000003 111.186 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.521 ' HB2' HD12 ' B' ' 234' ' ' LEU . 11.7 mm-40 -112.04 149.34 32.19 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 108.021 -1.103 . . . . 74.219999999999999 108.021 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -45.38 106.16 0.11 Allowed Glycine 0 C--O 1.242 0.648 0 O-C-N 123.701 0.626 . . . . 63.439999999999998 112.729 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.593 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 20.3 m 68.67 35.45 3.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.425 1.09 . . . . 62.439999999999998 110.744 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.682 HD11 ' SG ' ' B' ' 236' ' ' CYS . 3.1 tm? -155.59 125.04 6.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.883 0.373 . . . . 75.120000000000005 110.954 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' B' ' 249' ' ' CYS . 81.2 mtt180 -123.84 120.06 31.51 Favored 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 120.486 -0.485 . . . . 73.299999999999997 111.382 174.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' B' ' 234' ' ' LEU . 80.7 m -115.64 131.29 56.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 120.913 0.387 . . . . 62.439999999999998 111.78 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.2 132.11 62.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.814 -1.18 . . . . 74.120000000000005 107.814 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.749 ' O ' ' HA ' ' B' ' 226' ' ' THR . 48.1 mt -116.74 121.35 67.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.463 -0.335 . . . . 71.120000000000005 110.403 -173.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.596 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 35.2 m-85 -100.33 117.38 34.41 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 123.824 0.702 . . . . 75.409999999999997 109.127 175.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.731 HD11 HD13 ' A' ' 29' ' ' ILE . 7.8 mt -92.02 118.31 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.241 -1.763 . . . . 73.109999999999999 106.241 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 34.6 p -125.17 159.78 30.73 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 119.185 -1.006 . . . . 74.510000000000005 109.874 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.434 ' HD2' ' HG3' ' B' ' 243' ' ' ARG . 0.4 OUTLIER -76.26 7.96 3.79 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.862 1.06 . . . . 63.32 113.862 -178.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.434 ' HG3' ' HD2' ' B' ' 242' ' ' LYS . 99.9 mtt180 -130.01 15.29 5.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.371 0.605 . . . . 54.340000000000003 110.012 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 136.73 -154.47 22.16 Favored Glycine 0 CA--C 1.485 -1.818 0 C-N-CA 119.703 -1.236 . . . . 54.140000000000001 112.557 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.432 ' HG ' HG21 ' A' ' 47' ' ' VAL . 2.8 mm? -133.44 152.78 51.95 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.047 0.451 . . . . 72.299999999999997 111.135 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 15.7 ttmm -129.8 130.02 44.81 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.253 -1.388 . . . . 71.319999999999993 107.253 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.13 128.25 74.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.76 0 N-CA-C 108.34 -0.985 . . . . 62.43 108.34 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 48.9 t -120.76 124.28 44.73 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 109.078 -0.712 . . . . 53.100000000000001 109.078 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 235' ' ' ARG . 80.4 m -123.25 133.93 54.15 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 119.571 -0.851 . . . . 63.439999999999998 112.041 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' B' ' 252' ' ' GLN . 37.4 t0 -117.27 104.93 49.58 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 106.343 -1.725 . . . . 74.140000000000001 106.343 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 6.3 Cg_exo -73.34 24.35 0.31 Allowed 'Trans proline' 0 N--CA 1.483 0.871 0 C-N-CA 124.157 3.238 . . . . 61.43 111.573 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.593 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 49.9 mt-30 63.33 68.71 0.6 Allowed 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 125.478 1.511 . . . . 75.400000000000006 110.621 -177.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -111.98 127.92 56.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.434 -1.712 . . . . 55.149999999999999 109.591 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 12.8 m 75.05 20.4 2.15 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.505 1.145 . . . . 63.109999999999999 109.533 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -82.54 69.56 9.33 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.125 0.964 . . . . 71.150000000000006 111.739 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.53 -6.39 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 113.807 -1.542 . . . . 65.010000000000005 107.154 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -124.38 106.31 10.12 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.352 -1.749 . . . . 74.439999999999998 109.52 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.6 t0 64.57 166.79 0.16 Allowed 'General case' 0 CA--C 1.561 1.375 0 O-C-N 124.083 0.864 . . . . 54.539999999999999 113.286 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.37 22.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 124.182 0.993 . . . . 74.510000000000005 108.493 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 86.0 t 77.54 106.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.199 1.399 . . . . 62.119999999999997 110.447 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -74.32 79.2 1.84 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.81 -0.632 . . . . 73.400000000000006 110.841 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.7 t -177.7 92.63 0.03 OUTLIER 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.843 -1.54 . . . . 75.150000000000006 106.843 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.37 72.21 1.31 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.901 0.858 . . . . 74.219999999999999 111.815 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -137.65 82.34 1.92 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.79 -1.096 . . . . 64.120000000000005 109.195 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -165.01 134.0 3.46 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.666 -0.697 . . . . 70.420000000000002 110.045 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 115.318 -0.855 . . . . 53.450000000000003 109.816 178.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 108.406 -0.961 . . . . 65.450000000000003 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.73 96.32 1.02 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.491 -0.862 . . . . 70.040000000000006 111.167 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -147.8 112.22 5.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.944 0.402 . . . . 75.420000000000002 111.158 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -91.28 154.27 19.37 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.488 -0.93 . . . . 73.140000000000001 108.488 174.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.24 141.94 14.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 119.744 -0.782 . . . . 34.539999999999999 111.284 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.0 m -89.71 123.43 33.72 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.586 -0.734 . . . . 54.009999999999998 109.292 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.51 -52.22 66.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.783 -0.821 . . . . 72.239999999999995 108.783 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -144.52 -176.03 4.88 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.824 -1.176 . . . . 60.25 107.824 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -61.94 110.86 1.68 Allowed 'General case' 0 C--O 1.247 0.939 0 CA-C-O 121.53 0.681 . . . . 63.109999999999999 112.452 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 m -85.58 109.6 18.65 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.201 -1.407 . . . . 74.0 107.201 176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.4 m -121.39 153.45 37.8 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.289 -0.634 . . . . 70.400000000000006 109.289 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.623 HG13 HD12 ' B' ' 214' ' ' LEU . 16.3 t -96.91 130.55 45.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.281 -1.007 . . . . 72.019999999999996 108.281 175.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.2 p -129.74 110.22 11.59 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.678 -0.692 . . . . 72.329999999999998 109.327 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.571 HD21 ' HG ' ' B' ' 214' ' ' LEU . 82.3 mt -114.74 118.83 34.71 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 115.505 -0.771 . . . . 64.230000000000004 109.169 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -102.3 142.07 34.12 Favored 'General case' 0 N--CA 1.408 -2.543 0 CA-C-N 114.753 -1.112 . . . . 63.039999999999999 110.825 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.586 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.7 t -128.57 165.08 21.45 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.08 -1.452 . . . . 75.0 107.08 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -59.98 -77.18 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 114.243 1.201 . . . . 65.310000000000002 114.243 -174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -152.54 106.71 3.13 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.672 -0.811 . . . . 74.140000000000001 111.54 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 7.7 mp -124.03 96.72 41.94 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 107.441 -1.318 . . . . 70.230000000000004 107.441 175.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.06 139.99 81.78 Favored 'Trans proline' 0 C--O 1.247 0.974 0 C-N-CA 122.062 1.841 . . . . 70.439999999999998 113.226 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.86 147.89 32.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.763 -1.108 . . . . 73.409999999999997 108.032 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 t -82.54 -22.79 34.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.687 -0.405 . . . . 64.510000000000005 110.513 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -150.61 135.14 17.23 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.783 -0.451 . . . . 75.209999999999994 109.783 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 41' ' ' THR . 43.0 mm -81.61 107.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 N-CA-C 105.862 -1.903 . . . . 73.25 105.862 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 12.3 ptpt -120.34 155.73 32.75 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 111.579 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.6 p -124.45 129.66 51.06 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.323 -0.853 . . . . 62.5 112.146 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -108.37 142.2 39.06 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.018 -0.992 . . . . 74.329999999999998 108.338 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.4 p -115.98 123.53 48.24 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.7 0.762 . . . . 74.450000000000003 112.581 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.721 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 86.9 mt -102.85 135.33 40.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.773 -1.103 . . . . 64.109999999999999 108.411 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.9 p -133.9 30.59 3.68 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.05 0.452 . . . . 73.450000000000003 112.138 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.608 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 6.4 mm-40 -70.78 99.76 1.78 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 113.541 0.941 . . . . 75.129999999999995 113.541 -170.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.52 54.93 4.82 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 112.396 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 m 59.69 78.82 0.25 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.985 0.898 . . . . 64.0 109.491 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 30' ' ' THR . 68.2 tp -159.41 147.37 17.46 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.612 -1.255 . . . . 73.450000000000003 107.612 -172.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.47 111.49 11.32 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.235 -0.654 . . . . 72.329999999999998 109.235 169.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 4.2 t -116.85 134.33 54.91 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.21 -1.033 . . . . 62.210000000000001 108.21 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 t -117.23 128.45 74.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.961 -1.125 . . . . 53.109999999999999 107.961 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 26' ' ' THR . 67.3 mt -116.14 118.14 57.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.17 -0.678 . . . . 74.239999999999995 109.17 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.5 m-85 -99.98 115.19 29.11 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.348 -0.612 . . . . 75.430000000000007 109.348 177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 4.5 mt -94.48 117.26 37.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 105.842 -1.91 . . . . 71.239999999999995 105.842 174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.563 HG22 HG23 ' A' ' 24' ' ' ILE . 29.9 p -126.71 167.51 15.63 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 119.656 -0.818 . . . . 65.230000000000004 109.122 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.257 0.0 OUTLIER -71.9 -7.6 49.47 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.846 1.425 . . . . 70.239999999999995 114.846 -178.3 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -120.97 10.32 10.79 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.976 -0.453 . . . . 64.120000000000005 111.548 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 150.35 -171.67 30.22 Favored Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 117.792 -2.147 . . . . 65.299999999999997 114.441 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.8 mp -128.24 138.27 52.37 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.678 -0.761 . . . . 73.420000000000002 111.702 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.0 ttmt -115.29 121.88 44.23 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.627 -1.249 . . . . 62.210000000000001 107.627 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 12' ' ' VAL . 27.7 m -119.16 115.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-O 121.855 0.836 . . . . 41.049999999999997 109.071 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 25.8 t -120.64 96.93 5.32 Favored 'General case' 0 C--N 1.277 -2.554 0 C-N-CA 120.21 -0.596 . . . . 75.120000000000005 110.194 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 100.0 m -93.25 132.87 37.04 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.254 -0.578 . . . . 64.319999999999993 110.455 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.71 102.82 41.27 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.246 -1.02 . . . . 42.310000000000002 108.246 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.25 -1.95 12.07 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.984 2.456 . . . . 51.340000000000003 112.392 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 67.55 -63.44 0.3 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.677 1.191 . . . . 71.349999999999994 111.799 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 66.73 -57.69 0.4 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.646 1.578 . . . . 70.239999999999995 113.05 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.2 m -110.25 92.84 4.21 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.122 -1.066 . . . . 71.219999999999999 108.122 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -139.83 -26.25 0.8 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 112.181 0.437 . . . . 74.439999999999998 112.181 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.19 122.29 11.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 CA-C-O 121.664 0.745 . . . . 63.340000000000003 110.843 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -156.75 -42.93 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.66 -1.607 . . . . 62.329999999999998 106.66 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -125.94 -177.88 4.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 104.889 -2.263 . . . . 74.340000000000003 104.889 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.06 -5.7 10.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 107.523 -1.288 . . . . 72.25 107.523 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.1 t 78.55 75.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-N 113.016 -1.902 . . . . 70.439999999999998 110.461 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -91.07 99.86 12.81 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.786 -1.097 . . . . 74.420000000000002 109.293 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -142.98 -17.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.438 -0.801 . . . . 75.209999999999994 111.417 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.1 tmm? 65.69 96.77 0.05 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.056 0.943 . . . . 71.219999999999999 110.621 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -135.84 127.78 29.51 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.774 -0.648 . . . . 71.340000000000003 111.589 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -135.53 142.94 45.49 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.185 -0.672 . . . . 60.549999999999997 109.185 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--N 1.303 -1.438 0 N-CA-C 109.314 -0.624 . . . . 74.340000000000003 109.314 177.761 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.223 -0.658 . . . . 73.319999999999993 109.223 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -127.83 -71.95 0.16 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.037 -0.825 . . . . 75.420000000000002 111.037 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.9 t -156.29 81.51 0.98 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.333 -0.988 . . . . 75.239999999999995 108.333 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.73 91.56 2.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.871 0.843 . . . . 74.099999999999994 111.312 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.35 159.17 7.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.494 -0.775 . . . . 62.399999999999999 110.311 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.405 ' O ' ' HB ' ' B' ' 254' ' ' THR . 19.5 m -84.95 80.26 9.35 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 122.063 0.935 . . . . 50.409999999999997 109.27 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -144.87 -46.37 0.23 Allowed 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.875 -1.898 . . . . 62.310000000000002 105.875 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -94.63 123.75 38.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.964 -1.495 . . . . 65.109999999999999 106.964 173.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -95.86 100.84 12.49 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.648 0.737 . . . . 73.109999999999999 112.985 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -82.79 132.06 35.18 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.782 -1.099 . . . . 63.439999999999998 108.675 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.9 145.02 47.09 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 74.140000000000001 107.147 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.01 142.35 25.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.921 -0.399 . . . . 55.509999999999998 109.921 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.55 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 31.8 p -144.16 135.38 25.53 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.936 0.717 . . . . 75.510000000000005 112.936 -174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.623 HD12 HG13 ' A' ' 12' ' ' VAL . 15.6 mt -119.21 118.44 31.32 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-O 121.216 0.531 . . . . 74.430000000000007 110.136 169.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 37.2 p -99.47 111.77 24.07 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 108.253 -1.018 . . . . 72.129999999999995 108.253 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.42 HG23 HD13 ' B' ' 219' ' ' LEU . 4.9 t -101.13 166.26 10.88 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 115.253 -0.885 . . . . 75.109999999999999 110.636 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -35.47 -76.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.834 1.254 . . . . 75.109999999999999 113.937 -174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -171.92 116.28 0.37 Allowed 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.887 0.375 . . . . 74.510000000000005 110.529 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.42 HD13 HG23 ' B' ' 216' ' ' THR . 6.4 mp -125.44 105.71 27.59 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.432 -1.322 . . . . 63.119999999999997 107.432 176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.95 138.77 64.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 120.885 1.057 . . . . 50.43 111.434 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.439 HG11 HG22 ' B' ' 240' ' ' ILE . 33.9 m -131.24 162.44 39.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.725 -0.671 . . . . 73.430000000000007 110.539 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 36.7 t -72.09 -32.2 66.79 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.069 -0.514 . . . . 75.219999999999999 111.933 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -171.54 141.43 1.5 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.926 -0.398 . . . . 71.219999999999999 109.926 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' B' ' 240' ' ' ILE . 38.1 mm -70.5 114.16 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 106.134 -1.802 . . . . 74.239999999999995 106.134 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -139.37 163.35 32.74 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.862 -0.335 . . . . 75.109999999999999 110.477 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 13.2 p -122.24 134.16 54.7 Favored 'General case' 0 N--CA 1.417 -2.104 0 O-C-N 123.682 0.614 . . . . 72.530000000000001 112.049 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -108.07 127.66 53.98 Favored 'General case' 0 CA--C 1.475 -1.928 0 N-CA-C 108.362 -0.977 . . . . 74.450000000000003 108.362 173.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 57.6 m -107.7 120.97 43.71 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 108.498 -0.927 . . . . 64.239999999999995 108.498 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 87.0 mt -101.54 133.37 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.905 -1.146 . . . . 73.430000000000007 107.905 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.427 HG22 ' HG2' ' B' ' 235' ' ' ARG . 24.5 p -133.77 80.37 1.87 Allowed 'General case' 0 C--N 1.269 -2.908 0 CA-C-O 122.052 0.929 . . . . 74.099999999999994 110.265 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.488 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 54.3 mm-40 -96.07 150.03 20.94 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.32 -1.363 . . . . 74.349999999999994 107.32 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . -36.11 111.84 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 123.97 0.794 . . . . 55.020000000000003 113.989 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 21.6 m 71.12 34.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.682 1.193 . . . . 64.310000000000002 111.876 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' B' ' 251' ' ' PRO . 46.8 tp -157.81 136.64 11.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.952 0.723 . . . . 74.140000000000001 112.952 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.427 ' HG2' HG22 ' B' ' 230' ' ' THR . 99.3 mtt180 -128.1 113.12 15.35 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.427 -0.583 . . . . 74.129999999999995 109.427 172.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 229' ' ' ILE . 94.2 m -122.05 145.43 48.15 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 122.328 -0.232 . . . . 73.420000000000002 111.364 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.3 128.57 70.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.422 -0.955 . . . . 71.510000000000005 108.422 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' B' ' 226' ' ' THR . 52.9 mt -117.09 123.39 71.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 123.065 0.546 . . . . 73.129999999999995 110.069 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.8 m-85 -98.54 119.92 38.09 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 123.193 0.597 . . . . 74.519999999999996 110.794 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 29' ' ' ILE . 8.0 mt -96.17 118.18 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.076 -1.453 . . . . 72.140000000000001 107.076 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.535 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 46.5 p -124.43 166.15 16.5 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.403 -0.919 . . . . 74.310000000000002 109.037 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . 0.27 0.0 OUTLIER -75.83 -1.59 25.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.516 0.932 . . . . 75.409999999999997 113.516 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.52 -59.39 1.73 Allowed 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 108.726 -0.842 . . . . 73.0 108.726 170.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.421 ' C ' HD12 ' B' ' 245' ' ' LEU . . . -158.84 -153.34 6.76 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.569 -0.824 . . . . 51.210000000000001 112.508 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.421 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.5 mp -132.33 145.22 51.11 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 112.36 0.504 . . . . 61.32 112.36 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.1 ttmt -115.2 131.63 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.0 -1.111 . . . . 71.450000000000003 108.0 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.33 125.04 71.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.746 0.784 . . . . 65.120000000000005 110.338 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.8 t -123.4 136.86 54.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.007 -1.108 . . . . 42.5 108.007 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 84.8 m -135.16 134.75 40.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 113.564 0.949 . . . . 73.340000000000003 113.564 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.44 101.28 40.73 Favored Pre-proline 0 C--N 1.296 -1.728 0 CA-C-N 113.849 -1.523 . . . . 72.340000000000003 108.352 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 89.9 Cg_endo -77.89 14.8 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.113 2.542 . . . . 75.549999999999997 112.853 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.439 ' HB3' ' NE1' ' B' ' 255' ' ' TRP . 95.8 mt-30 68.24 -75.36 0.07 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 73.040000000000006 112.159 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 35.83 -81.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 74.439999999999998 116.424 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 206' ' ' SER . 16.6 m -69.1 -3.46 13.38 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.712 1.205 . . . . 74.430000000000007 112.755 -173.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.439 ' NE1' ' HB3' ' B' ' 252' ' ' GLN . 0.2 OUTLIER -81.51 -0.62 42.75 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.329 -0.857 . . . . 64.340000000000003 109.805 178.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.19 126.72 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-N 114.53 -1.214 . . . . 73.209999999999994 112.56 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 172.47 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 105.365 -2.087 . . . . 72.239999999999995 105.365 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.82 168.52 19.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 105.628 -1.99 . . . . 74.010000000000005 105.628 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.02 -16.71 16.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.24 0.543 . . . . 73.409999999999997 109.681 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.3 t 68.53 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.051 1.34 . . . . 64.010000000000005 111.892 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.5 124.29 16.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.8 -1.926 . . . . 54.100000000000001 105.8 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 44.6 m -146.6 -78.12 0.17 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 122.499 -0.126 . . . . 70.439999999999998 110.884 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -103.53 -57.48 2.03 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.835 -1.172 . . . . 70.019999999999996 107.835 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 67.1 136.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.2 1.926 . . . . 71.209999999999994 116.2 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -132.19 147.99 52.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.366 -1.346 . . . . 75.209999999999994 107.366 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 120.624 -0.43 . . . . 60.219999999999999 110.054 -177.885 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 109.292 -0.633 . . . . 63.539999999999999 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 32.1 2.45 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.453 -0.88 . . . . 53.039999999999999 111.269 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -101.2 102.72 13.68 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 120.782 0.325 . . . . 74.140000000000001 111.119 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.28 90.55 8.44 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.477 -1.305 . . . . 73.209999999999994 107.477 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.56 164.45 2.1 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-N 115.441 -0.8 . . . . 61.049999999999997 111.968 -172.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 m -86.27 138.59 31.73 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.921 -1.511 . . . . 73.420000000000002 106.921 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -123.62 144.25 49.73 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.629 -0.828 . . . . 74.409999999999997 110.477 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -55.57 131.64 46.74 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.158 0.983 . . . . 61.420000000000002 108.917 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -50.71 128.88 21.73 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 112.869 0.692 . . . . 63.32 112.869 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -94.94 122.82 37.99 Favored 'General case' 0 N--CA 1.401 -2.883 0 CA-C-N 115.163 -0.926 . . . . 53.310000000000002 108.896 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.3 m -120.03 144.45 47.54 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.296 -2.113 . . . . 74.510000000000005 105.296 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.38 152.48 19.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.615 -0.834 . . . . 65.200000000000003 111.213 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.0 p -122.94 130.37 52.74 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-O 121.536 0.684 . . . . 64.200000000000003 110.534 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 ' HB3' ' CG2' ' B' ' 212' ' ' VAL . 98.2 mt -113.68 129.54 56.55 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.875 -1.157 . . . . 70.530000000000001 107.875 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.1 p -94.23 141.21 28.82 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.176 -0.61 . . . . 73.019999999999996 111.92 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 44' ' ' GLY . 12.6 t -127.34 165.96 18.75 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.624 -1.25 . . . . 72.010000000000005 107.624 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -46.94 131.4 12.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.273 -0.639 . . . . 71.349999999999994 109.273 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -71.63 99.63 2.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.849 1.055 . . . . 63.340000000000003 113.849 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.69 132.93 23.85 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 106.79 -1.559 . . . . 65.400000000000006 106.79 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.65 141.02 77.77 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.712 1.608 . . . . 74.150000000000006 111.408 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.01 145.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.198 -0.667 . . . . 74.040000000000006 109.198 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.9 m -84.12 95.74 8.71 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 120.709 -0.396 . . . . 50.329999999999998 110.219 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 71.33 132.93 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.043 1.337 . . . . 71.450000000000003 113.003 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 41' ' ' THR . 28.1 mm -63.85 107.04 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 N-CA-C 106.103 -1.814 . . . . 64.150000000000006 106.103 174.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -106.16 156.2 18.68 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.274 -0.639 . . . . 52.200000000000003 109.274 -173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 7.1 p -124.21 130.19 52.1 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.297 1.221 . . . . 63.530000000000001 114.297 -176.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -108.43 134.32 51.39 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.066 -1.087 . . . . 73.120000000000005 108.066 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -111.69 126.17 54.75 Favored 'General case' 0 N--CA 1.418 -2.045 0 C-N-CA 119.761 -0.776 . . . . 73.450000000000003 110.384 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 80.8 mt -101.99 136.51 33.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 114.871 -1.058 . . . . 72.409999999999997 108.53 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.9 p -135.14 80.7 1.85 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.282 0.633 . . . . 74.349999999999994 110.167 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 19.9 mm-40 -114.13 99.79 7.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.181 -1.008 . . . . 65.019999999999996 111.435 -173.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.73 67.8 1.99 Allowed Glycine 0 CA--C 1.522 0.473 0 O-C-N 123.514 0.509 . . . . 73.299999999999997 113.299 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.8 m 68.13 12.15 8.66 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.32 1.048 . . . . 54.439999999999998 112.523 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.8 tm? -112.78 128.25 56.38 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.852 0.461 . . . . 74.430000000000007 109.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 35' ' ' ARG . 23.6 mtt180 -105.51 142.17 35.72 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 109.553 -0.536 . . . . 74.200000000000003 109.553 173.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 1.3 t -138.72 135.04 34.34 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 108.071 -1.085 . . . . 73.450000000000003 108.071 172.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.64 130.36 70.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.397 -0.964 . . . . 70.019999999999996 108.397 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 26' ' ' THR . 58.8 mt -116.46 118.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.607 -0.516 . . . . 71.200000000000003 109.607 -176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.62 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 44.8 m-85 -99.84 115.79 30.41 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.537 -0.912 . . . . 73.010000000000005 108.537 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.514 HD11 HD13 ' B' ' 229' ' ' ILE . 6.6 mt -91.95 117.78 36.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.295 -1.372 . . . . 71.120000000000005 107.295 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.575 ' HA ' HD12 ' A' ' 24' ' ' ILE . 42.6 p -112.01 165.34 12.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.837 -0.801 . . . . 70.310000000000002 108.837 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -63.08 -4.51 2.36 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 116.48 2.03 . . . . 75.329999999999998 116.48 -178.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -136.52 9.27 3.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 121.72 -0.612 . . . . 75.340000000000003 112.621 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.01 176.17 40.04 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 118.538 -1.791 . . . . 52.229999999999997 113.419 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.76 137.74 53.76 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.437 -0.579 . . . . 53.109999999999999 109.437 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 63.9 tttt -114.36 120.73 41.35 Favored 'General case' 0 C--N 1.268 -2.961 0 CA-C-N 115.064 -0.971 . . . . 74.450000000000003 109.536 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.56 136.34 52.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 116.029 -0.532 . . . . 64.109999999999999 110.016 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.36 99.82 4.07 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 109.192 -0.67 . . . . 72.420000000000002 109.192 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 93.0 m -92.23 133.8 35.48 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.164 0.507 . . . . 63.329999999999998 111.373 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -138.51 128.17 14.73 Favored Pre-proline 0 C--O 1.212 -0.871 0 C-N-CA 124.343 1.057 . . . . 71.209999999999994 108.183 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.49 28.84 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.526 2.817 . . . . 73.540000000000006 112.799 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 69.65 21.44 6.6 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.834 1.254 . . . . 75.239999999999995 110.119 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.72 -25.51 35.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.261 -0.881 . . . . 62.119999999999997 109.74 -177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.3 m -101.14 11.21 39.9 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 122.474 1.13 . . . . 75.329999999999998 108.484 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -117.28 -55.44 2.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.021 -0.991 . . . . 74.510000000000005 109.834 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t 56.96 97.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.429 1.092 . . . . 72.120000000000005 112.011 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 68.85 94.85 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.448 1.099 . . . . 75.219999999999999 110.014 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -117.75 153.49 33.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.313 -0.403 . . . . 74.109999999999999 111.167 -176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -85.16 -16.59 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.4 0.68 . . . . 65.5 111.852 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.8 t -86.69 103.88 13.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.999 0.905 . . . . 75.439999999999998 110.336 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -86.81 150.65 23.99 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.603 -1.181 . . . . 72.329999999999998 108.548 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -67.75 93.99 0.42 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.398 0.618 . . . . 73.099999999999994 111.006 174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 50.6 ttm -102.48 34.77 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.578 -1.638 . . . . 74.439999999999998 106.578 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -62.26 -37.79 86.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.967 -1.47 . . . . 70.129999999999995 111.203 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 50.18 85.08 0.03 OUTLIER 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.149 0.98 . . . . 72.200000000000003 111.333 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.456 1.102 . . . . 74.200000000000003 111.68 -176.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.369 -0.604 . . . . 75.129999999999995 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 127.22 54.3 0.14 Allowed Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.741 -0.742 . . . . 73.329999999999998 111.266 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 30.4 m -143.04 87.48 1.98 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.476 0.655 . . . . 73.329999999999998 109.523 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -110.2 130.69 55.5 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.729 -1.212 . . . . 75.400000000000006 107.729 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 23.8 m -103.09 103.12 14.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.199 0.523 . . . . 75.319999999999993 110.478 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 69.1 p -73.66 102.46 3.93 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 116.191 -0.459 . . . . 53.240000000000002 110.234 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.87 108.24 10.97 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.817 -0.808 . . . . 54.409999999999997 108.817 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -88.62 -54.95 3.92 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.172 -0.922 . . . . 71.319999999999993 109.525 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -124.16 126.12 45.61 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.245 -1.02 . . . . 72.25 108.245 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 8.8 t -95.82 97.75 9.9 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.086 0.946 . . . . 73.040000000000006 109.052 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 10.5 m -120.58 144.18 48.24 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.638 -1.245 . . . . 44.32 107.638 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.639 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 2.4 m -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 C-N-CA 123.698 0.799 . . . . 63.240000000000002 109.323 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 35.1 p -142.56 120.29 11.88 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.4 0.519 . . . . 75.030000000000001 112.4 -173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.544 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.5 mt -117.66 141.51 48.31 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 112.754 0.65 . . . . 73.310000000000002 112.754 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.407 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 17.7 p -94.7 128.07 41.12 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.052 -0.976 . . . . 55.439999999999998 110.931 176.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.3 t -147.33 148.28 31.22 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.099 -1.074 . . . . 75.040000000000006 108.099 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 69.66 169.27 0.3 Allowed 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.696 0.798 . . . . 61.439999999999998 111.577 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -129.21 12.95 6.12 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.013 0.435 . . . . 70.510000000000005 110.509 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 62.1 tp -91.79 110.39 43.26 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.754 -0.657 . . . . 74.209999999999994 109.535 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.73 148.84 90.52 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.707 2.271 . . . . 63.140000000000001 112.109 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.34 162.83 4.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 116.159 -0.473 . . . . 75.120000000000005 110.072 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 50.0 m -101.87 111.16 23.32 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.808 -0.812 . . . . 65.420000000000002 108.808 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 76.94 118.13 0.06 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.493 1.117 . . . . 72.120000000000005 112.956 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.9 mm -75.75 109.54 9.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.357 -2.09 . . . . 74.230000000000004 105.357 174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.2 ptpt -118.47 162.19 18.76 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.903 -173.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.9 p -120.65 133.17 55.38 Favored 'General case' 0 N--CA 1.421 -1.925 0 O-C-N 123.805 0.691 . . . . 71.430000000000007 112.438 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -108.58 137.12 47.05 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-N 115.424 -0.807 . . . . 74.129999999999995 109.144 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.8 p -108.4 122.28 46.67 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 122.072 0.939 . . . . 72.439999999999998 111.815 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' B' ' 236' ' ' CYS . 69.2 mt -102.37 138.17 27.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 114.45 -1.25 . . . . 72.430000000000007 108.248 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 41.4 p -134.18 86.12 2.25 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-O 121.042 0.448 . . . . 62.020000000000003 109.839 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.571 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 34.7 mm-40 -114.32 99.1 7.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.492 -0.883 . . . . 73.420000000000002 110.775 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 65.8 55.07 21.67 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.696 -0.764 . . . . 72.340000000000003 112.746 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.0 m 70.76 18.42 6.24 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.062 0.945 . . . . 64.040000000000006 112.518 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.7 tm? -111.37 125.44 53.86 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.677 -1.231 . . . . 72.209999999999994 107.677 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 87.1 mtt-85 -111.06 114.67 28.12 Favored 'General case' 0 C--O 1.196 -1.752 0 N-CA-C 110.023 -0.362 . . . . 72.120000000000005 110.023 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 1.8 t -111.41 136.84 49.99 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 119.284 -0.966 . . . . 71.040000000000006 109.511 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.9 t -113.96 125.93 71.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 107.842 -1.17 . . . . 70.120000000000005 107.842 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.7 mt -116.22 118.29 58.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.676 -0.49 . . . . 74.319999999999993 109.676 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.622 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 47.6 m-85 -95.58 115.4 27.37 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 123.625 0.77 . . . . 73.239999999999995 109.085 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 29' ' ' ILE . 7.9 mt -92.2 117.85 36.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.577 -1.638 . . . . 72.430000000000007 106.577 176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.577 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.2 p -115.59 166.73 11.59 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.09 -1.044 . . . . 72.230000000000004 110.007 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -19.02 5.41 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 116.477 2.028 . . . . 73.230000000000004 116.477 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -144.79 27.05 1.35 Allowed 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 112.482 0.549 . . . . 75.150000000000006 112.482 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 173.47 167.27 33.0 Favored Glycine 0 CA--C 1.486 -1.765 0 C-N-CA 118.253 -1.927 . . . . 71.019999999999996 113.383 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.504 HD11 ' SG ' ' A' ' 49' ' ' CYS . 5.6 mp -123.17 137.12 54.97 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.455 0.645 . . . . 72.439999999999998 110.776 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.622 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 63.4 tttt -115.31 120.48 39.8 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.466 -1.243 . . . . 73.299999999999997 109.864 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.78 136.85 48.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 109.542 -0.54 . . . . 72.239999999999995 109.542 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 19.4 t -137.47 111.57 8.41 Favored 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 108.204 -1.036 . . . . 73.0 108.204 176.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 73.3 m -97.58 133.62 41.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 119.759 -0.776 . . . . 65.019999999999996 110.435 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.425 ' OD2' ' HD1' ' B' ' 255' ' ' TRP . 24.7 t70 -124.91 117.03 26.01 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 109.154 -0.684 . . . . 62.539999999999999 109.154 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.14 33.5 0.35 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.533 2.822 . . . . 60.350000000000001 111.674 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.419 ' HG2' ' HE ' ' B' ' 235' ' ' ARG . 42.5 mt-30 67.67 44.06 1.72 Allowed 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.661 1.185 . . . . 65.019999999999996 110.128 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -96.39 -43.01 7.85 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 113.494 -1.684 . . . . 53.350000000000001 108.122 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.8 m -85.55 -35.63 20.96 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.539 -0.755 . . . . 64.150000000000006 109.098 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.425 ' HD1' ' OD2' ' B' ' 250' ' ' ASP . 82.5 m95 -79.65 -41.85 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.586 -0.734 . . . . 72.329999999999998 110.996 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 59.9 t 67.4 -64.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.476 1.111 . . . . 63.229999999999997 112.412 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -108.51 161.09 15.38 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.421 -0.955 . . . . 61.210000000000001 108.421 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -73.09 80.26 1.24 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.274 -1.01 . . . . 74.239999999999995 108.274 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.7 p -92.29 -11.1 9.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.001 -1.0 . . . . 72.409999999999997 110.757 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 52.1 t -76.28 97.66 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.179 -1.045 . . . . 64.430000000000007 108.179 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -103.11 106.4 16.91 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 107.947 -1.131 . . . . 74.239999999999995 107.947 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -140.48 86.9 2.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.339 0.59 . . . . 65.439999999999998 110.539 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 49.0 ttm -106.5 116.44 31.93 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.855 -0.795 . . . . 62.439999999999998 108.855 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.46 -25.74 23.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.043 -0.526 . . . . 73.329999999999998 110.963 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 71.05 166.34 0.3 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.157 0.983 . . . . 53.420000000000002 113.585 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? . . . . . 0 C--O 1.266 1.956 0 CA-C-N 115.277 -0.874 . . . . 72.129999999999995 109.993 178.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 120.561 0.22 . . . . 65.030000000000001 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.82 31.19 8.45 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.314 -0.946 . . . . 74.109999999999999 111.795 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -118.05 139.37 51.3 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.919 -0.771 . . . . 45.310000000000002 108.919 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.97 101.34 7.71 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.295 -0.632 . . . . 75.129999999999995 109.295 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.8 t -103.63 -50.9 9.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.924 0.869 . . . . 73.319999999999993 109.194 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 p -137.74 27.86 2.7 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.225 -1.398 . . . . 54.009999999999998 107.225 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.02 160.08 14.6 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.302 -1.317 . . . . 70.540000000000006 112.434 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -163.46 157.1 19.38 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 104.832 -2.284 . . . . 75.530000000000001 104.832 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -79.01 93.42 5.11 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.591 -2.003 . . . . 71.409999999999997 105.591 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 m -90.81 121.86 33.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.01 -0.995 . . . . 63.539999999999999 113.217 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.1 m -121.35 144.85 48.43 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.946 -1.872 . . . . 74.129999999999995 105.946 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -122.34 141.79 41.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.978 -0.689 . . . . 71.140000000000001 111.004 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 p -123.3 125.76 45.63 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 116.108 -0.497 . . . . 74.109999999999999 110.592 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' B' ' 212' ' ' VAL . 73.9 mt -119.69 124.62 46.69 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.826 -0.624 . . . . 71.530000000000001 110.876 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.5 p -94.17 117.5 30.21 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 115.661 -0.7 . . . . 75.299999999999997 109.251 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -139.26 135.03 33.44 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 108.271 -1.011 . . . . 74.409999999999997 108.271 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 57.3 -179.01 0.05 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.077 0.861 . . . . 62.439999999999998 112.323 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -138.02 90.33 2.47 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.012 -0.736 . . . . 73.019999999999996 109.012 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -126.06 116.73 23.88 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.025 -176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.6 140.59 82.11 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.628 1.552 . . . . 70.5 110.434 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.47 162.64 12.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.237 -0.438 . . . . 75.120000000000005 110.239 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.1 m -86.19 -20.72 28.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.241 0.543 . . . . 53.210000000000001 110.54 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 tpm_? -162.85 145.21 10.51 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.768 -1.197 . . . . 53.43 107.768 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.6 mm -89.72 107.74 18.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 103.892 -2.633 . . . . 73.450000000000003 103.892 169.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' HE3' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -115.69 158.29 23.0 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.387 -0.597 . . . . 74.549999999999997 109.387 -173.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.741 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.0 p -120.99 133.69 55.28 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 123.91 0.756 . . . . 44.420000000000002 111.667 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -109.16 135.82 49.66 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.691 -0.686 . . . . 74.319999999999993 109.325 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 3.4 p -108.53 123.43 48.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 121.629 0.728 . . . . 71.099999999999994 112.268 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.61 HD13 HD11 ' B' ' 240' ' ' ILE . 73.3 mt -104.04 133.26 48.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.21 -1.404 . . . . 73.239999999999995 107.21 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 37.3 p -134.97 95.87 3.4 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 109.601 -0.518 . . . . 63.310000000000002 109.601 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 2.2 pp20? -152.18 115.32 4.69 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 114.572 1.323 . . . . 64.400000000000006 114.572 -177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 56.42 5.16 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.234 -0.894 . . . . 72.519999999999996 112.922 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m 58.39 54.39 5.65 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.333 -0.988 . . . . 72.430000000000007 108.333 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.1 tm? -155.44 132.67 10.9 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.327 -0.851 . . . . 62.340000000000003 111.248 -171.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -117.52 142.81 46.73 Favored 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 107.62 -1.252 . . . . 72.299999999999997 107.62 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.9 t -139.03 142.38 38.26 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.637 -0.825 . . . . 65.420000000000002 108.79 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.09 131.66 69.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.441 -0.948 . . . . 72.400000000000006 108.441 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' O ' ' HA ' ' A' ' 26' ' ' THR . 60.4 mt -124.27 118.83 54.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.113 0.258 . . . . 61.439999999999998 111.137 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 48.3 m-85 -98.13 113.1 24.89 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 108.87 -0.789 . . . . 75.349999999999994 108.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.684 HD11 HD13 ' B' ' 229' ' ' ILE . 4.3 mt -96.79 117.76 41.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 106.911 -1.514 . . . . 55.130000000000003 106.911 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 24' ' ' ILE . 34.9 p -115.58 -176.05 2.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.459 -0.571 . . . . 74.409999999999997 109.459 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -80.86 -1.88 45.07 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.262 0.838 . . . . 72.439999999999998 113.262 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.37 5.37 5.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 112.708 0.632 . . . . 72.25 112.708 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.81 29.07 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 119.809 -1.186 . . . . 74.430000000000007 111.551 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 HD22 HG21 ' B' ' 247' ' ' VAL . 4.4 mp -131.64 153.33 50.07 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 111.913 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 17.9 ttmm -114.14 122.21 46.14 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 106.329 -1.73 . . . . 72.319999999999993 106.329 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.478 HG21 HD22 ' B' ' 245' ' ' LEU . 7.6 p -118.35 124.81 73.69 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.155 0 CA-C-O 121.667 0.746 . . . . 42.240000000000002 109.118 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.5 t -129.85 97.51 4.51 Favored 'General case' 0 N--CA 1.405 -2.721 0 C-N-CA 120.222 -0.591 . . . . 71.310000000000002 110.395 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' B' ' 245' ' ' LEU . 59.6 m -88.84 133.82 34.14 Favored 'General case' 0 N--CA 1.418 -2.031 0 C-N-CA 119.518 -0.873 . . . . 64.409999999999997 108.905 172.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.88 90.41 42.98 Favored Pre-proline 0 C--N 1.281 -2.393 0 CA-C-N 115.383 -0.826 . . . . 51.409999999999997 108.991 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 -22.8 30.88 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.723 2.948 . . . . 73.349999999999994 111.995 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 63.51 26.84 14.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.147 0.979 . . . . 73.299999999999997 112.16 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.74 97.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.104 0.478 . . . . 75.420000000000002 110.526 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.1 p -103.93 12.45 34.3 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.914 -0.585 . . . . 72.239999999999995 110.208 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -133.68 33.88 3.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.982 -0.553 . . . . 62.409999999999997 110.28 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.21 106.18 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.949 0.881 . . . . 65.329999999999998 110.393 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -112.89 -164.16 0.9 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.435 -0.802 . . . . 72.329999999999998 109.695 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -72.28 -47.98 45.97 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 116.064 -0.516 . . . . 72.430000000000007 109.808 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.5 72.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 121.938 0.875 . . . . 73.120000000000005 110.586 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.76 -27.4 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.277 -1.329 . . . . 73.400000000000006 107.913 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HA ' ' HE ' ' A' ' 61' ' ' ARG . 1.2 mmp_? -94.04 63.68 3.23 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.894 0.854 . . . . 75.519999999999996 110.204 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -165.57 97.25 0.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 126.021 1.729 . . . . 74.140000000000001 106.446 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.2 mmt -133.01 116.05 15.92 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 111.908 0.336 . . . . 64.129999999999995 111.908 -176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.44 135.28 52.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.583 -0.895 . . . . 74.299999999999997 108.583 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 85.0 mtm180 -93.21 174.84 7.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.291 0.567 . . . . 74.030000000000001 111.827 -174.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 66' ' ' LYS . 9.6 tmtt? . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 106.816 -1.55 . . . . 73.150000000000006 106.816 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.976 -0.75 . . . . 73.209999999999994 108.976 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.37 1.96 57.46 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.865 -1.061 . . . . 63.240000000000002 110.871 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 38.9 t -72.43 133.49 44.9 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.837 -0.431 . . . . 74.340000000000003 109.837 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -119.93 84.34 2.2 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.318 0.58 . . . . 61.049999999999997 110.409 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.18 -51.0 13.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.251 -1.759 . . . . 75.099999999999994 106.251 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 59.7 p -146.95 96.87 2.81 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.718 -1.128 . . . . 71.120000000000005 109.32 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.82 108.13 18.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.598 -0.728 . . . . 70.319999999999993 109.961 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -153.3 99.54 2.37 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.914 -0.585 . . . . 74.25 110.323 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 66.18 92.63 0.07 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.485 1.115 . . . . 65.150000000000006 112.046 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 27.8 p -82.9 124.01 29.94 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.383 -0.371 . . . . 64.0 110.739 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 26.7 m -120.82 145.14 47.89 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.348 -0.982 . . . . 52.539999999999999 108.348 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD13 ' A' ' 14' ' ' LEU . 19.4 m -120.07 135.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 64.400000000000006 110.134 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 57.6 p -132.14 132.24 43.05 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.182 0.438 . . . . 43.009999999999998 112.182 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 38.4 mt -133.69 144.08 48.93 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 121.527 0.679 . . . . 74.319999999999993 112.793 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.439 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 26.2 p -99.36 129.66 45.58 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.742 -1.117 . . . . 64.430000000000007 108.041 175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.0 t -148.02 136.05 21.15 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 109.917 -0.401 . . . . 33.039999999999999 109.917 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.91 -164.89 0.11 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.518 0.727 . . . . 62.229999999999997 111.6 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -131.8 100.69 5.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.488 -0.56 . . . . 74.239999999999995 109.488 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.533 HD23 ' H ' ' B' ' 219' ' ' LEU . 1.6 pt? -120.85 97.61 48.21 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 115.453 -0.794 . . . . 71.420000000000002 109.616 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.19 141.01 50.88 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.384 1.39 . . . . 74.299999999999997 111.078 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.22 157.26 43.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.249 -1.019 . . . . 75.450000000000003 108.249 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 27.8 t -87.36 -26.99 23.08 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.303 0.573 . . . . 61.219999999999999 109.694 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -153.08 151.51 30.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.883 -0.784 . . . . 63.25 108.883 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' B' ' 241' ' ' THR . 26.8 mm -87.52 110.89 21.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 105.898 -1.89 . . . . 64.439999999999998 105.898 176.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.581 ' HE3' ' HB ' ' B' ' 240' ' ' ILE . 0.0 OUTLIER -105.82 154.59 20.31 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.014 -0.735 . . . . 73.230000000000004 109.014 -176.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 19.8 p -119.85 132.63 55.63 Favored 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 123.92 0.762 . . . . 54.5 111.912 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -109.26 134.29 51.96 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.907 -1.146 . . . . 73.319999999999993 107.907 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.3 m -112.22 124.49 52.57 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 120.127 -0.629 . . . . 64.400000000000006 110.848 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 40' ' ' ILE . 78.8 mt -101.79 129.8 52.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.533 -0.914 . . . . 72.349999999999994 108.533 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 40.5 p -134.08 92.85 3.0 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 116.001 -0.545 . . . . 73.299999999999997 109.993 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' B' ' 234' ' ' LEU . 2.2 pp20? -150.23 123.89 9.16 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 112.854 0.687 . . . . 54.350000000000001 112.854 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.82 43.97 Favored Glycine 0 C--O 1.228 -0.265 0 CA-C-N 115.835 -0.62 . . . . 71.109999999999999 111.91 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.8 m 59.66 74.49 0.44 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.972 -0.751 . . . . 74.209999999999994 108.972 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' B' ' 230' ' ' THR . 52.4 tp -158.15 143.85 16.97 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.425 -0.807 . . . . 60.439999999999998 110.798 -172.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -133.0 111.98 11.46 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.03 -1.47 . . . . 61.240000000000002 107.03 171.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.672 ' O ' ' HA ' ' B' ' 228' ' ' THR . 3.7 t -119.22 140.3 50.44 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 120.0 -0.68 . . . . 53.140000000000001 109.176 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.6 t -124.23 129.8 73.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.809 -0.812 . . . . 61.039999999999999 108.809 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' B' ' 226' ' ' THR . 51.0 mt -118.68 118.76 58.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 109.94 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 37.2 m-85 -100.96 110.69 22.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.712 -0.847 . . . . 75.150000000000006 108.712 176.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 29' ' ' ILE . 3.1 mt -92.65 117.57 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 106.685 -1.598 . . . . 72.450000000000003 106.685 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.548 ' HA ' HD12 ' B' ' 224' ' ' ILE . 31.2 p -112.79 175.58 5.38 Favored 'General case' 0 N--CA 1.412 -2.354 0 C-N-CA 120.214 -0.594 . . . . 70.310000000000002 109.94 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' B' ' 242' ' ' LYS . 0.0 OUTLIER -70.86 -1.16 10.84 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.013 1.116 . . . . 72.409999999999997 114.013 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' B' ' 243' ' ' ARG . 69.9 ttt180 -148.0 18.46 1.11 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 121.55 0.69 . . . . 71.200000000000003 110.754 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 153.07 -167.56 31.76 Favored Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 118.915 -1.612 . . . . 55.530000000000001 112.311 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.596 HD11 ' SG ' ' A' ' 49' ' ' CYS . 4.0 mp -135.43 153.98 51.61 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.71 -0.796 . . . . 73.209999999999994 112.088 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.6 ttmm -114.68 121.55 43.72 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.38 -1.711 . . . . 64.510000000000005 106.38 173.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 45' ' ' LEU . 7.9 p -116.99 128.89 74.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-O 121.357 0.599 . . . . 62.210000000000001 109.803 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 34.5 t -135.87 106.19 6.41 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 120.449 -0.5 . . . . 71.25 110.589 -176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 92.6 m -100.13 133.41 44.57 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.584 -0.447 . . . . 60.219999999999999 111.334 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' B' ' 251' ' ' PRO . 19.2 t70 -126.21 116.74 23.57 Favored Pre-proline 0 C--O 1.2 -1.545 0 N-CA-C 107.684 -1.228 . . . . 71.150000000000006 107.684 174.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 23.6 Cg_exo -68.18 35.62 0.17 Allowed 'Trans proline' 0 CA--C 1.555 1.552 0 C-N-CA 123.958 3.106 . . . . 53.520000000000003 113.879 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 107.73 -1.211 . . . . 73.319999999999993 107.73 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -98.36 -51.01 4.11 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.175 -1.375 . . . . 53.240000000000002 112.225 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 81.2 p -98.71 0.26 44.22 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.031 -0.668 . . . . 51.439999999999998 111.811 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -112.78 102.67 10.69 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.167 0.803 . . . . 74.430000000000007 113.167 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.94 135.15 36.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.38 -1.341 . . . . 63.299999999999997 107.38 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -117.91 155.32 30.39 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.33 -0.548 . . . . 64.409999999999997 110.677 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' B' ' 260' ' ' VAL . 10.4 m-20 -87.63 -9.37 54.44 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.621 -0.881 . . . . 74.109999999999999 108.621 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 42.0 t 73.57 -6.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.955 1.302 . . . . 74.340000000000003 110.561 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' B' ' 258' ' ' ASP . 14.5 p -71.85 -26.9 26.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.748 -0.66 . . . . 70.329999999999998 110.277 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . 0.651 ' HA ' ' HE ' ' B' ' 261' ' ' ARG . 0.7 OUTLIER -96.7 6.82 47.95 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.937 -0.477 . . . . 72.510000000000005 111.759 179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 39.2 m -71.52 -30.12 65.56 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.52 -1.659 . . . . 61.100000000000001 106.52 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.0 100.75 11.96 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.288 -2.115 . . . . 71.540000000000006 105.288 170.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.04 167.33 10.34 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.779 -0.452 . . . . 74.430000000000007 109.779 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 265' ' ' ARG . 15.3 ttm180 -73.73 113.92 11.41 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 122.837 0.455 . . . . 75.040000000000006 111.378 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.418 -1.697 . . . . 72.010000000000005 106.418 177.52 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.213 -0.662 . . . . 73.209999999999994 109.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.63 131.17 2.46 Favored Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.608 -0.806 . . . . 44.329999999999998 111.157 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -80.51 95.1 6.38 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.35 0.595 . . . . 72.25 110.57 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.7 113.22 4.07 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.109999999999999 108.675 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.67 -22.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.951 -0.759 . . . . 61.5 108.951 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.3 t 67.4 -178.22 0.21 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.134 0.974 . . . . 72.230000000000004 109.349 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -97.91 102.1 13.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.862 -1.162 . . . . 73.109999999999999 107.862 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE2' ' OG1' ' A' ' 10' ' ' THR . 53.0 mtpt -121.98 135.33 54.84 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.246 -0.434 . . . . 75.120000000000005 110.62 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -94.47 72.46 3.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.012 -1.477 . . . . 74.420000000000002 107.012 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.439 ' OG1' ' HE2' ' A' ' 8' ' ' LYS . 67.9 m -115.79 124.69 51.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.88 -1.055 . . . . 72.430000000000007 112.023 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -123.27 144.11 49.62 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.249 -1.76 . . . . 72.420000000000002 106.249 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' B' ' 214' ' ' LEU . 31.0 m -105.18 131.66 53.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.869 -0.733 . . . . 74.109999999999999 109.319 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.478 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 33.2 p -134.41 140.92 46.63 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.928 0.714 . . . . 72.329999999999998 112.928 -173.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' B' ' 214' ' ' LEU . 70.5 mt -131.48 144.15 50.94 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.489 -0.778 . . . . 64.310000000000002 111.526 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.2 m -118.13 142.03 47.86 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 114.936 -1.029 . . . . 64.239999999999995 109.01 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.427 HG22 ' HA2' ' A' ' 44' ' ' GLY . 7.4 t -136.76 163.78 29.81 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.008 -0.738 . . . . 64.439999999999998 109.008 -176.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.07 128.99 20.13 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.348 -1.723 . . . . 75.299999999999997 106.348 175.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -47.28 114.4 0.86 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.599 0.963 . . . . 75.140000000000001 113.599 -168.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 tp -113.59 113.89 47.67 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 106.308 -1.738 . . . . 72.439999999999998 106.308 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.64 140.54 94.14 Favored 'Trans proline' 0 C--O 1.239 0.544 0 C-N-CA 122.257 1.972 . . . . 74.109999999999999 112.605 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 40' ' ' ILE . 19.6 m -129.05 148.4 33.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 108.285 -1.006 . . . . 52.509999999999998 108.285 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -80.04 86.32 5.53 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.32 -0.952 . . . . 74.049999999999997 109.45 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 71.61 145.91 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.313 . . . . 74.519999999999996 112.98 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 41' ' ' THR . 39.7 mm -73.16 126.42 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 106.922 -1.51 . . . . 74.450000000000003 106.922 177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HD2' HD12 ' A' ' 40' ' ' ILE . 12.8 ptpt -133.29 154.91 50.28 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.694 -0.402 . . . . 73.200000000000003 110.261 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.8 p -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.469 -0.787 . . . . 53.509999999999998 111.275 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 73.6 m-85 -107.8 141.91 38.64 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 108.174 -1.047 . . . . 70.140000000000001 108.174 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 10.7 m -120.34 124.05 44.61 Favored 'General case' 0 N--CA 1.408 -2.552 0 C-N-CA 119.591 -0.844 . . . . 73.319999999999993 110.323 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 HD11 ' B' ' 240' ' ' ILE . 71.3 mt -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.073 -1.454 . . . . 71.0 107.073 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.7 p -134.26 98.97 4.25 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 109.834 -0.432 . . . . 71.230000000000004 109.834 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -113.11 105.45 13.47 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.581 -0.896 . . . . 75.140000000000001 108.581 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -102.73 0.81 Allowed Glycine 0 C--N 1.304 -1.199 0 C-N-CA 119.583 -1.294 . . . . 62.43 111.877 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.6 m -118.15 18.74 13.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 109.462 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 49' ' ' CYS . 3.1 tm? -111.52 132.8 54.25 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.723 -0.672 . . . . 63.340000000000003 110.081 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 82.0 mtp180 -111.68 145.08 39.89 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 107.958 -1.127 . . . . 74.299999999999997 107.958 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 28' ' ' THR . 2.8 t -136.53 139.66 42.41 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 119.193 -1.003 . . . . 65.329999999999998 108.709 175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 41.0 t -124.79 129.43 73.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.965 -0.754 . . . . 74.430000000000007 108.965 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.6 mp -116.41 118.82 60.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.767 -0.456 . . . . 74.219999999999999 109.767 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.625 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 30.6 m-85 -96.65 116.3 28.88 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.881 -0.785 . . . . 72.420000000000002 108.881 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.778 HD11 HD13 ' B' ' 229' ' ' ILE . 3.8 mt -96.35 117.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 105.273 -2.121 . . . . 74.0 105.273 174.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.48 ' HA ' HD12 ' A' ' 24' ' ' ILE . 57.6 p -123.53 155.44 37.58 Favored 'General case' 0 N--CA 1.405 -2.721 0 N-CA-C 108.727 -0.842 . . . . 73.310000000000002 108.727 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.255 0.0 OUTLIER -70.59 2.71 3.72 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.934 1.087 . . . . 74.219999999999999 113.934 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -115.4 -12.14 11.77 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.459 -0.337 . . . . 74.549999999999997 111.779 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 163.68 -163.69 35.89 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.145 -1.502 . . . . 61.32 113.534 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.09 140.59 52.17 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.271 0.558 . . . . 64.140000000000001 111.824 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 31.8 ttmt -126.99 123.47 37.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.643 -0.873 . . . . 70.219999999999999 108.643 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 12' ' ' VAL . 7.2 p -119.89 123.78 71.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-O 121.653 0.74 . . . . 75.120000000000005 109.602 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.6 t -128.93 106.0 8.6 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.114 -0.494 . . . . 63.140000000000001 111.178 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 71.5 m -97.49 134.02 41.29 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.124 -0.63 . . . . 71.099999999999994 109.68 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -132.36 119.11 16.27 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.987 -0.746 . . . . 71.409999999999997 108.987 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 84.3 Cg_endo -77.03 39.46 0.72 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 123.949 3.099 . . . . 73.030000000000001 111.826 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.36 56.13 3.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.275 1.036 . . . . 73.5 109.783 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.82 -47.11 2.42 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.351 -1.295 . . . . 72.140000000000001 109.878 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.2 m -93.55 -41.35 9.8 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.48 -0.782 . . . . 74.140000000000001 110.857 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -81.61 -4.77 57.0 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 114.104 1.15 . . . . 74.209999999999994 114.104 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.54 132.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-O 121.811 0.815 . . . . 74.129999999999995 112.217 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -139.96 -58.67 0.55 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 104.635 -2.357 . . . . 62.409999999999997 104.635 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -168.94 112.93 0.56 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.685 -1.598 . . . . 73.409999999999997 108.155 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG13 HG23 ' A' ' 60' ' ' VAL . 12.2 p -178.68 -36.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.284 -0.416 . . . . 64.120000000000005 110.724 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG23 HG13 ' A' ' 59' ' ' VAL . 61.0 t -96.85 105.57 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 109.319 -0.623 . . . . 74.109999999999999 109.319 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -132.17 117.71 18.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.6 0.714 . . . . 65.340000000000003 110.548 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.0 m -139.36 114.01 9.22 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 115.455 -0.793 . . . . 64.019999999999996 109.138 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.98 114.66 10.32 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.304 -1.739 . . . . 74.140000000000001 106.304 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -103.98 118.18 36.06 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.917 0.389 . . . . 62.439999999999998 110.754 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -84.51 -51.93 6.52 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.801 -0.636 . . . . 73.409999999999997 110.025 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-N 116.518 -0.31 . . . . 72.019999999999996 111.107 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.239 0.53 0 N-CA-C 110.326 -0.25 . . . . 63.420000000000002 110.326 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.79 28.71 1.36 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 121.362 -0.447 . . . . 63.229999999999997 112.307 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.5 m -76.48 129.81 37.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.338 -0.616 . . . . 74.349999999999994 109.338 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -70.12 100.3 1.63 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.265 0.555 . . . . 72.349999999999994 112.296 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.33 -25.9 5.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.51 -0.922 . . . . 74.209999999999994 108.51 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 28.1 t 61.96 -169.38 0.18 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.798 -1.092 . . . . 72.109999999999999 109.509 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -95.79 93.11 6.89 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.369 -0.604 . . . . 53.329999999999998 109.369 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.9 165.55 23.93 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.507 -0.923 . . . . 62.450000000000003 108.507 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' B' ' 250' ' ' ASP . 45.8 ttp180 63.15 46.65 4.5 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 103.861 -2.644 . . . . 73.540000000000006 103.861 -164.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 23.3 m -70.58 131.24 43.67 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 112.863 -1.971 . . . . 52.229999999999997 109.372 -174.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 8.3 m -119.0 143.02 47.29 Favored 'General case' 0 N--CA 1.407 -2.586 0 N-CA-C 106.71 -1.589 . . . . 71.049999999999997 106.71 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 24.5 m -130.59 135.94 59.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.733 -0.84 . . . . 61.200000000000003 108.733 176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 79.2 p -123.01 126.53 47.31 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 120.232 -0.587 . . . . 24.43 111.202 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.515 HD21 ' HG ' ' A' ' 14' ' ' LEU . 72.7 mt -113.8 119.69 38.19 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.305 -0.861 . . . . 72.219999999999999 109.638 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 22.3 m -99.75 140.15 34.38 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.43 -0.805 . . . . 74.25 109.75 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.5 t -126.13 165.65 18.47 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 123.227 0.611 . . . . 43.539999999999999 110.014 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.28 138.3 9.99 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 107.366 -1.346 . . . . 74.510000000000005 107.366 176.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.74 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.967 0.907 . . . . 71.040000000000006 113.195 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 58.5 tp -118.37 116.27 35.44 Favored Pre-proline 0 C--N 1.299 -1.601 0 N-CA-C 107.259 -1.386 . . . . 62.329999999999998 107.259 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.5 140.26 56.72 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.502 1.468 . . . . 73.420000000000002 111.229 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 30.3 m -115.37 151.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.876 -1.157 . . . . 64.209999999999994 107.876 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.9 t -76.22 82.38 3.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.854 -0.738 . . . . 73.299999999999997 109.561 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 72.92 160.33 0.23 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.996 1.318 . . . . 64.040000000000006 113.189 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' B' ' 241' ' ' THR . 35.3 mm -84.93 128.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.116 -1.809 . . . . 70.230000000000004 106.116 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.58 ' HD2' HD12 ' B' ' 240' ' ' ILE . 11.9 ptpt -136.37 149.79 48.5 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.708 -0.478 . . . . 71.219999999999999 109.708 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.723 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 12.3 p -123.66 129.35 51.0 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 111.725 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -108.53 130.65 55.28 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.229 -1.026 . . . . 72.129999999999995 108.229 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 12.0 m -108.57 126.39 52.89 Favored 'General case' 0 N--CA 1.416 -2.156 0 C-N-CA 120.069 -0.652 . . . . 74.109999999999999 109.733 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.778 HD13 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -102.47 135.73 38.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.869 -1.059 . . . . 74.329999999999998 108.459 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 38.3 p -133.71 91.4 2.83 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 121.204 0.526 . . . . 74.099999999999994 109.702 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -96.52 99.56 11.2 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.176 -1.046 . . . . 72.129999999999995 108.176 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.99 -110.59 2.95 Favored Glycine 0 C--N 1.309 -0.955 0 C-N-CA 119.19 -1.481 . . . . 73.219999999999999 110.603 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' B' ' 252' ' ' GLN . 19.2 m -102.25 74.85 1.44 Allowed 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.659 -0.867 . . . . 74.200000000000003 108.659 175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.1 tm? -160.59 139.38 10.32 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 109.774 -0.454 . . . . 73.340000000000003 109.774 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.45 ' N ' HD13 ' B' ' 234' ' ' LEU . 16.7 mtp180 -122.49 128.0 50.27 Favored 'General case' 0 C--O 1.197 -1.688 0 N-CA-C 108.767 -0.827 . . . . 71.140000000000001 108.767 171.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.664 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 3.5 t -133.91 137.94 45.22 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.235 -1.024 . . . . 73.319999999999993 108.235 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 40.7 t -121.48 130.81 74.28 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 N-CA-C 108.948 -0.76 . . . . 53.229999999999997 108.948 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.7 mt -116.49 118.0 57.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.195 -0.669 . . . . 53.100000000000001 109.195 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 56.7 m-85 -99.01 118.13 35.1 Favored 'General case' 0 CA--C 1.485 -1.523 0 C-N-CA 123.532 0.733 . . . . 75.329999999999998 109.528 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 29' ' ' ILE . 3.8 mt -100.55 118.09 46.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.023 -1.843 . . . . 75.129999999999995 106.023 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.489 ' HA ' HD12 ' B' ' 224' ' ' ILE . 51.6 p -118.26 164.45 15.17 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.55 -0.907 . . . . 74.040000000000006 108.55 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 9.87 0.32 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 115.141 1.534 . . . . 71.200000000000003 115.141 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -140.38 -26.11 0.77 Allowed 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.299 0.851 . . . . 74.109999999999999 113.299 175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -160.25 171.9 36.59 Favored Glycine 0 CA--C 1.495 -1.164 0 C-N-CA 119.066 -1.54 . . . . 44.420000000000002 112.66 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.1 mp -121.08 137.06 54.84 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.864 0.364 . . . . 73.450000000000003 111.001 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 16.9 ttmm -115.54 122.56 46.06 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.329 -0.989 . . . . 71.019999999999996 108.329 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.62 129.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.529 -0.915 . . . . 74.120000000000005 108.529 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 35.0 t -137.01 109.5 7.41 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.524 -0.47 . . . . 74.049999999999997 111.319 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.485 ' HB3' HD21 ' B' ' 234' ' ' LEU . 72.7 m -107.71 134.62 50.42 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.183 0.516 . . . . 70.010000000000005 112.078 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' B' ' 209' ' ' ARG . 32.0 t70 -128.9 126.22 23.16 Favored Pre-proline 0 C--O 1.202 -1.414 0 C-N-CA 124.847 1.259 . . . . 72.530000000000001 108.087 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 8.1 Cg_exo -73.48 36.63 0.39 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.607 2.871 . . . . 54.340000000000003 112.926 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' B' ' 233' ' ' SER . 97.4 mt-30 59.05 39.82 22.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.237 1.018 . . . . 72.329999999999998 109.05 -177.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -99.1 -49.92 4.34 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.14 -1.391 . . . . 63.329999999999998 109.016 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' B' ' 209' ' ' ARG . 71.1 p -104.26 -24.03 13.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.922 -0.581 . . . . 63.219999999999999 109.834 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 74.9 m95 67.7 -76.32 0.05 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.455 1.102 . . . . 75.319999999999993 112.445 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.38 149.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.629 -0.508 . . . . 74.140000000000001 109.629 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -123.29 -72.78 0.67 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.717 -1.216 . . . . 74.010000000000005 107.717 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 169.89 109.45 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.98 -1.859 . . . . 73.209999999999994 105.98 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -170.89 -34.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.213 0.53 . . . . 73.519999999999996 110.764 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -85.71 102.97 12.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.321 -0.622 . . . . 71.109999999999999 109.321 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -126.94 141.13 51.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.079 -0.711 . . . . 63.439999999999998 109.079 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -92.78 93.29 8.36 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 109.233 -0.654 . . . . 75.420000000000002 109.233 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.15 91.72 3.76 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.18 -1.044 . . . . 72.540000000000006 108.18 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -175.3 97.66 0.08 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.632 -2.358 . . . . 63.039999999999999 104.632 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -85.07 -32.8 22.66 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 113.992 1.108 . . . . 75.030000000000001 113.992 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.856 0 C-N-CA 120.081 -0.648 . . . . 73.219999999999999 111.881 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.568 0.223 . . . . 62.020000000000003 111.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.0 -171.19 52.03 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.898 -0.668 . . . . 65.329999999999998 111.819 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.152 0.501 . . . . 60.409999999999997 110.66 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -145.34 -55.38 0.31 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.615 -0.513 . . . . 54.32 109.615 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.55 84.62 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 122.118 0.961 . . . . 61.030000000000001 113.188 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -94.41 -35.9 12.15 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.64 -1.615 . . . . 54.119999999999997 106.64 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.71 122.33 32.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.595 -1.261 . . . . 72.310000000000002 107.595 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.22 147.5 26.08 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.59 0.233 . . . . 75.219999999999999 110.831 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HG3' ' HE1' ' A' ' 55' ' ' TRP . 1.4 tmt_? -66.86 102.51 0.97 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.777 -1.564 . . . . 72.120000000000005 106.777 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -114.5 151.95 32.48 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.181 -0.918 . . . . 73.030000000000001 111.811 -169.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.5 m -118.64 144.42 46.17 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 105.685 -1.969 . . . . 64.150000000000006 105.685 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' B' ' 214' ' ' LEU . 18.0 m -116.61 133.48 63.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-O 121.266 0.555 . . . . 73.230000000000004 110.567 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -134.27 136.19 43.4 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.776 -0.578 . . . . 74.129999999999995 111.521 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' B' ' 214' ' ' LEU . 59.2 mt -124.83 140.8 52.6 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.469 0.652 . . . . 64.120000000000005 111.324 173.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -114.2 132.23 56.18 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.94 -1.027 . . . . 74.219999999999999 109.973 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.1 t -109.15 166.41 10.87 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 124.798 1.239 . . . . 71.109999999999999 107.832 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -41.72 -71.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.665 0.617 . . . . 74.5 112.665 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -173.68 103.88 0.12 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.542 0.687 . . . . 72.140000000000001 111.327 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.14 101.48 51.47 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 107.652 -1.24 . . . . 65.540000000000006 107.652 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.69 140.22 46.31 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.155 1.903 . . . . 74.209999999999994 114.298 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.74 149.01 27.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 106.329 -1.73 . . . . 62.539999999999999 106.329 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -80.1 -32.96 39.1 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.592 -0.443 . . . . 43.130000000000003 111.726 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -134.12 139.6 46.03 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 110.909 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 41' ' ' THR . 41.3 mm -81.79 108.99 15.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 105.67 -1.974 . . . . 65.540000000000006 105.67 174.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 12.6 ptpt -120.24 162.05 20.05 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 116.147 -0.478 . . . . 70.030000000000001 111.079 -172.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.745 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 16.7 p -127.3 129.6 47.97 Favored 'General case' 0 N--CA 1.424 -1.731 0 O-C-N 123.914 0.759 . . . . 71.239999999999995 112.433 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -109.45 137.4 47.36 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.852 -0.796 . . . . 64.319999999999993 108.852 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 5.0 m -111.1 129.19 56.0 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 120.323 -0.551 . . . . 55.310000000000002 109.549 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 69.4 mt -108.41 134.88 48.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.115 -0.948 . . . . 73.329999999999998 109.848 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 32.8 p -133.78 91.59 2.85 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.203 0.601 . . . . 61.439999999999998 110.143 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 34.4 mm-40 -124.15 109.63 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.705 -0.48 . . . . 63.409999999999997 109.705 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.74 49.48 59.22 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.995 -0.622 . . . . 61.310000000000002 112.159 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.6 m 59.81 74.34 0.45 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.96 0.886 . . . . 60.530000000000001 110.783 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.757 ' O ' ' HA ' ' A' ' 30' ' ' THR . 3.2 tm? -159.69 142.28 13.7 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.494 -1.669 . . . . 63.409999999999997 106.494 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HD13 ' A' ' 34' ' ' LEU . 70.2 mtp180 -126.18 115.49 19.85 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.685 -0.487 . . . . 75.239999999999995 109.685 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.684 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 2.6 t -116.07 140.33 49.39 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 119.804 -0.758 . . . . 72.25 108.982 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.36 128.53 75.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.775 -1.194 . . . . 73.019999999999996 107.775 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.745 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.1 mt -115.88 118.17 57.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 109.616 -0.512 . . . . 62.32 109.616 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 57.2 m-85 -97.66 110.81 23.3 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.224 1.01 . . . . 71.430000000000007 109.441 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 HD13 ' B' ' 229' ' ' ILE . 3.7 mt -93.74 118.24 39.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.551 ' HA ' HD12 ' A' ' 24' ' ' ILE . 44.3 p -119.08 162.27 18.88 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.295 -0.962 . . . . 74.340000000000003 109.533 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.81 3.82 1.77 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 115.051 1.501 . . . . 73.319999999999993 115.051 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -135.1 -1.62 2.63 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 112.205 0.446 . . . . 74.329999999999998 112.205 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 171.77 178.5 42.14 Favored Glycine 0 CA--C 1.468 -2.883 0 C-N-CA 117.671 -2.204 . . . . 74.430000000000007 113.093 -177.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD12 ' C ' ' A' ' 44' ' ' GLY . 7.2 mp -125.6 135.66 52.44 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.943 0.878 . . . . 73.120000000000005 112.941 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 69.1 tttt -115.11 122.46 46.2 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.097 -1.411 . . . . 70.129999999999995 110.005 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.38 132.23 71.54 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 CA-C-O 121.368 0.604 . . . . 74.129999999999995 109.703 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.9 t -133.4 103.68 6.07 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 120.297 -0.561 . . . . 73.239999999999995 110.006 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 92.9 m -96.73 133.75 40.9 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.184 -0.607 . . . . 65.329999999999998 110.746 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.71 117.74 26.12 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.256 -0.884 . . . . 63.420000000000002 109.87 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 9.47 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.295 2.663 . . . . 73.140000000000001 114.119 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 62.54 22.79 13.52 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.745 0.418 . . . . 64.549999999999997 111.923 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.3 -39.87 20.25 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 112.79 0.663 . . . . 22.300000000000001 112.79 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.5 p -99.43 -10.15 22.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 113.449 0.907 . . . . 74.349999999999994 113.449 -174.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 9' ' ' ARG . 36.0 m95 -104.95 105.55 15.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.675 -1.232 . . . . 75.109999999999999 107.675 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.251 19.8 m -71.03 72.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 115.094 1.516 . . . . 62.229999999999997 115.094 -178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -100.71 -36.64 9.05 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.84 -1.541 . . . . 74.099999999999994 106.84 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -128.94 127.81 42.49 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 104.451 -2.426 . . . . 72.129999999999995 104.451 170.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.85 -1.7 9.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 114.083 1.142 . . . . 44.439999999999998 114.083 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t 59.17 83.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.705 -0.85 . . . . 62.509999999999998 108.705 -174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HD3' ' OD1' ' A' ' 64' ' ' ASP . 2.1 ptm180 -88.02 153.51 21.22 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.618 -0.719 . . . . 61.539999999999999 110.593 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -113.45 80.61 1.39 Allowed 'General case' 0 N--CA 1.416 -2.149 0 CA-C-O 121.794 0.807 . . . . 53.509999999999998 109.017 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.04 -58.65 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.521 -2.029 . . . . 63.310000000000002 105.521 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' A' ' 61' ' ' ARG . 4.3 p-10 -123.44 144.76 49.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 106.46 -1.681 . . . . 64.109999999999999 106.46 173.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -134.97 -63.88 0.68 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.555 -0.535 . . . . 64.510000000000005 109.555 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 C--O 1.248 1.019 0 O-C-N 123.75 0.656 . . . . 74.430000000000007 112.057 178.396 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' B' ' 253' ' ' ALA . 34.6 m . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.131 0.967 . . . . 74.310000000000002 110.066 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -143.51 -131.2 2.47 Favored Glycine 0 C--N 1.299 -1.507 0 N-CA-C 108.857 -1.697 . . . . 70.329999999999998 108.857 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 20.0 m -63.22 -45.2 92.77 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.604 -1.628 . . . . 71.030000000000001 106.604 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -133.39 -46.37 0.83 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.159 -1.793 . . . . 62.409999999999997 106.159 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.89 179.4 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.435 -1.257 . . . . 74.109999999999999 107.818 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 23.2 t -149.2 89.05 1.62 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.438 -2.06 . . . . 73.540000000000006 105.438 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 14.9 t70 64.41 -161.68 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.772 -1.936 . . . . 73.109999999999999 105.772 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -106.58 -60.14 1.7 Allowed 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.333 -1.729 . . . . 54.219999999999999 106.333 174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 159.11 80.92 0.0 OUTLIER 'General case' 0 C--O 1.245 0.858 0 C-N-CA 128.081 2.552 . . . . 62.009999999999998 105.862 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 29.6 m -100.35 137.33 38.92 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.705 -1.134 . . . . 44.539999999999999 111.58 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 48.5 m -121.11 144.03 48.78 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.314 -1.735 . . . . 73.329999999999998 106.314 176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 34.0 m -108.59 144.23 17.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 C-N-CA 120.128 -0.629 . . . . 63.100000000000001 109.715 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 18.9 m -132.37 123.02 25.95 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.363 -0.535 . . . . 74.150000000000006 111.206 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.53 HD21 ' HG ' ' A' ' 14' ' ' LEU . 76.8 mt -114.57 119.8 38.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.576 -0.738 . . . . 65.019999999999996 110.714 -177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 11.3 m -94.13 127.89 40.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.959 -1.126 . . . . 72.439999999999998 107.959 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.1 t -144.78 136.65 25.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 120.722 -0.391 . . . . 74.319999999999993 111.762 -173.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 40.63 -99.41 0.03 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 116.878 2.177 . . . . 65.209999999999994 116.878 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -171.41 107.63 0.25 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.312 0.577 . . . . 75.150000000000006 109.736 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' B' ' 242' ' ' LYS . 5.5 mp -126.2 95.66 38.48 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.933 -0.479 . . . . 74.310000000000002 109.718 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -69.31 138.83 40.24 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 N-CA-C 108.915 -1.225 . . . . 65.430000000000007 108.915 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 27.1 m -137.52 134.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.961 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 25.0 m -68.75 -39.18 80.44 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.956 -0.757 . . . . 74.25 108.956 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -139.65 140.44 36.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.023 -0.535 . . . . 74.319999999999993 110.342 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 241' ' ' THR . 39.8 mm -74.2 108.24 5.54 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 N-CA-C 105.104 -2.184 . . . . 74.030000000000001 105.104 173.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 13.1 ptpt -106.44 156.34 18.64 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.528 -0.306 . . . . 74.319999999999993 110.436 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.773 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.2 p -122.28 129.92 52.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 112.529 0.566 . . . . 60.439999999999998 112.529 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.48 128.1 54.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.791 -1.189 . . . . 74.409999999999997 107.791 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 34.6 m -108.96 123.59 49.35 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 121.943 0.878 . . . . 73.329999999999998 110.603 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 40' ' ' ILE . 77.1 mt -101.31 130.33 50.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 114.256 -1.338 . . . . 70.040000000000006 108.018 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.795 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 39.2 p -134.76 87.23 2.33 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.693 -0.484 . . . . 71.200000000000003 109.693 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' B' ' 229' ' ' ILE . 28.8 mm-40 -113.39 99.3 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 120.452 -0.499 . . . . 54.240000000000002 110.378 -175.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 58.69 67.38 2.22 Favored Glycine 0 C--N 1.313 -0.716 0 O-C-N 123.281 0.363 . . . . 61.340000000000003 113.077 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.7 m 62.13 35.58 15.61 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.24 0.543 . . . . 72.140000000000001 111.453 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.795 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -131.91 124.93 30.48 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 108.098 -1.075 . . . . 54.310000000000002 108.098 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -106.2 137.6 43.86 Favored 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 108.057 -1.09 . . . . 75.25 108.057 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 228' ' ' THR . 0.5 OUTLIER -140.68 135.36 31.55 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 109.283 -0.636 . . . . 61.32 109.283 171.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 39.2 t -118.1 129.19 74.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.397 -0.964 . . . . 64.219999999999999 108.397 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.773 ' O ' ' HA ' ' B' ' 226' ' ' THR . 67.5 mt -115.76 118.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 109.702 -0.481 . . . . 64.219999999999999 109.702 -176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 51.4 m-85 -100.03 114.7 28.2 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.528 -0.915 . . . . 72.430000000000007 108.528 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 29' ' ' ILE . 4.9 mt -92.27 118.55 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 N-CA-C 107.424 -1.324 . . . . 65.340000000000003 107.424 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.522 ' HA ' HD12 ' B' ' 224' ' ' ILE . 43.4 p -117.07 170.5 8.6 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 119.543 -0.863 . . . . 75.409999999999997 110.933 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' B' ' 219' ' ' LEU 0.281 0.0 OUTLIER -61.32 -11.17 8.85 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 117.584 2.439 . . . . 73.230000000000004 117.584 -176.784 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -137.03 10.46 3.05 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 121.21 -0.931 . . . . 70.140000000000001 112.402 175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 165.94 -171.39 41.05 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 119.459 -1.353 . . . . 71.420000000000002 112.019 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.48 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.6 mp -126.63 153.67 45.03 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.763 0.792 . . . . 75.239999999999995 112.246 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 71.1 tttt -124.05 129.85 51.59 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.214 -1.357 . . . . 61.240000000000002 108.554 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 45' ' ' LEU . 11.6 p -130.67 134.82 61.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 109.63 -0.507 . . . . 73.5 109.63 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 236' ' ' CYS . 17.0 t -133.92 103.01 5.64 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 120.471 -0.492 . . . . 72.510000000000005 110.438 -175.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 58.7 m -96.47 140.83 30.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.853 0.835 . . . . 62.32 112.02 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -139.64 112.2 7.68 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 125.304 1.442 . . . . 72.420000000000002 107.879 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 72.7 Cg_endo -75.13 41.94 0.81 Allowed 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.269 2.646 . . . . 74.430000000000007 111.994 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.454 ' HB3' ' HE1' ' B' ' 255' ' ' TRP . 93.0 mt-30 57.52 50.46 11.1 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 122.278 1.037 . . . . 75.219999999999999 108.889 -174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.546 ' O ' ' HB ' ' B' ' 201' ' ' VAL . . . -100.69 -53.23 3.13 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.83 -1.532 . . . . 74.140000000000001 108.556 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 58.9 p -80.55 84.75 6.08 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 122.076 0.941 . . . . 34.340000000000003 113.139 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . 0.454 ' HE1' ' HB3' ' B' ' 252' ' ' GLN . 84.8 m95 -102.74 84.69 2.44 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.359 -2.089 . . . . 75.209999999999994 105.359 168.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.86 145.43 8.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.87 -0.604 . . . . 74.239999999999995 112.018 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.37 -27.15 62.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.49 -0.93 . . . . 74.409999999999997 108.49 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -68.93 171.46 8.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.295 -0.866 . . . . 74.340000000000003 110.522 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.16 0.83 9.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 116.261 -0.427 . . . . 51.229999999999997 111.01 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.0 t 71.28 88.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.575 0 C-N-CA 124.008 0.923 . . . . 64.540000000000006 108.661 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.3 104.73 16.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.501 -0.772 . . . . 72.409999999999997 112.073 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 34.9 t -155.7 74.69 0.88 Allowed 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 121.89 0.853 . . . . 72.040000000000006 109.611 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.34 89.94 4.91 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.299 -2.112 . . . . 74.209999999999994 105.299 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -168.71 168.64 10.57 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.978 -1.01 . . . . 74.299999999999997 109.179 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -109.37 -65.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.108 0.48 . . . . 65.420000000000002 110.631 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.302 -1.486 0 CA-C-N 115.722 -0.672 . . . . 63.539999999999999 109.541 -178.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.816 -0.439 . . . . 74.219999999999999 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.2 82.9 1.65 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.938 -0.648 . . . . 62.109999999999999 111.489 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 m -74.77 88.9 2.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.07 0.462 . . . . 61.32 110.592 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -147.5 -177.53 5.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.774 -1.195 . . . . 73.319999999999993 107.774 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.58 89.48 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 107.356 -1.35 . . . . 64.25 107.356 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.2 m -127.04 12.89 7.24 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.677 0.751 . . . . 71.430000000000007 109.422 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 91.74 7.28 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.895 -1.048 . . . . 75.219999999999999 110.219 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -99.73 127.84 45.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.083 -0.962 . . . . 60.240000000000002 109.408 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 66.74 87.89 0.12 Allowed 'General case' 0 C--O 1.249 1.039 0 C-N-CA 124.624 1.169 . . . . 73.299999999999997 107.941 -166.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 49' ' ' CYS . 89.6 m -78.71 100.06 6.9 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.971 -1.013 . . . . 74.340000000000003 109.952 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 7.7 m -120.97 143.03 49.23 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.408 -0.96 . . . . 74.219999999999999 108.408 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' HD12 ' B' ' 214' ' ' LEU . 27.6 m -132.95 140.77 46.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.212 -0.662 . . . . 73.439999999999998 109.212 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 p -122.4 120.88 35.27 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 110.888 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' B' ' 212' ' ' VAL . 64.0 mt -114.67 124.49 51.95 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.64 -1.164 . . . . 65.129999999999995 110.599 -175.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 m -103.25 141.36 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.126 0.488 . . . . 71.310000000000002 110.204 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.405 HG22 ' HA2' ' A' ' 44' ' ' GLY . 5.9 t -120.78 165.87 14.53 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -46.46 -58.93 3.31 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.052 0.541 . . . . 74.150000000000006 110.764 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HA ' ' HG3' ' A' ' 43' ' ' ARG . 60.4 ttp180 -171.57 123.98 0.56 Allowed 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.829 -1.174 . . . . 71.329999999999998 107.829 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 1.5 tm? -125.92 97.25 35.83 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 107.516 -1.29 . . . . 74.519999999999996 107.516 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 139.73 61.72 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 121.613 1.542 . . . . 74.329999999999998 112.716 -175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 40' ' ' ILE . 33.2 m -131.89 159.03 43.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 115.155 -0.93 . . . . 64.239999999999995 108.858 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -81.78 -25.34 35.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.602 -0.518 . . . . 71.109999999999999 109.602 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -171.07 150.71 3.09 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.889 -1.152 . . . . 63.140000000000001 107.889 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 41' ' ' THR . 34.0 mm -72.83 126.75 34.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 105.856 -1.905 . . . . 72.319999999999993 105.856 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 17.8 ptpt -135.76 162.29 33.18 Favored 'General case' 0 N--CA 1.421 -1.879 0 C-N-CA 119.219 -0.992 . . . . 74.230000000000004 110.963 -177.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 18.4 p -127.62 131.59 49.89 Favored 'General case' 0 N--CA 1.423 -1.813 0 O-C-N 124.005 0.816 . . . . 75.340000000000003 112.726 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.0 m-85 -107.92 134.9 50.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.462 -0.94 . . . . 71.540000000000006 108.462 173.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 20.9 m -113.37 120.99 43.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.835 -0.746 . . . . 62.450000000000003 109.815 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.682 HD13 HD11 ' B' ' 240' ' ' ILE . 84.6 mt -102.57 136.71 33.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.916 -1.142 . . . . 70.510000000000005 107.916 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 43.2 p -134.01 72.85 1.48 Allowed 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.294 0.569 . . . . 70.299999999999997 111.171 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 60.5 mm-40 -87.67 99.88 12.4 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.748 -0.381 . . . . 45.420000000000002 110.224 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.55 -137.23 27.13 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.918 -1.673 . . . . 73.349999999999994 108.918 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -86.22 83.36 7.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.316 -0.994 . . . . 61.140000000000001 108.316 172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 30' ' ' THR . 55.7 tp -159.85 147.35 16.72 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.252 -0.886 . . . . 73.430000000000007 109.747 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -130.73 136.22 48.55 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 107.888 -1.152 . . . . 61.210000000000001 107.888 171.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 28' ' ' THR . 4.4 t -138.98 140.04 38.09 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 108.694 -0.854 . . . . 44.100000000000001 108.694 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 38.9 t -127.36 128.88 70.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.259 -1.015 . . . . 54.130000000000003 108.259 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -116.25 118.45 58.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.754 -0.462 . . . . 63.420000000000002 109.754 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 50.6 m-85 -97.0 113.08 24.59 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 124.383 1.073 . . . . 72.439999999999998 109.604 177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.728 HD11 HD13 ' B' ' 229' ' ' ILE . 6.0 mt -96.25 117.8 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.186 -1.413 . . . . 74.209999999999994 107.186 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.479 ' HA ' HD12 ' A' ' 24' ' ' ILE . 30.9 p -121.31 160.98 22.84 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 119.156 -1.018 . . . . 63.32 109.887 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' LEU 0.258 0.0 OUTLIER -64.2 2.8 0.51 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 116.672 2.101 . . . . 74.439999999999998 116.672 -178.208 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 18' ' ' ARG . 65.1 ttt180 -148.95 14.73 0.92 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.104 -1.038 . . . . 74.230000000000004 111.032 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' HG22 ' A' ' 16' ' ' THR . . . 170.58 173.33 37.72 Favored Glycine 0 CA--C 1.472 -2.624 0 C-N-CA 118.879 -1.629 . . . . 74.409999999999997 112.109 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp -129.8 149.9 51.34 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.434 0.635 . . . . 72.25 111.375 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 61.3 tttt -128.77 125.32 37.61 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.799 -1.091 . . . . 73.209999999999994 109.37 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG21 HD22 ' B' ' 245' ' ' LEU . 7.2 p -123.59 134.6 65.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 N-CA-C 109.113 -0.699 . . . . 52.310000000000002 109.113 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 38.1 t -136.24 101.8 4.8 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 119.917 -0.713 . . . . 71.409999999999997 111.278 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 98.5 m -104.31 133.72 48.75 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -134.88 121.61 14.88 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.742 -1.207 . . . . 74.219999999999999 107.742 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 72.0 Cg_endo -71.55 19.5 0.26 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 123.872 3.048 . . . . 74.409999999999997 113.366 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 62.69 34.06 15.08 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.9 0.88 . . . . 74.209999999999994 109.724 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.95 -48.76 11.38 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.808 1.243 . . . . 45.100000000000001 113.78 -172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.8 m -141.36 23.01 2.18 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.337 -0.986 . . . . 71.299999999999997 108.337 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -114.29 -2.43 13.32 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.005 0.743 . . . . 71.109999999999999 113.005 -174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.6 p -115.62 -35.29 2.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 118.932 -1.107 . . . . 71.109999999999999 110.686 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 72.81 -42.66 0.54 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.561 1.544 . . . . 72.329999999999998 110.082 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 67.58 101.72 0.05 OUTLIER 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.665 1.186 . . . . 62.530000000000001 112.301 173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.35 3.09 8.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.626 0.727 . . . . 73.140000000000001 111.55 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.43 131.17 63.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.3 -0.63 . . . . 74.239999999999995 109.3 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -86.26 -59.29 2.33 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.372 -0.931 . . . . 74.439999999999998 109.617 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.0 p -88.06 108.56 19.3 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.622 0.725 . . . . 54.43 112.73 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.84 100.16 10.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.578 -2.378 . . . . 63.409999999999997 104.578 170.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.69 116.23 21.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.946 -0.57 . . . . 51.009999999999998 112.15 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -123.47 99.99 6.59 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.28 -1.007 . . . . 62.329999999999998 108.28 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.307 -1.244 0 N-CA-C 108.762 -0.829 . . . . 71.420000000000002 108.762 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.533 -0.543 . . . . 70.329999999999998 109.533 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 110.4 80.89 1.17 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 120.469 -0.872 . . . . 73.319999999999993 111.163 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 15.3 p -73.45 110.33 7.66 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.691 0.758 . . . . 73.310000000000002 111.691 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.08 121.55 36.3 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.329 -0.851 . . . . 75.430000000000007 108.926 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -92.98 87.04 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 CA-C-O 121.757 0.789 . . . . 75.409999999999997 109.302 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.8 m -154.71 145.11 22.1 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.216 -1.401 . . . . 65.530000000000001 107.216 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -132.97 145.86 51.26 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.199 0.523 . . . . 60.520000000000003 110.518 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -87.16 22.62 2.03 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 123.981 0.913 . . . . 74.349999999999994 110.701 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.96 72.64 0.5 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.45 1.5 . . . . 54.210000000000001 109.864 -176.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 86.3 m -80.55 146.6 31.19 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.961 -1.472 . . . . 70.200000000000003 110.599 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 52.9 m -119.31 143.83 47.16 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.041 -2.207 . . . . 74.019999999999996 105.041 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 14' ' ' LEU . 22.0 m -120.72 134.07 65.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.16 0.505 . . . . 64.530000000000001 110.307 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 17.5 p -140.17 126.35 19.85 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 112.31 0.485 . . . . 74.439999999999998 112.31 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.477 HD12 ' HB ' ' A' ' 12' ' ' VAL . 48.8 mt -124.07 136.17 54.06 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 113.474 0.916 . . . . 74.439999999999998 113.474 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 22.0 m -105.17 129.51 53.54 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 105.591 -2.003 . . . . 73.409999999999997 105.591 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 7.8 t -147.4 135.65 21.57 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.808 -1.157 . . . . 63.219999999999999 112.82 -170.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 51.47 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.174 1.79 . . . . 74.310000000000002 112.736 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.445 ' O ' ' HD3' ' B' ' 220' ' ' PRO . 50.5 ttp180 169.32 87.72 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.394 2.278 . . . . 73.030000000000001 105.68 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -97.69 102.65 13.77 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.352 -0.981 . . . . 71.420000000000002 108.352 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' B' ' 218' ' ' ARG . 74.5 Cg_endo -83.23 141.27 10.2 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.89 1.727 . . . . 72.150000000000006 113.918 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 240' ' ' ILE . 26.9 m -143.34 160.78 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.613 -1.254 . . . . 55.340000000000003 107.613 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -91.99 -14.16 29.87 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.426 -0.51 . . . . 75.420000000000002 111.727 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.45 138.68 19.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 120.003 -0.679 . . . . 55.329999999999998 111.111 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.524 HD12 ' HA ' ' B' ' 241' ' ' THR . 40.1 mm -82.53 107.55 14.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 N-CA-C 106.667 -1.605 . . . . 71.329999999999998 106.667 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.5 ' HD2' HD12 ' B' ' 240' ' ' ILE . 1.2 ptpm? -121.78 162.54 20.68 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.921 -0.581 . . . . 73.150000000000006 111.204 -173.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 21.0 p -125.86 130.27 51.02 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.663 -0.699 . . . . 72.349999999999994 111.902 177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -108.14 130.89 55.1 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.169 -1.048 . . . . 75.329999999999998 108.169 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 18.2 m -109.29 123.97 50.16 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.154 0.502 . . . . 64.219999999999999 110.318 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.728 HD13 HD11 ' A' ' 40' ' ' ILE . 59.0 mt -102.71 141.94 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.815 -1.18 . . . . 65.239999999999995 107.815 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.5 p -134.03 98.36 4.12 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 110.086 -0.339 . . . . 43.140000000000001 110.086 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -111.08 99.33 8.21 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.24 0.459 . . . . 74.439999999999998 112.24 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 77.24 -69.24 2.54 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.841 -0.618 . . . . 71.219999999999999 112.567 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 38.2 m -156.6 37.95 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' B' ' 230' ' ' THR . 3.0 tm? -132.94 125.02 28.9 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.103 -0.953 . . . . 62.229999999999997 109.397 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -107.11 114.09 27.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.799 -0.815 . . . . 71.120000000000005 108.799 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.2 t -112.78 140.98 47.11 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.807 -0.812 . . . . 71.040000000000006 108.807 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.45 131.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.913 -0.773 . . . . 72.409999999999997 108.913 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' B' ' 226' ' ' THR . 63.3 mt -115.86 118.43 58.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.309 -0.626 . . . . 43.530000000000001 109.309 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 45.6 m-85 -96.9 110.15 22.72 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.792 0.837 . . . . 63.130000000000003 109.381 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.682 HD11 HD13 ' A' ' 29' ' ' ILE . 4.1 mt -93.79 118.2 39.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 107.522 -1.288 . . . . 63.229999999999997 107.522 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.524 ' HA ' HD12 ' B' ' 224' ' ' ILE . 66.7 p -118.55 160.2 22.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 119.594 -0.843 . . . . 74.140000000000001 110.494 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 21.13 0.08 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.619 1.711 . . . . 63.32 115.619 -176.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -153.77 2.06 0.25 Allowed 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 121.553 0.692 . . . . 75.109999999999999 110.889 172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . 169.33 -172.05 43.33 Favored Glycine 0 CA--C 1.493 -1.29 0 C-N-CA 119.94 -1.124 . . . . 72.430000000000007 111.595 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.43 HD12 ' C ' ' B' ' 244' ' ' GLY . 6.0 mp -138.95 146.79 41.42 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.349 0.87 . . . . 60.119999999999997 113.349 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 61.9 tttt -117.13 132.56 56.63 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.356 -1.293 . . . . 74.230000000000004 109.606 175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 p -131.69 134.34 60.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.39 0.614 . . . . 75.040000000000006 110.48 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 35.1 t -135.78 110.58 8.72 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.577 -0.449 . . . . 54.219999999999999 110.352 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.611 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 93.9 m -95.12 133.22 39.19 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.056 -0.657 . . . . 43.409999999999997 109.299 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . 0.421 ' O ' HD22 ' B' ' 234' ' ' LEU . 10.6 t70 -129.58 133.82 25.51 Favored Pre-proline 0 C--O 1.193 -1.869 0 N-CA-C 107.957 -1.127 . . . . 55.200000000000003 107.957 -177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 250' ' ' ASP . 11.8 Cg_exo -73.81 25.5 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 123.06 2.507 . . . . 74.219999999999999 112.154 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' B' ' 250' ' ' ASP . 96.6 mt-30 65.84 28.88 10.71 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.483 1.113 . . . . 74.150000000000006 109.204 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.16 -46.55 7.04 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.553 -1.658 . . . . 60.130000000000003 110.043 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 26.7 m -74.63 -28.57 60.93 Favored 'General case' 0 C--O 1.209 -1.074 0 N-CA-C 108.751 -0.833 . . . . 53.149999999999999 108.751 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -77.96 1.21 21.45 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.754 -0.657 . . . . 74.430000000000007 112.535 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 10.7 p -122.36 4.87 5.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.182 -1.044 . . . . 74.129999999999995 108.182 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -123.32 -51.09 1.87 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.198 -0.91 . . . . 75.329999999999998 110.098 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.99 -170.61 0.19 Allowed 'General case' 0 C--O 1.25 1.113 0 C-N-CA 125.455 1.502 . . . . 72.230000000000004 109.743 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.15 -22.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.956 -0.757 . . . . 73.120000000000005 108.956 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.63 159.25 43.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 61.119999999999997 110.788 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . 0.42 ' N ' ' HD2' ' B' ' 261' ' ' ARG . 9.1 mpt_? -89.52 -27.55 20.22 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.647 0.737 . . . . 72.439999999999998 109.388 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 29.8 p -147.04 141.01 25.93 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.065 -0.97 . . . . 55.310000000000002 108.661 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 26.1 ttt -100.74 127.26 47.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.817 -0.438 . . . . 74.209999999999994 109.817 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -85.58 105.54 16.23 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.137 -0.69 . . . . 70.420000000000002 109.137 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -93.23 -62.51 1.36 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.304 -0.407 . . . . 73.030000000000001 110.602 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--N 1.296 -1.739 0 N-CA-C 108.075 -1.083 . . . . 62.350000000000001 108.075 -179.801 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.236 0.375 0 N-CA-C 109.957 -0.386 . . . . 73.140000000000001 109.957 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 30.58 11.9 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.335 -0.936 . . . . 62.409999999999997 112.679 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -78.81 -36.27 42.96 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.11 -1.07 . . . . 43.350000000000001 108.11 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 49.87 81.79 0.06 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 124.82 1.325 . . . . 72.329999999999998 114.134 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.64 161.55 21.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.594 -0.891 . . . . 73.209999999999994 108.594 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -64.65 101.34 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.374 0.607 . . . . 70.019999999999996 109.515 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.689 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 20.5 t70 -88.98 85.84 6.8 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.8 -0.636 . . . . 75.010000000000005 110.719 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 7' ' ' ASP . 65.6 mttm 161.29 167.39 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 129.423 3.089 . . . . 70.409999999999997 106.692 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -88.1 85.86 7.02 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 107.837 -1.171 . . . . 72.239999999999995 107.837 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -82.48 129.08 34.84 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.658 -1.155 . . . . 71.540000000000006 112.002 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 22.5 m -120.59 143.98 48.35 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 106.467 -1.679 . . . . 75.310000000000002 106.467 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 214' ' ' LEU . 7.1 m -130.95 135.79 59.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 109.658 -0.497 . . . . 74.510000000000005 109.658 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 46' ' ' LYS . 28.1 p -132.78 131.56 41.27 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.698 0.629 . . . . 61.439999999999998 112.698 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.58 HD12 ' HB ' ' B' ' 212' ' ' VAL . 71.3 mt -125.62 144.25 50.66 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.086 -0.506 . . . . 73.239999999999995 111.909 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 p -98.64 141.48 31.42 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.46 -0.791 . . . . 74.319999999999993 109.825 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -127.84 165.3 20.42 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.509 -0.552 . . . . 32.310000000000002 109.509 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.06 84.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.752 1.019 . . . . 71.230000000000004 113.752 -176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 18' ' ' ARG 0.349 0.0 OUTLIER 43.39 101.81 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.112 2.264 . . . . 74.230000000000004 117.112 173.446 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' LYS . 83.5 mt -125.44 98.33 35.18 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 109.151 -0.685 . . . . 64.319999999999993 109.151 176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.37 140.25 39.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.271 1.314 . . . . 62.350000000000001 112.063 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -142.85 150.88 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.959 -0.756 . . . . 72.439999999999998 108.959 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.1 m -76.55 -37.14 57.09 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.026 0.441 . . . . 65.239999999999995 110.603 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -145.93 136.09 23.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.147 -0.479 . . . . 72.340000000000003 111.134 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 41' ' ' THR . 35.8 mm -70.44 124.22 26.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 N-CA-C 105.845 -1.909 . . . . 73.5 105.845 173.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 13.9 ptpt -130.54 154.97 47.27 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 120.207 -0.597 . . . . 72.430000000000007 110.928 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 33.5 p -120.55 132.01 54.96 Favored 'General case' 0 N--CA 1.422 -1.87 0 O-C-N 123.902 0.751 . . . . 63.219999999999999 111.611 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 82.3 m-85 -109.25 129.34 55.51 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.686 -0.688 . . . . 72.430000000000007 109.226 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 24.6 m -109.13 121.31 44.88 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.472 0.653 . . . . 74.230000000000004 110.197 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.703 HD13 HD11 ' B' ' 240' ' ' ILE . 85.8 mt -103.67 134.81 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.126 -0.943 . . . . 71.120000000000005 108.676 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 68.9 p -127.76 94.46 3.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.173 0.511 . . . . 43.109999999999999 110.462 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 46.0 mm-40 -119.77 101.22 7.74 Favored 'General case' 0 C--O 1.213 -0.863 0 C-N-CA 120.062 -0.655 . . . . 53.340000000000003 110.305 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.88 64.0 3.1 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.949 -0.643 . . . . 15.210000000000001 113.452 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.416 ' C ' HE21 ' A' ' 52' ' ' GLN . 24.2 m 61.99 20.73 11.8 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.333 0.653 . . . . 74.310000000000002 111.488 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.685 HD11 ' SG ' ' A' ' 36' ' ' CYS . 1.7 tm? -114.98 139.85 49.51 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.515 0.726 . . . . 74.310000000000002 109.933 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG2' HG22 ' A' ' 30' ' ' THR . 92.1 mtt180 -125.28 112.15 16.05 Favored 'General case' 0 C--O 1.205 -1.261 0 C-N-CA 120.497 -0.481 . . . . 74.530000000000001 111.242 176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.685 ' SG ' HD11 ' A' ' 34' ' ' LEU . 56.2 m -111.12 144.82 39.65 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.924 -0.769 . . . . 61.219999999999999 108.924 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 33.7 t -133.29 130.9 57.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.906 -0.776 . . . . 71.340000000000003 108.906 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mp -117.01 122.12 69.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 110.281 -0.266 . . . . 71.319999999999993 110.281 -178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.3 m-85 -98.81 117.09 32.51 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 73.209999999999994 108.896 176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.782 HD11 HD13 ' B' ' 229' ' ' ILE . 5.3 mt -92.69 118.0 37.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.423 -1.695 . . . . 54.329999999999998 106.423 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.49 HG22 HG23 ' A' ' 24' ' ' ILE . 30.2 p -121.92 163.66 18.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 C-N-CA 119.354 -0.938 . . . . 73.219999999999999 110.202 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.71 -10.81 29.93 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 116.337 1.977 . . . . 71.019999999999996 116.337 -178.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -135.92 2.08 2.82 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.465 -0.772 . . . . 73.120000000000005 112.653 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.61 40.37 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.972 -1.585 . . . . 73.430000000000007 112.997 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD13 HG22 ' B' ' 247' ' ' VAL . 75.1 mt -136.76 130.96 32.75 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.086 -0.709 . . . . 75.319999999999993 109.086 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 18.4 ttmm -115.26 120.73 40.67 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.358 -0.979 . . . . 61.140000000000001 108.358 178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.12 130.3 66.05 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 108.249 -1.019 . . . . 55.140000000000001 108.249 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 49.8 t -127.76 150.62 49.72 Favored 'General case' 0 C--N 1.261 -3.266 0 N-CA-C 107.448 -1.316 . . . . 72.540000000000006 107.448 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' HD21 ' A' ' 34' ' ' LEU . 8.9 t -153.78 141.58 20.08 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 117.83 -1.548 . . . . 62.130000000000003 111.629 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 52' ' ' GLN . 17.9 t70 -135.88 112.85 10.62 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.431 -1.259 . . . . 74.519999999999996 108.161 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 74.4 Cg_endo -74.12 26.16 0.34 Allowed 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 123.034 2.49 . . . . 74.219999999999999 112.13 176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 50' ' ' ASP . 41.8 mt-30 63.45 -88.72 0.03 OUTLIER 'General case' 0 C--O 1.25 1.102 0 C-N-CA 126.193 1.797 . . . . 64.150000000000006 112.991 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.08 -159.34 0.32 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.473 -0.936 . . . . 72.209999999999994 108.473 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 p -81.77 116.36 21.43 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 120.797 -0.361 . . . . 62.130000000000003 110.927 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -95.79 -10.19 29.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.938 -0.764 . . . . 73.450000000000003 108.938 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.2 t 73.61 -67.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.591 1.156 . . . . 72.219999999999999 111.643 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -146.38 -45.62 0.19 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.56 0.948 . . . . 74.519999999999996 113.56 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -74.06 125.99 29.52 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.628 -0.429 . . . . 73.219999999999999 110.409 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.15 -48.38 2.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 112.736 0.643 . . . . 75.510000000000005 112.736 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t 66.13 90.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.59 0.756 . . . . 60.439999999999998 109.674 -173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -135.83 151.09 49.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.343 -0.844 . . . . 73.049999999999997 109.693 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -154.88 135.3 13.33 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.374 -0.232 . . . . 63.340000000000003 110.374 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 51.5 ttm -84.5 94.24 8.51 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.38 -1.711 . . . . 62.030000000000001 106.38 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -108.6 153.65 23.09 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.973 -0.558 . . . . 62.399999999999999 109.812 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -76.33 -159.57 0.12 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 123.179 0.592 . . . . 72.349999999999994 111.492 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? . . . . . 0 C--N 1.313 -0.997 0 N-CA-C 108.63 -0.878 . . . . 73.209999999999994 108.63 -179.043 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.25 1.091 0 N-CA-C 110.289 -0.263 . . . . 54.210000000000001 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.56 99.45 0.18 Allowed Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.927 -0.654 . . . . 71.510000000000005 112.348 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 19.4 m -84.55 -21.53 30.43 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.139 -1.06 . . . . 71.129999999999995 108.139 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . 0.328 46.0 mt-10 60.42 67.42 0.84 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.132 -1.395 . . . . 71.099999999999994 113.665 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.09 144.5 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 112.622 -2.081 . . . . 70.420000000000002 106.114 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 27.1 t -97.98 113.02 24.75 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.16 -1.052 . . . . 62.119999999999997 108.16 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.29 74.87 8.27 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.941 0.877 . . . . 75.510000000000005 109.807 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -149.67 83.76 1.41 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.02 -1.445 . . . . 74.409999999999997 108.821 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -94.34 97.66 10.36 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.463 1.125 . . . . 63.310000000000002 108.316 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 41.1 p -92.09 153.23 19.51 Favored 'General case' 0 C--N 1.272 -2.786 0 CA-C-N 113.273 -1.785 . . . . 64.540000000000006 111.157 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 248' ' ' CYS . 38.6 m -117.31 143.2 46.19 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 103.344 -2.835 . . . . 63.32 103.344 172.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.58 ' HB ' HD12 ' A' ' 14' ' ' LEU . 33.7 m -121.14 144.72 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 118.8 -1.16 . . . . 64.420000000000002 111.277 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 28.8 p -122.05 116.11 23.68 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 115.096 -0.956 . . . . 61.32 109.5 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 12' ' ' VAL . 68.0 mt -113.91 119.7 38.18 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-O 121.784 0.802 . . . . 73.239999999999995 110.003 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' B' ' 244' ' ' GLY . 53.0 m -106.17 124.11 49.07 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 114.642 -1.163 . . . . 71.120000000000005 111.515 -175.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.5 t -100.88 165.25 11.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 105.808 -1.923 . . . . 41.140000000000001 105.808 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . 0.306 14.0 mm100 -72.42 91.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 115.918 1.821 . . . . 55.5 115.918 -173.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . 0.278 18.3 ptp180 40.53 81.53 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 127.249 2.219 . . . . 72.25 116.765 173.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.98 105.97 41.66 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.106 -1.442 . . . . 62.210000000000001 107.106 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.99 141.52 44.52 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.038 1.825 . . . . 65.219999999999999 113.307 -173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.5 163.03 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.347 -1.353 . . . . 63.229999999999997 107.347 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 47.0 m -94.83 -30.48 14.19 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.07 0.462 . . . . 72.200000000000003 111.329 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -131.5 122.54 26.35 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 122.108 -0.37 . . . . 75.209999999999994 111.646 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' B' ' 241' ' ' THR . 36.6 mm -74.99 112.32 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 104.887 -2.264 . . . . 64.140000000000001 104.887 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' B' ' 225' ' ' LYS . 13.7 ptpt -126.49 161.94 26.78 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.71 -0.396 . . . . 72.099999999999994 110.835 -173.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 22.0 p -123.18 137.13 54.97 Favored 'General case' 0 N--CA 1.425 -1.716 0 O-C-N 123.779 0.674 . . . . 75.519999999999996 111.927 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -115.05 133.26 56.19 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.136 -1.061 . . . . 74.430000000000007 108.136 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 21.6 m -114.77 122.29 45.92 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.651 0.738 . . . . 53.350000000000001 111.011 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.782 HD13 HD11 ' A' ' 40' ' ' ILE . 73.2 mt -101.97 142.15 16.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.917 -1.038 . . . . 64.340000000000003 108.517 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 33.7 p -135.61 93.37 2.95 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 122.809 0.444 . . . . 41.229999999999997 110.613 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.471 ' HG2' HG22 ' B' ' 229' ' ' ILE . 40.6 mm-40 -120.95 99.84 6.73 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.829 -0.348 . . . . 74.310000000000002 111.615 -175.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 59.63 59.08 11.21 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 121.131 -0.557 . . . . 70.439999999999998 113.315 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 50.8 m 71.1 14.41 6.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.897 0.879 . . . . 72.450000000000003 111.947 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.8 tm? -112.62 125.24 54.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.401 -0.962 . . . . 61.140000000000001 108.401 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 81.3 mtt180 -107.78 144.16 35.32 Favored 'General case' 0 C--O 1.184 -2.392 0 N-CA-C 107.938 -1.134 . . . . 65.329999999999998 107.938 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.61 ' HB3' ' HB ' ' B' ' 229' ' ' ILE . 2.2 t -139.73 141.79 36.87 Favored 'General case' 0 C--N 1.277 -2.577 0 C-N-CA 119.724 -0.79 . . . . 60.030000000000001 109.488 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.43 130.13 73.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.643 -0.873 . . . . 74.239999999999995 108.643 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.718 ' O ' ' HA ' ' B' ' 226' ' ' THR . 64.7 mt -116.76 119.05 60.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.97 -0.382 . . . . 73.019999999999996 109.97 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 29.0 m-85 -99.86 121.32 41.13 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.873 -0.788 . . . . 73.030000000000001 108.873 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 29' ' ' ILE . 6.3 mt -97.39 118.21 43.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.654 -1.61 . . . . 73.209999999999994 106.654 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.541 ' HA ' HD12 ' B' ' 224' ' ' ILE . 44.0 p -114.91 172.77 6.84 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 119.321 -0.952 . . . . 65.349999999999994 109.411 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 11.25 3.37 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.514 0.931 . . . . 72.200000000000003 113.514 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -119.74 -53.56 2.19 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.565 -0.743 . . . . 62.340000000000003 109.468 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 215' ' ' THR . . . -158.75 -161.32 10.98 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.565 -0.826 . . . . 31.039999999999999 111.415 -177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.21 149.26 43.11 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.78 -0.768 . . . . 72.340000000000003 112.196 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 19.0 ttmm -114.96 136.59 52.95 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.942 -1.503 . . . . 72.310000000000002 106.942 176.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 45' ' ' LEU . 8.9 p -132.83 129.14 57.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.596 0 N-CA-C 109.017 -0.735 . . . . 72.239999999999995 109.017 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' B' ' 211' ' ' CYS . 37.6 t -132.52 101.28 5.26 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 120.477 -0.489 . . . . 60.149999999999999 110.668 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 88.2 m -93.38 134.18 35.87 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.587 -0.845 . . . . 54.329999999999998 109.899 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -130.32 115.08 17.31 Favored Pre-proline 0 C--N 1.304 -1.398 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 109.981 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.92 16.82 1.76 Allowed 'Trans proline' 0 C--O 1.248 1.023 0 C-N-CA 123.392 2.728 . . . . 73.409999999999997 111.746 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 68.85 -76.96 0.05 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.478 1.511 . . . . 72.340000000000003 111.981 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.14 -93.37 0.04 OUTLIER 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.368 1.067 . . . . 63.210000000000001 112.285 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 23.0 p -148.53 107.49 3.86 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 123.337 0.655 . . . . 72.25 110.383 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -93.19 -21.15 19.82 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.366 -0.605 . . . . 74.209999999999994 109.366 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 57.2 t 69.22 -77.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.706 1.202 . . . . 54.439999999999998 109.291 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -158.34 17.57 0.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 73.329999999999998 109.846 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -123.0 104.05 8.99 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.951 -0.568 . . . . 72.230000000000004 109.94 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.74 -23.68 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 116.001 -0.545 . . . . 55.420000000000002 110.639 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 56.3 t 70.37 95.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.86 0.864 . . . . 74.209999999999994 109.675 -176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -120.27 100.26 7.07 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.385 -0.825 . . . . 71.319999999999993 112.312 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 50.6 m -87.09 100.17 12.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.325 -1.361 . . . . 51.439999999999998 107.325 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 51.9 ttm -59.52 106.81 0.5 Allowed 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 111.8 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.05 118.25 10.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.132 -0.94 . . . . 74.219999999999999 110.142 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.83 105.76 11.36 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.981 -0.554 . . . . 74.200000000000003 110.108 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? . . . . . 0 C--N 1.299 -1.622 0 N-CA-C 106.96 -1.496 . . . . 65.010000000000005 106.96 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.377 -0.601 . . . . 71.230000000000004 109.377 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.04 159.49 10.95 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 119.849 -1.167 . . . . 73.439999999999998 112.9 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -144.54 44.65 1.4 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 104.586 -2.376 . . . . 31.02 104.586 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.4 101.34 4.07 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.869 -1.968 . . . . 73.510000000000005 111.726 -171.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -122.14 95.19 3.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.146 -0.934 . . . . 74.239999999999995 109.25 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 m -74.33 -18.22 60.73 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.305 -0.861 . . . . 72.209999999999994 111.56 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -83.39 68.64 9.79 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.305 1.05 . . . . 61.409999999999997 111.688 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -148.7 166.05 29.54 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.217 -1.772 . . . . 70.450000000000003 106.217 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.22 111.87 18.77 Favored 'General case' 0 C--N 1.271 -2.834 0 N-CA-C 107.053 -1.462 . . . . 74.409999999999997 107.053 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 38.1 p -73.12 86.27 1.37 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.504 0.669 . . . . 63.420000000000002 110.518 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 13.0 m -131.56 145.0 51.5 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 107.473 -1.306 . . . . 73.109999999999999 107.473 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.62 139.64 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 108.837 -0.801 . . . . 70.349999999999994 108.837 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.5 p -122.82 133.81 54.43 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.428 0.632 . . . . 62.310000000000002 112.095 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD21 ' HG ' ' B' ' 214' ' ' LEU . 75.2 mt -125.57 123.95 40.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.016 -0.993 . . . . 75.049999999999997 109.833 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -100.9 123.86 45.73 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.836 -0.431 . . . . 71.409999999999997 109.836 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -148.21 136.19 21.03 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.35 -0.611 . . . . 75.150000000000006 109.35 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 63.13 -169.92 0.18 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 123.506 0.722 . . . . 73.540000000000006 112.697 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -144.99 23.82 1.51 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.148 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.21 122.45 85.27 Favored Pre-proline 0 C--N 1.318 -0.77 0 C-N-CA 120.087 -0.645 . . . . 65.310000000000002 111.042 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.92 141.36 44.37 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.251 1.967 . . . . 72.209999999999994 112.252 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.408 HG11 HG22 ' A' ' 40' ' ' ILE . 30.3 m -106.43 148.02 11.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.451 -0.795 . . . . 50.229999999999997 109.044 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.8 m -56.44 -48.73 76.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.973 0.416 . . . . 72.239999999999995 110.329 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -141.94 143.39 33.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.85 -0.796 . . . . 73.239999999999995 108.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 41.6 mm -72.19 100.48 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 104.772 -2.307 . . . . 71.310000000000002 104.772 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HD2' HD12 ' A' ' 40' ' ' ILE . 19.2 ptpt -105.13 158.83 16.31 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 115.858 -0.61 . . . . 65.0 109.908 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 4.5 p -127.07 129.55 48.21 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.857 -0.611 . . . . 64.200000000000003 112.437 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 85.6 m-85 -107.82 122.77 47.45 Favored 'General case' 0 C--O 1.199 -1.578 0 CA-C-N 115.412 -0.813 . . . . 73.409999999999997 109.615 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.1 m -109.33 120.61 43.05 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.914 -0.773 . . . . 71.329999999999998 108.914 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.603 HD13 HD11 ' B' ' 240' ' ' ILE . 6.7 mt -114.21 153.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.849 -1.167 . . . . 73.150000000000006 107.849 -176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.9 p -133.89 99.85 4.57 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-O 121.47 0.652 . . . . 72.25 112.547 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 1.1 mp0 -101.54 99.52 9.83 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.514 -0.767 . . . . 64.150000000000006 109.738 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.92 -93.5 0.95 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.539 -0.839 . . . . 71.349999999999994 111.416 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -135.09 25.92 3.56 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.697 -1.223 . . . . 73.310000000000002 107.697 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD21 ' SG ' ' A' ' 49' ' ' CYS . 1.6 tm? -112.57 143.08 44.35 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.125 -1.398 . . . . 72.239999999999995 110.047 -176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 93.4 mtt180 -121.18 114.88 22.04 Favored 'General case' 0 C--O 1.184 -2.366 0 C-N-CA 122.425 0.29 . . . . 74.549999999999997 110.972 177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.597 ' SG ' HD11 ' A' ' 34' ' ' LEU . 16.0 m -109.78 131.04 55.42 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.472 -0.768 . . . . 73.420000000000002 109.464 176.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 21.4 t -124.66 130.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 N-CA-C 109.307 -0.627 . . . . 72.439999999999998 109.307 -175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 26' ' ' THR . 4.5 mp -117.24 122.43 69.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 120.723 0.297 . . . . 61.539999999999999 111.039 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 24.7 m-85 -98.64 110.97 23.48 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 124.554 1.141 . . . . 74.129999999999995 109.018 176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.717 HD11 HD13 ' B' ' 229' ' ' ILE . 6.9 mt -92.65 118.66 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.256 -1.387 . . . . 42.049999999999997 107.256 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . 43.7 p -117.16 167.14 11.45 Favored 'General case' 0 N--CA 1.407 -2.605 0 C-N-CA 119.508 -0.877 . . . . 73.030000000000001 110.249 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -3.88 3.38 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 115.965 1.839 . . . . 64.310000000000002 115.965 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -138.02 15.74 2.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 112.64 0.607 . . . . 65.109999999999999 112.64 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.8 -161.02 29.35 Favored Glycine 0 CA--C 1.473 -2.553 0 C-N-CA 118.273 -1.918 . . . . 74.010000000000005 112.07 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.667 HD11 ' SG ' ' B' ' 249' ' ' CYS . 4.1 mp -133.54 148.13 51.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 74.219999999999999 112.392 -174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 57.2 tttt -116.53 119.87 36.95 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.292 -1.322 . . . . 72.549999999999997 107.634 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.99 119.76 61.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.413 1.102 . . . . 74.109999999999999 109.041 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 22.0 t -121.13 117.58 27.52 Favored 'General case' 0 C--N 1.251 -3.677 0 N-CA-C 107.646 -1.242 . . . . 74.409999999999997 107.646 -174.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.658 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.6 t -120.3 134.56 55.24 Favored 'General case' 0 N--CA 1.394 -3.238 0 C-N-CA 117.118 -1.833 . . . . 32.119999999999997 110.445 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 52' ' ' GLN . 25.8 t70 -122.82 107.73 33.37 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 113.87 -1.514 . . . . 64.099999999999994 112.115 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -84.83 34.02 0.5 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.077 2.518 . . . . 51.240000000000002 109.011 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' HA ' ' NE1' ' A' ' 55' ' ' TRP . 45.1 mt-30 71.72 79.06 0.16 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.757 1.623 . . . . 73.219999999999999 111.071 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.2 -36.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.651 -1.159 . . . . 73.549999999999997 111.286 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 p -85.91 26.72 0.95 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 111.154 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.478 ' NE1' ' HA ' ' A' ' 52' ' ' GLN . 15.1 m95 -73.22 12.09 0.63 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.374 -0.83 . . . . 70.450000000000003 112.74 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.1 -11.3 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.102 -1.073 . . . . 74.120000000000005 108.102 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 73.59 96.1 0.07 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.215 1.406 . . . . 74.109999999999999 113.878 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -173.7 84.64 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.359 -1.292 . . . . 71.510000000000005 108.835 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.11 -37.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 75.299999999999997 109.616 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.9 t 66.08 93.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.393 -0.821 . . . . 53.240000000000002 110.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -74.8 95.37 2.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.665 -0.865 . . . . 71.209999999999994 108.665 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.8 t -87.58 90.52 8.4 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.891 -0.595 . . . . 70.439999999999998 111.381 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 mmt -147.14 102.92 3.55 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 114.409 -1.269 . . . . 63.420000000000002 108.239 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.58 -60.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.111 -0.495 . . . . 72.200000000000003 110.568 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -144.04 108.08 4.74 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.804 -0.813 . . . . 74.010000000000005 108.804 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt . . . . . 0 C--N 1.301 -1.507 0 CA-C-N 116.08 -0.509 . . . . 63.32 111.262 -176.653 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.243 0.723 0 CA-C-O 120.952 0.406 . . . . 45.549999999999997 110.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.49 -173.08 45.29 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 109.76 -1.336 . . . . 72.439999999999998 109.76 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 49.4 m -95.2 90.98 6.07 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 117.545 0.672 . . . . 34.329999999999998 110.836 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -93.33 2.41 56.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.643 -0.708 . . . . 63.450000000000003 110.669 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.82 127.85 35.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.502 -0.772 . . . . 65.040000000000006 110.802 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 49.0 m -90.4 -20.23 23.04 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.046 -0.524 . . . . 74.25 110.75 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -93.38 98.84 11.48 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-O 121.599 0.714 . . . . 75.340000000000003 112.169 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -128.98 126.32 39.32 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.54 -1.209 . . . . 75.349999999999994 108.289 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.413 ' HD3' ' N ' ' B' ' 209' ' ' ARG . 0.4 OUTLIER -92.63 105.09 17.31 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.108 -0.701 . . . . 62.509999999999998 109.108 176.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 15.1 p -79.68 84.35 5.52 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 121.787 0.803 . . . . 54.130000000000003 110.906 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 248' ' ' CYS . 18.4 m -125.07 145.24 50.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.636 -1.246 . . . . 75.299999999999997 107.636 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 14' ' ' LEU . 16.6 m -131.14 135.05 60.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 109.325 -0.621 . . . . 74.120000000000005 109.325 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 29.3 p -136.14 136.76 40.32 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 112.979 0.733 . . . . 74.200000000000003 112.979 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.429 ' HG ' HD21 ' A' ' 14' ' ' LEU . 61.5 mt -133.61 143.9 48.92 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.459 0.647 . . . . 73.129999999999995 112.614 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -96.12 127.94 42.59 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 114.956 -1.02 . . . . 75.150000000000006 110.741 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 5.2 t -147.62 143.8 27.96 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.415 -1.328 . . . . 72.400000000000006 107.415 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 68.25 -178.67 0.22 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.931 0.769 . . . . 72.430000000000007 110.471 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -145.6 20.81 1.5 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.465 0.65 . . . . 72.409999999999997 110.212 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.23 125.75 71.45 Favored Pre-proline 0 CA--C 1.511 -0.551 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 108.999 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.4 Cg_endo -71.44 141.03 37.73 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 121.405 1.404 . . . . 74.230000000000004 111.362 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.14 158.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.799 -0.637 . . . . 64.439999999999998 109.696 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 m -64.58 -30.14 71.17 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.385 0.428 . . . . 63.219999999999999 111.953 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -170.25 145.94 2.84 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.413 -0.588 . . . . 75.200000000000003 109.413 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 241' ' ' THR . 37.7 mm -76.6 99.7 2.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 105.623 -1.992 . . . . 74.530000000000001 105.623 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.572 ' HD2' HD12 ' B' ' 240' ' ' ILE . 18.5 ptpt -106.23 147.03 29.56 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.402 -0.817 . . . . 75.099999999999994 110.582 -174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.696 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 14.7 p -115.68 132.51 56.61 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.775 -0.648 . . . . 74.040000000000006 111.583 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 92.0 m-85 -114.59 132.28 56.4 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.652 -0.87 . . . . 74.319999999999993 108.652 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 22.7 m -109.38 127.24 54.2 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.268 0.556 . . . . 73.030000000000001 110.322 -177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.717 HD13 HD11 ' A' ' 40' ' ' ILE . 2.4 mt -112.26 154.4 13.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 108.02 -1.104 . . . . 64.150000000000006 108.02 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . . . . . . . . . 21.2 p -136.76 98.11 3.7 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 112.669 0.618 . . . . 75.129999999999995 112.669 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.551 ' OE2' HG22 ' B' ' 229' ' ' ILE . 1.6 mp0 -102.82 97.53 7.67 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.572 -0.899 . . . . 70.150000000000006 108.572 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.49 -110.6 3.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.075 -0.583 . . . . 64.239999999999995 112.153 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 24.0 m -99.09 12.86 34.81 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.502 0.668 . . . . 72.310000000000002 110.119 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 249' ' ' CYS . 3.3 tm? -112.9 138.65 49.43 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 72.030000000000001 109.255 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -115.63 149.93 37.51 Favored 'General case' 0 C--O 1.195 -1.808 0 N-CA-C 106.091 -1.818 . . . . 75.400000000000006 106.091 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 2.9 t -138.67 155.12 48.54 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 118.787 -1.165 . . . . 63.240000000000002 109.523 175.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 24.8 t -134.8 134.78 53.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.214 -1.032 . . . . 75.129999999999995 108.214 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' B' ' 226' ' ' THR . 70.9 mt -115.9 123.45 71.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 109.379 -0.6 . . . . 71.129999999999995 109.379 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 42.7 m-85 -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 124.206 1.003 . . . . 73.409999999999997 109.222 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.603 HD11 HD13 ' A' ' 29' ' ' ILE . 6.8 mt -92.62 118.59 38.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 106.66 -1.607 . . . . 73.340000000000003 106.66 176.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.517 ' HA ' ' CD1' ' B' ' 224' ' ' ILE . 50.8 p -117.0 166.34 12.3 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.736 -0.786 . . . . 72.420000000000002 110.463 -176.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -69.13 -2.21 9.71 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.189 1.552 . . . . 62.109999999999999 115.189 -175.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -135.44 15.85 3.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.572 0.582 . . . . 75.310000000000002 112.572 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 150.76 -161.92 29.18 Favored Glycine 0 CA--C 1.489 -1.578 0 C-N-CA 118.628 -1.749 . . . . 75.530000000000001 112.772 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 36' ' ' CYS . 5.5 mp -126.96 144.34 51.03 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 111.826 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 62.8 tttt -119.31 120.7 37.75 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.44 -1.255 . . . . 75.319999999999993 108.516 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.19 136.62 52.56 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-O 121.153 0.502 . . . . 71.030000000000001 110.711 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' B' ' 211' ' ' CYS . 29.2 t -136.4 108.95 7.42 Favored 'General case' 0 C--N 1.284 -2.265 0 C-N-CA 120.163 -0.615 . . . . 63.140000000000001 109.624 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 45' ' ' LEU . 86.6 m -95.79 133.5 39.84 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 119.074 -1.05 . . . . 73.109999999999999 110.266 176.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -117.43 113.86 38.54 Favored Pre-proline 0 C--N 1.296 -1.731 0 C-N-CA 124.979 1.312 . . . . 72.439999999999998 112.174 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 33.89 0.5 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.646 2.897 . . . . 72.109999999999999 110.601 174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 68.98 46.6 0.82 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.035 1.334 . . . . 60.439999999999998 110.202 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -146.7 -9.21 0.48 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.671 0.989 . . . . 44.310000000000002 113.671 -176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 68.4 p -95.66 4.36 53.11 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.228 0.537 . . . . 73.299999999999997 111.945 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -78.44 84.1 4.61 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 116.518 2.044 . . . . 71.400000000000006 116.518 -172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . 0.414 HG23 ' H ' ' B' ' 257' ' ' ARG . 16.8 m -118.09 -54.97 3.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.092 -1.447 . . . . 72.409999999999997 107.092 166.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . 0.414 ' H ' HG23 ' B' ' 256' ' ' VAL . 59.0 ttp180 167.17 106.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 125.34 1.456 . . . . 73.099999999999994 108.631 172.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' B' ' 259' ' ' VAL . 12.3 t70 -153.44 93.55 1.71 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.537 -1.283 . . . . 73.409999999999997 107.537 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.457 ' HA ' ' CZ ' ' B' ' 239' ' ' PHE . 7.7 p 175.65 -39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.754 -0.657 . . . . 52.420000000000002 111.304 -175.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.4 t 65.27 95.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.61 -1.256 . . . . 71.120000000000005 107.61 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -59.86 113.35 2.24 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 113.786 1.032 . . . . 71.329999999999998 113.786 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.6 t -102.11 -162.4 0.92 Allowed 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.036 -1.839 . . . . 73.230000000000004 106.036 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 66.0 mtt 63.92 36.26 10.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.607 0.718 . . . . 63.310000000000002 110.116 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.0 141.72 58.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.402 -1.272 . . . . 73.400000000000006 109.653 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -57.78 121.94 11.66 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.864 0.466 . . . . 74.329999999999998 110.155 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 120.949 -0.301 . . . . 64.219999999999999 111.02 179.434 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.662 -0.495 . . . . 70.140000000000001 109.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.76 93.54 1.75 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.727 -0.749 . . . . 73.200000000000003 112.609 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -113.03 118.53 35.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.904 -1.147 . . . . 71.319999999999993 107.904 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -150.73 176.91 10.59 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 122.392 -0.192 . . . . 71.530000000000001 110.599 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -88.31 147.41 5.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.229 0.537 . . . . 41.43 111.929 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -95.28 118.11 31.47 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.581 -0.896 . . . . 53.130000000000003 108.581 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.19 160.81 19.1 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.939 -0.763 . . . . 75.030000000000001 108.939 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 79.54 -43.66 0.29 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.892 1.277 . . . . 72.109999999999999 111.174 -174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -138.6 85.97 2.12 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.098 0.475 . . . . 74.019999999999996 111.825 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -80.14 86.47 5.57 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.712 0.768 . . . . 65.340000000000003 109.165 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.4 m -123.95 149.33 46.06 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.033 -1.469 . . . . 74.319999999999993 107.033 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.47 132.07 69.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 109.04 -0.726 . . . . 50.549999999999997 109.04 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -136.22 142.56 44.08 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.141 -0.624 . . . . 74.219999999999999 110.365 -174.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HG ' HD21 ' B' ' 214' ' ' LEU . 66.5 mt -135.21 139.68 44.7 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 121.392 0.615 . . . . 62.240000000000002 111.775 174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 43' ' ' ARG . 26.2 m -97.21 111.75 23.85 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.838 -1.171 . . . . 74.239999999999995 107.838 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -147.96 151.53 35.95 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 109.563 -0.532 . . . . 64.150000000000006 109.563 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 19' ' ' LEU . 63.0 tt0 73.33 144.39 0.07 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.68 1.192 . . . . 74.099999999999994 111.817 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -108.91 19.43 19.61 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.38 0.511 . . . . 72.200000000000003 112.38 -176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 7.3 mp -99.04 108.07 47.45 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 110.129 -0.323 . . . . 74.219999999999999 110.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.99 141.4 36.59 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 122.184 1.923 . . . . 65.230000000000004 113.177 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 42' ' ' LYS . 33.6 m -104.78 158.03 5.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.045 -1.094 . . . . 74.239999999999995 108.045 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.9 m -89.44 113.09 24.39 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.655 -0.818 . . . . 61.210000000000001 110.47 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 75.73 125.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.79 1.236 . . . . 54.43 112.957 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.51 109.53 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.447 -1.686 . . . . 74.319999999999993 106.447 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -112.07 149.16 32.48 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.282 -0.567 . . . . 72.109999999999999 110.604 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.732 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 5.9 p -120.83 129.52 53.58 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 112.92 0.711 . . . . 62.119999999999997 112.92 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -109.05 135.14 50.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.913 -1.143 . . . . 73.319999999999993 107.913 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 27.6 m -114.11 126.15 54.76 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 119.716 -0.794 . . . . 54.219999999999999 110.732 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.747 HD13 HD11 ' B' ' 240' ' ' ILE . 95.1 mt -101.31 137.88 27.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.903 -1.147 . . . . 71.129999999999995 107.903 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 41.3 p -134.22 82.74 1.99 Allowed 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 122.899 0.48 . . . . 73.239999999999995 110.741 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 23.7 mm-40 -113.51 99.68 7.94 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.734 -0.387 . . . . 74.310000000000002 111.307 -175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.78 60.01 8.35 Favored Glycine 0 C--O 1.247 0.969 0 C-N-CA 121.349 -0.453 . . . . 74.120000000000005 113.484 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m 64.36 36.37 9.12 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.429 0.633 . . . . 72.129999999999995 110.659 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 30' ' ' THR . 2.9 tm? -127.84 124.51 37.72 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 107.489 -1.3 . . . . 71.299999999999997 107.489 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 75.2 mtp180 -111.38 117.86 34.25 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 109.462 -0.57 . . . . 75.120000000000005 109.462 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 28' ' ' THR . 1.8 t -119.5 131.65 55.62 Favored 'General case' 0 C--N 1.262 -3.216 0 C-N-CA 119.691 -0.804 . . . . 33.329999999999998 109.363 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 t -115.53 127.66 73.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 N-CA-C 108.161 -1.051 . . . . 62.240000000000002 108.161 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.732 ' O ' ' HA ' ' A' ' 26' ' ' THR . 53.1 mt -116.46 118.74 59.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 109.177 -0.675 . . . . 64.109999999999999 109.177 -175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 8.8 m-85 -102.65 117.09 33.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.574 -0.898 . . . . 65.25 108.574 177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD11 HD13 ' B' ' 229' ' ' ILE . 3.6 mt -94.35 118.51 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 105.731 -1.951 . . . . 74.5 105.731 174.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.1 p -111.59 164.61 12.81 Favored 'General case' 0 N--CA 1.403 -2.8 0 C-N-CA 118.767 -1.173 . . . . 74.150000000000006 109.031 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -62.38 -15.26 47.66 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.312 0.856 . . . . 54.039999999999999 113.312 177.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 15' ' ' THR . 94.2 mtt180 -145.92 71.53 1.27 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.62 -0.511 . . . . 70.209999999999994 109.62 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 15' ' ' THR . . . 123.81 -173.07 16.53 Favored Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.458 -1.353 . . . . 53.149999999999999 113.247 172.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' C ' ' A' ' 44' ' ' GLY . 5.0 mp -141.38 153.72 45.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.403 0.621 . . . . 72.430000000000007 111.489 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 34.4 ttmt -125.2 120.95 32.74 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.127 -1.064 . . . . 53.43 108.127 174.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.48 126.34 72.0 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-O 121.689 0.757 . . . . 72.239999999999995 110.158 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 32.3 t -131.33 95.05 3.68 Favored 'General case' 0 N--CA 1.413 -2.296 0 C-N-CA 120.116 -0.634 . . . . 75.129999999999995 110.263 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 84.8 m -92.39 134.22 35.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.697 -0.483 . . . . 53.229999999999997 109.697 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -134.43 115.51 12.69 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.345 -0.613 . . . . 65.340000000000003 109.345 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.5 Cg_endo -75.46 42.33 0.89 Allowed 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.917 3.078 . . . . 73.349999999999994 112.018 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 59.96 66.94 0.91 Allowed 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.548 1.139 . . . . 61.299999999999997 110.963 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.98 -36.37 2.19 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 113.409 -1.723 . . . . 70.019999999999996 107.503 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 m -108.03 87.03 2.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.894 -1.048 . . . . 73.329999999999998 108.34 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -144.51 95.81 2.77 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.27 1.033 . . . . 71.239999999999995 110.294 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 m -129.05 -165.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 CA-C-N 113.708 -1.587 . . . . 51.210000000000001 107.397 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -78.78 84.88 4.82 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.031 -1.099 . . . . 73.120000000000005 108.031 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -149.13 99.35 2.94 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 114.535 -1.212 . . . . 72.010000000000005 108.65 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.49 69.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.706 1.241 . . . . 63.32 110.152 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -85.93 129.34 38.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 114.373 -1.285 . . . . 52.229999999999997 110.1 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' ' HD2' ' A' ' 61' ' ' ARG 0.355 4.5 ppt_? -134.79 71.74 1.45 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.635 1.207 . . . . 75.140000000000001 112.924 176.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.1 m -92.87 120.0 32.77 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.688 -1.142 . . . . 65.530000000000001 108.834 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.9 ptm -147.32 150.19 34.29 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.554 -0.458 . . . . 65.040000000000006 110.988 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -89.74 157.32 18.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.295 -1.002 . . . . 71.209999999999994 108.295 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -129.17 112.08 13.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.153 -1.054 . . . . 73.150000000000006 108.153 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 C--N 1.3 -1.583 0 N-CA-C 107.432 -1.321 . . . . 50.509999999999998 107.432 179.449 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.68 0 N-CA-C 110.019 -0.363 . . . . 70.329999999999998 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -114.68 -147.66 9.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.367 -1.493 . . . . 30.02 109.367 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 37.7 t -79.47 89.03 5.02 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.65 -1.241 . . . . 75.099999999999994 107.65 173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.15 163.0 31.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.377 -0.829 . . . . 70.040000000000006 109.594 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.2 135.21 28.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 111.966 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.6 m -98.37 149.2 22.9 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.03 -0.532 . . . . 65.510000000000005 109.784 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.07 160.09 23.28 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.17 -0.307 . . . . 70.319999999999993 110.17 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . 0.495 ' C ' ' HD3' ' B' ' 209' ' ' ARG . 95.6 mttt 71.37 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.108 1.363 . . . . 73.140000000000001 110.101 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' B' ' 208' ' ' LYS . 0.3 OUTLIER -139.94 170.95 14.93 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.936 -1.505 . . . . 64.209999999999994 106.936 177.309 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 28.7 m -109.05 105.57 15.13 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.873 -0.731 . . . . 74.310000000000002 111.12 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 31.6 m -125.72 147.76 49.27 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.733 -1.58 . . . . 71.5 106.733 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 14' ' ' LEU . 28.6 m -127.29 140.13 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 120.439 -0.505 . . . . 65.409999999999997 110.077 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -123.6 135.79 54.15 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.436 -0.579 . . . . 74.140000000000001 109.436 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.539 HD21 ' HG ' ' A' ' 14' ' ' LEU . 78.1 mt -121.81 123.29 41.44 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.846 -0.616 . . . . 72.420000000000002 110.762 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 23.3 m -94.08 125.42 38.69 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 107.965 -1.124 . . . . 53.329999999999998 107.965 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -147.21 138.52 23.93 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 120.991 -0.284 . . . . 63.219999999999999 110.238 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 62.37 -168.11 0.2 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.088 0.867 . . . . 73.519999999999996 112.422 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -140.61 13.0 2.32 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.449 -0.341 . . . . 75.430000000000007 110.945 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.6 128.02 45.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 C-N-CA 120.491 -0.483 . . . . 73.439999999999998 111.304 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' B' ' 242' ' ' LYS . 41.8 Cg_endo -68.36 159.17 54.49 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.701 2.268 . . . . 62.240000000000002 112.629 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.63 160.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 109.802 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 20.3 m -76.59 86.55 3.27 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 110.577 -0.157 . . . . 65.540000000000006 110.577 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 72.48 142.15 0.06 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.134 1.374 . . . . 73.010000000000005 111.572 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 241' ' ' THR . 37.2 mm -69.48 104.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 106.239 -1.763 . . . . 45.539999999999999 106.239 174.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.477 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 11.3 ptpt -109.24 149.58 29.2 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.726 -0.389 . . . . 73.299999999999997 110.588 -175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 11.1 p -116.66 131.08 57.04 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.801 -0.636 . . . . 73.049999999999997 112.136 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -107.98 129.58 55.11 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.101 -1.074 . . . . 75.450000000000003 108.101 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 6.4 m -109.09 125.61 52.32 Favored 'General case' 0 N--CA 1.409 -2.492 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 109.609 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.699 HD13 HD11 ' A' ' 40' ' ' ILE . 76.0 mt -102.35 145.05 12.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.716 -1.216 . . . . 73.099999999999994 107.716 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 35.9 p -135.47 95.98 3.37 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 123.029 0.532 . . . . 75.150000000000006 110.216 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 53.7 mm-40 -121.69 98.94 6.19 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.433 0.531 . . . . 74.420000000000002 112.433 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 61.46 58.86 11.26 Favored Glycine 0 C--N 1.307 -1.054 0 CA-C-O 119.848 -0.418 . . . . 72.209999999999994 113.197 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 49.4 m 68.47 24.38 7.14 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.645 0.736 . . . . 72.310000000000002 111.322 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' B' ' 230' ' ' THR . 2.3 tm? -123.37 125.56 45.23 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.979 -1.119 . . . . 63.420000000000002 107.979 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' B' ' 229' ' ' ILE . 71.3 mtm180 -105.7 150.36 25.54 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 107.447 -1.316 . . . . 72.150000000000006 107.447 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 249' ' ' CYS . 3.1 t -139.39 138.71 36.79 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 108.418 -0.956 . . . . 73.120000000000005 108.418 173.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 29.1 t -120.71 125.86 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.874 -0.787 . . . . 74.319999999999993 108.874 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.721 ' O ' ' HA ' ' B' ' 226' ' ' THR . 54.9 mt -117.23 118.78 59.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.972 -0.558 . . . . 74.030000000000001 109.7 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 30.0 m-85 -98.66 114.53 27.05 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.529 -0.915 . . . . 75.409999999999997 108.529 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 29' ' ' ILE . 3.9 mt -92.42 118.34 37.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.194 -1.78 . . . . 73.510000000000005 106.194 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.526 ' HA ' HD12 ' B' ' 224' ' ' ILE . 54.7 p -112.39 164.25 13.47 Favored 'General case' 0 N--CA 1.409 -2.485 0 C-N-CA 119.838 -0.745 . . . . 52.549999999999997 109.725 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' B' ' 220' ' ' PRO . 0.0 OUTLIER -68.91 4.38 1.54 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 115.338 1.607 . . . . 55.210000000000001 115.338 -177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -149.66 20.66 0.92 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.197 0.599 . . . . 54.0 111.549 173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.449 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 159.32 -168.09 35.18 Favored Glycine 0 CA--C 1.494 -1.226 0 C-N-CA 118.713 -1.708 . . . . 75.409999999999997 112.855 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.449 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.1 mp -138.91 153.9 48.31 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.072 0.463 . . . . 64.109999999999999 111.854 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 33.8 ttmt -121.26 129.52 53.19 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.788 -1.189 . . . . 75.230000000000004 107.788 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.409 ' HB ' HD22 ' A' ' 45' ' ' LEU . 27.4 m -122.53 127.95 75.2 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.485 0.66 . . . . 54.310000000000002 109.52 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 t -137.76 106.2 5.82 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 109.118 -0.697 . . . . 70.140000000000001 109.118 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' B' ' 236' ' ' CYS . 90.8 m -85.11 132.77 34.26 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 117.83 -1.548 . . . . 74.0 109.89 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -121.75 112.74 32.1 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.59 1.156 . . . . 44.140000000000001 110.328 -172.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.444 ' HG3' ' NE2' ' A' ' 17' ' ' GLN . 8.0 Cg_exo -75.3 40.73 0.7 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 123.585 2.857 . . . . 61.439999999999998 111.937 177.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 69.66 38.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.255 1.022 . . . . 72.200000000000003 109.397 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -100.61 -46.82 5.07 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.71 -1.132 . . . . 54.43 111.441 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' B' ' 209' ' ' ARG . 23.4 m -82.68 79.0 9.21 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.682 0.753 . . . . 73.030000000000001 110.899 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -127.0 -14.47 5.53 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.717 -0.674 . . . . 74.319999999999993 109.721 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 35.8 m -72.22 -25.22 23.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.286 -0.87 . . . . 71.099999999999994 109.683 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.18 98.74 7.52 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.484 -2.413 . . . . 73.430000000000007 104.484 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -83.84 109.19 17.35 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.321 -0.854 . . . . 71.439999999999998 110.584 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.61 -43.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.644 -0.707 . . . . 73.340000000000003 111.662 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.08 113.91 20.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.409 0.623 . . . . 71.400000000000006 111.014 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -150.59 149.89 30.49 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.248 -0.649 . . . . 64.430000000000007 109.248 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 28.6 m -94.79 130.39 41.36 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.889 -1.152 . . . . 75.329999999999998 107.889 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.46 111.65 5.67 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 113.102 0.779 . . . . 71.120000000000005 113.102 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.21 174.13 15.92 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.143 -1.799 . . . . 74.140000000000001 106.143 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . 0.407 ' HD2' ' C ' ' B' ' 265' ' ' ARG . 4.9 tmm_? -125.42 113.77 17.96 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.113 -1.069 . . . . 64.230000000000004 108.113 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 107.335 -1.357 . . . . 72.140000000000001 107.335 -179.387 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 109.414 -0.587 . . . . 63.219999999999999 109.414 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.17 -11.2 61.96 Favored Glycine 0 N--CA 1.433 -1.544 0 C-N-CA 120.292 -0.956 . . . . 62.310000000000002 112.779 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m 61.98 35.64 16.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.472 -0.936 . . . . 62.340000000000003 108.472 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -66.35 117.45 8.62 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.243 -1.344 . . . . 55.210000000000001 112.736 -174.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -98.14 111.63 28.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 106.028 -1.842 . . . . 62.539999999999999 106.028 171.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 p -72.35 -67.98 0.51 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 113.068 0.766 . . . . 62.409999999999997 113.068 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.71 155.91 35.21 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.79 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -78.71 -32.45 46.91 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.778 0.659 . . . . 62.539999999999999 112.778 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 1.2 tmm_? -131.38 105.65 7.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.639 0.733 . . . . 64.450000000000003 110.525 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 m -101.67 149.49 24.09 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.76 -1.109 . . . . 65.519999999999996 109.315 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 m -120.88 145.04 48.06 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.35 -1.352 . . . . 44.299999999999997 107.35 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' B' ' 214' ' ' LEU . 34.5 m -109.11 134.1 52.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.252 -0.579 . . . . 61.340000000000003 110.045 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 p -123.36 141.76 51.66 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.53 0.681 . . . . 75.019999999999996 112.578 -176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' HG ' ' B' ' 214' ' ' LEU . 36.8 mt -120.33 119.72 33.95 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.823 -1.08 . . . . 74.510000000000005 110.334 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 m -95.96 141.4 29.42 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.164 -1.05 . . . . 73.150000000000006 108.164 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.9 t -134.6 166.45 22.88 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.811 -0.811 . . . . 74.129999999999995 108.811 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -46.91 146.74 1.54 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.896 0.478 . . . . 72.439999999999998 110.06 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -69.86 86.92 0.52 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.902 1.075 . . . . 63.119999999999997 113.902 -175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.81 145.46 30.75 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 107.91 -1.144 . . . . 60.409999999999997 107.91 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.94 140.79 5.95 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 121.674 1.582 . . . . 73.319999999999993 114.047 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.44 163.77 17.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.875 -1.528 . . . . 64.340000000000003 106.875 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.521 ' HB2' ' HA3' ' B' ' 232' ' ' GLY . 27.7 t -65.64 -51.8 56.73 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.816 0.341 . . . . 61.43 111.394 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -151.11 -179.8 7.63 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.569 -0.9 . . . . 74.140000000000001 108.569 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 41' ' ' THR . 30.6 mm -101.98 124.59 55.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 105.662 -1.977 . . . . 65.510000000000005 105.662 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HE2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.78 154.97 43.26 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 120.197 -0.601 . . . . 74.329999999999998 110.162 -177.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 2.5 p -115.57 131.72 56.85 Favored 'General case' 0 N--CA 1.417 -2.096 0 O-C-N 124.388 1.055 . . . . 70.109999999999999 111.762 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.99 137.71 48.28 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 108.457 -0.942 . . . . 65.530000000000001 108.457 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 19.2 m -112.26 121.44 44.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 109.251 -0.648 . . . . 70.519999999999996 109.251 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 240' ' ' ILE . 80.9 mt -102.49 128.91 54.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.327 -0.99 . . . . 72.329999999999998 108.327 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 46.8 p -128.56 88.49 2.74 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 108.821 -0.807 . . . . 45.420000000000002 108.821 177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -123.25 118.46 27.65 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 119.042 -1.063 . . . . 65.129999999999995 108.999 -177.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.32 47.59 83.02 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.512 -0.767 . . . . 41.140000000000001 113.084 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m 63.95 36.28 10.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.912 0.863 . . . . 74.230000000000004 111.241 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.3 tm? -128.46 130.76 48.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.001 -1.0 . . . . 64.209999999999994 108.585 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 99.6 mtt180 -115.02 111.53 21.25 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 118.96 0.8 . . . . 75.200000000000003 111.696 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 29' ' ' ILE . 48.9 m -112.58 138.52 49.24 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 122.967 0.507 . . . . 53.539999999999999 110.059 177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.95 133.91 66.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.004 -1.11 . . . . 64.439999999999998 108.004 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 26' ' ' THR . 45.7 mt -123.11 120.14 59.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 116.048 -0.523 . . . . 62.329999999999998 111.35 -173.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 39.6 m-85 -101.61 115.11 29.78 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 109.359 -0.608 . . . . 73.019999999999996 109.359 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.657 HD11 HD13 ' B' ' 229' ' ' ILE . 2.7 mt -103.0 117.46 48.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.344 -1.724 . . . . 63.310000000000002 106.344 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HG23 ' A' ' 24' ' ' ILE . 30.7 p -119.38 173.29 7.05 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.686 -0.806 . . . . 64.239999999999995 108.933 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.54 27.34 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 113.267 0.84 . . . . 74.25 113.267 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -159.96 -34.65 0.06 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.981 0.419 . . . . 74.439999999999998 110.868 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.94 167.41 27.76 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 119.301 -1.428 . . . . 73.140000000000001 113.067 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -125.98 135.92 52.4 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.533 -0.543 . . . . 63.030000000000001 109.533 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 32.5 ttmt -117.47 127.85 54.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.526 -0.546 . . . . 75.420000000000002 109.526 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -116.59 115.42 48.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 CA-C-O 122.323 1.059 . . . . 73.310000000000002 109.31 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 9' ' ' ARG . 24.2 t -121.17 125.44 47.17 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 106.938 -1.504 . . . . 74.400000000000006 106.938 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' SG ' HD21 ' A' ' 34' ' ' LEU . 10.0 t -139.54 146.04 39.41 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 117.116 -1.834 . . . . 71.340000000000003 112.553 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -136.92 114.37 10.03 Favored Pre-proline 0 C--O 1.221 -0.408 0 C-N-CA 124.656 1.183 . . . . 71.439999999999998 108.531 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 88.1 Cg_endo -76.74 34.47 0.44 Allowed 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 123.404 2.736 . . . . 73.439999999999998 111.941 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 70.18 77.86 0.2 Allowed 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 125.065 1.346 . . . . 63.130000000000003 110.813 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.4 -55.62 0.58 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.464 -1.244 . . . . 65.219999999999999 108.637 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.7 m -88.66 -22.95 23.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.325 -0.991 . . . . 72.019999999999996 108.325 176.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 m0 66.75 36.02 4.83 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.73 -1.123 . . . . 74.420000000000002 111.278 174.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.9 m -65.33 160.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.828 -0.624 . . . . 75.319999999999993 111.358 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -142.62 166.67 24.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.381 -0.372 . . . . 75.400000000000006 110.43 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -137.71 147.09 44.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.178 -1.786 . . . . 64.420000000000002 106.178 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.05 4.68 5.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.888 -0.725 . . . . 65.140000000000001 111.88 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.8 p -126.57 90.9 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 122.453 1.12 . . . . 55.039999999999999 112.356 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -107.69 105.29 15.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.196 -0.911 . . . . 71.310000000000002 109.492 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 t -94.96 117.23 29.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.386 -0.968 . . . . 65.430000000000007 108.386 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 52.4 ttp -116.3 116.3 27.49 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.908 0.385 . . . . 64.439999999999998 111.012 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -120.45 163.54 17.75 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.134 -1.061 . . . . 44.340000000000003 108.134 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -146.31 95.99 2.7 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.865 -0.42 . . . . 73.25 109.865 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HD3' ' HA2' ' B' ' 232' ' ' GLY . 63.8 tttp . . . . . 0 C--O 1.256 1.432 0 CA-C-N 116.14 -0.482 . . . . 53.130000000000003 110.279 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.244 0.774 0 N-CA-C 108.699 -0.852 . . . . 50.340000000000003 108.699 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.52 47.85 0.99 Allowed Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 111.156 -0.778 . . . . 64.120000000000005 111.156 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 24.3 m -127.56 98.52 5.25 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 109.185 -0.672 . . . . 60.119999999999997 109.185 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -106.72 101.16 10.63 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 116.068 -0.515 . . . . 74.120000000000005 111.036 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.4 108.97 18.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.038 -1.097 . . . . 75.120000000000005 108.038 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 24.9 p -82.6 -52.01 7.22 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.222 0.534 . . . . 65.209999999999994 111.687 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.1 -176.52 6.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.787 -0.642 . . . . 72.329999999999998 111.186 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.08 -43.62 9.29 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.352 0.501 . . . . 75.430000000000007 112.352 -174.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -129.24 89.39 2.85 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.283 -1.006 . . . . 73.099999999999994 108.283 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 62.1 m -77.8 147.2 35.36 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.667 -1.151 . . . . 75.120000000000005 112.024 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' CYS . . . . . . . . . . . . . 34.0 m -121.03 156.75 31.51 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.931 -1.137 . . . . 70.319999999999993 107.931 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.437 ' HB ' HD22 ' A' ' 14' ' ' LEU . 17.3 m -121.03 140.91 43.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 120.792 0.329 . . . . 73.340000000000003 110.284 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' B' ' 246' ' ' LYS . 54.9 p -138.57 136.34 35.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.909 -0.494 . . . . 74.530000000000001 112.254 -176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.554 ' HG ' HD21 ' A' ' 14' ' ' LEU . 54.4 mt -122.93 134.87 54.34 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.31 0.576 . . . . 61.210000000000001 110.878 171.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 9.5 m -104.47 136.91 43.15 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 107.21 -1.404 . . . . 71.120000000000005 107.21 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 9.9 t -139.45 164.13 30.68 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.313 -0.625 . . . . 74.150000000000006 109.313 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -48.45 126.74 11.98 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 123.562 0.539 . . . . 74.040000000000006 110.614 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 56.6 mtm180 -44.91 118.64 1.7 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 116.402 2.001 . . . . 65.329999999999998 116.402 -169.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.71 116.08 52.72 Favored Pre-proline 0 N--CA 1.443 -0.793 0 N-CA-C 104.674 -2.343 . . . . 73.319999999999993 104.674 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.49 139.4 49.01 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 121.014 1.143 . . . . 75.310000000000002 111.589 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.448 HG11 HG22 ' B' ' 240' ' ' ILE . 33.2 m -133.03 162.38 40.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-N 115.972 -0.558 . . . . 74.150000000000006 109.772 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 39.0 t -77.51 -39.68 45.36 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.689 0.28 . . . . 71.430000000000007 110.99 -178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -155.3 141.61 18.55 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.812 -0.355 . . . . 63.210000000000001 110.993 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.606 HG23 HG22 ' B' ' 241' ' ' THR . 40.5 mm -71.01 103.68 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 105.313 -2.106 . . . . 65.400000000000006 105.313 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' B' ' 225' ' ' LYS . 17.8 ptpt -122.57 157.19 32.64 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 120.291 -0.564 . . . . 72.549999999999997 111.172 -172.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' B' ' 238' ' ' ILE . 20.4 p -116.62 133.18 56.32 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.91 0.756 . . . . 73.120000000000005 111.781 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' B' ' 237' ' ' VAL . 75.9 m-85 -109.16 127.97 54.64 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.332 -0.988 . . . . 71.200000000000003 108.332 173.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' B' ' 236' ' ' CYS . 36.9 m -109.45 119.87 40.78 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.111 -0.7 . . . . 51.210000000000001 109.111 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 40' ' ' ILE . 83.9 mt -104.83 129.36 57.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-N 114.987 -1.006 . . . . 73.409999999999997 108.647 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' B' ' 234' ' ' LEU . 43.2 p -127.24 92.27 3.48 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.91 -0.586 . . . . 63.420000000000002 110.586 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' B' ' 234' ' ' LEU . 0.0 OUTLIER -122.51 122.93 40.07 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 113.04 0.755 . . . . 65.109999999999999 113.04 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . 0.521 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . 49.78 50.25 32.37 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.796 -0.638 . . . . 73.099999999999994 113.995 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 48.6 m 69.74 67.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.575 0.75 . . . . 75.209999999999994 111.106 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' B' ' 230' ' ' THR . 1.9 tm? -159.9 144.57 14.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.264 -0.88 . . . . 74.120000000000005 109.213 -175.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -128.09 111.74 13.82 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.243 0.474 . . . . 74.299999999999997 111.186 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' CYS . . . . . 0.643 ' SG ' HD11 ' B' ' 234' ' ' LEU . 55.1 m -111.63 143.05 43.15 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.859 -0.793 . . . . 74.140000000000001 108.859 175.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 227' ' ' TYR . 25.9 t -130.54 133.03 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.944 -1.132 . . . . 73.340000000000003 107.944 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' B' ' 226' ' ' THR . 56.3 mt -125.06 123.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.22 0.325 . . . . 73.420000000000002 110.507 -176.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 246' ' ' LYS . 23.2 m-85 -98.43 116.36 30.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.302 -0.629 . . . . 73.329999999999998 109.302 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . 0.758 HD11 HD13 ' A' ' 29' ' ' ILE . 7.3 mt -92.38 118.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.918 -1.512 . . . . 63.340000000000003 106.918 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' THR . . . . . 0.606 HG22 HG23 ' B' ' 224' ' ' ILE . 50.7 p -122.21 158.77 28.7 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.475 -0.89 . . . . 62.049999999999997 109.442 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.72 2.86 2.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 114.074 1.138 . . . . 73.129999999999995 114.074 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' B' ' 218' ' ' ARG . 48.4 mtt180 -124.79 6.72 8.09 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 111.876 0.324 . . . . 72.109999999999999 111.876 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . 0.464 ' C ' HD12 ' B' ' 245' ' ' LEU . . . 144.42 -155.04 26.14 Favored Glycine 0 CA--C 1.483 -1.968 0 C-N-CA 118.868 -1.634 . . . . 72.140000000000001 112.13 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.464 HD12 ' C ' ' B' ' 244' ' ' GLY . 5.6 mp -140.86 146.2 37.21 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.87 -0.732 . . . . 75.120000000000005 112.605 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . 0.594 ' HB3' ' HB2' ' B' ' 239' ' ' PHE . 32.0 ttmt -115.79 121.51 42.65 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.682 -1.229 . . . . 73.140000000000001 107.682 174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' VAL . . . . . 0.41 HG23 HG23 ' B' ' 212' ' ' VAL . 31.7 m -115.63 127.41 73.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-O 121.994 0.902 . . . . 72.140000000000001 109.977 176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' CYS . . . . . . . . . . . . . 33.3 t -129.24 146.21 51.19 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 107.119 -1.438 . . . . 71.420000000000002 107.119 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' B' ' 234' ' ' LEU . 9.1 t -152.49 147.19 25.94 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 117.568 -1.653 . . . . 74.209999999999994 112.159 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -139.81 115.92 8.14 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 125.358 1.463 . . . . 71.409999999999997 108.944 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' B' ' 234' ' ' LEU . 92.0 Cg_endo -76.99 39.35 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.633 2.889 . . . . 65.340000000000003 112.173 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 68.46 73.03 0.29 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 124.99 1.316 . . . . 73.209999999999994 110.671 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -135.26 -56.44 0.8 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.102 -0.954 . . . . 63.109999999999999 109.329 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' THR . . . . . . . . . . . . . 66.0 m -92.27 96.23 10.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.552 0.691 . . . . 74.219999999999999 110.021 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -95.84 91.57 6.11 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 112.738 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.88 107.36 20.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.387 -0.968 . . . . 72.209999999999994 108.387 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.02 105.82 1.13 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.366 -0.834 . . . . 70.109999999999999 112.578 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.63 93.74 8.9 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.397 -0.594 . . . . 73.129999999999995 109.397 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.52 -7.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.934 0.873 . . . . 75.120000000000005 109.481 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.8 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 114.976 -1.011 . . . . 71.120000000000005 111.262 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -114.56 91.57 3.67 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.211 -1.403 . . . . 74.510000000000005 107.211 173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.8 t -108.71 100.51 9.74 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.251 -0.648 . . . . 61.140000000000001 109.251 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 55.6 ttp -106.44 95.92 6.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.823 -0.626 . . . . 75.129999999999995 109.932 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.01 93.22 7.52 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.919 -0.582 . . . . 75.200000000000003 110.088 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -145.07 90.24 2.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.46 -0.941 . . . . 72.439999999999998 108.46 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--O 1.257 1.473 0 C-N-CA 124.581 1.152 . . . . 71.329999999999998 111.742 -177.949 . . . . . . . . 0 0 . 1 stop_ save_